{"items": "689", "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish", "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.", "feed": [{"title": "InnovationRx: New Ways To Connect With Epic", "url": "https://www.forbes.com/sites/katiejennings/2024/01/17/innovationrx-new-ways-to-connect-with-epic/", "time_published": "20240117T232746", "authors": ["Alex Knapp"], "summary": "InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. or any healthtech company - from tiny startups to publicly-traded behemoths - being able to exchange data with Epic Systems, the nation's largest electronic health records company, is an important rite ...", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/61194f26fc0f0597f354c339/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds", "source": "Forbes", "category_within_source": "n/a", "source_domain": "www.forbes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.116921, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.041901", "ticker_sentiment_score": "0.069347", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVS", "relevance_score": "0.083687", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RADCQ", "relevance_score": "0.041901", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "XM", "relevance_score": "0.041901", "ticker_sentiment_score": "0.069347", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.041901", "ticker_sentiment_score": "0.135095", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.041901", "ticker_sentiment_score": "0.101487", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina  ( ILMN )  Shares Down 1.2% Post Preliminary Q4 Results", "url": "https://www.zacks.com/stock/news/2210848/illumina-ilmn-shares-down-12-post-preliminary-q4-results", "time_published": "20240116T151100", "authors": ["Zacks Equity Research"], "summary": "Illumina's (ILMN) fourth-quarter 2023 results are likely to reflect the impacts of the adoption of its new generation of distributed liquid biopsy assay.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/45/26891.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.576289"}], "overall_sentiment_score": 0.132771, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MMSI", "relevance_score": "0.159043", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAH", "relevance_score": "0.311829", "ticker_sentiment_score": "0.18889", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DVA", "relevance_score": "0.311829", "ticker_sentiment_score": "0.221213", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.517534", "ticker_sentiment_score": "0.06701", "ticker_sentiment_label": "Neutral"}]}, {"title": "Is Invesco S&P 500 Equal Weight Health Care ETF  ( RSPH )  a Strong ETF Right Now?", "url": "https://www.zacks.com/stock/news/2210508/is-invesco-sp-500-equal-weight-health-care-etf-rsph-a-strong-etf-right-now", "time_published": "20240116T112006", "authors": ["Zacks Equity Research"], "summary": "Smart Beta ETF report for ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default272.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999992"}], "overall_sentiment_score": 0.361191, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ALGN", "relevance_score": "0.121959", "ticker_sentiment_score": "0.062526", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.182047", "ticker_sentiment_score": "0.294432", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTLT", "relevance_score": "0.121959", "ticker_sentiment_score": "0.062526", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.121959", "ticker_sentiment_score": "0.062526", "ticker_sentiment_label": "Neutral"}]}, {"title": "Concentric by Ginkgo and Illumina collaborate to deploy biosurveillance technologies around the world - Ginkgo Bioworks Holdings  ( NYSE:DNA ) , Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/24/01/n36628358/concentric-by-ginkgo-and-illumina-collaborate-to-deploy-biosurveillance-technologies-around-the-wo", "time_published": "20240115T120000", "authors": ["PRNewswire"], "summary": "The companies plan to join forces to set up pathogen monitoring programs utilizing Illumina technology across Concentric's global network", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.191712, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "DNA", "relevance_score": "0.299478", "ticker_sentiment_score": "0.028998", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.602533", "ticker_sentiment_score": "0.288281", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Concentric by Ginkgo and Illumina collaborate to deploy biosurveillance technologies around the world", "url": "https://www.prnewswire.com/news-releases/concentric-by-ginkgo-and-illumina-collaborate-to-deploy-biosurveillance-technologies-around-the-world-302034254.html", "time_published": "20240115T120000", "authors": ["Ginkgo Bioworks"], "summary": "The companies plan to join forces to set up pathogen monitoring programs utilizing Illumina technology across Concentric's global network", "banner_image": "https://mma.prnewswire.com/media/1583909/Ginkgo_Logo_Lockup.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.196108, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "DNA", "relevance_score": "0.488777", "ticker_sentiment_score": "0.072453", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.577979", "ticker_sentiment_score": "0.282302", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Epigenetics Market is Expected to Reach $4.3 Billion | MarketsandMarkets.", "url": "https://www.benzinga.com/pressreleases/24/01/g36608815/epigenetics-market-is-expected-to-reach-4-3-billion-marketsandmarkets", "time_published": "20240112T123000", "authors": ["Globe Newswire"], "summary": "Chicago, Jan. 12, 2024 ( GLOBE NEWSWIRE ) -- Epigenetics market in terms of revenue was estimated to be worth $1.8 billion in 2023 and is poised to reach $4.3 billion by 2028, growing at a CAGR of 18.3% from 2023 to 2028 according to a latest report published by MarketsandMarkets\u2122.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.202922, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BIO", "relevance_score": "0.037446", "ticker_sentiment_score": "0.086428", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.037446", "ticker_sentiment_score": "0.086428", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGC", "relevance_score": "0.037446", "ticker_sentiment_score": "0.092268", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABCZF", "relevance_score": "0.037446", "ticker_sentiment_score": "0.086428", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.112008", "ticker_sentiment_score": "0.101352", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.037446", "ticker_sentiment_score": "0.086428", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina  ( NASDAQ:ILMN )  Lifted to Buy at StockNews.com", "url": "https://www.defenseworld.net/2024/01/11/illumina-nasdaqilmn-lifted-to-buy-at-stocknews-com.html", "time_published": "20240111T090041", "authors": ["Defense World Staff"], "summary": "StockNews.com upgraded shares of Illumina ( NASDAQ:ILMN - Free Report ) from a hold rating to a buy rating in a research report report published on Wednesday. Other equities research analysts also recently issued reports about the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/illumina-inc-logo.png?v=20221026153253&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.752319"}, {"topic": "Earnings", "relevance_score": "0.990786"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.32064, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BK", "relevance_score": "0.096477", "ticker_sentiment_score": "0.22338", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.774534", "ticker_sentiment_score": "0.505941", "ticker_sentiment_label": "Bullish"}, {"ticker": "PSMT", "relevance_score": "0.048327", "ticker_sentiment_score": "0.128896", "ticker_sentiment_label": "Neutral"}]}, {"title": "InnovationRx: The Pharma M&A Horizon", "url": "https://www.forbes.com/sites/alexknapp/2024/01/10/innovationrx-the-pharma-ma-horizon/", "time_published": "20240110T223605", "authors": ["Katie Jennings"], "summary": "InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. This year's J.P.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/659f1a9e481808d851a2941e/0x0.jpg?format=jpg&height=900&width=1600&fit=bounds", "source": "Forbes", "category_within_source": "n/a", "source_domain": "www.forbes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.102626, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.031949", "ticker_sentiment_score": "0.10987", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.031949", "ticker_sentiment_score": "0.019629", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.063848", "ticker_sentiment_score": "0.074039", "ticker_sentiment_label": "Neutral"}, {"ticker": "RADCQ", "relevance_score": "0.031949", "ticker_sentiment_score": "-0.019976", "ticker_sentiment_label": "Neutral"}, {"ticker": "HARP", "relevance_score": "0.031949", "ticker_sentiment_score": "0.106472", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.031949", "ticker_sentiment_score": "0.064503", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBA", "relevance_score": "0.031949", "ticker_sentiment_score": "0.003864", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPMC", "relevance_score": "0.031949", "ticker_sentiment_score": "0.148205", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFLY", "relevance_score": "0.031949", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Biden administration's antitrust victories are much-needed wins for consumers", "url": "https://www.marketwatch.com/story/biden-administrations-antitrust-victories-are-major-wins-for-consumers-a4536ea6", "time_published": "20240110T203400", "authors": ["Joseph E. Stiglitz"], "summary": "In the constant struggle to promote competition, score one for ordinary Americans.", "banner_image": "https://images.mktw.net/im-486066/social", "source": "MarketWatch", "category_within_source": "Top Stories", "source_domain": "www.marketwatch.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.156072, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ADBE", "relevance_score": "0.081138", "ticker_sentiment_score": "0.061742", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.081138", "ticker_sentiment_score": "0.087895", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSSMY", "relevance_score": "0.081138", "ticker_sentiment_score": "0.058513", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.121445", "ticker_sentiment_score": "0.024804", "ticker_sentiment_label": "Neutral"}]}, {"title": "Should You Invest in the Invesco Biotechnology & Genome ETF  ( PBE ) ?", "url": "https://www.zacks.com/stock/news/2207718/should-you-invest-in-the-invesco-biotechnology-genome-etf-pbe", "time_published": "20240109T215449", "authors": ["Zacks Equity Research"], "summary": "Sector ETF report for ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default27.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.202758, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "VRTX", "relevance_score": "0.128135", "ticker_sentiment_score": "0.069783", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.19117", "ticker_sentiment_score": "0.112309", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.128135", "ticker_sentiment_score": "0.069783", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBIX", "relevance_score": "0.128135", "ticker_sentiment_score": "0.069783", "ticker_sentiment_label": "Neutral"}]}, {"title": "DEADLINE ALERT for PAYC, ILMN, and JRVR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Illumina  ( NASDAQ:ILMN ) , James River Gr Hldgs  ( NASDAQ:JRVR ) ", "url": "https://www.benzinga.com/pressreleases/24/01/g36561288/deadline-alert-for-payc-ilmn-and-jrvr-the-law-offices-of-frank-r-cruz-reminds-investors-of-class-a", "time_published": "20240109T170700", "authors": ["Globe Newswire"], "summary": "LOS ANGELES, Jan. 09, 2024 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.684621"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.048694, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.233556", "ticker_sentiment_score": "-0.179232", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JRVR", "relevance_score": "0.233556", "ticker_sentiment_score": "-0.179232", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PAYC", "relevance_score": "0.15697", "ticker_sentiment_score": "0.144911", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Shares Trading Higher After Confirming Partnership With Johnson & Johnson Unit - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/earnings/24/01/36559887/illumina-shares-trading-higher-after-confirming-partnership-with-johnson-johnson-unit", "time_published": "20240109T165059", "authors": ["Nabaparna Bhattacharya"], "summary": "Illumina, Inc. ILMN shares are trading higher after announcing preliminary financial results for the fourth quarter ( Q4 ) and fiscal year 2023. For Q4, the company reported preliminary consolidated revenue of approximately $1.115 billion, up 3% from Q4 2022. The analyst consensus stands at ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/09/bz_pharma_briefs.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.684621"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.106718, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.766141", "ticker_sentiment_score": "0.294902", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.366061", "ticker_sentiment_score": "0.365218", "ticker_sentiment_label": "Bullish"}]}, {"title": "ILMN DEADLINE TODAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important January 9 Deadline in Securities Class Action - ILMN - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/24/01/g36559894/ilmn-deadline-today-rosen-recognized-investor-counsel-encourages-illumina-inc-investors-with-losse", "time_published": "20240109T160408", "authors": ["Globe Newswire"], "summary": "NEW YORK, Jan. 09, 2024 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Illumina, Inc. ILMN between May 1, 2023 and October 16, 2023, both dates inclusive ( the \"Class Period\" ) , of the important January 9, 2024 lead plaintiff ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.157548, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.064449", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.253646", "ticker_sentiment_score": "0.203662", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday - Acuity Brands  ( NYSE:AYI ) ", "url": "https://www.benzinga.com/news/24/01/36559598/acuity-brands-posts-upbeat-earnings-joins-accolade-urban-outfitters-and-other-big-stocks-moving-high", "time_published": "20240109T155903", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday. Shares of Acuity Brands, Inc. AYI rose sharply Tuesday's session after the company reported better-than-expected first-quarter earnings.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/09/acuity_brands_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.967645"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.261371, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "OFIX", "relevance_score": "0.276909", "ticker_sentiment_score": "0.238758", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNPR", "relevance_score": "0.276909", "ticker_sentiment_score": "0.53359", "ticker_sentiment_label": "Bullish"}, {"ticker": "SRPT", "relevance_score": "0.276909", "ticker_sentiment_score": "0.438134", "ticker_sentiment_label": "Bullish"}, {"ticker": "IGMS", "relevance_score": "0.186738", "ticker_sentiment_score": "0.487136", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.186738", "ticker_sentiment_score": "0.342138", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HPQ", "relevance_score": "0.09402", "ticker_sentiment_score": "0.301407", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RXRX", "relevance_score": "0.186738", "ticker_sentiment_score": "0.487136", "ticker_sentiment_label": "Bullish"}, {"ticker": "URBN", "relevance_score": "0.186738", "ticker_sentiment_score": "0.123339", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHC", "relevance_score": "0.276909", "ticker_sentiment_score": "0.160074", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AYI", "relevance_score": "0.363388", "ticker_sentiment_score": "0.063425", "ticker_sentiment_label": "Neutral"}, {"ticker": "CENX", "relevance_score": "0.276909", "ticker_sentiment_score": "0.493612", "ticker_sentiment_label": "Bullish"}, {"ticker": "MXCT", "relevance_score": "0.186738", "ticker_sentiment_score": "0.227418", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ACMR", "relevance_score": "0.276909", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESTA", "relevance_score": "0.276909", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "UP", "relevance_score": "0.09402", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPE", "relevance_score": "0.186738", "ticker_sentiment_score": "0.412742", "ticker_sentiment_label": "Bullish"}, {"ticker": "ACCD", "relevance_score": "0.186738", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Illumina Rallied 36.6% in December", "url": "https://www.fool.com/investing/2024/01/09/why-illumina-rallied-366-in-december/", "time_published": "20240109T120500", "authors": ["Billy Duberstein"], "summary": "The beaten-down gene sequencing company is getting a further shakeup.", "banner_image": "https://g.foolcdn.com/editorial/images/760588/scientist-altering-dna-genome-project.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.175413, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SPGI", "relevance_score": "0.057215", "ticker_sentiment_score": "0.249005", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.777571", "ticker_sentiment_score": "0.280358", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina  ( ILMN )  Extends Partnership to Advance Cancer Test", "url": "https://www.zacks.com/stock/news/2207167/illumina-ilmn-extends-partnership-to-advance-cancer-test", "time_published": "20240108T174500", "authors": ["Zacks Equity Research"], "summary": "Illumina (ILMN) aims to work with other pharmaceutical industry leaders to enhance and expand the utility of its WGS MRD assay.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.279224, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HQY", "relevance_score": "0.207571", "ticker_sentiment_score": "0.03419", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.207571", "ticker_sentiment_score": "0.13357", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVA", "relevance_score": "0.156461", "ticker_sentiment_score": "0.122378", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.44622", "ticker_sentiment_score": "0.35565", "ticker_sentiment_label": "Bullish"}]}, {"title": "Page 40903 of", "url": "https://www.financialexpress.com/about-news/page/40903/", "time_published": "20240107T233534", "authors": [], "summary": "Animal science experts are hopeful of producing more cloned buffalo calves over the next few months. This, despite the fact\u2026 Major development plans have been initiated in the last two years in Bathinda, one of the oldest towns of Punjab.", "banner_image": "https://www.financialexpress.com/wp-content/themes/ie-network-theme/assets/src/img/default-img-fe.jpg", "source": "The Financial Express", "category_within_source": "n/a", "source_domain": "www.financialexpress.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.173357, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.395012", "ticker_sentiment_score": "0.300379", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Illumina, Inc. of Class Action Lawsuit and Upcoming Deadline - ILMN", "url": "https://www.prnewswire.com/news-releases/shareholder-alert--pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-illumina-inc-of-class-action-lawsuit-and-upcoming-deadline--ilmn-302027316.html", "time_published": "20240106T154500", "authors": ["Pomerantz LLP"], "summary": "SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Illumina, Inc ... PR ...", "banner_image": "https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.538269"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.744043"}], "overall_sentiment_score": 0.055788, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.678981", "ticker_sentiment_score": "0.138165", "ticker_sentiment_label": "Neutral"}]}, {"title": "ILLUMINA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Illumina, Inc. and Encourages Investors to Contact the Firm - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/24/01/g36521002/illumina-deadline-alert-bragar-eagel-squire-p-c-reminds-investors-that-a-class-action-lawsuit-has-", "time_published": "20240106T020000", "authors": ["Globe Newswire"], "summary": "NEW YORK, Jan. 05, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Illumina, Inc. ( \"Illumina\" or the \"Company\" ) ILMN in the United States District Court for the ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": -0.019438, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.605639", "ticker_sentiment_score": "-0.039325", "ticker_sentiment_label": "Neutral"}]}, {"title": "ILMN FINAL DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action - ILMN - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/24/01/g36518169/ilmn-final-deadline-alert-rosen-a-leading-law-firm-encourages-illumina-inc-investors-to-secure-cou", "time_published": "20240105T212444", "authors": ["Globe Newswire"], "summary": "NEW YORK, Jan. 05, 2024 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Illumina, Inc. ILMN between May 1, 2023 and October 16, 2023, both dates inclusive ( the \"Class Period\" ) , of the important January 9, 2024 lead plaintiff ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.157548, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.064449", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.253646", "ticker_sentiment_score": "0.203662", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Illumina, Inc.  ( ILMN )  - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/24/01/g36514487/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains", "time_published": "20240105T180103", "authors": ["Globe Newswire"], "summary": "LOS ANGELES, Jan. 05, 2024 ( GLOBE NEWSWIRE ) --", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.038814, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.06697", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.59928", "ticker_sentiment_score": "0.071099", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina's MRD Technology For Cancer Testing Collaborates With Johnson & Johnson Unit - Illumina  ( NASDAQ:ILMN ) , Johnson & Johnson  ( NYSE:JNJ ) ", "url": "https://www.benzinga.com/markets/equities/24/01/36513008/illuminas-mrd-technology-for-cancer-testing-collaborates-with-johnson-johnson-unit", "time_published": "20240105T170110", "authors": ["Nabaparna Bhattacharya"], "summary": "Illumina, Inc. ILMN announced it has signed an agreement with Janssen Research & Development, a unit of Johnson & Johnson JNJ.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/05/ilmn_co.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.29039, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.739411", "ticker_sentiment_score": "0.299567", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.29234", "ticker_sentiment_score": "0.324453", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "ILLUMINA SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James  ( Josh )  Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/24/01/g36511714/illumina-shareholder-action-reminder-faruqi-faruqi-securities-litigation-partner-james-josh-wilson", "time_published": "20240105T154500", "authors": ["Globe Newswire"], "summary": "If you suffered losses exceeding $100,000 investing in Illumina securities between September 21, 2020 and November 9, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 ( Ext. 1310 ) .", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": 0.132578, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.618228", "ticker_sentiment_score": "-0.018348", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina expands collaboration with Janssen to advance molecular residual disease cancer test - PR Newswire", "url": "https://www.prnewswire.com/news-releases/illumina-expands-collaboration-with-janssen-to-advance-molecular-residual-disease-cancer-test-302026993.html", "time_published": "20240105T141500", "authors": [], "summary": "Illumina expands collaboration with Janssen to advance molecular residual disease cancer test PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.208032, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.066047", "ticker_sentiment_score": "0.066086", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.066047", "ticker_sentiment_score": "0.066086", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.592742", "ticker_sentiment_score": "0.293403", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "DELFI Diagnostics Appoints Susan Tousi as New Chief Executive Officer - PR Newswire", "url": "https://www.prnewswire.com/news-releases/delfi-diagnostics-appoints-susan-tousi-as-new-chief-executive-officer-302026894.html", "time_published": "20240105T120000", "authors": [], "summary": "DELFI Diagnostics Appoints Susan Tousi as New Chief Executive Officer PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.185902, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HPQ", "relevance_score": "0.081276", "ticker_sentiment_score": "0.070748", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.16171", "ticker_sentiment_score": "0.09261", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYEL", "relevance_score": "0.040691", "ticker_sentiment_score": "0.215221", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 -  ( NASDAQ: ILMN ) ", "url": "https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-illumina-inc-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-january-9-2024--nasdaq-ilmn-302026778.html", "time_published": "20240105T104500", "authors": ["The Gross Law Firm"], "summary": "SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a ... PR ...", "banner_image": "https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.047451, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.348919", "ticker_sentiment_score": "0.143891", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why You Should Retain Myriad Genetics  ( MYGN )  Stock Now", "url": "https://www.zacks.com/stock/news/2205758/heres-why-you-should-retain-myriad-genetics-mygn-stock-now", "time_published": "20240104T161000", "authors": ["Zacks Equity Research"], "summary": "Investors are optimistic about Myriad Genetics (MYGN) on robust testing volumes and strong solvency position.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.650727"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.917436"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.19904, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HQY", "relevance_score": "0.221313", "ticker_sentiment_score": "0.047962", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.221313", "ticker_sentiment_score": "0.14043", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVA", "relevance_score": "0.166935", "ticker_sentiment_score": "0.127628", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.056011", "ticker_sentiment_score": "0.144361", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.425925", "ticker_sentiment_score": "0.237625", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FOREX:USD", "relevance_score": "0.056011", "ticker_sentiment_score": "-0.051902", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 -  ( NASDAQ: ILMN ) ", "url": "https://www.benzinga.com/pressreleases/24/01/g36475903/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-illumina-inc-of-a-class-action-lawsu", "time_published": "20240103T185200", "authors": ["Globe Newswire"], "summary": "NEW YORK, Jan. 03, 2024 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Illumina, Inc.. Shareholders who purchased shares of ILMN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.059375, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.308246", "ticker_sentiment_score": "0.126373", "ticker_sentiment_label": "Neutral"}]}, {"title": "Market Whales and Their Recent Bets on ILMN Options - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/markets/options/24/01/36475816/market-whales-and-their-recent-bets-on-ilmn-options", "time_published": "20240103T184542", "authors": ["Benzinga Insights"], "summary": "Financial giants have made a conspicuous bearish move on Illumina. Our analysis of options history for Illumina ILMN revealed 23 unusual trades. Delving into the details, we found 21% of traders were bullish, while 78% showed bearish tendencies.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.088614, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.729067", "ticker_sentiment_score": "-0.131469", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Acelyrin, Illumina, and Roblox and Encourages Investors to Contact the Firm - Illumina  ( NASDAQ:ILMN ) , Roblox  ( NYSE:RBLX ) ", "url": "https://www.benzinga.com/pressreleases/24/01/g36463179/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-acely", "time_published": "20240103T020000", "authors": ["Globe Newswire"], "summary": "NEW YORK, Jan. 02, 2024 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Acelyrin, Inc. SLRN, Illumina, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.918141"}, {"topic": "Earnings", "relevance_score": "0.972756"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": -0.073184, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.303644", "ticker_sentiment_score": "-0.087489", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBLX", "relevance_score": "0.441698", "ticker_sentiment_score": "-0.081437", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRN", "relevance_score": "0.230235", "ticker_sentiment_score": "-0.110168", "ticker_sentiment_label": "Neutral"}]}, {"title": "DEADLINE ALERT for PAYC, ILMN, and JRVR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Illumina  ( NASDAQ:ILMN ) , James River Gr Hldgs  ( NASDAQ:JRVR ) ", "url": "https://www.benzinga.com/pressreleases/24/01/g36455483/deadline-alert-for-payc-ilmn-and-jrvr-the-law-offices-of-frank-r-cruz-reminds-investors-of-class-a", "time_published": "20240102T170600", "authors": ["Globe Newswire"], "summary": "LOS ANGELES, Jan. 02, 2024 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.684621"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.048694, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.233556", "ticker_sentiment_score": "-0.179232", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JRVR", "relevance_score": "0.233556", "ticker_sentiment_score": "-0.179232", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PAYC", "relevance_score": "0.15697", "ticker_sentiment_score": "0.144911", "ticker_sentiment_label": "Neutral"}]}, {"title": "DEADLINE ALERT for FMC, ILMN, PAYC, JRVR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders - Illumina  ( NASDAQ:ILMN ) , FMC  ( NYSE:FMC ) ", "url": "https://www.benzinga.com/pressreleases/24/01/g36455484/deadline-alert-for-fmc-ilmn-payc-jrvr-law-offices-of-howard-g-smith-reminds-investors-of-class-act", "time_published": "20240102T170600", "authors": ["Globe Newswire"], "summary": "BENSALEM, Pa., Jan. 02, 2024 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.77141"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.022132, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSSMY", "relevance_score": "0.320279", "ticker_sentiment_score": "0.079039", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.109455", "ticker_sentiment_score": "0.121419", "ticker_sentiment_label": "Neutral"}, {"ticker": "JRVR", "relevance_score": "0.163539", "ticker_sentiment_score": "-0.033498", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAYC", "relevance_score": "0.109455", "ticker_sentiment_score": "0.121419", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Illumina, Inc. of Class Action Lawsuit and Upcoming Deadline - ILMN - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/24/01/g36454114/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-illum", "time_published": "20240102T155537", "authors": ["Globe Newswire"], "summary": "NEW YORK, Jan. 02, 2024 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against Illumina, Inc ( \"Illumina\" or the \"Company\" ) ILMN. The class action, filed in the United States District Court for the Southern District of California, and docketed under ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.538269"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.839681"}], "overall_sentiment_score": 0.041169, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.658507", "ticker_sentiment_score": "0.103236", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ALERT: Levi & Korsinsky Notifies Illumina, Inc. ( ILMN )  Investors of a Class Action Lawsuit and Upcoming Deadline", "url": "https://www.prnewswire.com/news-releases/shareholder-alert-levi--korsinsky-notifies-illumina-incilmn-investors-of-a-class-action-lawsuit-and-upcoming-deadline-302024293.html", "time_published": "20240102T104500", "authors": ["Levi & Korsinsky", "LLP"], "summary": "SHAREHOLDER ALERT: Levi & Korsinsky Notifies Illumina, Inc. ( ILMN ) Investors of a Class Action Lawsuit and ... PR ...", "banner_image": "https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.100833, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.615462", "ticker_sentiment_score": "0.014709", "ticker_sentiment_label": "Neutral"}]}, {"title": "ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important January 9 Deadline in Securities Class Action - ILMN - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/24/01/g36444431/rosen-a-globally-recognized-law-firm-encourages-illumina-inc-investors-with-losses-to-secure-couns", "time_published": "20240101T163700", "authors": ["Globe Newswire"], "summary": "NEW YORK, Jan. 01, 2024 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Illumina, Inc. ILMN between May 1, 2023 and October 16, 2023, both dates inclusive ( the \"Class Period\" ) , of the important January 9, 2024 lead plaintiff ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.157548, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.064449", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.253646", "ticker_sentiment_score": "0.203662", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "INVESTOR ALERT: Levi & Korsinsky Notifies Illumina, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ILMN", "url": "https://markets.businessinsider.com/news/stocks/investor-alert-levi-%C2%A0korsinsky-notifies-illumina-inc-investors-of-a-class-action-lawsuit-and-upcoming-deadline-%E2%80%93%C2%A0ilmn-1032935213", "time_published": "20240101T150000", "authors": ["PRESS RELEASE ACCESSWIRE"], "summary": "INVESTOR ALERT: Levi & Korsinsky Notifies Illumina, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline ...", "banner_image": "https://markets.businessinsider.com/Images/FacebookIcon.jpg", "source": "Business Insider", "category_within_source": "RSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.049815, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.447528", "ticker_sentiment_score": "-0.252476", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "ILMN Final Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Filed against Illumina, Inc.  ( ILMN )  - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36441996/ilmn-final-deadline-kessler-topaz-meltzer-check-llp-reminds-investors-of-lead-plaintiff-deadline-i", "time_published": "20231231T165000", "authors": ["Globe Newswire"], "summary": "RADNOR, Pa., Dec. 31, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against Illumina, Inc. ( ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.046082, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.804375", "ticker_sentiment_score": "-0.052827", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Shareholder Alert", "url": "https://markets.businessinsider.com/news/stocks/illumina-shareholder-alert-1032832991", "time_published": "20231230T144400", "authors": ["NEWSFILE"], "summary": "Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options", "banner_image": "https://api.newsfilecorp.com/newsinfo/192461/208", "source": "Business Insider", "category_within_source": "RSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.744043"}], "overall_sentiment_score": 0.133364, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.646056", "ticker_sentiment_score": "-0.011315", "ticker_sentiment_label": "Neutral"}]}, {"title": "Combined net worth of 500 richest surges by $1.5 trn in 2023, Musk leads", "url": "https://www.business-standard.com/world-news/combined-net-worth-of-500-richest-surges-by-1-5-trn-in-2023-musk-leads-123122901146_1.html", "time_published": "20231229T171950", "authors": ["Bloomberg"], "summary": "It was a comeback year for the world's wealthiest. The combined net worth of the 500 richest people surged by $1.5 trillion in 2023, fully rebounding from the $1.4 trillion lost the year prior, according to the Bloomberg Billionaires Index.", "banner_image": "https://bsmedia.business-standard.com/_media/bs/img/article/2023-12/30/full/1703874636-7726.jpg", "source": "Business Standard", "category_within_source": "GoogleRSS", "source_domain": "www.business-standard.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.102654, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.043264", "ticker_sentiment_score": "0.077197", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.0864", "ticker_sentiment_score": "0.132613", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.043264", "ticker_sentiment_score": "-0.114103", "ticker_sentiment_label": "Neutral"}, {"ticker": "NWSAL", "relevance_score": "0.043264", "ticker_sentiment_score": "-0.057706", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFTBF", "relevance_score": "0.043264", "ticker_sentiment_score": "-0.125404", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVS", "relevance_score": "0.043264", "ticker_sentiment_score": "-0.098281", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEWOW", "relevance_score": "0.043264", "ticker_sentiment_score": "-0.125404", "ticker_sentiment_label": "Neutral"}, {"ticker": "LRLCF", "relevance_score": "0.043264", "ticker_sentiment_score": "0.267441", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "12 Stocks Turn $10,000 Into $320,800 In 12 Months", "url": "https://www.investors.com/etfs-and-funds/sectors/sp500-12-stocks-turn-10000-into-in-12-months-2023/", "time_published": "20231229T130000", "authors": ["MATT KRANTZ", "Investor's Business Daily"], "summary": "Talk about a strong finish. Investors who hung onto the top S&P 500 stocks this year ended up much richer for the effort.", "banner_image": "https://www.investors.com/wp-content/uploads/2016/10/stock-money-12-adobe.jpeg.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.352067, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ANET", "relevance_score": "0.092569", "ticker_sentiment_score": "0.16205", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NCLH", "relevance_score": "0.092569", "ticker_sentiment_score": "0.16205", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTLT", "relevance_score": "0.092569", "ticker_sentiment_score": "0.16205", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.138464", "ticker_sentiment_score": "0.187464", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EXPE", "relevance_score": "0.092569", "ticker_sentiment_score": "0.16205", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CNC", "relevance_score": "0.092569", "ticker_sentiment_score": "0.16205", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SPGI", "relevance_score": "0.046363", "ticker_sentiment_score": "0.102595", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Acelyrin, Illumina, and Roblox and Encourages Investors to Contact the Firm - Illumina  ( NASDAQ:ILMN ) , Roblox  ( NYSE:RBLX ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36420302/bragar-eagel-squire-p-c-reminds-investors-that-class-action-lawsuits-have-been-filed-against-acely", "time_published": "20231229T020000", "authors": ["Globe Newswire"], "summary": "NEW YORK, Dec. 28, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Acelyrin, Inc. SLRN, Illumina, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.918141"}, {"topic": "Earnings", "relevance_score": "0.972756"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": -0.073184, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.303644", "ticker_sentiment_score": "-0.087489", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBLX", "relevance_score": "0.441698", "ticker_sentiment_score": "-0.081437", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRN", "relevance_score": "0.230235", "ticker_sentiment_score": "-0.110168", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Illumina, Inc. of Class Action Lawsuit and Upcoming Deadline - ILMN", "url": "https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-reminds-shareholders-with-losses-on-their-investment-in-illumina-inc-of-class-action-lawsuit-and-upcoming-deadline--ilmn-302023530.html", "time_published": "20231229T004000", "authors": ["Pomerantz LLP"], "summary": "SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Illumina, Inc ... PR ...", "banner_image": "https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.538269"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.744043"}], "overall_sentiment_score": 0.055788, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.678981", "ticker_sentiment_score": "0.138165", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why You Should Retain Illumina  ( ILMN )  Stock for Now", "url": "https://www.zacks.com/stock/news/2203319/heres-why-you-should-retain-illumina-ilmn-stock-for-now", "time_published": "20231228T180200", "authors": ["Zacks Equity Research"], "summary": "Investors are optimistic about Illumina's (ILMN) strength in the genomics market and strong solvency position.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.99489"}], "overall_sentiment_score": 0.264288, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.046184", "ticker_sentiment_score": "0.233216", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PACB", "relevance_score": "0.046184", "ticker_sentiment_score": "0.233216", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.356865", "ticker_sentiment_score": "0.316312", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TMO", "relevance_score": "0.046184", "ticker_sentiment_score": "0.233216", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PODD", "relevance_score": "0.137934", "ticker_sentiment_score": "0.054256", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.046184", "ticker_sentiment_score": "0.233216", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HAE", "relevance_score": "0.227859", "ticker_sentiment_score": "0.157356", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DXCM", "relevance_score": "0.137934", "ticker_sentiment_score": "0.054256", "ticker_sentiment_label": "Neutral"}]}, {"title": "ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action - ILMN - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36414237/rosen-trusted-investor-counsel-encourages-illumina-inc-investors-to-secure-counsel-before-importan", "time_published": "20231228T165009", "authors": ["Globe Newswire"], "summary": "NEW YORK, Dec. 28, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Illumina, Inc. ILMN between September 21, 2020 and November 9, 2023, both dates inclusive ( the \"Class Period\" ) , of the important January 9, 2024 lead ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.744043"}], "overall_sentiment_score": 0.122151, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.06623", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.26042", "ticker_sentiment_score": "0.173073", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "ILMN Investors Have Opportunity to Lead Illumina, Inc. Securities Fraud Lawsuit", "url": "https://www.prnewswire.com/news-releases/ilmn-investors-have-opportunity-to-lead-illumina-inc-securities-fraud-lawsuit-302023073.html", "time_published": "20231228T160000", "authors": ["Glancy Prongay & Murray LLP"], "summary": "LOS ANGELES, Dec. 28, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ( \"GPM\" ) announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Illumina, Inc. ( \"Illumina\" or the \"Company\" ) ( NASDAQ: ) .", "banner_image": "https://mma.prnewswire.com/media/1219482/Glancy_Prongay_and_Murray_LLP.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.227504, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.124809", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.362505", "ticker_sentiment_score": "0.216367", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Illumina, Inc.  ( ILMN )  - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36401619/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains", "time_published": "20231227T174938", "authors": ["Globe Newswire"], "summary": "LOS ANGELES, Dec. 27, 2023 ( GLOBE NEWSWIRE ) --", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.038814, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.06697", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.59928", "ticker_sentiment_score": "0.071099", "ticker_sentiment_label": "Neutral"}]}, {"title": "DEADLINE ALERT for PAYC, ILMN, and JRVR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Illumina  ( NASDAQ:ILMN ) , James River Gr Hldgs  ( NASDAQ:JRVR ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36400718/deadline-alert-for-payc-ilmn-and-jrvr-the-law-offices-of-frank-r-cruz-reminds-investors-of-class-a", "time_published": "20231227T170600", "authors": ["Globe Newswire"], "summary": "LOS ANGELES, Dec. 27, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.684621"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.048694, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.233556", "ticker_sentiment_score": "-0.179232", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JRVR", "relevance_score": "0.233556", "ticker_sentiment_score": "-0.179232", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PAYC", "relevance_score": "0.15697", "ticker_sentiment_score": "0.144911", "ticker_sentiment_label": "Neutral"}]}, {"title": "Class Action Lawsuit Filed Against Illumina, Inc.  ( ILMN )  on Behalf of Investors - Nationally Ranked Investors' Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36399471/class-action-lawsuit-filed-against-illumina-inc-ilmn-on-behalf-of-investors-nationally-ranked-inve", "time_published": "20231227T160504", "authors": ["Globe Newswire"], "summary": "ATLANTA, Dec. 27, 2023 ( GLOBE NEWSWIRE ) -- Holzer & Holzer, LLC informs investors that a shareholder class action lawsuit has been filed against Illumina, Inc. ( \"Illumina\" or the \"Company\" ) ILMN. The lawsuit alleges Illumina made false or misleading statements and/or omitted material adverse ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.009806, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.701875", "ticker_sentiment_score": "0.062406", "ticker_sentiment_label": "Neutral"}]}, {"title": "ILLUMINA SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James  ( Josh )  Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36399047/illumina-shareholder-notice-faruqi-faruqi-securities-litigation-partner-james-josh-wilson-encourag", "time_published": "20231227T154500", "authors": ["Globe Newswire"], "summary": "If you suffered losses exceeding $100,000 investing in Illumina securities between September 21, 2020 and November 9, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 ( Ext. 1310 ) .", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": 0.132578, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.618228", "ticker_sentiment_score": "-0.018348", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ALERT: Levi & Korsinsky Notifies Illumina, Inc. ( ILMN )  Investors of a Class Action Lawsuit and Upcoming Deadline", "url": "https://www.prnewswire.com/news-releases/shareholder-alert-levi--korsinsky-notifies-illumina-incilmn-investors-of-a-class-action-lawsuit-and-upcoming-deadline-302022520.html", "time_published": "20231227T104500", "authors": ["Levi & Korsinsky", "LLP"], "summary": "SHAREHOLDER ALERT: Levi & Korsinsky Notifies Illumina, Inc. ( ILMN ) Investors of a Class Action Lawsuit and ... PR ...", "banner_image": "https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.100833, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.615462", "ticker_sentiment_score": "0.014709", "ticker_sentiment_label": "Neutral"}]}, {"title": "ROSEN, NATIONAL TRIAL COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action - ILMN", "url": "https://www.prnewswire.com/news-releases/rosen-national-trial-counsel-encourages-illumina-inc-investors-to-secure-counsel-before-important-january-9-deadline-in-securities-class-action--ilmn-302022390.html", "time_published": "20231226T181500", "authors": ["P. A.", "THE ROSEN LAW FIRM"], "summary": "ROSEN, NATIONAL TRIAL COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel Before Important ... PR ...", "banner_image": "https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.221019, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.067727", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.329112", "ticker_sentiment_score": "0.369724", "ticker_sentiment_label": "Bullish"}]}, {"title": "SHAREHOLDER ALERT: Levi & Korsinsky Notifies Illumina, Inc. ( ILMN )  Investors of a Class Action Lawsuit and Upcoming Deadline", "url": "https://www.prnewswire.com/news-releases/shareholder-alert-levi--korsinsky-notifies-illumina-incilmn-investors-of-a-class-action-lawsuit-and-upcoming-deadline-302021452.html", "time_published": "20231226T104500", "authors": ["LLP", "Levi & Korsinsky"], "summary": "SHAREHOLDER ALERT: Levi & Korsinsky Notifies Illumina, Inc. ( ILMN ) Investors of a Class Action Lawsuit and ... PR ...", "banner_image": "https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.100833, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.615462", "ticker_sentiment_score": "0.014709", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina  ( ILMN )  Forced to Divest GRAIL, While Investor Class Action Now Alleges An Expanded Fraudulent Period - Hagens Berman - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36379387/illumina-ilmn-forced-to-divest-grail-while-investor-class-action-now-alleges-an-expanded-fraudulen", "time_published": "20231225T161200", "authors": ["Globe Newswire"], "summary": "SAN FRANCISCO, Dec. 25, 2023 ( GLOBE NEWSWIRE ) -- Hagens Berman urges Illumina, Inc. ILMN investors who suffered substantial losses to submit your losses now. The alleged fraudulent purchase period has been expanded.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.029013, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.833423", "ticker_sentiment_score": "-0.028944", "ticker_sentiment_label": "Neutral"}]}, {"title": "ILMN DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP - Important January 9, 2024 Deadline Reminder in Illumina, Inc.  ( ILMN )  Securities Class Action Lawsuit", "url": "https://markets.businessinsider.com/news/stocks/ilmn-deadline-reminder-kessler-topaz-meltzer-check-llp-important-january-9-2024-deadline-reminder-in-illumina-inc.-ilmn-securities-class-action-lawsuit-1032924730", "time_published": "20231225T145100", "authors": ["NEWSFILE"], "summary": "ILMN DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP - Important January 9, 2024 Deadline Reminder in Illumina, Inc. (ILMN) Securities Class Action Lawsuit ...", "banner_image": "https://api.newsfilecorp.com/newsinfo/192021/208", "source": "Business Insider", "category_within_source": "RSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.048637, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.824658", "ticker_sentiment_score": "-0.07376", "ticker_sentiment_label": "Neutral"}]}, {"title": "ILLUMINA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Illumina, Inc. and Encourages Investors to Contact the Firm - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36377706/illumina-alert-bragar-eagel-squire-p-c-reminds-investors-that-a-class-action-lawsuit-has-been-file", "time_published": "20231225T020000", "authors": ["Globe Newswire"], "summary": "NEW YORK, Dec. 24, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Illumina, Inc. ( \"Illumina\" or the \"Company\" ) ILMN in the United States District Court for the ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": -0.021874, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.611653", "ticker_sentiment_score": "-0.039526", "ticker_sentiment_label": "Neutral"}]}, {"title": "ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ILMN - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36377203/rosen-trusted-national-trial-counsel-encourages-illumina-inc-investors-with-losses-to-secure-couns", "time_published": "20231224T181900", "authors": ["Globe Newswire"], "summary": "NEW YORK, Dec. 24, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Illumina, Inc. ILMN between May 1, 2023 and October 16, 2023, both dates inclusive ( the \"Class Period\" ) , of the important January 9, 2024 lead plaintiff ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.157537, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.064104", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.252332", "ticker_sentiment_score": "0.202835", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina Deadline Reminder", "url": "https://markets.businessinsider.com/news/stocks/illumina-deadline-reminder-1032923760", "time_published": "20231224T143100", "authors": ["NEWSFILE"], "summary": "Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options", "banner_image": "https://api.newsfilecorp.com/newsinfo/192144/208", "source": "Business Insider", "category_within_source": "RSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.744043"}], "overall_sentiment_score": 0.13335, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.644706", "ticker_sentiment_score": "-0.011301", "ticker_sentiment_label": "Neutral"}]}, {"title": "Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Illumina, Inc.  ( ILMN )  - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36369173/gainey-mckenna-egleston-announces-a-class-action-lawsuit-has-been-filed-against-illumina-inc-ilmn", "time_published": "20231222T200821", "authors": ["Globe Newswire"], "summary": "NEW YORK, Dec. 22, 2023 ( GLOBE NEWSWIRE ) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California on behalf of all persons or entities who purchased or otherwise acquired Illumina, ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.066333, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.53784", "ticker_sentiment_score": "0.264418", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Final Deadline Approaching for Illumina, Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Illumina, Inc.  ( ILMN )  Investors of January 9, 2024 Lead Plaintiff Deadline - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36369068/final-deadline-approaching-for-illumina-inc-investors-kessler-topaz-meltzer-check-llp-reminds-illu", "time_published": "20231222T200000", "authors": ["Globe Newswire"], "summary": "RADNOR, Pa., Dec. 22, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against Illumina, Inc. ( ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.04852, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.785986", "ticker_sentiment_score": "-0.048346", "ticker_sentiment_label": "Neutral"}]}, {"title": "Market In Merry Mood Heading Into Christmas: Weekly Review", "url": "https://www.investors.com/news/stock-market-rally-is-in-merry-mood-heading-into-christmas-weekend-weekly-review/", "time_published": "20231222T173000", "authors": ["Investor's Business Daily", "IBD STAFF"], "summary": "The stock market rally suffered a sharp sell-off Wednesday, but the major indexes were flat to slightly higher for the week. Micron Technology ( MU ) jumped on strong earnings and guidance, lifting key chip-gear makers and other semiconductor plays.", "banner_image": "https://www.investors.com/wp-content/uploads/2020/12/Stock-ChristmasTree-NYSE-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Economy - Monetary", "relevance_score": "0.928139"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": -0.123408, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMVT", "relevance_score": "0.064161", "ticker_sentiment_score": "-0.170562", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AMAT", "relevance_score": "0.0428", "ticker_sentiment_score": "0.10249", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRMNF", "relevance_score": "0.021408", "ticker_sentiment_score": "-0.249094", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LPG", "relevance_score": "0.0428", "ticker_sentiment_score": "-0.004971", "ticker_sentiment_label": "Neutral"}, {"ticker": "NISTF", "relevance_score": "0.021408", "ticker_sentiment_score": "-0.027664", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRTX", "relevance_score": "0.064161", "ticker_sentiment_score": "0.159217", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TCTZF", "relevance_score": "0.021408", "ticker_sentiment_score": "-0.249094", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NTES", "relevance_score": "0.0428", "ticker_sentiment_score": "-0.265243", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TSLA", "relevance_score": "0.127908", "ticker_sentiment_score": "-0.099146", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLY", "relevance_score": "0.0428", "ticker_sentiment_score": "-0.094598", "ticker_sentiment_label": "Neutral"}, {"ticker": "LRCX", "relevance_score": "0.0428", "ticker_sentiment_score": "0.10249", "ticker_sentiment_label": "Neutral"}, {"ticker": "BILI", "relevance_score": "0.0428", "ticker_sentiment_score": "-0.265243", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FDX", "relevance_score": "0.148994", "ticker_sentiment_score": "-0.214209", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AYX", "relevance_score": "0.064161", "ticker_sentiment_score": "0.148185", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.064161", "ticker_sentiment_score": "-0.017067", "ticker_sentiment_label": "Neutral"}, {"ticker": "MU", "relevance_score": "0.085476", "ticker_sentiment_score": "-0.005311", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKE", "relevance_score": "0.169975", "ticker_sentiment_score": "-0.176036", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AIR", "relevance_score": "0.021408", "ticker_sentiment_score": "0.043908", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACN", "relevance_score": "0.0428", "ticker_sentiment_score": "-0.130435", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOGL", "relevance_score": "0.0428", "ticker_sentiment_score": "-0.004971", "ticker_sentiment_label": "Neutral"}, {"ticker": "HEI", "relevance_score": "0.0428", "ticker_sentiment_score": "0.043648", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.0428", "ticker_sentiment_score": "0.15626", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KMX", "relevance_score": "0.0428", "ticker_sentiment_score": "-0.071178", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGI", "relevance_score": "0.021408", "ticker_sentiment_score": "0.043908", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADBE", "relevance_score": "0.148994", "ticker_sentiment_score": "-0.058615", "ticker_sentiment_label": "Neutral"}, {"ticker": "GPCR", "relevance_score": "0.0428", "ticker_sentiment_score": "-0.094598", "ticker_sentiment_label": "Neutral"}, {"ticker": "WOR", "relevance_score": "0.0428", "ticker_sentiment_score": "0.148808", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARGX", "relevance_score": "0.0428", "ticker_sentiment_score": "-0.164222", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CTAS", "relevance_score": "0.0428", "ticker_sentiment_score": "0.012956", "ticker_sentiment_label": "Neutral"}, {"ticker": "STNG", "relevance_score": "0.0428", "ticker_sentiment_score": "-0.004971", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFRM", "relevance_score": "0.064161", "ticker_sentiment_score": "0.054092", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMT", "relevance_score": "0.085476", "ticker_sentiment_score": "0.055684", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Illumina, Inc. - ILMN - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36365161/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-illumina-inc-il", "time_published": "20231222T161900", "authors": ["Globe Newswire"], "summary": "NEW YORK, Dec. 22, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Illumina, Inc. ( \"Illumina\" or the \"Company\" ) ILMN. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": -0.072195, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.822", "ticker_sentiment_score": "-0.20474", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Illumina  ( ILMN )  Forced to Divest GRAIL, While Investor Class Action Now Alleges An Expanded Fraudulent Period - Hagens Berman - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36364409/illumina-ilmn-forced-to-divest-grail-while-investor-class-action-now-alleges-an-expanded-fraudulen", "time_published": "20231222T154942", "authors": ["Globe Newswire"], "summary": "SAN FRANCISCO, Dec. 22, 2023 ( GLOBE NEWSWIRE ) -- Hagens Berman urges Illumina, Inc. ILMN investors who suffered substantial losses to submit your losses now. The alleged fraudulent purchase period has been expanded.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.029013, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.833423", "ticker_sentiment_score": "-0.028944", "ticker_sentiment_label": "Neutral"}]}, {"title": "These 3 Big Pharma Stocks Are Making Big Plays With AI", "url": "https://www.fool.com/investing/2023/12/22/3-big-pharma-stocks-are-making-big-plays-with-ai/", "time_published": "20231222T121500", "authors": ["Alex Carchidi"], "summary": "Opportunity is in the air with AI, and these pharma giants are seizing the moment.", "banner_image": "https://g.foolcdn.com/editorial/images/758794/biotech-pharma-researchers-talk-lab.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.171475, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LLY", "relevance_score": "0.207571", "ticker_sentiment_score": "0.149466", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.052455", "ticker_sentiment_score": "-0.026011", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABSI", "relevance_score": "0.104683", "ticker_sentiment_score": "0.099062", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.104683", "ticker_sentiment_score": "0.068798", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.052455", "ticker_sentiment_score": "0.04473", "ticker_sentiment_label": "Neutral"}]}, {"title": "INVESTOR ALERT: Levi & Korsinsky Reminds Illumina, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2024 - ILMN", "url": "https://markets.businessinsider.com/news/stocks/investor-alert-levi-%C2%A0korsinsky-reminds-illumina-inc-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of%C2%A0january-9-2024--%C2%A0ilmn-1032919926", "time_published": "20231221T152000", "authors": ["PRESS RELEASE ACCESSWIRE"], "summary": "INVESTOR ALERT: Levi & Korsinsky Reminds Illumina, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January ...", "banner_image": "https://markets.businessinsider.com/Images/FacebookIcon.jpg", "source": "Business Insider", "category_within_source": "RSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.049815, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.447528", "ticker_sentiment_score": "-0.252476", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "ILLUMINA INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/illumina-investor-deadline-approaching-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-100-000-in-illumina-to-contact-him-directly-to-discuss-their-options-302020678.html", "time_published": "20231221T150000", "authors": [], "summary": "ILLUMINA INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James ( Josh ) Wilson Encourages ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.650727"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.151561, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GDHG", "relevance_score": "0.065327", "ticker_sentiment_score": "0.2196", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.587597", "ticker_sentiment_score": "-0.014303", "ticker_sentiment_label": "Neutral"}, {"ticker": "JRVR", "relevance_score": "0.065327", "ticker_sentiment_score": "0.2196", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "ILLUMINA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Illumina, Inc. and Encourages Investors to Contact the Firm - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36336820/illumina-alert-bragar-eagel-squire-p-c-reminds-investors-that-a-class-action-lawsuit-has-been-file", "time_published": "20231221T020000", "authors": ["Globe Newswire"], "summary": "NEW YORK, Dec. 20, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Illumina, Inc. ( \"Illumina\" or the \"Company\" ) ILMN in the United States District Court for the ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": -0.021874, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.611653", "ticker_sentiment_score": "-0.039526", "ticker_sentiment_label": "Neutral"}]}, {"title": "DEADLINE ALERT for FMC, ILMN, PAYC, JRVR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders - Illumina  ( NASDAQ:ILMN ) , FMC  ( NYSE:FMC ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36330832/deadline-alert-for-fmc-ilmn-payc-jrvr-law-offices-of-howard-g-smith-reminds-investors-of-class-act", "time_published": "20231220T181202", "authors": ["Globe Newswire"], "summary": "BENSALEM, Pa., Dec. 20, 2023 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.77141"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.039236, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSSMY", "relevance_score": "0.270973", "ticker_sentiment_score": "0.071347", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JRVR", "relevance_score": "0.164656", "ticker_sentiment_score": "-0.033654", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAYC", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 -  ( NASDAQ: ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36330084/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-illumina-inc-of-a-class-action-lawsu", "time_published": "20231220T174100", "authors": ["Globe Newswire"], "summary": "NEW YORK, Dec. 20, 2023 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Illumina, Inc.. Shareholders who purchased shares of ILMN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.059416, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.309539", "ticker_sentiment_score": "0.126785", "ticker_sentiment_label": "Neutral"}]}, {"title": "Skye Fund III Issues Letter Regarding Opposition to SomaLogic's Proposed Merger with Standard BioTools - Standard BioTools  ( NASDAQ:LAB ) , SomaLogic  ( NASDAQ:SLGC ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36324353/skye-fund-iii-issues-letter-regarding-opposition-to-somalogics-proposed-merger-with-standard-bioto", "time_published": "20231220T140000", "authors": ["Globe Newswire"], "summary": "Believes that the Proposed Merger Grossly Undervalues SomaLogic and Ignores its Revolutionary Products, Considerable Cash Position, and Strong Balance Sheet Iterates that SomaLogic can Thrive as a Standalone Enterprise and Does Not Need Standard BioTools to Thrive", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Mergers", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.94762"}, {"topic": "Earnings", "relevance_score": "0.161647"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.180624, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SLGC", "relevance_score": "0.703655", "ticker_sentiment_score": "0.308662", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LAB", "relevance_score": "0.431065", "ticker_sentiment_score": "0.202112", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.11324", "ticker_sentiment_score": "0.062056", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLK", "relevance_score": "0.03786", "ticker_sentiment_score": "0.053631", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.03786", "ticker_sentiment_score": "0.053631", "ticker_sentiment_label": "Neutral"}]}, {"title": "ILLUMINA ONGOING DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James  ( Josh )  Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36307134/illumina-ongoing-deadline-alert-faruqi-faruqi-securities-litigation-partner-james-josh-wilson-enco", "time_published": "20231219T154500", "authors": ["Globe Newswire"], "summary": "NEW YORK, Dec. 19, 2023 ( GLOBE NEWSWIRE ) -- If you suffered losses exceeding $100,000 investing in Illumina securities between May 1, 2023 and October 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 ( Ext. ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": 0.130116, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.61135", "ticker_sentiment_score": "-0.014582", "ticker_sentiment_label": "Neutral"}]}, {"title": "Appointment of Chief Business Officer", "url": "https://www.globenewswire.com/news-release/2023/12/19/2798406/0/en/Appointment-of-Chief-Business-Officer.html", "time_published": "20231219T120000", "authors": ["Avacta Group"], "summary": "19 December ...", "banner_image": "https://ml-eu.globenewswire.com/Resource/Download/c823accc-858a-46ea-8e62-394b3f424022", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.340392, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AVCTF", "relevance_score": "0.429541", "ticker_sentiment_score": "0.489377", "ticker_sentiment_label": "Bullish"}, {"ticker": "DSSMY", "relevance_score": "0.05654", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.05654", "ticker_sentiment_score": "0.056998", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.05654", "ticker_sentiment_score": "0.067917", "ticker_sentiment_label": "Neutral"}]}, {"title": "ROSEN, LEADING INVESTOR COUNSEL, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ILMN - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36294489/rosen-leading-investor-counsel-encourages-illumina-inc-investors-with-losses-to-secure-counsel-bef", "time_published": "20231218T230800", "authors": ["Globe Newswire"], "summary": "NEW YORK, Dec. 18, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Illumina, Inc. ILMN between May 1, 2023 and October 16, 2023, both dates inclusive ( the \"Class Period\" ) , of the important January 9, 2024 lead plaintiff ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.157537, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.064104", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.252332", "ticker_sentiment_score": "0.202835", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina  ( ILMN )  Investors Bring Class Action for Insiders' Failure to Disclose Conflicts of Interest of GRAIL Deal - Hagens Berman - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36291756/illumina-ilmn-investors-bring-class-action-for-insiders-failure-to-disclose-conflicts-of-interest-", "time_published": "20231218T211356", "authors": ["Globe Newswire"], "summary": "SAN FRANCISCO, Dec. 18, 2023 ( GLOBE NEWSWIRE ) -- Hagens Berman urges Illumina, Inc. ILMN investors who suffered substantial losses to submit your losses now. Class Period: May 1, 2023 - Oct. 16, 2023Lead Plaintiff Deadline: Jan. 9, 2024Visit: www.hbsslaw.com/investor-fraud/ILMN Contact An ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.017096, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.829093", "ticker_sentiment_score": "0.020735", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Illumina, Inc. - ILMN", "url": "https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-illumina-inc---ilmn-302018131.html", "time_published": "20231218T210800", "authors": ["Pomerantz LLP"], "summary": "NEW YORK, Dec. 18, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Illumina, Inc. ( \"Illumina\" or the \"Company\" ) ( NASDAQ: ILMN ) . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.", "banner_image": "https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.650727"}], "overall_sentiment_score": -0.050805, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.839757", "ticker_sentiment_score": "-0.163285", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "DEADLINE ALERT for PAYC, ILMN, and JRVR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Illumina  ( NASDAQ:ILMN ) , James River Gr Hldgs  ( NASDAQ:JRVR ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36287125/deadline-alert-for-payc-ilmn-and-jrvr-the-law-offices-of-frank-r-cruz-reminds-investors-of-class-a", "time_published": "20231218T170700", "authors": ["Globe Newswire"], "summary": "LOS ANGELES, Dec. 18, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.684621"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.07269, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.159043", "ticker_sentiment_score": "-0.22263", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JRVR", "relevance_score": "0.159043", "ticker_sentiment_score": "-0.22263", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PAYC", "relevance_score": "0.079921", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Illumina  ( ILMN )  Stock Is Trading Higher Today - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/large-cap/23/12/36283288/illumina-grail-8b-saga-ends-after-it-battles-regulators-for-3-years", "time_published": "20231218T165504", "authors": ["Vandana Singh"], "summary": "On Sunday, gene-sequencing company Illumina Inc ILMN agreed to divest cancer diagnostic test maker Grail Inc as the companies battled with the U.S. and European antitrust regulators for almost three years after announcing the acquisition.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/18/ilmn.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.043138, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.807885", "ticker_sentiment_score": "0.052595", "ticker_sentiment_label": "Neutral"}]}, {"title": "Adobe calls off $20 bn deal to acquire Figma after pushback from Europe", "url": "https://www.business-standard.com/companies/news/adobe-calls-off-20-bn-deal-to-acquire-figma-after-pushback-from-europe-123121801183_1.html", "time_published": "20231218T163709", "authors": ["AP"], "summary": "Adobe, based in San Jose, California, sells software for creating, publishing and promoting content, and managing documents. Adobe's planned $20 billion acquisition of online design company Figma is being called off due to pushback in Europe over antitrust concerns, the companies said Monday.", "banner_image": "https://bsmedia.business-standard.com/_media/bs/img/article/2023-12/14/full/1702519694-752.jpg?im=FitAndFill=(826,465)", "source": "Business Standard", "category_within_source": "GoogleRSS", "source_domain": "www.business-standard.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.147449, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ADBE", "relevance_score": "0.099066", "ticker_sentiment_score": "0.285789", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MSFT", "relevance_score": "0.099066", "ticker_sentiment_score": "-0.224819", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "IRBT", "relevance_score": "0.099066", "ticker_sentiment_score": "-0.14065", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.099066", "ticker_sentiment_score": "-0.14065", "ticker_sentiment_label": "Neutral"}]}, {"title": "Adobe calls off $20 billion deal for Figma after pushback from Europe over possible antitrust issues", "url": "https://apnews.com/article/adobe-figma-acquisition-regulatory-6997e3a40ef309a147f13e3ed3e773fe", "time_published": "20231218T162400", "authors": ["MICHELLE CHAPMAN"], "summary": "Adobe's planned $20 billion acquisition of online design company Figma is being called off due to pushback in Europe over antitrust concerns, the companies said Monday.", "banner_image": "https://dims.apnews.com/dims4/default/2d67277/2147483647/strip/true/crop/4896x3261+0+1/resize/599x399!/quality/90/?url=https%3A%2F%2Fassets.apnews.com%2F16%2Ff4%2Fe8fcd8b040335bd8103eb94f02d3%2F73b69ae810af460ab88c695d6fd1746e", "source": "Associated Press", "category_within_source": "Markets", "source_domain": "apnews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.141755, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ADBE", "relevance_score": "0.104683", "ticker_sentiment_score": "0.290754", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MSFT", "relevance_score": "0.104683", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRBT", "relevance_score": "0.104683", "ticker_sentiment_score": "-0.163211", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ILMN", "relevance_score": "0.104683", "ticker_sentiment_score": "-0.163211", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Dow Jones Holds Record Highs After Economic Data; Tesla Rival Wins $2 Bil. Deal", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-holds-record-highs-after-economic-data-tesla-rival-wins-2-billion-deal/", "time_published": "20231218T155700", "authors": ["Investor's Business Daily", "VIDYA RAMAKRISHNAN"], "summary": "Dow Jones Holds Record Highs After Economic Data. Tesla Rival Wins $2 Bil. Deal Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2020/03/stock-Nike-15-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.998333"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.769861"}], "overall_sentiment_score": 0.208499, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.124809", "ticker_sentiment_score": "0.438377", "ticker_sentiment_label": "Bullish"}, {"ticker": "META", "relevance_score": "0.124809", "ticker_sentiment_score": "0.438377", "ticker_sentiment_label": "Bullish"}, {"ticker": "AAPL", "relevance_score": "0.124809", "ticker_sentiment_score": "-0.101101", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSCO", "relevance_score": "0.124809", "ticker_sentiment_score": "-0.101101", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVX", "relevance_score": "0.124809", "ticker_sentiment_score": "-0.101101", "ticker_sentiment_label": "Neutral"}, {"ticker": "FCEL", "relevance_score": "0.124809", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.124809", "ticker_sentiment_score": "-0.166089", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NISTF", "relevance_score": "0.062597", "ticker_sentiment_score": "0.059009", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKR", "relevance_score": "0.124809", "ticker_sentiment_score": "0.438377", "ticker_sentiment_label": "Bullish"}, {"ticker": "MU", "relevance_score": "0.124809", "ticker_sentiment_score": "-0.026348", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKE", "relevance_score": "0.124809", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACN", "relevance_score": "0.186259", "ticker_sentiment_score": "-0.033581", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.124809", "ticker_sentiment_score": "-0.101101", "ticker_sentiment_label": "Neutral"}, {"ticker": "COST", "relevance_score": "0.124809", "ticker_sentiment_score": "0.438377", "ticker_sentiment_label": "Bullish"}, {"ticker": "TSLA", "relevance_score": "0.124809", "ticker_sentiment_score": "0.08871", "ticker_sentiment_label": "Neutral"}, {"ticker": "FANG", "relevance_score": "0.124809", "ticker_sentiment_score": "0.438377", "ticker_sentiment_label": "Bullish"}, {"ticker": "NIO", "relevance_score": "0.124809", "ticker_sentiment_score": "0.08871", "ticker_sentiment_label": "Neutral"}, {"ticker": "INTC", "relevance_score": "0.124809", "ticker_sentiment_score": "-0.101101", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADBE", "relevance_score": "0.186259", "ticker_sentiment_score": "0.204165", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FDX", "relevance_score": "0.124809", "ticker_sentiment_score": "-0.026348", "ticker_sentiment_label": "Neutral"}, {"ticker": "PANW", "relevance_score": "0.124809", "ticker_sentiment_score": "0.198843", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Nio Jumps On 1,000-Kilometer Drive, Mideast Investment", "url": "https://www.investors.com/news/nio-stock-china-ev-maker-jumps-on-landmark-1000-kilometer-drive-abu-dhabi-investment/", "time_published": "20231218T112800", "authors": ["Investor's Business Daily", "ED CARSON"], "summary": "Nio Stock Jumps On China EV Maker's Landmark 1,000-Kilometer Drive, Abu Dhabi Investment Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2022/01/Stock-nioET7-01-company.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.980922"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.068422, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "XPEV", "relevance_score": "0.306963", "ticker_sentiment_score": "-0.01132", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.207571", "ticker_sentiment_score": "0.215541", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NIO", "relevance_score": "0.852206", "ticker_sentiment_score": "0.166569", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.104683", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCTZF", "relevance_score": "0.104683", "ticker_sentiment_score": "0.145504", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 -  ( NASDAQ: ILMN ) ", "url": "https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-illumina-inc-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-january-9-2024--nasdaq-ilmn-302017169.html", "time_published": "20231218T104500", "authors": ["LLP", "Levi & Korsinsky"], "summary": "SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a ... PR ...", "banner_image": "https://mma.prnewswire.com/media/2280334/Levi_and_Korsinsky_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.047451, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.348919", "ticker_sentiment_score": "0.143891", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina to sell cancer-test maker Grail after latest antitrust ruling", "url": "https://www.marketwatch.com/story/illumina-to-sell-cancer-test-maker-grail-latest-after-antitrust-ruling-014b11d9", "time_published": "20231217T215300", "authors": ["Mike Murphy"], "summary": "Illumina Inc. said Sunday it will sell its Grail unit, after a federal appeals court on Friday found the $7.1 billion acquisition in 2021 to be anticompetitive.", "banner_image": "https://images.mktw.net/im-756589/social", "source": "MarketWatch", "category_within_source": "Top Stories", "source_domain": "www.marketwatch.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.002392, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.924319", "ticker_sentiment_score": "0.004251", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina To Sell Grail After Antitrust Ruling", "url": "https://www.investors.com/news/technology/illumina-to-sell-grail-after-us-antitrust-ruling/", "time_published": "20231217T205200", "authors": ["Investor's Business Daily", "ED CARSON"], "summary": "Illumina To Sell Grail After U.S. Antitrust Ruling Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2016/04/Biz07-041816-company.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": -0.045505, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.70749", "ticker_sentiment_score": "-0.256785", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Lowey Dannenberg Notifies Illumina, Inc.  ( \"Illumina\" or the \"Company\" )   ( NASDAQ: ILMN )  Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36275164/lowey-dannenberg-notifies-illumina-inc-illumina-or-the-company-nasdaq-ilmn-investors-of-securities", "time_published": "20231217T201524", "authors": ["Globe Newswire"], "summary": "NEW YORK, Dec. 17, 2023 ( GLOBE NEWSWIRE ) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Illumina, Inc. ( \"Illumina\" or the \"Company\" ) ILMN for violations of the federal securities laws on ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.0, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.441698", "ticker_sentiment_score": "0.035372", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Announces Decision to Divest GRAIL", "url": "https://www.prnewswire.com/news-releases/illumina-announces-decision-to-divest-grail-302017383.html", "time_published": "20231217T193700", "authors": ["Inc.", "Illumina"], "summary": "SAN DIEGO, Dec. 17, 2023 /PRNewswire/ -- Today, Illumina, Inc. ( NASDAQ: ILMN ) announced that the company will divest GRAIL.", "banner_image": "https://mma.prnewswire.com/media/1876671/Illumina_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.102112, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.080458", "ticker_sentiment_score": "0.071158", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.080458", "ticker_sentiment_score": "0.071158", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.455525", "ticker_sentiment_score": "0.277077", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ILMN", "url": "https://www.prnewswire.com/news-releases/rosen-trusted-investor-counsel-encourages-illumina-inc-investors-with-losses-to-secure-counsel-before-important-deadline-in-securities-class-action--ilmn-302017153.html", "time_published": "20231216T220000", "authors": ["P. A.", "THE ROSEN LAW FIRM"], "summary": "ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before ... PR ...", "banner_image": "https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.221019, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.067727", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.329112", "ticker_sentiment_score": "0.369724", "ticker_sentiment_label": "Bullish"}]}, {"title": "Court Sides With FTC Finding Illumina-Grail Deal Anticompetitive", "url": "https://www.wsj.com/health/healthcare/court-sides-with-ftc-finding-illumina-grail-deal-anticompetitive-ad2efe8d", "time_published": "20231216T193200", "authors": ["Dave Michaels"], "summary": "Judges also fault agency for not properly considering Illumina's plan to fix drawbacks.", "banner_image": "https://images.wsj.net/im-901931?width=700&height=466", "source": "Wall Street Journal", "category_within_source": "Business", "source_domain": "www.wsj.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.011732, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.769861", "ticker_sentiment_score": "-0.019668", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina, Inc. Lead Plaintiff Deadline Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the ILMN Class Action - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36270532/illumina-inc-lead-plaintiff-deadline-alert-robbins-llp-reminds-investors-of-the-lead-plaintiff-dea", "time_published": "20231216T070952", "authors": ["Globe Newswire"], "summary": "SAN DIEGO, Dec. 16, 2023 ( GLOBE NEWSWIRE ) -- Robbins LLP reminds investors that a shareholder filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired Illumina, Inc. ILMN securities between May 1, 2023 and October 16, 2023.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}], "overall_sentiment_score": -0.002404, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.7887", "ticker_sentiment_score": "-0.032215", "ticker_sentiment_label": "Neutral"}]}, {"title": "ILLUMINA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Illumina, Inc. and Encourages Investors to Contact the Firm - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36269504/illumina-alert-bragar-eagel-squire-p-c-reminds-investors-that-a-class-action-lawsuit-has-been-file", "time_published": "20231216T020000", "authors": ["Globe Newswire"], "summary": "NEW YORK, Dec. 15, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Illumina, Inc. ( \"Illumina\" or the \"Company\" ) ILMN in the United States District Court for the ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": -0.021874, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.611653", "ticker_sentiment_score": "-0.039526", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina  ( ILMN )  Investors Bring Class Action for Insiders' Failure to Disclose Conflicts of Interest of GRAIL Deal - Hagens Berman - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36267169/illumina-ilmn-investors-bring-class-action-for-insiders-failure-to-disclose-conflicts-of-interest-", "time_published": "20231215T214733", "authors": ["Globe Newswire"], "summary": "SAN FRANCISCO, Dec. 15, 2023 ( GLOBE NEWSWIRE ) -- Hagens Berman urges Illumina, Inc. ILMN investors who suffered substantial losses to submit your losses now. Class Period: May 1, 2023 - Oct. 16, 2023Lead Plaintiff Deadline: Jan. 9, 2024Visit: www.hbsslaw.com/investor-fraud/ILMN Contact An ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.017096, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.829093", "ticker_sentiment_score": "0.020735", "ticker_sentiment_label": "Neutral"}]}, {"title": "DEADLINE ALERT for FMC, ILMN, PAYC, JRVR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders - Illumina  ( NASDAQ:ILMN ) , FMC  ( NYSE:FMC ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36261355/deadline-alert-for-fmc-ilmn-payc-jrvr-law-offices-of-howard-g-smith-reminds-investors-of-class-act", "time_published": "20231215T170000", "authors": ["Globe Newswire"], "summary": "BENSALEM, Pa., Dec. 15, 2023 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.77141"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.039236, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSSMY", "relevance_score": "0.270973", "ticker_sentiment_score": "0.075551", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JRVR", "relevance_score": "0.164656", "ticker_sentiment_score": "-0.033654", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAYC", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "ILLUMINA SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James  ( Josh )  Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36259804/illumina-shareholder-action-reminder-faruqi-faruqi-securities-litigation-partner-james-josh-wilson", "time_published": "20231215T154500", "authors": ["Globe Newswire"], "summary": "If you suffered losses exceeding $100,000 investing in Illumina securities between May 1, 2023 and October 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 ( Ext. 1310 ) .", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": 0.132578, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.618228", "ticker_sentiment_score": "-0.018348", "ticker_sentiment_label": "Neutral"}]}, {"title": "ESG gains would be few without the Magnificent Seven", "url": "https://www.ft.com/content/8f4463c8-1e83-4bfc-a370-62cd41c35bf1", "time_published": "20231215T144945", "authors": ["Alice Ross"], "summary": "This time last year, sustainable fund managers were fairly gloomy about the prospect of returns in 2023. Environmental, social and governance strategies had a bad year as the Ukraine war drove energy stocks up. Tech stocks, which sustainable funds often hold, did not do well.", "banner_image": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fwww.ft.com%2F__origami%2Fservice%2Fimage%2Fv2%2Fimages%2Fraw%2Fhttps%253A%252F%252Fd1e00ek4ebabms.cloudfront.net%252Fproduction%252F6f34d061-63d0-49b1-823a-5eed990d127a.jpg%3Fsource%3Dnext-article%26fit%3Dscale-down%26quality%3Dhighest%26width%3D700%26dpr%3D1?source=next&fit=scale-down&dpr=2&width=240", "source": "Financial Times", "category_within_source": "GoogleRSS", "source_domain": "www.ft.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.918141"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Blockchain", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.246583, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TT", "relevance_score": "0.042346", "ticker_sentiment_score": "0.250001", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DE", "relevance_score": "0.042346", "ticker_sentiment_score": "-0.033978", "ticker_sentiment_label": "Neutral"}, {"ticker": "GCEI", "relevance_score": "0.042346", "ticker_sentiment_score": "-0.011998", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.168197", "ticker_sentiment_score": "0.108792", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.042346", "ticker_sentiment_score": "0.16349", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IMXXF", "relevance_score": "0.042346", "ticker_sentiment_score": "0.194899", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GS", "relevance_score": "0.042346", "ticker_sentiment_score": "0.079945", "ticker_sentiment_label": "Neutral"}, {"ticker": "ECL", "relevance_score": "0.042346", "ticker_sentiment_score": "-0.033978", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.042346", "ticker_sentiment_score": "0.079945", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTST", "relevance_score": "0.042346", "ticker_sentiment_score": "0.034868", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.042346", "ticker_sentiment_score": "0.079945", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDNS", "relevance_score": "0.042346", "ticker_sentiment_score": "0.194899", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SPGI", "relevance_score": "0.042346", "ticker_sentiment_score": "-0.011998", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Analyst Optimistic On Company's Prospects For 'Accelerated Growth' - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/12/36238033/illumina-analyst-optimistic-on-companys-prospects-for-accelerated-growth", "time_published": "20231214T155521", "authors": ["Priya Nigam"], "summary": "Illumina, Inc. ILMN has come to loggerheads with EU antitrust regulators related to their investigation into the $7.1 billion acquisition of Grail. Although the company faces near-term headwinds, its strong positioning in the large Next Generation Sequencing ( NGS ) market could propel growth in ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/14/illumina_shutter.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.289378, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.940989", "ticker_sentiment_score": "0.487133", "ticker_sentiment_label": "Bullish"}]}, {"title": "Myriad Genetics'  ( MYGN )  New Partnerships Aid Amid FX Woes", "url": "https://www.zacks.com/stock/news/2197835/myriad-genetics-mygn-new-partnerships-aid-amid-fx-woes", "time_published": "20231214T132200", "authors": ["Zacks Equity Research"], "summary": "Myriad Genetics (MYGN) continues to record strong revenue growth from companion diagnostics, including significant revenue share from its proprietary myChoiceCDx test.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7b/850.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.998287"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.089132, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PODD", "relevance_score": "0.142005", "ticker_sentiment_score": "0.053895", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAE", "relevance_score": "0.234458", "ticker_sentiment_score": "0.087521", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.142005", "ticker_sentiment_score": "0.053895", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.047559", "ticker_sentiment_score": "0.032908", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.525827", "ticker_sentiment_score": "0.070115", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.142005", "ticker_sentiment_score": "0.020589", "ticker_sentiment_label": "Neutral"}]}, {"title": "Important January 9, 2024 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Illumina, Inc. Investors of Securities Fraud Class Action Lawsuit - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36226004/important-january-9-2024-deadline-reminder-kessler-topaz-meltzer-check-llp-reminds-illumina-inc-in", "time_published": "20231213T211700", "authors": ["Globe Newswire"], "summary": "RADNOR, Pa., Dec. 13, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against Illumina, Inc. ( ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.04852, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.785986", "ticker_sentiment_score": "-0.048346", "ticker_sentiment_label": "Neutral"}]}, {"title": "Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Illumina, Inc.  ( ILMN )  - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36221874/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains", "time_published": "20231213T180955", "authors": ["Globe Newswire"], "summary": "LOS ANGELES, Dec. 13, 2023 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP ( \"GPM\" ) reminds investors of the upcoming January 9, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Illumina, Inc. ( \"Illumina\" or ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.038814, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.06697", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.59928", "ticker_sentiment_score": "0.067505", "ticker_sentiment_label": "Neutral"}]}, {"title": "DEADLINE ALERT for PAYC, ILMN, and JRVR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Illumina  ( NASDAQ:ILMN ) , James River Gr Hldgs  ( NASDAQ:JRVR ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36220354/deadline-alert-for-payc-ilmn-and-jrvr-the-law-offices-of-frank-r-cruz-reminds-investors-of-class-a", "time_published": "20231213T170600", "authors": ["Globe Newswire"], "summary": "LOS ANGELES, Dec. 13, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.684621"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.07269, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.159043", "ticker_sentiment_score": "-0.22263", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JRVR", "relevance_score": "0.159043", "ticker_sentiment_score": "-0.22263", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PAYC", "relevance_score": "0.079921", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina, Inc. investors: Please contact the Portnoy Law Firm to recover your losses - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36209695/illumina-inc-investors-please-contact-the-portnoy-law-firm-to-recover-your-losses", "time_published": "20231213T024710", "authors": ["Globe Newswire"], "summary": "Investors can contact the law firm at no cost to learn more about recovering their losses", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.126894, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.531019", "ticker_sentiment_score": "-0.31543", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Illumina Versus European Commission: Legal Battle Over Grail Acquisition Reaches Critical Stage - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/markets/equities/23/12/36202820/illumina-versus-european-commission-legal-battle-over-grail-acquisition-reaches-critical-stage", "time_published": "20231212T191238", "authors": ["Vandana Singh"], "summary": "Illumina Inc ILMN reportedly clashed with EU antitrust regulators, alleging an overreach in their investigation into its $7.1 billion acquisition of Grail Inc.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/12/ilmn.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": -0.026421, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.659096", "ticker_sentiment_score": "0.127909", "ticker_sentiment_label": "Neutral"}]}, {"title": "UPDATE - Lowey Dannenberg Notifies Illumina, Inc.  ( \"Illumina\" or the \"Company\" )   ( NASDAQ: ILMN )  Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36202524/update-lowey-dannenberg-notifies-illumina-inc-illumina-or-the-company-nasdaq-ilmn-investors-of-sec", "time_published": "20231212T172454", "authors": ["Globe Newswire"], "summary": "NEW YORK, Dec. 12, 2023 ( GLOBE NEWSWIRE ) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Illumina, Inc. ( \"Illumina\" or the \"Company\" ) ILMN for violations of the federal securities laws on ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.0, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.441698", "ticker_sentiment_score": "0.035372", "ticker_sentiment_label": "Neutral"}]}, {"title": "Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Illumina, Inc.  ( ILMN )  Investors and Encourages Investors to Contact the Firm Before January 9, 2024 - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36202307/kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-on-behalf-of-illu", "time_published": "20231212T171633", "authors": ["Globe Newswire"], "summary": "NEW YORK, Dec. 12, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.098652, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.744196", "ticker_sentiment_score": "0.175292", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina partners with HaploX to build a domestically produced flagship benchtop sequencing system", "url": "https://www.prnewswire.com/apac/news-releases/illumina-partners-with-haplox-to-build-a-domestically-produced-flagship-benchtop-sequencing-system-302012340.html", "time_published": "20231212T093100", "authors": ["Illumina"], "summary": "SHENZHEN, China, Dec. 12, 2023 /PRNewswire/ -- On December 9, Illumina, a global leader in DNA sequencing and array-based technologies, and HaploX, a China-based high-tech company specializing in oncology liquid biopsy and genetic big data, jointly announced the official launch of the first ...", "banner_image": "https://mma.prnewswire.com/media/2298670/image_5016922_38038818.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.391618, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.043579", "ticker_sentiment_score": "0.104909", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.043579", "ticker_sentiment_score": "0.104909", "ticker_sentiment_label": "Neutral"}, {"ticker": "SZIHF", "relevance_score": "0.215319", "ticker_sentiment_score": "0.225726", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.215319", "ticker_sentiment_score": "0.261524", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ILMN - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36188802/rosen-top-ranked-investor-counsel-encourages-illumina-inc-investors-with-losses-to-secure-counsel-", "time_published": "20231212T003600", "authors": ["Globe Newswire"], "summary": "NEW YORK, Dec. 11, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Illumina, Inc. ILMN between May 1, 2023 and October 16, 2023, both dates inclusive ( the \"Class Period\" ) , of the important January 9, 2024 lead plaintiff ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.162344, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.064797", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.254973", "ticker_sentiment_score": "0.204498", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina  ( ILMN )  Investors Bring Class Action for Insiders' Failure to Disclose Conflicts of Interest of GRAIL Deal - Hagens Berman - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36180304/illumina-ilmn-investors-bring-class-action-for-insiders-failure-to-disclose-conflicts-of-interest-", "time_published": "20231211T165813", "authors": ["Globe Newswire"], "summary": "SAN FRANCISCO, Dec. 11, 2023 ( GLOBE NEWSWIRE ) -- Hagens Berman urges Illumina, Inc. ILMN investors who suffered substantial losses to submit your losses now. Class Period: May 1, 2023 - Oct. 16, 2023Lead Plaintiff Deadline: Jan. 9, 2024Visit: www.hbsslaw.com/investor-fraud/ILMN Contact An ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.017096, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.829093", "ticker_sentiment_score": "0.020735", "ticker_sentiment_label": "Neutral"}]}, {"title": "Global Proteomics Market Size is Estimated to Reach USD 79.50 billion by 2031, Growing at a CAGR of 12.21%: Straits Research", "url": "https://www.benzinga.com/pressreleases/23/12/g36177244/global-proteomics-market-size-is-estimated-to-reach-usd-79-50-billion-by-2031-growing-at-a-cagr-of", "time_published": "20231211T144000", "authors": ["Globe Newswire"], "summary": "New York, United States, Dec. 11, 2023 ( GLOBE NEWSWIRE ) -- Proteomics refers to the all-encompassing study of proteins. It is an area of disease diagnosis that is experiencing rapid growth. The field of proteomics searches for proteins associated with disease and investigates their function, ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.251837, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.071677", "ticker_sentiment_score": "0.075408", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.035875", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.035875", "ticker_sentiment_score": "0.05988", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.107335", "ticker_sentiment_score": "0.080235", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRKR", "relevance_score": "0.035875", "ticker_sentiment_score": "0.05988", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.035875", "ticker_sentiment_score": "0.05988", "ticker_sentiment_label": "Neutral"}, {"ticker": "WAT", "relevance_score": "0.035875", "ticker_sentiment_score": "0.05988", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERFSF", "relevance_score": "0.035875", "ticker_sentiment_score": "0.05988", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.035875", "ticker_sentiment_score": "0.05988", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.071677", "ticker_sentiment_score": "0.092533", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina  ( ILMN )  Expands Globally Despite Macroeconomic Woes", "url": "https://www.zacks.com/stock/news/2196086/illumina-ilmn-expands-globally-despite-macroeconomic-woes", "time_published": "20231211T141300", "authors": ["Zacks Equity Research"], "summary": "The NovaSeq X launch strengthens Illumina's (ILMN) competitive position in high-throughput sequencing.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/08/595.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.972193"}], "overall_sentiment_score": 0.187342, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PODD", "relevance_score": "0.120834", "ticker_sentiment_score": "0.049781", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAE", "relevance_score": "0.200024", "ticker_sentiment_score": "0.07719", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.120834", "ticker_sentiment_score": "0.049781", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.387674", "ticker_sentiment_score": "0.167359", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Laboratory information management system (LIMS) market to grow by USD 897.05 million from 2022 to 2023 | Abbott ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/laboratory-information-management-system-lims-market-to-grow-by-usd-897-05-million-from-2022-to-2023--abbott-laboratories-accelerated-technology-laboratories-inc-agile-frameworks-llc-and-more-among-the-key-companies-in-the-m-302010642.html", "time_published": "20231211T013000", "authors": [], "summary": "Laboratory information management system ( LIMS ) market to grow by USD 897.05 million from 2022 to 2023 | Abbott ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.279211, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.061315", "ticker_sentiment_score": "0.098009", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.061315", "ticker_sentiment_score": "0.098009", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHMZF", "relevance_score": "0.061315", "ticker_sentiment_score": "0.098009", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.061315", "ticker_sentiment_score": "0.098009", "ticker_sentiment_label": "Neutral"}]}, {"title": "EHANG ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/ehang-ongoing-deadline-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-100-000-in-ehang-to-contact-him-directly-to-discuss-their-options-302010639.html", "time_published": "20231210T204500", "authors": [], "summary": "EHANG ONGOING DEADLINE ALERT: Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.082858, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VOD", "relevance_score": "0.131643", "ticker_sentiment_score": "-0.092833", "ticker_sentiment_label": "Neutral"}, {"ticker": "EH", "relevance_score": "0.638022", "ticker_sentiment_score": "-0.201423", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SKIN", "relevance_score": "0.066047", "ticker_sentiment_score": "0.208641", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SZIHF", "relevance_score": "0.066047", "ticker_sentiment_score": "-0.075127", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.131643", "ticker_sentiment_score": "0.224129", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UTHR", "relevance_score": "0.131643", "ticker_sentiment_score": "-0.092833", "ticker_sentiment_label": "Neutral"}]}, {"title": "ILLUMINA DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/illumina-deadline-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-exceeding-100-000-in-illumina-to-contact-him-directly-to-discuss-their-options-302010636.html", "time_published": "20231210T151500", "authors": [], "summary": "ILLUMINA DEADLINE ALERT: Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.650727"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.151568, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CHPT", "relevance_score": "0.130926", "ticker_sentiment_score": "0.259128", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.59016", "ticker_sentiment_score": "-0.014336", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBN2:MU", "relevance_score": "0.065685", "ticker_sentiment_score": "0.231728", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AstraZeneca Just Joined the AI Drug Development Craze, but Is It a Buy in 2024?", "url": "https://www.fool.com/investing/2023/12/10/astrazeneca-just-joined-the-ai-drug-development/", "time_published": "20231210T134500", "authors": ["Alex Carchidi"], "summary": "It'll take a few years for its latest moves to pay off, assuming they do.", "banner_image": "https://g.foolcdn.com/editorial/images/757523/two-investors-meet-and-discuss.jpg", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.228775, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABSI", "relevance_score": "0.110717", "ticker_sentiment_score": "0.077865", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDGR", "relevance_score": "0.055492", "ticker_sentiment_score": "0.29", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AZN", "relevance_score": "0.272181", "ticker_sentiment_score": "0.100053", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.055492", "ticker_sentiment_score": "0.008996", "ticker_sentiment_label": "Neutral"}]}, {"title": "ROSEN, A TOP RANKED LAW FIRM, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ILMN", "url": "https://www.prnewswire.com/news-releases/rosen-a-top-ranked-law-firm-encourages-illumina-inc-investors-with-losses-to-secure-counsel-before-important-deadline-in-securities-class-action--ilmn-302010333.html", "time_published": "20231208T202700", "authors": ["P. A.", "THE ROSEN LAW FIRM"], "summary": "ROSEN, A TOP RANKED LAW FIRM, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before ... PR ...", "banner_image": "https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.221019, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.067536", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.328236", "ticker_sentiment_score": "0.369039", "ticker_sentiment_label": "Bullish"}]}, {"title": "DEADLINE ALERT for FMC, ILMN, PAYC, JRVR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders - Illumina  ( NASDAQ:ILMN ) , FMC  ( NYSE:FMC ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36157720/deadline-alert-for-fmc-ilmn-payc-jrvr-law-offices-of-howard-g-smith-reminds-investors-of-class-act", "time_published": "20231208T180346", "authors": ["Globe Newswire"], "summary": "BENSALEM, Pa., Dec. 08, 2023 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.77141"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.039236, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSSMY", "relevance_score": "0.270973", "ticker_sentiment_score": "0.071347", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JRVR", "relevance_score": "0.164656", "ticker_sentiment_score": "-0.033654", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAYC", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina  ( ILMN )  Investors Bring Class Action for Insiders' Failure to Disclose Conflicts of Interest of GRAIL Deal - Hagens Berman - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36153645/illumina-ilmn-investors-bring-class-action-for-insiders-failure-to-disclose-conflicts-of-interest-", "time_published": "20231208T142700", "authors": ["Globe Newswire"], "summary": "SAN FRANCISCO, Dec. 08, 2023 ( GLOBE NEWSWIRE ) -- Hagens Berman urges Illumina, Inc. ILMN investors who suffered substantial losses to submit your losses now. Class Period: May 1, 2023 - Oct. 16, 2023Lead Plaintiff Deadline: Jan. 9, 2024Visit: www.hbsslaw.com/investor-fraud/ILMN Contact An ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.017096, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.829093", "ticker_sentiment_score": "0.020735", "ticker_sentiment_label": "Neutral"}]}, {"title": "ROSEN, LEADING INVESTOR COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ILMN - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36146869/rosen-leading-investor-counsel-encourages-illumina-inc-investors-to-secure-counsel-before-importan", "time_published": "20231208T002040", "authors": ["Globe Newswire"], "summary": "NEW YORK, Dec. 07, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Illumina, Inc. ILMN between May 1, 2023 and October 16, 2023, both dates inclusive ( the \"Class Period\" ) , of the important January 9, 2024 lead plaintiff ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.162344, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.064797", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.254973", "ticker_sentiment_score": "0.204498", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "DEADLINE ALERT for PAYC, ILMN, and JRVR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Illumina  ( NASDAQ:ILMN ) , James River Gr Hldgs  ( NASDAQ:JRVR ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36138353/deadline-alert-for-payc-ilmn-and-jrvr-the-law-offices-of-frank-r-cruz-reminds-investors-of-class-a", "time_published": "20231207T170600", "authors": ["Globe Newswire"], "summary": "LOS ANGELES, Dec. 07, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.684621"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.07269, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.159043", "ticker_sentiment_score": "-0.22263", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JRVR", "relevance_score": "0.159043", "ticker_sentiment_score": "-0.22263", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PAYC", "relevance_score": "0.079921", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Options Trading: A Deep Dive into Market Sentiment - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/markets/options/23/12/36120529/illumina-options-trading-a-deep-dive-into-market-sentiment", "time_published": "20231206T200127", "authors": ["Benzinga Insights"], "summary": "Whales with a lot of money to spend have taken a noticeably bearish stance on Illumina. Looking at options history for Illumina ILMN we detected 8 trades. If we consider the specifics of each trade, it is accurate to state that 25% of the investors opened trades with bullish expectations and 75% ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.073835, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.678673", "ticker_sentiment_score": "-0.026508", "ticker_sentiment_label": "Neutral"}]}, {"title": "ILLUMINA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Illumina, Inc. and Encourages Investors to Contact the Firm - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36105631/illumina-alert-bragar-eagel-squire-p-c-reminds-investors-that-a-class-action-lawsuit-has-been-file", "time_published": "20231206T020000", "authors": ["Globe Newswire"], "summary": "NEW YORK, Dec. 05, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Illumina, Inc. ( \"Illumina\" or the \"Company\" ) ILMN in the United States District Court for the ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": -0.021874, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.611653", "ticker_sentiment_score": "-0.039526", "ticker_sentiment_label": "Neutral"}]}, {"title": "Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Illumina, Inc.  ( ILMN )  - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36093767/glancy-prongay-murray-llp-reminds-investors-of-looming-deadline-in-the-class-action-lawsuit-agains", "time_published": "20231205T150000", "authors": ["Globe Newswire"], "summary": "LOS ANGELES, Dec. 05, 2023 ( GLOBE NEWSWIRE ) -- Glancy Prongay & Murray LLP ( \"GPM\" ) reminds investors of the upcoming January 9, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Illumina, Inc. ( \"Illumina\" or ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.038814, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.06697", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.59928", "ticker_sentiment_score": "0.067505", "ticker_sentiment_label": "Neutral"}]}, {"title": "Investors Sue Illumina  ( ILMN )  for Concealing Facts Concerning GRAIL Acquisition - Hagens Berman - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36077111/investors-sue-illumina-ilmn-for-concealing-facts-concerning-grail-acquisition-hagens-berman", "time_published": "20231204T194036", "authors": ["Globe Newswire"], "summary": "SAN FRANCISCO, Dec. 04, 2023 ( GLOBE NEWSWIRE ) -- Hagens Berman urges Illumina, Inc. ILMN investors who suffered substantial losses to submit your losses now. Class Period: May 1, 2023 - Oct. 16, 2023Lead Plaintiff Deadline: Jan. 9, 2024Visit: www.hbsslaw.com/investor-fraud/ILMN Contact An ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.009769, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.849667", "ticker_sentiment_score": "0.091563", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Unusual Options Activity - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/markets/options/23/12/36076108/illumina-unusual-options-activity", "time_published": "20231204T184544", "authors": ["Benzinga Insights"], "summary": "Investors with a lot of money to spend have taken a bullish stance on Illumina ILMN. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.064085, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.719473", "ticker_sentiment_score": "0.057881", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina, Inc.  ( ILMN )  Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds ILMN Investors of Securities Fraud Class Action Lawsuit Filed On Their Behalf - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36071792/illumina-inc-ilmn-shareholder-reminder-kessler-topaz-meltzer-check-llp-reminds-ilmn-investors-of-s", "time_published": "20231204T154000", "authors": ["Globe Newswire"], "summary": "RADNOR, Pa., Dec. 04, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against Illumina, Inc. ( ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.04852, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.785986", "ticker_sentiment_score": "-0.048346", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 -  ( NASDAQ: ILMN ) ", "url": "https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-illumina-inc-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-january-9-2024--nasdaq-ilmn-302003739.html", "time_published": "20231204T104500", "authors": ["The Gross Law Firm"], "summary": "SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a ... PR ...", "banner_image": "https://mma.prnewswire.com/media/2280333/The_Gross_Law_Firm_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.047451, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.348919", "ticker_sentiment_score": "0.143891", "ticker_sentiment_label": "Neutral"}]}, {"title": "In-vitro Diagnostics Market to grow by USD 33.16 billion from 2021 to 2026| The rising geriatric population with chronic ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/in-vitro-diagnostics-market-to-grow-by-usd-33-16-billion--from-2021-to-2026-the-rising-geriatric-population-with-chronic-and-infectious-diseases-drives-the-market-growth--technavio-302003823.html", "time_published": "20231204T032000", "authors": [], "summary": "In-vitro Diagnostics Market to grow by USD 33.16 billion from 2021 to 2026| The rising geriatric population with chronic ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.135751, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BMXMF", "relevance_score": "0.062926", "ticker_sentiment_score": "0.148111", "ticker_sentiment_label": "Neutral"}, {"ticker": "A", "relevance_score": "0.062926", "ticker_sentiment_score": "0.148111", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMAWF", "relevance_score": "0.062926", "ticker_sentiment_score": "0.148111", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSMXF", "relevance_score": "0.062926", "ticker_sentiment_score": "0.148111", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.062926", "ticker_sentiment_score": "0.148111", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.062926", "ticker_sentiment_score": "0.148111", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.062926", "ticker_sentiment_score": "0.148111", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.062926", "ticker_sentiment_score": "0.148111", "ticker_sentiment_label": "Neutral"}, {"ticker": "DGX", "relevance_score": "0.062926", "ticker_sentiment_score": "0.148111", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDX", "relevance_score": "0.062926", "ticker_sentiment_score": "0.148111", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.062926", "ticker_sentiment_score": "0.148111", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSRLF", "relevance_score": "0.062926", "ticker_sentiment_score": "0.148111", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRFS", "relevance_score": "0.062926", "ticker_sentiment_score": "0.148111", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.062926", "ticker_sentiment_score": "0.148111", "ticker_sentiment_label": "Neutral"}]}, {"title": "ILLUMINA SHAREHOLDER ALERT: Faruqi & Faruqi Securities Litigation Partner James  ( Josh )  Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36058089/illumina-shareholder-alert-faruqi-faruqi-securities-litigation-partner-james-josh-wilson-encourage", "time_published": "20231202T150000", "authors": ["Globe Newswire"], "summary": "If you suffered losses exceeding $100,000 investing in Illumina securities between May 1, 2023 and October 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 ( Ext. 1310 ) .", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": 0.12788, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.62382", "ticker_sentiment_score": "-0.018431", "ticker_sentiment_label": "Neutral"}]}, {"title": "ROSEN, A LEADING LAW FIRM, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ILMN - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36052485/rosen-a-leading-law-firm-encourages-illumina-inc-investors-with-losses-to-secure-counsel-before-im", "time_published": "20231201T204100", "authors": ["Globe Newswire"], "summary": "NEW YORK, Dec. 01, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Illumina, Inc. ILMN between May 1, 2023 and October 16, 2023, both dates inclusive ( the \"Class Period\" ) , of the important January 9, 2024 lead plaintiff ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.157537, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.064104", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.252332", "ticker_sentiment_score": "0.202835", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "DEADLINE ALERT for FMC, ILMN, PAYC, JRVR: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders - Illumina  ( NASDAQ:ILMN ) , FMC  ( NYSE:FMC ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36049356/deadline-alert-for-fmc-ilmn-payc-jrvr-law-offices-of-howard-g-smith-reminds-investors-of-class-act", "time_published": "20231201T182005", "authors": ["Globe Newswire"], "summary": "BENSALEM, Pa., Dec. 01, 2023 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.77141"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.039236, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DSSMY", "relevance_score": "0.270973", "ticker_sentiment_score": "0.071347", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JRVR", "relevance_score": "0.164656", "ticker_sentiment_score": "-0.033654", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAYC", "relevance_score": "0.110209", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "DEADLINE ALERT for PAYC, ILMN, and JRVR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Illumina  ( NASDAQ:ILMN ) , James River Gr Hldgs  ( NASDAQ:JRVR ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36047696/deadline-alert-for-payc-ilmn-and-jrvr-the-law-offices-of-frank-r-cruz-reminds-investors-of-class-a", "time_published": "20231201T170600", "authors": ["Globe Newswire"], "summary": "LOS ANGELES, Dec. 01, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.684621"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.07269, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.159043", "ticker_sentiment_score": "-0.22263", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JRVR", "relevance_score": "0.159043", "ticker_sentiment_score": "-0.22263", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PAYC", "relevance_score": "0.079921", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Transcript: Why markets had a stellar November", "url": "https://www.ft.com/content/3ac9be16-2b8c-4e48-b9eb-505d8889a0dd", "time_published": "20231201T050017", "authors": [], "summary": "This is an audio transcript of the FT News Briefing podcast episode: 'Why markets had a stellar November' Good morning from the Financial Times. Today is Friday, December 1st. And this is your FT News Briefing. Russian oil sanctions could be here to stay.", "banner_image": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2Fadcb99a3-1a93-4114-aad7-20af1dfb5b06.jpg?source=next-article&fit=scale-down&quality=highest&width=700&dpr=1", "source": "Financial Times", "category_within_source": "GoogleRSS", "source_domain": "www.ft.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.890401"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}, {"topic": "Earnings", "relevance_score": "0.576289"}], "overall_sentiment_score": 0.12187, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.041251", "ticker_sentiment_score": "-0.047108", "ticker_sentiment_label": "Neutral"}]}, {"title": "ILLUMINA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Illumina, Inc. and Encourages Investors to Contact the Firm - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g36036650/illumina-alert-bragar-eagel-squire-p-c-reminds-investors-that-a-class-action-lawsuit-has-been-file", "time_published": "20231201T020000", "authors": ["Globe Newswire"], "summary": "NEW YORK, Nov. 30, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Illumina, Inc. ( \"Illumina\" or the \"Company\" ) ILMN in the United States District Court for the ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": -0.021873, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.608634", "ticker_sentiment_score": "-0.039425", "ticker_sentiment_label": "Neutral"}]}, {"title": "Disney CEO Bob Iger says 'No. 1 priority' is turning around Marvel, acknowledges 'too many sequels' after box office misses | Business", "url": "https://www.cnn.com/2023/11/29/media/marvel-movies-bob-iger-disney/index.html", "time_published": "20231129T231400", "authors": ["Liam Reilly", "Jon Passantino"], "summary": "Disney CEO Bob Iger says 'No. 1 priority' is turning around Marvel, acknowledges 'too many sequels' after box office misses ...", "banner_image": "https://media.cnn.com/api/v1/images/stellar/prod/230831123358-01-the-marvels.jpg?c=16x9&q=h_144,w_256,c_fill", "source": "CNN", "category_within_source": "Markets", "source_domain": "www.cnn.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.218228, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NYT", "relevance_score": "0.057079", "ticker_sentiment_score": "0.093943", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYOC", "relevance_score": "0.057079", "ticker_sentiment_score": "-0.054", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.057079", "ticker_sentiment_score": "-0.03595", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.170075", "ticker_sentiment_score": "0.221931", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "US Supreme Court case on SEC could have wide impact on agency enforcement", "url": "https://www.reuters.com/business/us-supreme-court-case-sec-could-have-wide-impact-agency-enforcement-2023-11-29/", "time_published": "20231129T213000", "authors": ["Mike Scarcella"], "summary": "The seal of the U.S. Securities and Exchange Commission ( SEC ) is seen at their headquarters in Washington, D.C., U.S., May 12, 2021. REUTERS/Andrew Kelly/File Photo Acquire Licensing Rights Nov 29 ( Reuters ) - The U.S. Supreme Court on Wednesday heard arguments on whether the U.S.", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/AL4Y36Y4HROH7F5ASBV4JTQ2EI.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.014608, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MAT", "relevance_score": "0.2306", "ticker_sentiment_score": "0.029257", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.154951", "ticker_sentiment_score": "-0.001393", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina, Inc. investors: Please contact the Portnoy Law Firm to recover your losses - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35992141/illumina-inc-investors-please-contact-the-portnoy-law-firm-to-recover-your-losses", "time_published": "20231128T234616", "authors": ["Globe Newswire"], "summary": "Investors can contact the law firm at no cost to learn more about recovering their losses", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.124463, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.526455", "ticker_sentiment_score": "-0.313928", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Illumina, Inc.  ( ILMN )  Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Illumina, Inc. Class Action - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35971144/illumina-inc-ilmn-class-action-alert-robbins-llp-reminds-investors-of-the-lead-plaintiff-deadline-", "time_published": "20231128T004513", "authors": ["Globe Newswire"], "summary": "SAN DIEGO, Nov. 27, 2023 ( GLOBE NEWSWIRE ) -- Robbins LLP reminds investors that a shareholder filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired Illumina, Inc. ILMN securities between May 1, 2023 and October 16, 2023.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}], "overall_sentiment_score": -0.002404, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.7887", "ticker_sentiment_score": "-0.032215", "ticker_sentiment_label": "Neutral"}]}, {"title": "Lowey Dannenberg Notifies Illumina, Inc.  ( \"Illumina\" or the \"Company\" )   ( NASDAQ: ILMN )  Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35966839/lowey-dannenberg-notifies-illumina-inc-illumina-or-the-company-nasdaq-ilmn-investors-of-securities", "time_published": "20231127T195215", "authors": ["Globe Newswire"], "summary": "NEW YORK, Nov. 27, 2023 ( GLOBE NEWSWIRE ) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Illumina, Inc. ( \"Illumina\" or the \"Company\" ) ILMN for violations of the federal securities laws on ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.0, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.339356", "ticker_sentiment_score": "0.029277", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.116348", "ticker_sentiment_score": "0.013758", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 -  ( NASDAQ: ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35965370/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-illumina-inc-of-a-class-action-lawsu", "time_published": "20231127T181700", "authors": ["Globe Newswire"], "summary": "NEW YORK, Nov. 27, 2023 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Illumina, Inc. Shareholders who purchased shares of ILMN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.056952, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.310843", "ticker_sentiment_score": "0.127199", "ticker_sentiment_label": "Neutral"}]}, {"title": "HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Illumina  ( ILMN )  Investors with Substantial Losses to Contact Firm's Attorneys, Deadline Approaching in Securities Fraud Class Action - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35959068/hagens-berman-national-trial-attorneys-encourages-illumina-ilmn-investors-with-substantial-losses-", "time_published": "20231127T142200", "authors": ["Globe Newswire"], "summary": "SAN FRANCISCO, Nov. 27, 2023 ( GLOBE NEWSWIRE ) -- Hagens Berman urges Illumina, Inc. ILMN investors who suffered substantial losses to submit your losses now. Class Period: May 1, 2023 - Oct. 16, 2023Lead Plaintiff Deadline: Jan. 9, 2024Visit: www.hbsslaw.com/investor-fraud/ILMN", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.009775, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.85246", "ticker_sentiment_score": "0.091713", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Illumina Investors of a Lead Plaintiff Deadline of January 9, 2024", "url": "https://www.prnewswire.com/news-releases/shareholder-alert-the-law-offices-of-vincent-wong-remind-illumina-investors-of-a-lead-plaintiff-deadline-of-january-9-2024-301995438.html", "time_published": "20231127T104500", "authors": ["The Law Offices of Vincent Wong"], "summary": "SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Illumina Investors of a Lead Plaintiff Deadline of ... PR ...", "banner_image": "https://mma.prnewswire.com/media/2280315/Law_Offices_of_Vincent_Wong_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.064535, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.511256", "ticker_sentiment_score": "0.033711", "ticker_sentiment_label": "Neutral"}]}, {"title": "ROSEN, A LONGSTANDING LAW FIRM, Encourages Illumina, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ILMN - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35952251/rosen-a-longstanding-law-firm-encourages-illumina-inc-investors-with-losses-to-secure-counsel-befo", "time_published": "20231126T230300", "authors": ["Globe Newswire"], "summary": "NEW YORK, Nov. 26, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Illumina, Inc. ILMN between May 1, 2023 and October 16, 2023, both dates inclusive ( the \"Class Period\" ) , of the important January 9, 2024 lead plaintiff ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.157537, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.064104", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.252332", "ticker_sentiment_score": "0.19135", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "ILLUMINA ONGOING DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James  ( Josh )  Wilson Encourages Investors Who Suffered Losses In Illumina To Contact Him Directly To Discuss Their Options - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35951497/illumina-ongoing-deadline-alert-faruqi-faruqi-securities-litigation-partner-james-josh-wilson-enco", "time_published": "20231126T150000", "authors": ["Globe Newswire"], "summary": "If you purchased or acquired securities in Illumina between May 1, 2023 and October 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 ( Ext. 1310 ) . You may also click here for additional information: ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}], "overall_sentiment_score": 0.143898, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.621014", "ticker_sentiment_score": "0.010994", "ticker_sentiment_label": "Neutral"}]}, {"title": "ILLUMINA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Illumina, Inc. and Encourages Investors to Contact the Firm - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35950307/illumina-alert-bragar-eagel-squire-p-c-reminds-investors-that-a-class-action-lawsuit-has-been-file", "time_published": "20231126T020000", "authors": ["Globe Newswire"], "summary": "NEW YORK, Nov. 25, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Illumina, Inc. ( \"Illumina\" or the \"Company\" ) ILMN in the United States District Court for the ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": -0.021874, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.611653", "ticker_sentiment_score": "-0.039526", "ticker_sentiment_label": "Neutral"}]}, {"title": "ILMN Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Illumina, Inc.  ( ILMN )  Investors of Securities Fraud Class Action Lawsuit - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35949276/ilmn-class-action-reminder-kessler-topaz-meltzer-check-llp-reminds-illumina-inc-ilmn-investors-of-", "time_published": "20231125T155700", "authors": ["Globe Newswire"], "summary": "RADNOR, Pa., Nov. 25, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against Illumina, Inc. ( ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.04852, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.785986", "ticker_sentiment_score": "-0.048346", "ticker_sentiment_label": "Neutral"}]}, {"title": "ILLUMINA DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/illumina-deadline-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-in-illumina-to-contact-him-directly-to-discuss-their-options-301996286.html", "time_published": "20231125T151500", "authors": [], "summary": "ILLUMINA DEADLINE ALERT: Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.155815, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.592742", "ticker_sentiment_score": "0.010737", "ticker_sentiment_label": "Neutral"}, {"ticker": "NWG", "relevance_score": "0.131643", "ticker_sentiment_score": "0.246735", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "ACELYRIN DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/acelyrin-deadline-alert-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-in-acelyrin-to-contact-him-directly-to-discuss-their-options-301996113.html", "time_published": "20231125T151500", "authors": [], "summary": "ACELYRIN DEADLINE ALERT: Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.682689"}, {"topic": "Financial Markets", "relevance_score": "0.972756"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.166336, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ADBE", "relevance_score": "0.060541", "ticker_sentiment_score": "0.189058", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.120733", "ticker_sentiment_score": "0.215482", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SLRN", "relevance_score": "0.637911", "ticker_sentiment_score": "0.029487", "ticker_sentiment_label": "Neutral"}]}, {"title": "Microfluidic Market for Healthcare Application to grow by USD 43.27 billion from 2022 to 2027 | Growth Driven by the ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/microfluidic-market-for-healthcare-application-to-grow-by-usd-43-27-billion-from-2022-to-2027--growth-driven-by-the-compact-size-of-microfluidic-devices--technavio-301996828.html", "time_published": "20231124T231500", "authors": [], "summary": "Microfluidic Market for Healthcare Application to grow by USD 43.27 billion from 2022 to 2027 | Growth Driven by the ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.208298, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BMXMF", "relevance_score": "0.062434", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "A", "relevance_score": "0.062434", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.062434", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MASS", "relevance_score": "0.062434", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.062434", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDY", "relevance_score": "0.062434", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.062434", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.062434", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMECF", "relevance_score": "0.062434", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GE", "relevance_score": "0.062434", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.062434", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Illumina, Inc.  ( ILMN )  Investors and Encourages Investors to Contact the Firm Before January 9, 2024 - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35940238/kirby-mcinerney-llp-reminds-investors-that-a-class-action-lawsuit-has-been-filed-on-behalf-of-illu", "time_published": "20231124T150000", "authors": ["Globe Newswire"], "summary": "NEW YORK, Nov. 24, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.098652, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.744196", "ticker_sentiment_score": "0.175292", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Illumina, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ILMN", "url": "https://www.prnewswire.com/news-releases/rosen-a-globally-respected-law-firm-encourages-illumina-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action--ilmn-301996191.html", "time_published": "20231123T220000", "authors": ["P. A.", "THE ROSEN LAW FIRM"], "summary": "ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Illumina, Inc. Investors to Secure Counsel Before ... PR ...", "banner_image": "https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.221019, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.067536", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.328236", "ticker_sentiment_score": "0.369039", "ticker_sentiment_label": "Bullish"}]}, {"title": "Population Screening Market Is Expected To Reach $35.3 Billion By 2027 With The Rising Prevalence Of Cancer As Per The Business Research Company's Population Screening Global Market Report 2023", "url": "https://www.benzinga.com/pressreleases/23/11/g35920043/population-screening-market-is-expected-to-reach-35-3-billion-by-2027-with-the-rising-prevalence-o", "time_published": "20231122T163000", "authors": ["Globe Newswire"], "summary": "LONDON, Nov. 22, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Population Screening Global Market Report 2023, the global population screening market is gearing up for substantial growth, set to rise from $25.04 billion in 2022 to $27.02 billion in 2023, showcasing a ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.20794, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABT", "relevance_score": "0.058188", "ticker_sentiment_score": "0.147997", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEMHF", "relevance_score": "0.058188", "ticker_sentiment_score": "0.147997", "ticker_sentiment_label": "Neutral"}, {"ticker": "DGX", "relevance_score": "0.058188", "ticker_sentiment_score": "0.147997", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.058188", "ticker_sentiment_score": "-0.002023", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.058188", "ticker_sentiment_score": "0.147997", "ticker_sentiment_label": "Neutral"}]}, {"title": "Next-Generation Sequencing Data Analysis Market is Expected to Reach USD 5.4 billion by 2032, with a Projected 16.6 % CAGR| Transparency Market Research Inc.", "url": "https://www.benzinga.com/pressreleases/23/11/g35918471/next-generation-sequencing-data-analysis-market-is-expected-to-reach-usd-5-4-billion-by-2032-with-", "time_published": "20231122T153000", "authors": ["Globe Newswire"], "summary": "Wilmington, Delaware, United States, Nov. 22, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global next-generation sequencing data analysis market stood at US$ 1.17 billion in 2022 and the global market is projected to reach US$ 5.4 billion in 2032.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.125377, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.083687", "ticker_sentiment_score": "0.002067", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGC", "relevance_score": "0.041901", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "DEADLINE ALERT for PAYC, ILMN, and JRVR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Illumina  ( NASDAQ:ILMN ) , James River Gr Hldgs  ( NASDAQ:JRVR ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35912996/deadline-alert-for-payc-ilmn-and-jrvr-the-law-offices-of-frank-r-cruz-reminds-investors-of-class-a", "time_published": "20231122T112900", "authors": ["Globe Newswire"], "summary": "LOS ANGELES, Nov. 22, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.684621"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.07269, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.159043", "ticker_sentiment_score": "-0.22263", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JRVR", "relevance_score": "0.159043", "ticker_sentiment_score": "-0.22263", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PAYC", "relevance_score": "0.079921", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Illumina Investors of a Lead Plaintiff Deadline of January 9, 2024 - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35902708/shareholder-alert-the-law-offices-of-vincent-wong-remind-illumina-investors-of-a-lead-plaintiff-de", "time_published": "20231121T181000", "authors": ["Globe Newswire"], "summary": "NEW YORK, Nov. 21, 2023 ( GLOBE NEWSWIRE ) -- Attention Illumina, Inc. ( \"Illumina\" ) ILMN shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between May 1, 2023 and October 16, 2023.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.054039, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.739411", "ticker_sentiment_score": "0.040239", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Illumina, Inc. - ILMN - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35896084/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-illumina-inc-il", "time_published": "20231121T144300", "authors": ["Globe Newswire"], "summary": "NEW YORK, Nov. 21, 2023 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Illumina, Inc. ( \"Illumina\" or the \"Company\" ) ILMN. Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": -0.069752, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.813165", "ticker_sentiment_score": "-0.200276", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "ILLUMINA ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Illumina, Inc. and Encourages Investors to Contact the Firm - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35886409/illumina-alert-bragar-eagel-squire-p-c-reminds-investors-that-a-class-action-lawsuit-has-been-file", "time_published": "20231121T020000", "authors": ["Globe Newswire"], "summary": "NEW YORK, Nov. 20, 2023 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Illumina, Inc. ( \"Illumina\" or the \"Company\" ) ILMN in the United States District Court for the ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": -0.021873, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.608634", "ticker_sentiment_score": "-0.039425", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ALERT: Levi & Korsinsky Notifies Illumina, Inc.  ( ILMN )  Investors of a Class Action Lawsuit and Upcoming Deadline - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35879022/shareholder-alert-levi-korsinsky-notifies-illumina-inc-ilmn-investors-of-a-class-action-lawsuit-an", "time_published": "20231120T180100", "authors": ["Globe Newswire"], "summary": "NEW YORK, Nov. 20, 2023 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Illumina, Inc. ( \"Illumina\" or the \"Company\" ) ILMN of a class action securities lawsuit.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.075769, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.568148", "ticker_sentiment_score": "-0.049056", "ticker_sentiment_label": "Neutral"}]}, {"title": "Myriad Genetics  ( MYGN )  Expands Pharma Services With New Pact", "url": "https://www.zacks.com/stock/news/2186741/myriad-genetics-mygn-expands-pharma-services-with-new-pact", "time_published": "20231120T161800", "authors": ["Zacks Equity Research"], "summary": "Myriad Genetics (MYGN) will market the Personalis ImmunoID NeXT ultra-comprehensive biomarker discovery platform to its pharmaceutical partners with a new collaboration.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.983605"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.098602, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PODD", "relevance_score": "0.191675", "ticker_sentiment_score": "0.067239", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAE", "relevance_score": "0.314017", "ticker_sentiment_score": "0.113074", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.191675", "ticker_sentiment_score": "0.067239", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.064449", "ticker_sentiment_score": "0.031156", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.428632", "ticker_sentiment_score": "0.288083", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Illumina Investors of a Lead Plaintiff Deadline of January 9, 2024", "url": "https://www.prnewswire.com/news-releases/shareholder-alert-the-law-offices-of-vincent-wong-remind-illumina-investors-of-a-lead-plaintiff-deadline-of-january-9-2024-301992405.html", "time_published": "20231120T104500", "authors": ["The Law Offices of Vincent Wong"], "summary": "SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Illumina Investors of a Lead Plaintiff Deadline of ... PR ...", "banner_image": "https://mma.prnewswire.com/media/2280279/Wong_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.064535, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.511256", "ticker_sentiment_score": "0.033711", "ticker_sentiment_label": "Neutral"}]}, {"title": "ILLUMINA ONGOING DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James  ( Josh )  Wilson Encourages Investors Who Suffered Losses In Illumina To Contact Him Directly To Discuss Their Options - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35865341/illumina-ongoing-deadline-alert-faruqi-faruqi-securities-litigation-partner-james-josh-wilson-enco", "time_published": "20231119T153000", "authors": ["Globe Newswire"], "summary": "If you purchased or acquired securities in Illumina between May 1, 2023 and October 16, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 ( Ext. 1310 ) . You may also click here for additional information: ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}], "overall_sentiment_score": 0.143898, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.621014", "ticker_sentiment_score": "0.010994", "ticker_sentiment_label": "Neutral"}]}, {"title": "ILLUMINA SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/illumina-shareholder-action-reminder-securities-litigation-partner-james-josh-wilson-encourages-investors-who-suffered-losses-in-illumina-to-contact-him-directly-to-discuss-their-options-301992700.html", "time_published": "20231118T151500", "authors": [], "summary": "ILLUMINA SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James ( Josh ) Wilson Encourages ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.153442, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ADBE", "relevance_score": "0.06623", "ticker_sentiment_score": "0.189555", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.59404", "ticker_sentiment_score": "0.010749", "ticker_sentiment_label": "Neutral"}]}, {"title": "10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies", "url": "https://www.prnewswire.com/news-releases/10x-genomics-wins-another-patent-infringement-case-against-nanostring-technologies-301992620.html", "time_published": "20231117T222200", "authors": ["10x Genomics", "Inc"], "summary": "Jury Awards 10x Genomics Over $31 Million in Damages and Finds All Seven Asserted Patents Valid and Willfully Infringed by NanoString GeoMx Decision is Third Ruling Against NanoString, Showing Serial Infringement of 10x Patents", "banner_image": "https://mma.prnewswire.com/media/1700607/10x_Genomics_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.795202"}], "overall_sentiment_score": 0.019268, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NSTG", "relevance_score": "0.061081", "ticker_sentiment_score": "-0.004016", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.030563", "ticker_sentiment_score": "-0.09457", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.434514", "ticker_sentiment_score": "0.102226", "ticker_sentiment_label": "Neutral"}]}, {"title": "DEADLINE ALERT for PAYC, ILMN, and JRVR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Illumina  ( NASDAQ:ILMN ) , James River Gr Hldgs  ( NASDAQ:JRVR ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35852665/deadline-alert-for-payc-ilmn-and-jrvr-the-law-offices-of-frank-r-cruz-reminds-investors-of-class-a", "time_published": "20231117T170600", "authors": ["Globe Newswire"], "summary": "LOS ANGELES, Nov. 17, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.684621"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.07269, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.159043", "ticker_sentiment_score": "-0.22263", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JRVR", "relevance_score": "0.159043", "ticker_sentiment_score": "-0.22263", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PAYC", "relevance_score": "0.079921", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Filed Against Illumina, Inc. - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35841392/kessler-topaz-meltzer-check-llp-announces-a-securities-fraud-class-action-filed-against-illumina-i", "time_published": "20231117T002317", "authors": ["Globe Newswire"], "summary": "RADNOR, Pa., Nov. 16, 2023 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of California against Illumina, Inc. ( ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.04852, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.785986", "ticker_sentiment_score": "-0.048346", "ticker_sentiment_label": "Neutral"}]}, {"title": "ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ILMN - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35840361/rosen-recognized-investor-counsel-encourages-illumina-inc-investors-to-secure-counsel-before-impor", "time_published": "20231116T224100", "authors": ["Globe Newswire"], "summary": "NEW YORK, Nov. 16, 2023 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Illumina, Inc. ILMN between May 1, 2023 and October 16, 2023, both dates inclusive ( the \"Class Period\" ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.143859, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.064449", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.253646", "ticker_sentiment_score": "0.126162", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina: Company Investigated by the Portnoy Law Firm - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35839419/illumina-company-investigated-by-the-portnoy-law-firm", "time_published": "20231116T215003", "authors": ["Globe Newswire"], "summary": "Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Nov. 16, 2023 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises Illumina, Inc. ( \"Illumina\" or \"the Company\" ) ILMN investors that the firm has initiated an investigation into possible ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.00241, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.608634", "ticker_sentiment_score": "-0.057372", "ticker_sentiment_label": "Neutral"}]}, {"title": "Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Illumina, Inc.  ( ILMN )  - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35836548/gainey-mckenna-egleston-announces-a-class-action-lawsuit-has-been-filed-against-illumina-inc-ilmn", "time_published": "20231116T195753", "authors": ["Globe Newswire"], "summary": "NEW YORK, Nov. 16, 2023 ( GLOBE NEWSWIRE ) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons or entities who purchased or otherwise acquired Illumina, ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.093109, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.478939", "ticker_sentiment_score": "0.301426", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Illumina, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2024 -  ( NASDAQ: ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35834439/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-illumina-inc-of-a-class-action-lawsu", "time_published": "20231116T181500", "authors": ["Globe Newswire"], "summary": "NEW YORK, Nov. 16, 2023 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Illumina, Inc. Shareholders who purchased shares of ILMN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.056952, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.310843", "ticker_sentiment_score": "0.127199", "ticker_sentiment_label": "Neutral"}]}, {"title": "QIAGEN  ( QGEN )  Expands Sample Technologies Line With New Launch", "url": "https://www.zacks.com/stock/news/2185396/qiagen-qgen-expands-sample-technologies-line-with-new-launch", "time_published": "20231116T145800", "authors": ["Zacks Equity Research"], "summary": "QIAGEN's (QGEN) latest launches will better address the special needs of researchers working with challenging samples, allowing them to work more efficiently.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/4c/2710.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.27567, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "QGEN", "relevance_score": "0.286082", "ticker_sentiment_score": "0.252355", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABT", "relevance_score": "0.097259", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.193078", "ticker_sentiment_score": "0.027615", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.193078", "ticker_sentiment_score": "0.027615", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.04872", "ticker_sentiment_score": "0.167946", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina  ( ILMN )  Launches Initiative on Pathogen Sequencing", "url": "https://www.zacks.com/stock/news/2185110/illumina-ilmn-launches-initiative-on-pathogen-sequencing", "time_published": "20231116T114900", "authors": ["Zacks Equity Research"], "summary": "Illumina (ILMN) introduces a new initiative to drive more equitable access to genomics globally.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/13/54831.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972193"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.132554, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PODD", "relevance_score": "0.140896", "ticker_sentiment_score": "0.053661", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAE", "relevance_score": "0.232661", "ticker_sentiment_score": "0.086979", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.140896", "ticker_sentiment_score": "0.053661", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.364053", "ticker_sentiment_score": "0.1515", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Investors Sue Illumina  ( ILMN )  for Concealing Facts Concerning GRAIL Acquisition - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35818510/investors-sue-illumina-ilmn-for-concealing-facts-concerning-grail-acquisition", "time_published": "20231115T225757", "authors": ["Globe Newswire"], "summary": "SAN FRANCISCO, Nov. 15, 2023 ( GLOBE NEWSWIRE ) -- Hagens Berman urges Illumina, Inc. ILMN investors who suffered substantial losses to submit your losses now. Class Period: May 1, 2023 - Oct. 16, 2023Lead Plaintiff Deadline: Jan. 9, 2024Visit: www.hbsslaw.com/investor-fraud/ILMN Contact An ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.009769, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.849667", "ticker_sentiment_score": "0.091563", "ticker_sentiment_label": "Neutral"}]}, {"title": "Exclusive: ValueAct takes stakes in Recruit and Expedia, says they are poised for strong growth", "url": "https://www.reuters.com/markets/deals/valueact-takes-stakes-recruit-expedia-says-they-are-poised-strong-growth-2023-11-15/", "time_published": "20231115T165900", "authors": ["Svea Herbst-Bayliss"], "summary": "The Recruit logo is displayed at its headquarters in Tokyo, Japan May 10, 2022. REUTERS/Mayu Sakoda/ Acquire Licensing Rights", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/X5KLRIWKSJMUVLPPOMTE4F43JA.jpg", "source": "Reuters", "category_within_source": "Markets", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Earnings", "relevance_score": "0.576289"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.268431, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EXPE", "relevance_score": "0.333557", "ticker_sentiment_score": "0.26388", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MSFT", "relevance_score": "0.068698", "ticker_sentiment_score": "0.235335", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RBLX", "relevance_score": "0.068698", "ticker_sentiment_score": "0.050131", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.068698", "ticker_sentiment_score": "0.050131", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.068698", "ticker_sentiment_score": "0.050131", "ticker_sentiment_label": "Neutral"}]}, {"title": "Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Illumina, Inc.  ( ILMN )  - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35792402/shareholder-alert-robbins-llp-informs-shareholders-of-class-action-filed-against-illumina-inc-ilmn", "time_published": "20231114T222837", "authors": ["Globe Newswire"], "summary": "SAN DIEGO, Nov. 14, 2023 ( GLOBE NEWSWIRE ) -- Robbins LLP informs investors that a shareholder filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired Illumina, Inc. ILMN securities between May 1, 2023 and October 16, 2023.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}], "overall_sentiment_score": -0.002404, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.7887", "ticker_sentiment_score": "-0.032215", "ticker_sentiment_label": "Neutral"}]}, {"title": "Class Action Lawsuit Filed Against Illumina, Inc.  ( ILMN )  on Behalf of Investors - Nationally Ranked Investors' Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35782146/class-action-lawsuit-filed-against-illumina-inc-ilmn-on-behalf-of-investors-nationally-ranked-inve", "time_published": "20231114T164148", "authors": ["Globe Newswire"], "summary": "ATLANTA, Nov. 14, 2023 ( GLOBE NEWSWIRE ) -- Holzer & Holzer, LLC informs investors that a shareholder class action lawsuit has been filed against Illumina, Inc. ( \"Illumina\" or the \"Company\" ) ILMN. The lawsuit alleges Illumina made false or misleading statements and/or omitted material adverse ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.009807, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.704675", "ticker_sentiment_score": "0.062515", "ticker_sentiment_label": "Neutral"}]}, {"title": "As Illumina stock bounces off a 10-year low, analysts see no quick fix", "url": "https://www.marketwatch.com/story/as-illumina-stock-bounces-off-a-10-year-low-analysts-see-no-quick-fix-3348af60", "time_published": "20231114T154100", "authors": ["Eleanor Laise"], "summary": "DNA-sequencing company juggles leadership transition, questions about a new product launch, and unwinding of a troubled acquisition ...", "banner_image": "https://images.mktw.net/im-756589/social", "source": "MarketWatch", "category_within_source": "Top Stories", "source_domain": "www.marketwatch.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": -0.055589, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVR", "relevance_score": "0.056011", "ticker_sentiment_score": "0.025105", "ticker_sentiment_label": "Neutral"}, {"ticker": "A", "relevance_score": "0.056011", "ticker_sentiment_score": "-0.011997", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTD", "relevance_score": "0.111747", "ticker_sentiment_score": "-0.040816", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.739039", "ticker_sentiment_score": "-0.070902", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.111747", "ticker_sentiment_score": "-0.040816", "ticker_sentiment_label": "Neutral"}]}, {"title": "LGND or ILMN: Which Is the Better Value Stock Right Now?", "url": "https://www.zacks.com/stock/news/2183460/lgnd-or-ilmn-which-is-the-better-value-stock-right-now", "time_published": "20231113T164010", "authors": ["Zacks Equity Research"], "summary": "LGND vs. ILMN: Which Stock Is the Better Value Option?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default36.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.838487"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.491145, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.657184", "ticker_sentiment_score": "0.581601", "ticker_sentiment_label": "Bullish"}, {"ticker": "LGND", "relevance_score": "0.764287", "ticker_sentiment_score": "0.611427", "ticker_sentiment_label": "Bullish"}]}, {"title": "Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle-income countries", "url": "https://www.prnewswire.com/apac/news-releases/illumina-launches-global-health-access-initiative-to-support-acceleration-of-pathogen-sequencing-in-low--and-middle-income-countries-301985472.html", "time_published": "20231113T141500", "authors": ["Illumina", "Inc."], "summary": "Illumina launches Global Health Access Initiative to support acceleration of pathogen sequencing in low- and middle ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1876671/Illumina_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.10789, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.044551", "ticker_sentiment_score": "0.105156", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.044551", "ticker_sentiment_score": "0.105156", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.345073", "ticker_sentiment_score": "0.187788", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Company News for Nov 13, 2023", "url": "https://www.zacks.com/stock/news/2183133/company-news-for-nov-13-2023", "time_published": "20231113T130200", "authors": ["Zacks Equity Research"], "summary": "Companies In The News Are: ILMN, CTRE, WPM, FLO.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f6/47493.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.576289"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}], "overall_sentiment_score": 0.073997, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "FLO", "relevance_score": "0.601928", "ticker_sentiment_score": "-0.351004", "ticker_sentiment_label": "Bearish"}, {"ticker": "CTRE", "relevance_score": "0.601928", "ticker_sentiment_score": "0.254949", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WPM", "relevance_score": "0.601928", "ticker_sentiment_score": "0.467332", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.601928", "ticker_sentiment_score": "0.010663", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Illumina, Inc. with Losses of $100,000 to Contact the Firm", "url": "https://markets.businessinsider.com/news/stocks/shareholder-action-alert-the-schall-law-firm-encourages-investors-in-illumina-inc.-with-losses-of-100000-to-contact-the-firm-1032808393", "time_published": "20231111T022700", "authors": ["NEWSFILE"], "summary": "SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Illumina, Inc. with Losses of $100000 ... - Markets Insider ...", "banner_image": "https://api.newsfilecorp.com/newsinfo/187115/208", "source": "Business Insider", "category_within_source": "GoogleRSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": -0.022001, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.572601", "ticker_sentiment_score": "-0.174837", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Illumina, Inc. investors: Please contact the Portnoy Law Firm to recover your losses - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35735284/illumina-inc-investors-please-contact-the-portnoy-law-firm-to-recover-your-losses", "time_published": "20231110T231222", "authors": ["Globe Newswire"], "summary": "LOS ANGELES, Nov. 10, 2023 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises Illumina, Inc. ( \"Illumina\" or the \"Company\" ) ILMN investors that a lawsuit filed on behalf of investors that purchased Illumina securities between May 1, 2023 and October 16, 2023, inclusive ( the \"Class Period\" ) .", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.107966, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.546745", "ticker_sentiment_score": "-0.320477", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Dow Jones Gains 280 Points On Economic Data; Plug Dives On Warning", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-gains-250-points-on-soft-data-plug-dives-on-warning/", "time_published": "20231110T185300", "authors": ["Investor's Business Daily", "VIDYA RAMAKRISHNAN"], "summary": "Dow Jones Gains 280 Points On Economic Data. Plug Dives On ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2021/01/Stock-TaiwanSemi-fabEntrance-company.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.995015"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.009689, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.123844", "ticker_sentiment_score": "-0.080546", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.123844", "ticker_sentiment_score": "-0.080546", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTD", "relevance_score": "0.123844", "ticker_sentiment_score": "-0.253768", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "U", "relevance_score": "0.123844", "ticker_sentiment_score": "0.153224", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.123844", "ticker_sentiment_score": "-0.231767", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "INTC", "relevance_score": "0.123844", "ticker_sentiment_score": "-0.080546", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLNK", "relevance_score": "0.123844", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKE", "relevance_score": "0.123844", "ticker_sentiment_score": "-0.080546", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOCS", "relevance_score": "0.123844", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLUG", "relevance_score": "0.123844", "ticker_sentiment_score": "-0.124845", "ticker_sentiment_label": "Neutral"}, {"ticker": "BA", "relevance_score": "0.123844", "ticker_sentiment_score": "-0.080546", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Illumina Inc Stock Is Falling - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/23/11/35730319/why-illumina-inc-stock-is-falling", "time_published": "20231110T172733", "authors": ["Erica Kollmann"], "summary": "llumina, Inc. ILMN shares are trading lower Friday after the company reported mixed third-quarter financial results on Thursday. Illumina reported quarterly earnings of 33 cents per share, beating the analyst consensus estimate of 12 cents per share and quarterly revenue of $1.12 billion, missing ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/11/10/illumina_inc_stock_falling_ilmn_shares_down_earnings.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.976913"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.109853, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.92456", "ticker_sentiment_score": "0.131719", "ticker_sentiment_label": "Neutral"}]}, {"title": "Dow Jones Rally Led By Intel Stock, Boeing; Security Software Leader Makes Bullish Move Ahead Of Results", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-rally-intel-stock-boeing-security-software-leader-bullish-move/", "time_published": "20231110T155200", "authors": ["Investor's Business Daily", "KEN SHREVE"], "summary": "Dow Jones Rally Led By Intel Stock, Boeing. Security Software ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2018/05/Stock-dow-04-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Economy - Monetary", "relevance_score": "0.451494"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.990786"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.098462, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NVDA", "relevance_score": "0.218817", "ticker_sentiment_score": "-0.029431", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.110462", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRWD", "relevance_score": "0.110462", "ticker_sentiment_score": "0.205961", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CVX", "relevance_score": "0.165031", "ticker_sentiment_score": "-0.156415", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TTD", "relevance_score": "0.218817", "ticker_sentiment_score": "-0.048211", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.110462", "ticker_sentiment_score": "-0.290295", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MS", "relevance_score": "0.055364", "ticker_sentiment_score": "-0.182918", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DDOG", "relevance_score": "0.110462", "ticker_sentiment_score": "0.254792", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WYNN", "relevance_score": "0.110462", "ticker_sentiment_score": "-0.290295", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DEO", "relevance_score": "0.110462", "ticker_sentiment_score": "-0.290295", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MSFT", "relevance_score": "0.110462", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "QLYS", "relevance_score": "0.110462", "ticker_sentiment_score": "0.205961", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LNW", "relevance_score": "0.165031", "ticker_sentiment_score": "0.33561", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "U", "relevance_score": "0.110462", "ticker_sentiment_score": "-0.290295", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "INTC", "relevance_score": "0.110462", "ticker_sentiment_score": "0.132857", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAT", "relevance_score": "0.110462", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMD", "relevance_score": "0.110462", "ticker_sentiment_score": "0.293621", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ZS", "relevance_score": "0.165031", "ticker_sentiment_score": "0.179389", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FTI", "relevance_score": "0.165031", "ticker_sentiment_score": "0.081095", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBER", "relevance_score": "0.110462", "ticker_sentiment_score": "0.293621", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BA", "relevance_score": "0.110462", "ticker_sentiment_score": "0.132857", "ticker_sentiment_label": "Neutral"}, {"ticker": "PANW", "relevance_score": "0.110462", "ticker_sentiment_score": "0.205961", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "DNA-Reading Giant Crashes As Macro Pressures Guidance - Again", "url": "https://www.investors.com/news/technology/illumina-stock-crashes-after-pointing-to-slow-growth-again/", "time_published": "20231110T154200", "authors": ["Investor's Business Daily", "ALLISON GATLIN"], "summary": "Illumina Stock Crashes After Pointing To Slow Growth - Again Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2021/04/Stock-illumina-01-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.744043"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.980922"}], "overall_sentiment_score": -0.023964, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AZN", "relevance_score": "0.061159", "ticker_sentiment_score": "-0.133025", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.855104", "ticker_sentiment_score": "-0.107239", "ticker_sentiment_label": "Neutral"}]}, {"title": "Wall St eyes higher open as traders digest Powell's comments, await more data", "url": "https://www.reuters.com/markets/us/futures-mixed-after-powells-hawkish-tone-more-data-awaited-2023-11-10/", "time_published": "20231110T134800", "authors": ["Shristi A", "Amruta Khandekar"], "summary": "Traders work on the floor at the New York Stock Exchange ( NYSE ) in New York City, U.S., October 27, 2023. REUTERS/Brendan McDermid Acquire Licensing Rights", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/4QXBW6RP45FBRHDZQXLNRGX5UY.jpg", "source": "Reuters", "category_within_source": "Markets", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Economy - Monetary", "relevance_score": "0.838487"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.918141"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.077085, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NVDA", "relevance_score": "0.079921", "ticker_sentiment_score": "0.150708", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TSLA", "relevance_score": "0.079921", "ticker_sentiment_score": "0.150708", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "U", "relevance_score": "0.079921", "ticker_sentiment_score": "-0.308909", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ILMN", "relevance_score": "0.079921", "ticker_sentiment_score": "0.31097", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "COR", "relevance_score": "0.079921", "ticker_sentiment_score": "0.02318", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBA", "relevance_score": "0.079921", "ticker_sentiment_score": "0.02318", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLUG", "relevance_score": "0.079921", "ticker_sentiment_score": "-0.472876", "ticker_sentiment_label": "Bearish"}]}, {"title": "Synaptics To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday - Illumina  ( NASDAQ:ILMN ) , Hawaiian Electric Indus  ( NYSE:HE ) ", "url": "https://www.benzinga.com/news/23/11/35723825/synaptics-to-rally-over-41-here-are-10-top-analyst-forecasts-for-friday", "time_published": "20231110T130410", "authors": ["Lisa Levin"], "summary": "Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. B. Riley Securities raised Telos Corporation TLS price target from $2.75 to $4.5. B.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/11/10/synaptics_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.055757, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "HAWEL", "relevance_score": "0.16171", "ticker_sentiment_score": "0.041644", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGT", "relevance_score": "0.240489", "ticker_sentiment_score": "0.232992", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "U", "relevance_score": "0.240489", "ticker_sentiment_score": "-0.118471", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.16171", "ticker_sentiment_score": "0.041644", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.240489", "ticker_sentiment_score": "-0.123895", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERA", "relevance_score": "0.240489", "ticker_sentiment_score": "0.091559", "ticker_sentiment_label": "Neutral"}, {"ticker": "TLS", "relevance_score": "0.240489", "ticker_sentiment_score": "0.251555", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PLUG", "relevance_score": "0.240489", "ticker_sentiment_score": "0.003826", "ticker_sentiment_label": "Neutral"}, {"ticker": "HE", "relevance_score": "0.081276", "ticker_sentiment_score": "0.031059", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYNA", "relevance_score": "0.240489", "ticker_sentiment_score": "-0.036615", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWOU", "relevance_score": "0.16171", "ticker_sentiment_score": "-0.16093", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Illumina  ( ILMN )  Q3 Earnings Surpass Estimates, '23 View Cut", "url": "https://www.zacks.com/stock/news/2182172/illumina-ilmn-q3-earnings-surpass-estimates-23-view-cut", "time_published": "20231110T125200", "authors": ["Zacks Equity Research"], "summary": "Illumina (ILMN) reports solid earnings in the third quarter of 2023 amid a challenging macro environment.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c0/53200.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.650727"}], "overall_sentiment_score": 0.106773, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MEDP", "relevance_score": "0.147818", "ticker_sentiment_score": "0.021667", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENSG", "relevance_score": "0.147818", "ticker_sentiment_score": "0.021675", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.147818", "ticker_sentiment_score": "0.050945", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.571596", "ticker_sentiment_score": "0.259398", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "US Stocks Could Wobble As Powell's Inflation Obsession Intensifies Rate Uncertainty: Will Nasdaq Wipe Off Week's Gains? - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ", "url": "https://www.benzinga.com/news/earnings/23/11/35722783/us-stocks-could-wobble-as-powells-inflation-obsession-intensifies-rate-uncertainty-will-nasdaq-wipe", "time_published": "20231110T120817", "authors": ["Shanthi Rexaline"], "summary": "U.S. stocks are priming for a lackluster open on Friday, with the index futures trading on a narrowly mixed note. Interest rate worries have likely perked up, as reflected by the upward move in bond yields. Traders are also left to digest some disappointing earnings reports.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Loss-In-stocks.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Economy - Monetary", "relevance_score": "0.990678"}, {"topic": "Financial Markets", "relevance_score": "0.99676"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": -0.122034, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "HOLX", "relevance_score": "0.098255", "ticker_sentiment_score": "-0.028445", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTS", "relevance_score": "0.098255", "ticker_sentiment_score": "-0.028445", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTD", "relevance_score": "0.098255", "ticker_sentiment_score": "-0.028445", "ticker_sentiment_label": "Neutral"}, {"ticker": "U", "relevance_score": "0.098255", "ticker_sentiment_score": "-0.028445", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.098255", "ticker_sentiment_score": "-0.028445", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLNK", "relevance_score": "0.098255", "ticker_sentiment_score": "-0.028445", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPLA", "relevance_score": "0.049221", "ticker_sentiment_score": "-0.050987", "ticker_sentiment_label": "Neutral"}, {"ticker": "WYNN", "relevance_score": "0.098255", "ticker_sentiment_score": "-0.028445", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLUG", "relevance_score": "0.098255", "ticker_sentiment_score": "-0.430977", "ticker_sentiment_label": "Bearish"}, {"ticker": "IVZ", "relevance_score": "0.049221", "ticker_sentiment_score": "0.062998", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHHLF", "relevance_score": "0.049221", "ticker_sentiment_score": "-0.026661", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGF-A", "relevance_score": "0.049221", "ticker_sentiment_score": "-0.026661", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.098255", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:ETH", "relevance_score": "0.146916", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:ETC", "relevance_score": "0.098255", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Unity Software, Groupon, Trade Desk And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Applied Optoelectronics  ( NASDAQ:AAOI ) , Ballard Power Systems  ( NASDAQ:BLDP ) ", "url": "https://www.benzinga.com/news/23/11/35722026/unity-software-groupon-trade-desk-and-other-big-stocks-moving-lower-in-fridays-pre-market-session", "time_published": "20231110T112443", "authors": ["Lisa Levin"], "summary": "U.S. stock futures traded mixed this morning on Friday, with the Dow Jones futures gaining around 40 points this morning. Shares of Unity Software Inc. U fell sharply in pre-market trading after the company reported worse-than-expected third-quarter revenue results.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/11/10/unity_software_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.723405"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.997874"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": -0.133757, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AAOI", "relevance_score": "0.18967", "ticker_sentiment_score": "-0.28837", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FCEL", "relevance_score": "0.18967", "ticker_sentiment_score": "-0.398988", "ticker_sentiment_label": "Bearish"}, {"ticker": "TTD", "relevance_score": "0.18967", "ticker_sentiment_score": "0.237306", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.18967", "ticker_sentiment_score": "-0.234368", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "WEST", "relevance_score": "0.18967", "ticker_sentiment_score": "-0.309373", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GRPN", "relevance_score": "0.18967", "ticker_sentiment_score": "-0.060567", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLDP", "relevance_score": "0.281153", "ticker_sentiment_score": "0.136374", "ticker_sentiment_label": "Neutral"}, {"ticker": "WYNN", "relevance_score": "0.18967", "ticker_sentiment_score": "-0.361294", "ticker_sentiment_label": "Bearish"}, {"ticker": "PLUG", "relevance_score": "0.18967", "ticker_sentiment_score": "-0.060567", "ticker_sentiment_label": "Neutral"}, {"ticker": "DEO", "relevance_score": "0.281153", "ticker_sentiment_score": "0.357701", "ticker_sentiment_label": "Bullish"}, {"ticker": "HAWEL", "relevance_score": "0.095517", "ticker_sentiment_score": "-0.373891", "ticker_sentiment_label": "Bearish"}, {"ticker": "WRK", "relevance_score": "0.095517", "ticker_sentiment_score": "-0.214977", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "U", "relevance_score": "0.368773", "ticker_sentiment_score": "-0.251742", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HE", "relevance_score": "0.095517", "ticker_sentiment_score": "-0.373891", "ticker_sentiment_label": "Bearish"}]}, {"title": "Lions Gate shares rise on surprise profit, Plug Power stock plunges on supply warning and more moving stocks", "url": "https://www.marketwatch.com/story/lions-gate-shares-rise-on-surprise-profit-plug-power-stock-plunges-on-supply-warning-and-more-moving-stocks-19f59cf7", "time_published": "20231110T104900", "authors": ["MarketWatch"], "summary": "Shares in Synaptics, Lions Gate Entertainment, Plug Power, Trade Desk, Unity Software and Illumina were all active in pre market trading.", "banner_image": "https://images.mktw.net/im-885093/social", "source": "MarketWatch", "category_within_source": "Top Stories", "source_domain": "www.marketwatch.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.650727"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.1275, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "TTD", "relevance_score": "0.353059", "ticker_sentiment_score": "0.155297", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "U", "relevance_score": "0.353059", "ticker_sentiment_score": "-0.273664", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ILMN", "relevance_score": "0.353059", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLUG", "relevance_score": "0.353059", "ticker_sentiment_score": "-0.505027", "ticker_sentiment_label": "Bearish"}, {"ticker": "SYNA", "relevance_score": "0.353059", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DEO", "relevance_score": "0.353059", "ticker_sentiment_score": "-0.33762", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LGF-A", "relevance_score": "0.181137", "ticker_sentiment_score": "0.061412", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina cuts annual profit forecast for second straight quarter", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/illumina-cuts-annual-profit-forecast-second-straight-quarter-2023-11-09/", "time_published": "20231109T225000", "authors": ["Reuters"], "summary": "A sign at the front entrance to the global headquarters of Illumina is pictured in San Diego, California, U.S., November 28, 2022. REUTERS/Mike Blake/File Photo Acquire Licensing Rights", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/WZ5NP67GVBJXFJ4WZXXR7OPFHU.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Earnings", "relevance_score": "0.650727"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.078904, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.542261", "ticker_sentiment_score": "-0.10456", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Reports Financial Results for Third Quarter of Fiscal Year 2023", "url": "https://www.prnewswire.com/news-releases/illumina-reports-financial-results-for-third-quarter-of-fiscal-year-2023-301983971.html", "time_published": "20231109T210500", "authors": ["Illumina", "Inc."], "summary": "SAN DIEGO, Nov. 9, 2023 /PRNewswire/ -- Illumina, Inc. ( Nasdaq: ILMN ) ( \"Illumina\" or the \"company\" ) today announced its financial results for the third quarter of fiscal year 2023, which include the consolidated financial results for GRAIL.", "banner_image": "https://mma.prnewswire.com/media/1876671/Illumina_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Economy - Monetary", "relevance_score": "0.108179"}, {"topic": "Financial Markets", "relevance_score": "0.999921"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.140129, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.010792", "ticker_sentiment_score": "0.084855", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.010792", "ticker_sentiment_score": "0.084855", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.254529", "ticker_sentiment_score": "0.112471", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTEFF", "relevance_score": "0.010792", "ticker_sentiment_score": "-0.055944", "ticker_sentiment_label": "Neutral"}]}, {"title": "S&P 500, Nasdaq Futures Mixed: Wall Street To Snap Longest Rally Since 2021? - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ", "url": "https://www.benzinga.com/news/earnings/23/11/35697040/wall-streets-longest-winning-streak-since-2021-to-snap-today-earnings-bond-yields-in-focus-ahead-of", "time_published": "20231109T122502", "authors": ["Shanthi Rexaline"], "summary": "The stock market's momentum appears to be waning, and futures suggest a mixed opening for Thursday. Earnings reports have generally been positive, with companies like Walt Disney Co. DIS posting encouraging quarterly results.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/nyse-shutter.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Economy - Monetary", "relevance_score": "0.928139"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.999975"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": 0.053097, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DNUT", "relevance_score": "0.082535", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WYNN", "relevance_score": "0.082535", "ticker_sentiment_score": "-0.051986", "ticker_sentiment_label": "Neutral"}, {"ticker": "WB", "relevance_score": "0.082535", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.041323", "ticker_sentiment_score": "0.151745", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HBI", "relevance_score": "0.082535", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAZR", "relevance_score": "0.082535", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGF-A", "relevance_score": "0.041323", "ticker_sentiment_score": "-0.049395", "ticker_sentiment_label": "Neutral"}, {"ticker": "DV", "relevance_score": "0.082535", "ticker_sentiment_score": "-0.051986", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOUN", "relevance_score": "0.082535", "ticker_sentiment_score": "-0.051986", "ticker_sentiment_label": "Neutral"}, {"ticker": "U", "relevance_score": "0.082535", "ticker_sentiment_score": "-0.051986", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMC", "relevance_score": "0.082535", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDX", "relevance_score": "0.082535", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLNK", "relevance_score": "0.082535", "ticker_sentiment_score": "-0.051986", "ticker_sentiment_label": "Neutral"}, {"ticker": "VSAT", "relevance_score": "0.082535", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPCE", "relevance_score": "0.082535", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVAX", "relevance_score": "0.082535", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTS", "relevance_score": "0.082535", "ticker_sentiment_score": "-0.051986", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.082535", "ticker_sentiment_score": "-0.051986", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLUG", "relevance_score": "0.082535", "ticker_sentiment_score": "-0.051986", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOLX", "relevance_score": "0.082535", "ticker_sentiment_score": "-0.051986", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGM", "relevance_score": "0.082535", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.082535", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "USFD", "relevance_score": "0.082535", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUBS", "relevance_score": "0.082535", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LI", "relevance_score": "0.082535", "ticker_sentiment_score": "0.123655", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFRM", "relevance_score": "0.082535", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.123526", "ticker_sentiment_score": "0.204878", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Investment bankers see dealmaking lull storing pent-up demand", "url": "https://www.reuters.com/markets/deals/reuters-next-investment-bankers-see-dealmaking-lull-storing-pent-up-demand-2023-11-08/", "time_published": "20231108T204100", "authors": ["Anirban Sen"], "summary": "A man is seen silhouetted wearing a protective face mask, amid the coronavirus disease ( COVID-19 ) pandemic, walking near the financial district of New York City, U.S., October 18, 2021. REUTERS/Shannon Stapleton/File Photo Acquire Licensing Rights", "banner_image": "https://s3.amazonaws.com/arc-authors/test/f9933778-f234-4e05-95e5-0a2ada95c2d1.png", "source": "Reuters", "category_within_source": "Markets", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.769861"}], "overall_sentiment_score": 0.095733, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.064623", "ticker_sentiment_score": "-0.018143", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.064623", "ticker_sentiment_score": "0.091084", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVX", "relevance_score": "0.064623", "ticker_sentiment_score": "-0.045026", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.064623", "ticker_sentiment_score": "-0.018143", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.064623", "ticker_sentiment_score": "-0.082394", "ticker_sentiment_label": "Neutral"}, {"ticker": "HES", "relevance_score": "0.064623", "ticker_sentiment_score": "-0.045026", "ticker_sentiment_label": "Neutral"}, {"ticker": "XOM", "relevance_score": "0.064623", "ticker_sentiment_score": "-0.045026", "ticker_sentiment_label": "Neutral"}, {"ticker": "GHL", "relevance_score": "0.064623", "ticker_sentiment_score": "0.20443", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GS", "relevance_score": "0.064623", "ticker_sentiment_score": "0.193381", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PXD", "relevance_score": "0.064623", "ticker_sentiment_score": "-0.045026", "ticker_sentiment_label": "Neutral"}]}, {"title": "Powell Takes the Stage, Followed by Mickey: Fed Speakers and Disney Earnings Dominate Wednesday's Proceedings - Comcast  ( NASDAQ:CMCSA ) , Walt Disney  ( NYSE:DIS ) ", "url": "https://www.benzinga.com/markets/23/11/35680187/powell-takes-the-stage-followed-by-mickey-fed-speakers-and-disney-earnings-dominate-wednesdays-proce", "time_published": "20231108T175103", "authors": ["Schwab Center for Financial Research"], "summary": "( Wednesday market open ) Today serves up remarks from Federal Reserve Chairman Jerome Powell for breakfast followed by an after-school snack of Walt Disney DIS earnings. In between, investors can munch on a host of Treasury auctions and Fed speeches.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/11/08/shutterstock_2255716461.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.972193"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.995015"}, {"topic": "Earnings", "relevance_score": "0.999336"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.019297, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "TGT", "relevance_score": "0.042271", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGM", "relevance_score": "0.042271", "ticker_sentiment_score": "0.115449", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSCO", "relevance_score": "0.042271", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.042271", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDX", "relevance_score": "0.042271", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WYNN", "relevance_score": "0.084423", "ticker_sentiment_score": "0.10872", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCZ", "relevance_score": "0.021143", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HD", "relevance_score": "0.042271", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:JPY", "relevance_score": "0.021143", "ticker_sentiment_score": "0.074673", "ticker_sentiment_label": "Neutral"}]}, {"title": "Global Precision Medicine Market Size Demonstrates Consistent Growth with a CAGR of 11.12%, with North America Taking a Leading Role - Illumina  ( NASDAQ:ILMN ) , Bristol-Myers Squibb  ( NYSE:BMY ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35674541/global-precision-medicine-market-size-demonstrates-consistent-growth-with-a-cagr-of-11-12-with-nor", "time_published": "20231108T145000", "authors": ["Globe Newswire"], "summary": "New York, United States, Nov. 08, 2023 ( GLOBE NEWSWIRE ) -- Precision medicine is a new approach to treating and preventing disease that considers each individual's genetic, environmental, and lifestyle differences. Giving the proper treatment to the right patient at the right time is the goal ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "0.108179"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.145794, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.039353", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.039353", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PACB", "relevance_score": "0.039353", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.194868", "ticker_sentiment_score": "0.144939", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.039353", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.039353", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.156461", "ticker_sentiment_score": "0.115839", "ticker_sentiment_label": "Neutral"}]}, {"title": "Sentiment Check: Market Under Pressure as Positive Feelings Dip Following Hawkish Remarks from Fed Official", "url": "https://www.benzinga.com/markets/23/11/35661550/sentiment-check-market-under-pressure-as-positive-feelings-dip-following-hawkish-remarks-from-fed-of", "time_published": "20231107T220839", "authors": ["Schwab Center for Financial Research"], "summary": "( Tuesday market open ) ) Five Federal Reserve officials are speaking today, but words from another Fed policymaker yesterday helped lead to early losses on Wall Street. Stocks fell in premarket trading on ideas that the battle against inflation may not be won and rate hikes may not be over.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/11/07/screenshot_2023-11-07_at_4.52.35_pm.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Economy - Monetary", "relevance_score": "0.928139"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.992549"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.99237"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.038682, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "TD", "relevance_score": "0.10579", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "OXY", "relevance_score": "0.042421", "ticker_sentiment_score": "0.062698", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.042421", "ticker_sentiment_score": "0.052988", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGM", "relevance_score": "0.10579", "ticker_sentiment_score": "0.015397", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.042421", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "INTC", "relevance_score": "0.042421", "ticker_sentiment_score": "-0.123705", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDX", "relevance_score": "0.042421", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCHW", "relevance_score": "0.063594", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WYNN", "relevance_score": "0.084722", "ticker_sentiment_score": "0.05653", "ticker_sentiment_label": "Neutral"}, {"ticker": "HD", "relevance_score": "0.042421", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBER", "relevance_score": "0.063594", "ticker_sentiment_score": "0.067112", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.042421", "ticker_sentiment_score": "-0.161099", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Pharmacogenomics Market Forecast 2023-2027: Market Growth Trends And Key Driving Factors As Per The Business Research Company's Pharmacogenomics Global Market Report 2023", "url": "https://www.benzinga.com/pressreleases/23/11/g35650608/pharmacogenomics-market-forecast-2023-2027-market-growth-trends-and-key-driving-factors-as-per-the", "time_published": "20231107T163000", "authors": ["Globe Newswire"], "summary": "LONDON, Nov. 07, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's report on the pharmacogenomics market, the global pharmacogenomics market is on an impressive growth trajectory, surging from $7.26 billion in 2022 to $7.97 billion in 2023, reflecting a robust compound annual ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.218245, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ERFSF", "relevance_score": "0.050148", "ticker_sentiment_score": "0.106276", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.050148", "ticker_sentiment_score": "0.106276", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.050148", "ticker_sentiment_score": "0.106276", "ticker_sentiment_label": "Neutral"}]}, {"title": "Seeking Clues to Illumina  ( ILMN )  Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics", "url": "https://www.zacks.com/stock/news/2179335/seeking-clues-to-illumina-ilmn-q3-earnings-a-peek-into-wall-street-projections-for-key-metrics", "time_published": "20231106T154100", "authors": ["Zacks Equity Research"], "summary": "Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Illumina (ILMN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2023.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default236.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.125208, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.36392", "ticker_sentiment_score": "0.120716", "ticker_sentiment_label": "Neutral"}]}, {"title": "Proteomics market to grow by USD 21.74 billion from 2022 to 2027|Agilent Technologies Inc., Applied Biomics Inc., Bio ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/proteomics-market-to-grow-by-usd-21-74-billion-from-2022-to-2027agilent-technologies-inc-applied-biomics-inc-bio-rad-laboratories-inc-and-more-among-the-key-companies-in-the-market---technavio-301977686.html", "time_published": "20231106T061500", "authors": [], "summary": "Proteomics market to grow by USD 21.74 billion from 2022 to 2027|Agilent Technologies Inc., Applied Biomics Inc., Bio ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.249164, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.066414", "ticker_sentiment_score": "0.106305", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.066414", "ticker_sentiment_score": "0.106305", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.066414", "ticker_sentiment_score": "0.106305", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRKR", "relevance_score": "0.066414", "ticker_sentiment_score": "0.106305", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSRLF", "relevance_score": "0.066414", "ticker_sentiment_score": "0.106305", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.066414", "ticker_sentiment_score": "0.106305", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.066414", "ticker_sentiment_score": "0.106305", "ticker_sentiment_label": "Neutral"}, {"ticker": "WAT", "relevance_score": "0.066414", "ticker_sentiment_score": "0.106305", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLK", "relevance_score": "0.066414", "ticker_sentiment_score": "0.106305", "ticker_sentiment_label": "Neutral"}]}, {"title": "Jim Cramer Highlights Key Earnings To Watch In The Energy Sector This Week: 'Bullish Herd To Continue To Thunder' - Celsius Holdings  ( NASDAQ:CELH ) , Trade Desk  ( NASDAQ:TTD ) , Illumina  ( NASDAQ:ILMN ) , Emerson Electric  ( NYSE:EMR ) ", "url": "https://www.benzinga.com/news/earnings/23/11/35606620/jim-cramer-highlights-key-earnings-to-watch-in-the-energy-sector-this-week-bullish-herd-to-continue", "time_published": "20231104T182221", "authors": ["Nabaparna Bhattacharya"], "summary": "CNBC market analyst Jim Cramer outlined the critical financial events and earnings disclosures anticipated in the upcoming week, spotlighting oil and gas companies such as Coterra Energy Inc. CTRA and Diamondback Energy, Inc. FANG, which are expected to share their financial performance.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/11/04/shutterstock_730916917.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.206494, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CELH", "relevance_score": "0.186738", "ticker_sentiment_score": "0.247756", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OXY", "relevance_score": "0.186738", "ticker_sentiment_score": "0.247756", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FANG", "relevance_score": "0.276909", "ticker_sentiment_score": "0.096154", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTD", "relevance_score": "0.186738", "ticker_sentiment_score": "0.163046", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.186738", "ticker_sentiment_score": "-0.040847", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.186738", "ticker_sentiment_score": "-0.040847", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMR", "relevance_score": "0.186738", "ticker_sentiment_score": "0.247756", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "K", "relevance_score": "0.186738", "ticker_sentiment_score": "0.182121", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DVN", "relevance_score": "0.186738", "ticker_sentiment_score": "0.247756", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTRA", "relevance_score": "0.186738", "ticker_sentiment_score": "-0.00455", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.186738", "ticker_sentiment_score": "-0.040847", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cramer's week ahead: Watch for earnings from oil and gas outfits", "url": "https://www.cnbc.com/2023/11/03/cramers-week-ahead-watch-for-earnings-from-oil-and-gas-outfits.html", "time_published": "20231103T224916", "authors": ["Julie Coleman"], "summary": "CNBC's Jim Cramer on Friday gave investors his insight on next week's Wall Street happenings.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107328952-1699054358MM-A-110323-short.jpg?v=1699054357&w=750&h=422&vtcrop=y", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.170467, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.079392", "ticker_sentiment_score": "-0.091551", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMR", "relevance_score": "0.079392", "ticker_sentiment_score": "0.095004", "ticker_sentiment_label": "Neutral"}, {"ticker": "K", "relevance_score": "0.079392", "ticker_sentiment_score": "0.137814", "ticker_sentiment_label": "Neutral"}, {"ticker": "FANG", "relevance_score": "0.079392", "ticker_sentiment_score": "0.095004", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTD", "relevance_score": "0.079392", "ticker_sentiment_score": "-0.111371", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.158", "ticker_sentiment_score": "-0.14516", "ticker_sentiment_label": "Neutral"}]}, {"title": "Mild Jobs Report Puts More Pressure On Falling Yields as Stocks On Pace For Best Week In A Year - Apple  ( NASDAQ:AAPL ) , Walt Disney  ( NYSE:DIS ) ", "url": "https://www.benzinga.com/markets/23/11/35597954/mild-jobs-report-puts-more-pressure-on-falling-yields-as-stocks-on-pace-for-best-week-in-a-year", "time_published": "20231103T174516", "authors": ["Schwab Center for Financial Research"], "summary": "( Friday market open ) A mild October U.S. jobs report Friday doesn't appear likely to dent recent market optimism about interest rates. The benchmark 10-year Treasury note yield fell another 10 basis points immediately after the data, potentially loosening pressure on stocks.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/11/03/shutterstock_1723527190_17.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.890401"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.055611, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ZBH", "relevance_score": "0.042048", "ticker_sentiment_score": "0.085772", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.104866", "ticker_sentiment_score": "0.071795", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.042048", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMCI", "relevance_score": "0.042048", "ticker_sentiment_score": "0.104984", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.042048", "ticker_sentiment_score": "0.085772", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHOP", "relevance_score": "0.042048", "ticker_sentiment_score": "0.104984", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTST", "relevance_score": "0.021031", "ticker_sentiment_score": "0.072576", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMND", "relevance_score": "0.042048", "ticker_sentiment_score": "0.104984", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBAY", "relevance_score": "0.042048", "ticker_sentiment_score": "0.085772", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDX", "relevance_score": "0.042048", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMD", "relevance_score": "0.042048", "ticker_sentiment_score": "0.104984", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBER", "relevance_score": "0.08398", "ticker_sentiment_score": "0.064132", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.042048", "ticker_sentiment_score": "-0.185859", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte  ( TIL )  Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer  ( SITC )  Annual Meeting", "url": "https://www.globenewswire.com/news-release/2023/11/03/2773037/0/en/Turnstone-Biologics-Presents-Preclinical-Data-Highlighting-Potential-for-Selected-Tumor-Infiltrating-Lymphocyte-TIL-Therapy-in-Solid-Tumors-at-the-2023-Society-for-Immunotherapy-of.html", "time_published": "20231103T100000", "authors": ["Turnstone Biologics Corp."], "summary": "Posters showcase Turnstone's novel Selected TIL programs which are designed to selectively expand the most potent tumor-reactive T cells for solid tumors.", "banner_image": "https://ml.globenewswire.com/Resource/Download/62caadda-2217-4cf7-af77-d7d1f53c8c31", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.105656, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.028388", "ticker_sentiment_score": "0.061237", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSBX", "relevance_score": "0.085022", "ticker_sentiment_score": "0.017827", "ticker_sentiment_label": "Neutral"}]}, {"title": "Treasuries, Stocks Extend Gains Following Fed Meeting as Apple, Jobs Report Loom - ConocoPhillips  ( NYSE:COP ) , Amazon.com  ( NASDAQ:AMZN ) ", "url": "https://www.benzinga.com/markets/23/11/35571776/treasuries-stocks-extend-gains-following-fed-meeting-as-apple-jobs-report-loom", "time_published": "20231102T174043", "authors": ["Schwab Center for Financial Research"], "summary": "( Thursday market open ) The World Series is over, but Wall Street remains in the thick of this week's triple play of a Fed meeting, Apple ( NASDAQ: AAPL ) earnings and Friday's October jobs report. So far, stocks are building up a lead as worries lessen about future Federal Reserve rate hikes.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/11/02/shutterstock_534465157_8.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Economy - Monetary", "relevance_score": "0.9545"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.009665, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ROKU", "relevance_score": "0.045353", "ticker_sentiment_score": "0.26219", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ZBH", "relevance_score": "0.045353", "ticker_sentiment_score": "0.086519", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.157778", "ticker_sentiment_score": "-0.029655", "ticker_sentiment_label": "Neutral"}, {"ticker": "COP", "relevance_score": "0.045353", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.045353", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.045353", "ticker_sentiment_score": "0.086519", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAH", "relevance_score": "0.045353", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHOP", "relevance_score": "0.045353", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.045353", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBAY", "relevance_score": "0.045353", "ticker_sentiment_score": "0.086519", "ticker_sentiment_label": "Neutral"}, {"ticker": "INTC", "relevance_score": "0.045353", "ticker_sentiment_score": "0.055727", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDX", "relevance_score": "0.045353", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLY", "relevance_score": "0.045353", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBER", "relevance_score": "0.045353", "ticker_sentiment_score": "0.086519", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.045353", "ticker_sentiment_score": "0.055727", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.045353", "ticker_sentiment_score": "-0.187044", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MAR", "relevance_score": "0.045353", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Earnings Preview: Illumina  ( ILMN )  Q3 Earnings Expected to Decline", "url": "https://www.zacks.com/stock/news/2177328/earnings-preview-illumina-ilmn-q3-earnings-expected-to-decline", "time_published": "20231102T140049", "authors": ["Zacks Equity Research"], "summary": "Illumina (ILMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default343.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.121687, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.257442", "ticker_sentiment_score": "0.001977", "ticker_sentiment_label": "Neutral"}, {"ticker": "GILD", "relevance_score": "0.087185", "ticker_sentiment_score": "0.038018", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cloudera Bolsters Executive Team to Accelerate Business Growth and Deliver Trusted Enterprise AI", "url": "https://www.prnewswire.com/news-releases/cloudera-bolsters-executive-team-to-accelerate-business-growth-and-deliver-trusted-enterprise-ai-301975897.html", "time_published": "20231102T130000", "authors": ["Inc.", "Cloudera"], "summary": "The trio of hires will directly support Charles Sansbury, who took the reins as CEO of the hybrid data leader in August", "banner_image": "https://mma.prnewswire.com/media/2264488/Cloudera_logo_blue_ID_4a9939806ece__large.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.354883, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "HPQ", "relevance_score": "0.058615", "ticker_sentiment_score": "0.060009", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.058615", "ticker_sentiment_score": "0.076005", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.058615", "ticker_sentiment_score": "0.076005", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina: Company Investigated by the Portnoy Law Firm - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/10/g35527905/illumina-company-investigated-by-the-portnoy-law-firm", "time_published": "20231031T225553", "authors": ["Globe Newswire"], "summary": "Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Oct. 31, 2023 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises Illumina, Inc. ( \"Illumina\" or \"the Company\" ) ILMN investors that the firm has initiated an investigation into possible ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.031152, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.612033", "ticker_sentiment_score": "-0.057536", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Law Offices of Frank R. Cruz Announces Investigation of Illumina, Inc.  ( ILMN )  on Behalf of Investors - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/10/g35517804/the-law-offices-of-frank-r-cruz-announces-investigation-of-illumina-inc-ilmn-on-behalf-of-investor", "time_published": "20231031T153827", "authors": ["Globe Newswire"], "summary": "LOS ANGELES, Oct. 31, 2023 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Illumina, Inc. ( \"Illumina\" or the \"Company\" ) ILMN concerning whether the board breached its fiduciary duties to shareholders.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.14316, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.629492", "ticker_sentiment_score": "0.364956", "ticker_sentiment_label": "Bullish"}]}, {"title": "The Next Generation Sequencing Market to grow at a CAGR of 12.45% from 2022 to 2027|10X Genomics Inc., Azenta ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/the-next-generation-sequencing-market-to-grow-at-a-cagr-of-12-45-from-2022-to-202710x-genomics-inc-azenta-inc-bgi-genomics-co-ltd-bio-rad-laboratories-incand-more-among-the-key-companies-in-the-market---technavio-301972064.html", "time_published": "20231031T053500", "authors": [], "summary": "The Next Generation Sequencing Market to grow at a CAGR of 12.45% from 2022 to 2027|10X Genomics Inc., Azenta ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.146116, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KNCAF", "relevance_score": "0.05833", "ticker_sentiment_score": "0.048994", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.05833", "ticker_sentiment_score": "0.048994", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.05833", "ticker_sentiment_score": "0.048994", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.05833", "ticker_sentiment_score": "0.048994", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZTA", "relevance_score": "0.05833", "ticker_sentiment_score": "0.048994", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.05833", "ticker_sentiment_score": "0.048994", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONTTF", "relevance_score": "0.05833", "ticker_sentiment_score": "0.048994", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.05833", "ticker_sentiment_score": "0.048994", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPK", "relevance_score": "0.05833", "ticker_sentiment_score": "0.048994", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAB", "relevance_score": "0.05833", "ticker_sentiment_score": "0.048994", "ticker_sentiment_label": "Neutral"}, {"ticker": "LH", "relevance_score": "0.05833", "ticker_sentiment_score": "0.048994", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERFSF", "relevance_score": "0.05833", "ticker_sentiment_score": "0.048994", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Unusual Options Activity - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/markets/options/23/10/35499325/illumina-unusual-options-activity", "time_published": "20231030T194545", "authors": ["Benzinga Insights"], "summary": "Someone with a lot of money to spend has taken a bullish stance on Illumina ILMN. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.180651, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.742397", "ticker_sentiment_score": "0.253423", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Proteomics market to grow by USD 21.74 billion from 2022 to 2027|Agilent Technologies Inc., Applied Biomics Inc., Bio ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/proteomics-market-to-grow-by-usd-21-74-billion-from-2022-to-2027agilent-technologies-inc-applied-biomics-inc-bio-rad-laboratories-inc-biognosys-ag-and-more-among-the-key-companies-in-the-market---technavio-301970472.html", "time_published": "20231030T061500", "authors": [], "summary": "Proteomics market to grow by USD 21.74 billion from 2022 to 2027|Agilent Technologies Inc., Applied Biomics Inc., Bio ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.263629, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.049322", "ticker_sentiment_score": "0.118369", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.049322", "ticker_sentiment_score": "0.118369", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.049322", "ticker_sentiment_score": "0.118369", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRKR", "relevance_score": "0.049322", "ticker_sentiment_score": "0.118369", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSRLF", "relevance_score": "0.049322", "ticker_sentiment_score": "0.118369", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.049322", "ticker_sentiment_score": "0.118369", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.049322", "ticker_sentiment_score": "0.118369", "ticker_sentiment_label": "Neutral"}, {"ticker": "WAT", "relevance_score": "0.049322", "ticker_sentiment_score": "0.118369", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLK", "relevance_score": "0.049322", "ticker_sentiment_score": "0.118369", "ticker_sentiment_label": "Neutral"}]}, {"title": "Research Antibodies & Reagents Market is Expected to Reach $16.2 billion | MarketsandMarkets.", "url": "https://www.benzinga.com/pressreleases/23/10/g35462628/research-antibodies-reagents-market-is-expected-to-reach-16-2-billion-marketsandmarkets", "time_published": "20231027T123000", "authors": ["Globe Newswire"], "summary": "Chicago, Oct. 27, 2023 ( GLOBE NEWSWIRE ) -- The research antibodies and reagents industry is poised for significant growth in the near future, driven by advancing biotechnological research and increasing demand for high-quality tools to support scientific discovery.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.210747, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.119038", "ticker_sentiment_score": "0.025817", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABCM", "relevance_score": "0.119038", "ticker_sentiment_score": "0.023568", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.039811", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.079524", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.039811", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPA", "relevance_score": "0.039811", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVTY", "relevance_score": "0.039811", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Biotechnology reagents market size to increase by USD 36.01 billion | the high usage of biotechnology reagents in ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/biotechnology-reagents-market-size-to-increase-by-usd-36-01-billion--the-high-usage-of-biotechnology-reagents-in-diagnostic-and-therapeutic-applications-drives-market-growth--technavio-301969558.html", "time_published": "20231027T071500", "authors": [], "summary": "Biotechnology reagents market size to increase by USD 36.01 billion | the high usage of biotechnology reagents in ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.239272, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BMXMF", "relevance_score": "0.062597", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "A", "relevance_score": "0.062597", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMAWF", "relevance_score": "0.062597", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSMXF", "relevance_score": "0.062597", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.062597", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.062597", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WAT", "relevance_score": "0.062597", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.062597", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.062597", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDX", "relevance_score": "0.062597", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.062597", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.062597", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TOSCF", "relevance_score": "0.062597", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "LGND vs. ILMN: Which Stock Is the Better Value Option?", "url": "https://www.zacks.com/stock/news/2172995/lgnd-vs-ilmn-which-stock-is-the-better-value-option", "time_published": "20231026T154012", "authors": ["Zacks Equity Research"], "summary": "Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Ligand Pharmaceuticals ( LGND Quick QuoteLGND - ) or Illumina ( ILMN Quick QuoteILMN - ) . But which of these two companies is the best option for those looking for undervalued stocks?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default93.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.491266, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.692877", "ticker_sentiment_score": "0.582695", "ticker_sentiment_label": "Bullish"}, {"ticker": "LGND", "relevance_score": "0.749418", "ticker_sentiment_score": "0.597867", "ticker_sentiment_label": "Bullish"}]}, {"title": "Biotechnology Market to Hit $471.33 Billion, Globally, by 2025 - Exclusive Report by The Insight Partners", "url": "https://www.benzinga.com/pressreleases/23/10/g35388778/biotechnology-market-to-hit-471-33-billion-globally-by-2025-exclusive-report-by-the-insight-partne", "time_published": "20231024T100425", "authors": ["Globe Newswire"], "summary": "Pune, India, Oct. 24, 2023 ( GLOBE NEWSWIRE ) -- Biotechnology is a technology which based on the biology, it connects cellular and biomolecular processes for the development of technologies and products that helps to improve lives and the health of living organisms.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.223285, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.03878", "ticker_sentiment_score": "0.112288", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.077468", "ticker_sentiment_score": "0.116543", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.03878", "ticker_sentiment_score": "0.112288", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.03878", "ticker_sentiment_score": "0.112288", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.03878", "ticker_sentiment_score": "0.059599", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:EUR", "relevance_score": "0.03878", "ticker_sentiment_score": "0.106453", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.03878", "ticker_sentiment_score": "0.111307", "ticker_sentiment_label": "Neutral"}]}, {"title": "Best Penny Stocks This Week? 3 To Watch During Earnings Season", "url": "https://pennystocks.com/featured/2023/10/23/best-penny-stocks-this-week-3-to-watch-during-earnings-season/", "time_published": "20231023T174846", "authors": ["J. Samuel"], "summary": "The process of buying penny stocks is similar to purchasing any other stock shares. The main difference is penny stocks are often not listed on major exchanges like the NYSE and Nasdaq. Here are the key steps to buying penny stocks: \u2022 Find a broker that allows trading over-the-counter bulletin ...", "banner_image": "https://pennystocks.com/wp-content/uploads/2022/09/penny-stocks-to-buy-under-1-this-week.jpg", "source": "PennyStocks.com", "category_within_source": "n/a", "source_domain": "pennystocks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.99998"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Energy & Transportation", "relevance_score": "0.5"}], "overall_sentiment_score": 0.207508, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SAVE", "relevance_score": "0.023579", "ticker_sentiment_score": "0.161371", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SLGC", "relevance_score": "0.023579", "ticker_sentiment_score": "0.050971", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAB", "relevance_score": "0.047138", "ticker_sentiment_score": "0.090843", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.023579", "ticker_sentiment_score": "0.155362", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SEEL", "relevance_score": "0.070656", "ticker_sentiment_score": "-0.074707", "ticker_sentiment_label": "Neutral"}]}, {"title": "DNA Sequencing Market On A Consistent Growth Trajectory With 15.6% CAGR: Driven By The Battle Against Cancer As Per The Business Research Company's DNA Sequencing Global Market Report 2023", "url": "https://www.benzinga.com/pressreleases/23/10/g35377394/dna-sequencing-market-on-a-consistent-growth-trajectory-with-15-6-cagr-driven-by-the-battle-agains", "time_published": "20231023T153500", "authors": ["Globe Newswire"], "summary": "LONDON, Oct. 23, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's DNA Sequencing Global Market Report 2023, the global DNA sequencing market is poised for remarkable expansion, with projected growth from $10.24 billion in 2022 to $11.84 billion in 2023, reflecting an impressive ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.290463, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.056275", "ticker_sentiment_score": "0.059908", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTRA", "relevance_score": "0.056275", "ticker_sentiment_score": "0.059908", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.056275", "ticker_sentiment_score": "0.059908", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.056275", "ticker_sentiment_score": "0.059908", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.056275", "ticker_sentiment_score": "0.059908", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.056275", "ticker_sentiment_score": "0.059908", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.056275", "ticker_sentiment_score": "0.059908", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.056275", "ticker_sentiment_score": "0.059908", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEMHF", "relevance_score": "0.056275", "ticker_sentiment_score": "0.059908", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERFSF", "relevance_score": "0.056275", "ticker_sentiment_score": "0.059908", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.056275", "ticker_sentiment_score": "0.059908", "ticker_sentiment_label": "Neutral"}]}, {"title": "RNA Analysis Market is Expected to Reach $9.9 billion | MarketsandMarkets.", "url": "https://www.benzinga.com/pressreleases/23/10/g35373015/rna-analysis-market-is-expected-to-reach-9-9-billion-marketsandmarkets", "time_published": "20231023T130000", "authors": ["Globe Newswire"], "summary": "Chicago, Oct. 23, 2023 ( GLOBE NEWSWIRE ) -- The RNA analysis industry is poised for remarkable growth in the near future, driven by groundbreaking advancements in technology, research, and diagnostics.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.255893, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BMXMF", "relevance_score": "0.04497", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "A", "relevance_score": "0.089797", "ticker_sentiment_score": "0.052721", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.089797", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.089797", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.089797", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONTTF", "relevance_score": "0.04497", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.04497", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAB", "relevance_score": "0.04497", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERFSF", "relevance_score": "0.089797", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.04497", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Next Generation Sequencing Market to grow at a CAGR of 12.45% from 2022 to 2027|10X Genomics Inc., Azenta ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/the-next-generation-sequencing-market-to-grow-at-a-cagr-of-12-45-from-2022-to-202710x-genomics-inc-azenta-inc-bgi-genomics-co-ltd-bio-rad-laboratories-inc-are-among-the-major-companies-in-the-market---technavio-301963481.html", "time_published": "20231023T053500", "authors": [], "summary": "The Next Generation Sequencing Market to grow at a CAGR of 12.45% from 2022 to 2027|10X Genomics Inc., Azenta ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.136759, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KNCAF", "relevance_score": "0.061315", "ticker_sentiment_score": "0.02", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.061315", "ticker_sentiment_score": "0.02", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.061315", "ticker_sentiment_score": "0.02", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.061315", "ticker_sentiment_score": "0.02", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZTA", "relevance_score": "0.061315", "ticker_sentiment_score": "0.02", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.061315", "ticker_sentiment_score": "0.02", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONTTF", "relevance_score": "0.061315", "ticker_sentiment_score": "0.02", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.061315", "ticker_sentiment_score": "0.02", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPK", "relevance_score": "0.061315", "ticker_sentiment_score": "0.02", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAB", "relevance_score": "0.061315", "ticker_sentiment_score": "0.02", "ticker_sentiment_label": "Neutral"}, {"ticker": "LH", "relevance_score": "0.061315", "ticker_sentiment_score": "0.02", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERFSF", "relevance_score": "0.061315", "ticker_sentiment_score": "0.02", "ticker_sentiment_label": "Neutral"}]}, {"title": "Proteomics market to grow by USD 21,749.32 million from 2022 to 2027 | Agilent Technologies Inc., Applied Biomics ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/proteomics-market-to-grow-by-usd-21-749-32-million-from-2022-to-2027--agilent-technologies-inc-applied-biomics-inc-bio-rad-laboratories-inc-are-among-the-major-companies-in-the-market---technavio-301963242.html", "time_published": "20231022T050000", "authors": [], "summary": "Proteomics market to grow by USD 21,749.32 million from 2022 to 2027 | Agilent Technologies Inc., Applied Biomics ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.265818, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.049322", "ticker_sentiment_score": "0.118369", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.049322", "ticker_sentiment_score": "0.118369", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.049322", "ticker_sentiment_score": "0.118369", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRKR", "relevance_score": "0.049322", "ticker_sentiment_score": "0.118369", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSRLF", "relevance_score": "0.049322", "ticker_sentiment_score": "0.118369", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.049322", "ticker_sentiment_score": "0.118369", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.049322", "ticker_sentiment_score": "0.118369", "ticker_sentiment_label": "Neutral"}, {"ticker": "WAT", "relevance_score": "0.049322", "ticker_sentiment_score": "0.118369", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLK", "relevance_score": "0.049322", "ticker_sentiment_score": "0.118369", "ticker_sentiment_label": "Neutral"}]}, {"title": "Is the Options Market Predicting a Spike in Illumina  ( ILMN )  Stock?", "url": "https://www.zacks.com/stock/news/2169442/is-the-options-market-predicting-a-spike-in-illumina-ilmn-stock", "time_published": "20231020T123200", "authors": ["Zacks Equity Research"], "summary": "Investors need to pay close attention to Illumina (ILMN) stock based on the movements in the options market lately.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7b/850.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.050225, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.572601", "ticker_sentiment_score": "0.072591", "ticker_sentiment_label": "Neutral"}]}, {"title": "CIO Leadership: The Visionary Leadership Needed to Drive an Enterprise Generative AI Strategy will Power the Discussion at the 2023 Charlotte IT Executive Leadership Summit in Partnership with SIM Charlotte on November 9", "url": "https://www.benzinga.com/pressreleases/23/10/g35337937/cio-leadership-the-visionary-leadership-needed-to-drive-an-enterprise-generative-ai-strategy-will-", "time_published": "20231019T191025", "authors": ["Globe Newswire"], "summary": "WESTPORT. Conn., Oct. 19, 2023 ( GLOBE NEWSWIRE ) -- HMG Strategy, the World's #1 platform for enabling technology executives to reimagine the enterprise and reshape the business world, is excited to announce that its 2023 Charlotte IT Executive Leadership Summit in Partnership with SIM ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.11864, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SCGLF", "relevance_score": "0.021408", "ticker_sentiment_score": "-0.306767", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "WIT", "relevance_score": "0.021408", "ticker_sentiment_score": "0.035035", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPWK", "relevance_score": "0.021408", "ticker_sentiment_score": "0.106915", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNUT", "relevance_score": "0.021408", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNG", "relevance_score": "0.064161", "ticker_sentiment_score": "0.066255", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRKTF", "relevance_score": "0.064161", "ticker_sentiment_score": "0.066255", "ticker_sentiment_label": "Neutral"}, {"ticker": "NPO", "relevance_score": "0.021408", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMNI", "relevance_score": "0.021408", "ticker_sentiment_score": "0.035035", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTG", "relevance_score": "0.0428", "ticker_sentiment_score": "0.082159", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBW", "relevance_score": "0.021408", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "APOG", "relevance_score": "0.021408", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.021408", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PANW", "relevance_score": "0.064161", "ticker_sentiment_score": "0.066255", "ticker_sentiment_label": "Neutral"}, {"ticker": "LNVGF", "relevance_score": "0.021408", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLY", "relevance_score": "0.064161", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.021408", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KWR", "relevance_score": "0.021408", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHSCP", "relevance_score": "0.0428", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXC", "relevance_score": "0.0428", "ticker_sentiment_score": "0.034423", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOX", "relevance_score": "0.021408", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPB", "relevance_score": "0.021408", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTNX", "relevance_score": "0.10673", "ticker_sentiment_score": "0.067222", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSSMY", "relevance_score": "0.021408", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTNT", "relevance_score": "0.064161", "ticker_sentiment_score": "0.066255", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALB", "relevance_score": "0.0428", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYSD", "relevance_score": "0.021408", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNC", "relevance_score": "0.021408", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZS", "relevance_score": "0.064161", "ticker_sentiment_score": "0.066255", "ticker_sentiment_label": "Neutral"}]}, {"title": "Revvity, Inc. and Element Biosciences, Inc. Pioneer Next-Generation Sequencing Kits Market with Innovative Genomic Analysis Solutions", "url": "https://www.prnewswire.com/news-releases/revvity-inc-and-element-biosciences-inc-pioneer-next-generation-sequencing-kits-market-with-innovative-genomic-analysis-solutions-301960404.html", "time_published": "20231018T211500", "authors": ["Research and Markets"], "summary": "Revvity, Inc. and Element Biosciences, Inc. Pioneer Next-Generation Sequencing Kits Market with Innovative Genomic ... PR ...", "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.231406, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.057079", "ticker_sentiment_score": "0.174987", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BIO", "relevance_score": "0.057079", "ticker_sentiment_score": "0.174987", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ONTTF", "relevance_score": "0.057079", "ticker_sentiment_score": "0.174987", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.113866", "ticker_sentiment_score": "-0.012728", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVTY", "relevance_score": "0.057079", "ticker_sentiment_score": "0.210035", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Cathie Wood Just Added $5 Million of This Stock After It Had a Steep Pullback. Is It a No-Brainer Buy?", "url": "https://www.fool.com/investing/2023/10/18/cathie-wood-just-added-million-of-this-stock-pacp/", "time_published": "20231018T095200", "authors": ["Keith Speights"], "summary": "This innovator is targeting a huge, rapidly growing market.", "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.161647"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.999921"}], "overall_sentiment_score": 0.316047, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PACB", "relevance_score": "0.123844", "ticker_sentiment_score": "-0.003517", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.06211", "ticker_sentiment_score": "0.121041", "ticker_sentiment_label": "Neutral"}]}, {"title": "Activist Icahn sues Illumina board over Grail acquisition - FT", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/activist-icahn-sues-illumina-board-over-grail-acquisition-ft-2023-10-17/", "time_published": "20231017T233900", "authors": ["Reuters"], "summary": "Billionaire activist-investor Carl Icahn gives an interview on FOX Business Network's Neil Cavuto show in New York, U.S. on February 11, 2014. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/LYA4W3IEQZKBBHH2XTESC6UKOA.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.156267, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.414559", "ticker_sentiment_score": "-0.367291", "ticker_sentiment_label": "Bearish"}]}, {"title": "Executives leave BlackRock, ISS to lead governance at Longacre Square", "url": "https://www.reuters.com/business/finance/executives-leave-blackrock-iss-lead-governance-longacre-square-2023-10-17/", "time_published": "20231017T103300", "authors": ["Svea Herbst-Bayliss"], "summary": "A trader works as a screen displays the trading information for BlackRock on the floor of the New York Stock Exchange ( NYSE ) in New York City, U.S., October 14, 2022. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/QD2PORFRDFMWLCUIPBKJFFO5G4.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.093549, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.249106", "ticker_sentiment_score": "0.172589", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.126119", "ticker_sentiment_score": "-0.109847", "ticker_sentiment_label": "Neutral"}, {"ticker": "USFD", "relevance_score": "0.126119", "ticker_sentiment_score": "-0.109847", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why You Should Invest In Healthcare Stocks", "url": "https://www.kiplinger.com/investing/healthcare-stocks/why-you-should-invest-in-healthcare-stocks", "time_published": "20231015T140059", "authors": ["James K. Glassman"], "summary": "Healthcare stocks have had a rough few years. So why invest in them? First, I'm a contrarian. I like what's down. Second, healthcare is a booming industry, accounting for 18% of gross domestic product ( GDP ) in 2021, up from 12% in 1991. Third, the sector adds stability to any portfolio.", "banner_image": "https://cdn.mos.cms.futurecdn.net/KKJr2NN3xukR5Kxuhz2vrY-415-80.jpg", "source": "Kiplinger", "category_within_source": "n/a", "source_domain": "www.kiplinger.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.99737"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.183015, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SYK", "relevance_score": "0.099752", "ticker_sentiment_score": "0.18093", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.066598", "ticker_sentiment_score": "0.119713", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCA", "relevance_score": "0.099752", "ticker_sentiment_score": "0.087475", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.066598", "ticker_sentiment_score": "0.0641", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.066598", "ticker_sentiment_score": "-0.162455", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "IVZ", "relevance_score": "0.033328", "ticker_sentiment_score": "0.12656", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.099752", "ticker_sentiment_score": "-0.01214", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.099752", "ticker_sentiment_score": "0.276915", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DHR", "relevance_score": "0.066598", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KVUE", "relevance_score": "0.132733", "ticker_sentiment_score": "0.109596", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPGI", "relevance_score": "0.033328", "ticker_sentiment_score": "-0.068677", "ticker_sentiment_label": "Neutral"}, {"ticker": "WST", "relevance_score": "0.066598", "ticker_sentiment_score": "0.068343", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUGX", "relevance_score": "0.099752", "ticker_sentiment_score": "-0.041137", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.066598", "ticker_sentiment_score": "0.068343", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina to divest Grail within a year if it does not win challenge in EU court", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/illumina-divest-cancer-test-maker-grail-if-it-does-not-win-challenge-eu-court-2023-10-13/", "time_published": "20231013T183300", "authors": ["Reuters"], "summary": "Oct 13 ( Reuters ) - Illumina ( ILMN.O ) said on Friday it would divest cancer test maker Grail ( GRAL.O ) in 12 months, according to the terms of the order by the European Commission, if it does not win its challenge in court.", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/WAQTKXJ7KJMZPDKR3646MVINCM.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.126779, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.699089", "ticker_sentiment_score": "-0.519655", "ticker_sentiment_label": "Bearish"}]}, {"title": "Illumina responds to European Commission's divestiture order", "url": "https://www.prnewswire.com/news-releases/illumina-responds-to-european-commissions-divestiture-order-301956469.html", "time_published": "20231013T181000", "authors": ["Inc.", "Illumina"], "summary": "SAN DIEGO, Oct. 13, 2023 /PRNewswire/ -- Illumina, Inc. ( NASDAQ:ILMN ) , has received an order from the European Commission ( EC ) directing the company to divest GRAIL.", "banner_image": "https://mma.prnewswire.com/media/1876671/Illumina_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.146186, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.061159", "ticker_sentiment_score": "0.071002", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.061159", "ticker_sentiment_score": "0.071002", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.601325", "ticker_sentiment_score": "0.36718", "ticker_sentiment_label": "Bullish"}]}, {"title": "CIO Leadership: The Visionary Leadership Needed to Power New Business Growth Will Drive the Discussion at the 2023 Silicon Valley CIO Executive Leadership Summit on October 17", "url": "https://www.benzinga.com/pressreleases/23/10/g35225945/cio-leadership-the-visionary-leadership-needed-to-power-new-business-growth-will-drive-the-discuss", "time_published": "20231012T172055", "authors": ["Globe Newswire"], "summary": "WESTPORT, Conn., Oct. 12, 2023 ( GLOBE NEWSWIRE ) -- HMG Strategy, the World's #1 platform for enabling technology executives to reimagine the enterprise and reshape the business world, is excited to announce that its 2023 Silicon Valley CIO Executive Leadership Summit will be taking place on ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": 0.139354, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SCGLF", "relevance_score": "0.022621", "ticker_sentiment_score": "-0.308137", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "UPWK", "relevance_score": "0.022621", "ticker_sentiment_score": "0.107583", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNG", "relevance_score": "0.067791", "ticker_sentiment_score": "0.087678", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRKTF", "relevance_score": "0.067791", "ticker_sentiment_score": "0.087678", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXTR", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTG", "relevance_score": "0.045224", "ticker_sentiment_score": "0.083496", "ticker_sentiment_label": "Neutral"}, {"ticker": "S", "relevance_score": "0.022621", "ticker_sentiment_score": "0.085263", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBW", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "APOG", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FDX", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBGSF", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PANW", "relevance_score": "0.067791", "ticker_sentiment_score": "0.087678", "ticker_sentiment_label": "Neutral"}, {"ticker": "LNVGF", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRK-A", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KWR", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHSCP", "relevance_score": "0.045224", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPB", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTNX", "relevance_score": "0.112744", "ticker_sentiment_score": "0.091227", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSSMY", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTNT", "relevance_score": "0.067791", "ticker_sentiment_score": "0.087678", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGH", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYSD", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZS", "relevance_score": "0.067791", "ticker_sentiment_score": "0.087678", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRTC", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLB", "relevance_score": "0.022621", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Microsoft To Appeal Against $29B US Tax Claim By IRS, Michael McCaul Calls To Rush Vote For New Speaker - Top Headlines Today While US Was Sleeping", "url": "https://www.benzinga.com/news/23/10/35218906/microsoft-to-appeal-against-29b-us-tax-claim-by-irs-michael-mccaul-calls-to-rush-vote-for-new-speake", "time_published": "20231012T140600", "authors": ["Akanksha Bakshi"], "summary": "Qualcomm, Northrop Grumman And 2 Other Stocks Insiders Are Selling US Stocks Set To Open In Green After 4-Day Winning Streak On Earnings, Fed Pause Hopes - Will Inflation Data Wreck Rally? Red Flag For US Stocks? S&P 500 Valuations Near Dot-Com Boom Levels, Analysis Reveals", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/12/news.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.027307, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.051663", "ticker_sentiment_score": "0.181515", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GOOG", "relevance_score": "0.103109", "ticker_sentiment_score": "0.151436", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NVDA", "relevance_score": "0.051663", "ticker_sentiment_score": "-0.160489", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NOC", "relevance_score": "0.051663", "ticker_sentiment_score": "-0.199545", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TSLA", "relevance_score": "0.254042", "ticker_sentiment_score": "0.134477", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDNDF", "relevance_score": "0.051663", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "QCOM", "relevance_score": "0.051663", "ticker_sentiment_score": "-0.199545", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ILMN", "relevance_score": "0.051663", "ticker_sentiment_score": "-0.336852", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SONO", "relevance_score": "0.051663", "ticker_sentiment_score": "0.133396", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.154125", "ticker_sentiment_score": "0.086325", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:ETH", "relevance_score": "0.154125", "ticker_sentiment_score": "0.086325", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:DOGE", "relevance_score": "0.154125", "ticker_sentiment_score": "0.029853", "ticker_sentiment_label": "Neutral"}]}, {"title": "Top Stories Thursday, Oct 12: ChatGPT Parent OpenAI Aims At Budget-Friendly AI Innovations, Novo Nordisk's Popular Diabetes Drug Ozempic Faces Counterfeit Threat in Germany - Apple  ( NASDAQ:AAPL ) , ARM Holdings  ( NASDAQ:ARM ) ", "url": "https://www.benzinga.com/news/23/10/35220687/chatgpt-parent-openai-aims-at-budget-friendly-ai-innovations-novo-nordisks-popular-diabetes-drug-oze", "time_published": "20231012T135217", "authors": ["Vandana Singh"], "summary": "In a surprising turn of events, Apple Inc AAPL and its key suppliers in Taiwan are facing a significant sales slump despite the recent launch of the new iPhone and various Android devices.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/12/openai-avatar.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.999996"}], "overall_sentiment_score": 0.084268, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DMPZF", "relevance_score": "0.048523", "ticker_sentiment_score": "-0.21396", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AAPL", "relevance_score": "0.096866", "ticker_sentiment_score": "0.027156", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.144853", "ticker_sentiment_score": "-0.13336", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBA", "relevance_score": "0.144853", "ticker_sentiment_score": "-0.022868", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFY", "relevance_score": "0.144853", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARM", "relevance_score": "0.096866", "ticker_sentiment_score": "0.085914", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.144853", "ticker_sentiment_score": "0.163127", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OPGN", "relevance_score": "0.144853", "ticker_sentiment_score": "0.226056", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DAL", "relevance_score": "0.144853", "ticker_sentiment_score": "0.046024", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPZ", "relevance_score": "0.096866", "ticker_sentiment_score": "-0.227756", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TSM", "relevance_score": "0.096866", "ticker_sentiment_score": "-0.093282", "ticker_sentiment_label": "Neutral"}]}, {"title": "Will Illumina Give Up Cancer Test Maker Grail? Mulls $8B Acquisition's Fate Amid Antitrust Pressure - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/23/10/35216323/will-illumina-give-up-cancer-test-maker-grail-mulls-8b-acquisitions-fate-amid-antitrust-pressure", "time_published": "20231012T113814", "authors": ["Vandana Singh"], "summary": "Illumina Inc ILMN reportedly said it will divest its controversial acquisition of Grail as expeditiously as possible if the life sciences company loses either of the final appeals in U.S. or European courts.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/12/ilmn.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.068841, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.953183", "ticker_sentiment_score": "0.201941", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "EU orders biotech giant Illumina to unwind $7.1 billion purchase of cancer-screening company Grail", "url": "https://apnews.com/article/illumina-grail-eu-antitrust-order-5ffd8038660dd12b17bc4895dc0142e3", "time_published": "20231012T110100", "authors": ["RAF CASERT"], "summary": "BRUSSELS ( AP ) - The European Union on Thursday ordered U.S. biotech giant Illumina to undo its $7.1 billion purchase of cancer-screening company Grail because it closed the deal without approval of regulators in the 27-nation bloc.", "banner_image": "https://dims.apnews.com/dims4/default/c46cc36/2147483647/strip/true/crop/5795x3860+0+1/resize/599x399!/quality/90/?url=https%3A%2F%2Fassets.apnews.com%2Fc6%2Fa4%2Fa65f9a39aed314f47d9f9316eac4%2F4d7a87e7a27d4d759c49f2a8a6ca3d78", "source": "Associated Press", "category_within_source": "Business", "source_domain": "apnews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.026548, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.827318", "ticker_sentiment_score": "-0.016467", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina ordered by EU antitrust regulators to sell Grail", "url": "https://www.reuters.com/markets/deals/illumina-ordered-by-eu-antitrust-regulators-sell-grail-2023-10-12/", "time_published": "20231012T095809", "authors": ["Foo Yun Chee"], "summary": "BRUSSELS, Oct 12 ( Reuters ) - U.S. genetic testing company Illumina ( ILMN.O ) has been ordered by EU antitrust regulators to sell cancer test maker Grail ( GRAL.O ) after it completed the deal before securing their approval.", "banner_image": "https://s3.amazonaws.com/arc-authors/reuters/667527b5-7241-4d9c-bf23-822c102ec553.png", "source": "Reuters", "category_within_source": "Markets", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": -0.007233, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.100729", "ticker_sentiment_score": "0.07256", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.100729", "ticker_sentiment_score": "0.07256", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.624423", "ticker_sentiment_score": "-0.021917", "ticker_sentiment_label": "Neutral"}]}, {"title": "EU Orders US Biotech Firms To Unwind $7bn Merger", "url": "https://www.barrons.com/news/eu-orders-illumina-to-unwind-7bn-grail-buy-out-dbc7e4c2", "time_published": "20231012T094500", "authors": ["AFP - Agence France Presse"], "summary": "EU Orders Illumina To Unwind $7bn GRAIL ...", "banner_image": "https://asset.barrons.com/barrons/images/afp-metadata-default.jpg", "source": "Barrons", "category_within_source": "n/a", "source_domain": "www.barrons.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.195564, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.578355", "ticker_sentiment_score": "-0.339205", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Illumina to divest Grail if it loses final court appeals in US or EU", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/illumina-divest-grail-if-it-loses-final-court-appeals-2023-10-11/", "time_published": "20231011T202200", "authors": ["Reuters"], "summary": "Illumina's global headquarters is pictured in San Diego, California, U.S., November 28, 2022. REUTERS/Mike Blake/File Photo Acquire Licensing Rights Oct 11 ( Reuters ) - Illumina Inc ( ILMN.O ) said on Wednesday it will divest cancer test maker Grail ( GRAL.O ) if the U.S. life sciences company ...", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/EWNQV3WFCFKSFER657IKKRJMGQ.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.115696, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.570165", "ticker_sentiment_score": "-0.238987", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Illumina to get EU order on Thursday to divest Grail, source says", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/illumina-get-eu-order-thursday-divest-grail-source-says-2023-10-10/", "time_published": "20231010T221400", "authors": ["Foo Yun Chee"], "summary": "A sign at the front entrance to the global headquarters of Illumina is pictured in San Diego, California, U.S., November 28, 2022. REUTERS/Mike Blake/File Photo Acquire Licensing Rights", "banner_image": "https://s3.amazonaws.com/arc-authors/reuters/667527b5-7241-4d9c-bf23-822c102ec553.png", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.007178, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.12165", "ticker_sentiment_score": "0.078027", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.12165", "ticker_sentiment_score": "0.078027", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.716023", "ticker_sentiment_score": "-0.130027", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:EUR", "relevance_score": "0.12165", "ticker_sentiment_score": "0.172464", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Global Hereditary Testing Market Shows Strong 8.8% CAGR, Driving Demand for Hereditary Disorder Testing Kits", "url": "https://www.benzinga.com/pressreleases/23/10/g35168974/global-hereditary-testing-market-shows-strong-8-8-cagr-driving-demand-for-hereditary-disorder-test", "time_published": "20231010T181500", "authors": ["Globe Newswire"], "summary": "New York, United States, Oct. 10, 2023 ( GLOBE NEWSWIRE ) -- Hereditary genes are either transmitted to offspring or inheritable from parents. Hereditary testing examines an individual's genome for specific hereditary variations ( variants ) .", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.125839, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTG", "relevance_score": "0.113776", "ticker_sentiment_score": "0.053031", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWST", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.075995", "ticker_sentiment_score": "0.076191", "ticker_sentiment_label": "Neutral"}, {"ticker": "HESG", "relevance_score": "0.03804", "ticker_sentiment_score": "0.131654", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTRA", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTA", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPH", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLGT", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DGX", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LH", "relevance_score": "0.03804", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "LGND vs. ILMN: Which Stock Should Value Investors Buy Now?", "url": "https://www.zacks.com/stock/news/2163617/lgnd-vs-ilmn-which-stock-should-value-investors-buy-now", "time_published": "20231010T154010", "authors": ["Zacks Equity Research"], "summary": "LGND vs. ILMN: Which Stock Is the Better Value Option?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default166.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.838487"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.490695, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.546745", "ticker_sentiment_score": "0.507783", "ticker_sentiment_label": "Bullish"}, {"ticker": "LGND", "relevance_score": "0.682689", "ticker_sentiment_score": "0.589633", "ticker_sentiment_label": "Bullish"}]}, {"title": "Home Hardware paints the town with wellness-inspired 'Colour of the Year' palette for World Mental Health Day - Canada NewsWire", "url": "https://www.newswire.ca/news-releases/home-hardware-paints-the-town-with-wellness-inspired-colour-of-the-year-palette-for-world-mental-health-day-881816268.html", "time_published": "20231010T125600", "authors": [], "summary": "Home Hardware paints the town with wellness-inspired 'Colour of the Year' palette for World Mental Health Day Canada ...", "banner_image": null, "source": "Canada Newswire", "category_within_source": "n/a", "source_domain": "www.newswire.ca", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.33101, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.107495", "ticker_sentiment_score": "0.229337", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Israel imposes 'complete siege' on Gaza", "url": "https://www.ft.com/content/0f617926-dbe0-4bf5-817f-a8b79b9f03ac", "time_published": "20231010T040236", "authors": [], "summary": "This is an audio transcript of the FT News Briefing podcast episode: 'Israel imposes \"complete siege\" on Gaza' Good morning from the Financial Times. Today is Tuesday, October 10th, and this is your FT News Briefing. Israel is retaliating for a violent attack over the weekend.", "banner_image": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2Fc500be65-5078-4d74-9ca3-2ba3b9350c6c.jpg?source=next-article&fit=scale-down&quality=highest&width=700&dpr=1", "source": "Financial Times", "category_within_source": "GoogleRSS", "source_domain": "www.ft.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Economy - Fiscal", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.650727"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": -0.050921, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.168295", "ticker_sentiment_score": "-0.146659", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.028254", "ticker_sentiment_score": "-0.134834", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.056474", "ticker_sentiment_score": "-0.127227", "ticker_sentiment_label": "Neutral"}]}, {"title": "Israel imposes 'complete siege' on Gaza", "url": "https://www.ft.com/content/5eb3ab0c-4074-4019-a4a4-2703c3d2d56a", "time_published": "20231010T040025", "authors": [], "summary": "Israel imposed a \"complete siege\" of the Gaza Strip, the Bank of Israel said it planned to sell up to $30bn of dollar reserves to support the shekel, and EU regulators will order US biotech Illumina to sell cancer test developer Grail. Israel's central bank to sell $30bn of foreign reserves to ...", "banner_image": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fwww.ft.com%2F__origami%2Fservice%2Fimage%2Fv2%2Fimages%2Fraw%2Fhttps%253A%252F%252Fnext-video-editor-images.s3.ap-northeast-1.amazonaws.com%252Fbe6f3a49-6140-4725-887d-829fa59e5de2%3Fsource%3Dnext-article%26fit%3Dscale-down%26quality%3Dhighest%26width%3D700%26dpr%3D1?source=next-opengraph&fit=scale-down&width=900", "source": "Financial Times", "category_within_source": "GoogleRSS", "source_domain": "www.ft.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.011947, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.282234", "ticker_sentiment_score": "-0.252568", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Illumina Faces Mounting Pressure from Regulators Over $8B Grail Acquisition - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/m-a/23/10/35144395/illumina-faces-mounting-pressure-from-regulators-over-8b-grail-acquisition", "time_published": "20231009T132407", "authors": ["Vandana Singh"], "summary": "The European Union regulators are set to order Illumina Inc ILMN to divest its acquisition of cancer test developer Grail. The acquisition of Grail also fueled discontent among some of Illumina's shareholders.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/10/09/ilmn.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.164989, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.839535", "ticker_sentiment_score": "-0.307364", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "EU regulatory order for Illumina to sell Grail could come next week - FT", "url": "https://www.reuters.com/markets/deals/eu-regulatory-order-illumina-sell-grail-could-come-next-week-ft-2023-10-09/", "time_published": "20231009T131600", "authors": ["Reuters"], "summary": "Oct 9 ( Reuters ) - An order from EU competition regulators for Illumina ( ILMN.O ) to sell cancer detection test maker Grail could come as early as next week, the Financial Times reported on Monday, citing people with knowledge of the matter.", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/WAQTKXJ7KJMZPDKR3646MVINCM.jpg", "source": "Reuters", "category_within_source": "Markets", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": -0.048271, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.570165", "ticker_sentiment_score": "-0.296817", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "NVIDIA and Illumina have been highlighted as Zacks Bull and Bear of the Day", "url": "https://www.zacks.com/stock/news/2162569/nvidia-and-illumina-have-been-highlighted-as-zacks-bull-and-bear-of-the-day", "time_published": "20231009T122900", "authors": ["Zacks Equity Research"], "summary": "NVIDIA and Illumina are part of the Zacks Bull and Bear of the Day article.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c9/37456.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.658903"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.088242, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.015502", "ticker_sentiment_score": "-0.037541", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.359014", "ticker_sentiment_score": "0.093167", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.015502", "ticker_sentiment_score": "-0.141416", "ticker_sentiment_label": "Neutral"}, {"ticker": "GM", "relevance_score": "0.302429", "ticker_sentiment_score": "0.063042", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.184363", "ticker_sentiment_score": "0.02159", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bear of the Day: Illumina  ( ILMN ) ", "url": "https://www.zacks.com/commentary/2162224/bear-of-the-day-illumina-ilmn", "time_published": "20231009T102000", "authors": ["Kevin Cook"], "summary": "Contracting margins, antitrust over GRAIL, and the Icahn invasion all crash estimates and shares ...", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/57/40404.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.858979"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.080738, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.764792", "ticker_sentiment_score": "0.036319", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.085936", "ticker_sentiment_score": "-0.163518", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "'Geographical expansions, augmented investments for new solutions to remain key focal areas for MedGenome'", "url": "https://www.financialexpress.com/healthcare/diagnostic/geographical-expansions-augmented-investments-for-new-solutions-to-remain-key-focal-areas-for-medgenome/3266039/", "time_published": "20231008T033000", "authors": ["Sushmita Panda"], "summary": "Genomics plays an important role in disease diagnosis and treatment. According to a report by Markets and Markets, the global genomics market in terms of revenue was estimated to be worth $46.2 million in 2023 and is poised to reach $83.1 billion by 2028, growing at a CAGR OF 12.4 percent from ...", "banner_image": "https://www.financialexpress.com/wp-content/uploads/2023/10/WhatsApp-Image-2023-10-08-at-1.47.14-AM.jpeg", "source": "The Financial Express", "category_within_source": "n/a", "source_domain": "www.financialexpress.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Earnings", "relevance_score": "0.108179"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.28667, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "DTST", "relevance_score": "0.016975", "ticker_sentiment_score": "0.069814", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.016975", "ticker_sentiment_score": "0.03284", "ticker_sentiment_label": "Neutral"}, {"ticker": "NURAF", "relevance_score": "0.016975", "ticker_sentiment_score": "0.081776", "ticker_sentiment_label": "Neutral"}]}, {"title": "CIO Leadership: Leading as the CEO of Technology Will Drive the Discussion at the 2023 Minneapolis CIO Executive Leadership Summit on November 2", "url": "https://www.benzinga.com/pressreleases/23/10/g35113697/cio-leadership-leading-as-the-ceo-of-technology-will-drive-the-discussion-at-the-2023-minneapolis-", "time_published": "20231005T170747", "authors": ["Globe Newswire"], "summary": "WESTPORT, Conn., Oct. 05, 2023 ( GLOBE NEWSWIRE ) -- HMG Strategy, the World's #1 platform for enabling technology executives to reimagine the enterprise and reshape the business world, is excited to announce its 2023 Minneapolis CIO Executive Leadership Summit will be taking place on November 2 ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/f43e67d6-0c3c-4f68-9773-74ed31831e64", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": 0.152409, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "WOOF", "relevance_score": "0.021957", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPWK", "relevance_score": "0.043898", "ticker_sentiment_score": "0.077302", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNG", "relevance_score": "0.087663", "ticker_sentiment_score": "0.085607", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRKTF", "relevance_score": "0.065806", "ticker_sentiment_score": "0.08547", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNBR", "relevance_score": "0.021957", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXTR", "relevance_score": "0.021957", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTG", "relevance_score": "0.021957", "ticker_sentiment_score": "0.111139", "ticker_sentiment_label": "Neutral"}, {"ticker": "S", "relevance_score": "0.065806", "ticker_sentiment_score": "0.067312", "ticker_sentiment_label": "Neutral"}, {"ticker": "APOG", "relevance_score": "0.021957", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FDX", "relevance_score": "0.021957", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBGSF", "relevance_score": "0.021957", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.021957", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PANW", "relevance_score": "0.065806", "ticker_sentiment_score": "0.08547", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.021957", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRK-A", "relevance_score": "0.021957", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHSCP", "relevance_score": "0.043898", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TONPF", "relevance_score": "0.021957", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTNX", "relevance_score": "0.109455", "ticker_sentiment_score": "0.087923", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSSMY", "relevance_score": "0.021957", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTNT", "relevance_score": "0.065806", "ticker_sentiment_score": "0.08547", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGH", "relevance_score": "0.021957", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYSD", "relevance_score": "0.021957", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.021957", "ticker_sentiment_score": "0.144197", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZS", "relevance_score": "0.065806", "ticker_sentiment_score": "0.08547", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRTC", "relevance_score": "0.021957", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLB", "relevance_score": "0.021957", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "UIS", "relevance_score": "0.043898", "ticker_sentiment_score": "0.088071", "ticker_sentiment_label": "Neutral"}]}, {"title": "Precede Biosciences Emerges from Stealth to Dramatically Impact Precision Medicine with a First-in-Class Liquid Biopsy Platform", "url": "https://www.benzinga.com/pressreleases/23/10/g35103795/precede-biosciences-emerges-from-stealth-to-dramatically-impact-precision-medicine-with-a-first-in", "time_published": "20231005T110000", "authors": ["Globe Newswire"], "summary": "Unique genome-wide platform profiles circulating chromatin and the DNA methylome to deliver resolution into the dynamic activation of individual genes and pathways in diseased tissues from just 1mL of plasma", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.143082, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.031949", "ticker_sentiment_score": "-0.012406", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.031949", "ticker_sentiment_score": "-0.012406", "ticker_sentiment_label": "Neutral"}]}, {"title": "Lowey Dannenberg, P.C. is Investigating Illumina, Inc.  ( NASDAQ: ILMN )  for Potential Breaches of Fiduciary Duty by Its Board of Directors - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/10/g35090234/lowey-dannenberg-p-c-is-investigating-illumina-inc-nasdaq-ilmn-for-potential-breaches-of-fiduciary", "time_published": "20231004T140854", "authors": ["Globe Newswire"], "summary": "NEW YORK, Oct. 04, 2023 ( GLOBE NEWSWIRE ) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating a potential breach of fiduciary duty claim involving the board of directors of Illumina, Inc. ILMN ( \"Illumina\" ) .", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.119622, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.7887", "ticker_sentiment_score": "0.104202", "ticker_sentiment_label": "Neutral"}]}, {"title": "DNA Extraction, Isolation, Purification Market Worth $6.10 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners", "url": "https://www.benzinga.com/pressreleases/23/10/g35088858/dna-extraction-isolation-purification-market-worth-6-10-billion-globally-by-2030-exclusive-report-", "time_published": "20231004T132523", "authors": ["Globe Newswire"], "summary": "Pune, India, Oct. 04, 2023 ( GLOBE NEWSWIRE ) -- The method through which the DNA is purified is DNA extraction, by using physical and/or chemical methods from proteins, cell membranes, and other cellular components. Commercially available kits, as well as manual methods, are used for DNA ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.045622, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.048084", "ticker_sentiment_score": "0.016873", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.024053", "ticker_sentiment_score": "0.009203", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.024053", "ticker_sentiment_score": "0.009203", "ticker_sentiment_label": "Neutral"}, {"ticker": "GEHC", "relevance_score": "0.024053", "ticker_sentiment_score": "0.009203", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.024053", "ticker_sentiment_score": "-0.040798", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.072072", "ticker_sentiment_score": "0.056517", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.024053", "ticker_sentiment_score": "0.009203", "ticker_sentiment_label": "Neutral"}]}, {"title": "Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools - SomaLogic  ( NASDAQ:SLGC ) , Standard BioTools  ( NASDAQ:LAB ) ", "url": "https://www.benzinga.com/pressreleases/23/10/g35085856/standard-biotools-and-somalogic-to-combine-in-all-stock-merger-creating-a-diversified-leader-in-li", "time_published": "20231004T120000", "authors": ["Globe Newswire"], "summary": "Activates Standard BioTools' strategy to unlock value in underserved portion of $100 billion industry Establishes leading platform of multi-omic technologies with the highest throughput and highest data quality to power clinical research insights", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Mergers", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.999896"}, {"topic": "Earnings", "relevance_score": "0.955357"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.207697, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PWP", "relevance_score": "0.026591", "ticker_sentiment_score": "0.10477", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.013297", "ticker_sentiment_score": "0.008056", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGC", "relevance_score": "0.026591", "ticker_sentiment_score": "0.066397", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAB", "relevance_score": "0.666289", "ticker_sentiment_score": "0.29585", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.013297", "ticker_sentiment_score": "0.19833", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Charles River  ( CRL )  Launches LVV-based Gene Therapy Platform", "url": "https://www.zacks.com/stock/news/2158817/charles-river-crl-launches-lvv-based-gene-therapy-platform", "time_published": "20231002T153500", "authors": ["Zacks Equity Research"], "summary": "Charles River's (CRL) LVV platform provides medicinal developers with an efficient, dependable route to the clinic and the market.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7b/850.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.353777, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "QGEN", "relevance_score": "0.227538", "ticker_sentiment_score": "0.055928", "ticker_sentiment_label": "Neutral"}, {"ticker": "WGS", "relevance_score": "0.114956", "ticker_sentiment_score": "0.209015", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CRL", "relevance_score": "0.171688", "ticker_sentiment_score": "0.313033", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.171688", "ticker_sentiment_score": "0.149513", "ticker_sentiment_label": "Neutral"}]}, {"title": "MicroRNA (miRNA) Market size to grow by USD 2.02 billion from 2022-2027| BioGenex Laboratories Inc., BioVendor ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/microrna-mirna-market-size-to-grow-by-usd-2-02-billion-from-2022-2027-biogenex-laboratories-inc-biovendor-laboratorni-medicina-as-genecopoeia-inc-and-more-among-the-market-key-players---technavio-301942420.html", "time_published": "20230929T221500", "authors": [], "summary": "MicroRNA ( miRNA ) Market size to grow by USD 2.02 billion from 2022-2027| BioGenex Laboratories Inc., BioVendor ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.233699, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "QGEN", "relevance_score": "0.075397", "ticker_sentiment_score": "0.039334", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGLS", "relevance_score": "0.075397", "ticker_sentiment_score": "0.039334", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSTG", "relevance_score": "0.075397", "ticker_sentiment_score": "0.039334", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.075397", "ticker_sentiment_score": "0.039334", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.075397", "ticker_sentiment_score": "0.039334", "ticker_sentiment_label": "Neutral"}]}, {"title": "Looking At Illumina's Recent Unusual Options Activity - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/markets/options/23/09/35010618/looking-at-illuminas-recent-unusual-options-activity", "time_published": "20230929T191912", "authors": ["Benzinga Insights"], "summary": "A whale with a lot of money to spend has taken a noticeably bullish stance on Illumina. Looking at options history for Illumina ILMN we detected 10 strange trades. If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.191703, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.77688", "ticker_sentiment_score": "0.23171", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BCS", "relevance_score": "0.121037", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Lowey Dannenberg, P.C. is Investigating Illumina, Inc.  ( NASDAQ: ILMN )  for Potential Breaches of Fiduciary Duty by Its Board of Directors - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/09/g35009917/lowey-dannenberg-p-c-is-investigating-illumina-inc-nasdaq-ilmn-for-potential-breaches-of-fiduciary", "time_published": "20230929T184517", "authors": ["Globe Newswire"], "summary": "NEW YORK, Sept. 29, 2023 ( GLOBE NEWSWIRE ) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating a potential breach of fiduciary duty claim involving the board of directors of Illumina, Inc. ILMN ( \"Illumina\" ) .", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.119622, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.7887", "ticker_sentiment_score": "0.104202", "ticker_sentiment_label": "Neutral"}]}, {"title": "Guardant Health  ( GH )  Surges 8.8%: Is This an Indication of Further Gains?", "url": "https://www.zacks.com/stock/news/2157608/guardant-health-gh-surges-88-is-this-an-indication-of-further-gains", "time_published": "20230929T122300", "authors": ["Zacks Equity Research"], "summary": "Guardant Health (GH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default143.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.961735"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.206341, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GH", "relevance_score": "0.522854", "ticker_sentiment_score": "0.293598", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.430454", "ticker_sentiment_score": "-0.073084", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nike To Rally Around 53%? Here Are 10 Other Analyst Forecasts For Friday - Accenture  ( NYSE:ACN ) , Domino's Pizza  ( NYSE:DPZ ) ", "url": "https://www.benzinga.com/news/23/09/34999887/nike-to-rally-around-53-here-are-10-other-analyst-forecasts-for-friday", "time_published": "20230929T120356", "authors": ["Lisa Levin"], "summary": "Piper Sandler cut the price target for Accenture plc ACN from $312 to $300. Piper Sandler analyst Arvind Ramnani maintained a Neutral rating. Accenture shares rose 0.3% to $301.56 in pre-market trading. Stifel raised Editas Medicine, Inc. EDIT price target from $ $9 to $17.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/29/nike_-_logo_0.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.503496"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}], "overall_sentiment_score": 0.177093, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "C", "relevance_score": "0.198221", "ticker_sentiment_score": "0.004819", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHW", "relevance_score": "0.293506", "ticker_sentiment_score": "0.267947", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.293506", "ticker_sentiment_score": "0.054264", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.384397", "ticker_sentiment_score": "0.26847", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NKE", "relevance_score": "0.198221", "ticker_sentiment_score": "0.103348", "ticker_sentiment_label": "Neutral"}, {"ticker": "EDIT", "relevance_score": "0.293506", "ticker_sentiment_score": "0.252835", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FEMY", "relevance_score": "0.293506", "ticker_sentiment_score": "0.273967", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ACN", "relevance_score": "0.293506", "ticker_sentiment_score": "0.006547", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLS", "relevance_score": "0.293506", "ticker_sentiment_score": "-0.052552", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPZ", "relevance_score": "0.198221", "ticker_sentiment_score": "0.004819", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMPZF", "relevance_score": "0.09989", "ticker_sentiment_score": "0.003267", "ticker_sentiment_label": "Neutral"}, {"ticker": "QSR", "relevance_score": "0.293506", "ticker_sentiment_score": "0.303248", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BCS", "relevance_score": "0.198221", "ticker_sentiment_score": "0.039692", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRMB", "relevance_score": "0.293506", "ticker_sentiment_score": "0.303815", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KMX", "relevance_score": "0.293506", "ticker_sentiment_score": "0.215498", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "September's Shakeout: S&P 500, Nasdaq 100 See Just 13% Of Stocks Above 50-Day Average", "url": "https://markets.businessinsider.com/news/etf/september-s-shakeout-s-p-500-nasdaq-100-see-just-13-of-stocks-above-50-day-average-1032660395", "time_published": "20230927T160452", "authors": ["Piero Cingari"], "summary": "In a month marked by volatility, the stock market is sending out distress signals like never before. The S&P 500 and Nasdaq 100 have both hit yearly lows in terms of the percentage of stocks trading below their 50-day moving averages.", "banner_image": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2023/Stock.wance-paleri-NnRIrQ1USyw-unsplash.jpeg", "source": "Business Insider", "category_within_source": "RSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.972756"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}], "overall_sentiment_score": -0.048329, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LMT", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.25646", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DG", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.133425", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.158583", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "WBA", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.158583", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VLO", "relevance_score": "0.105604", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PODD", "relevance_score": "0.105604", "ticker_sentiment_score": "-0.133425", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGEN", "relevance_score": "0.105604", "ticker_sentiment_score": "0.158098", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IVZ", "relevance_score": "0.105604", "ticker_sentiment_score": "0.158098", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMGN", "relevance_score": "0.105604", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "QIAGEN  ( QGEN )  Extends QIAwave Product Line With New Kit", "url": "https://www.zacks.com/stock/news/2155451/qiagen-qgen-extends-qiawave-product-line-with-new-kit", "time_published": "20230926T124400", "authors": ["Zacks Equity Research"], "summary": "QIAGEN's (QGEN) new QIAwave kits broaden its selection of environmentally friendly products and reaffirm its commitment to helping researchers advance science.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7b/850.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.207573, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HQY", "relevance_score": "0.214462", "ticker_sentiment_score": "-0.056624", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.459624", "ticker_sentiment_score": "0.297274", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ITGR", "relevance_score": "0.214462", "ticker_sentiment_score": "0.156548", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DVA", "relevance_score": "0.214462", "ticker_sentiment_score": "0.08274", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.054236", "ticker_sentiment_score": "0.168814", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina Unusual Options Activity - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/markets/options/23/09/34827028/illumina-unusual-options-activity", "time_published": "20230922T160050", "authors": ["Benzinga Insights"], "summary": "A whale with a lot of money to spend has taken a noticeably bullish stance on Illumina. Looking at options history for Illumina ILMN we detected 21 strange trades. If we consider the specifics of each trade, it is accurate to state that 66% of the investors opened trades with bullish ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.17115, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.799626", "ticker_sentiment_score": "0.416306", "ticker_sentiment_label": "Bullish"}]}, {"title": "CCMB moves 83 terabytes of genomics data to AWS cloud to boost research", "url": "https://www.business-standard.com/companies/news/ccmb-moves-83-terabytes-of-genomics-data-to-aws-cloud-to-boost-research-123092201230_1.html", "time_published": "20230922T150030", "authors": ["Ashutosh Mishra"], "summary": "Amazon Web Services ( AWS ) on Friday announced that the Centre for Cellular and Molecular Biology ( CCMB ) -- India's premier research organisation for modern molecular biology and genomics -- has selected AWS as its preferred cloud provider to accelerate its genomics research projects.", "banner_image": "https://bsmedia.business-standard.com/_media/bs/img/article/2023-07/26/full/1690395058-7423.jpg?im=FitAndFill=(826,465)", "source": "Business Standard", "category_within_source": "GoogleRSS", "source_domain": "www.business-standard.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.035579, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AZN", "relevance_score": "0.074926", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.074926", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Biopsy Market to grow at a CAGR of 11.14% during the forecast period reaching USD 61.03 Bn. by 2029 - says Maximize Market Research", "url": "https://www.benzinga.com/pressreleases/23/09/g34788934/biopsy-market-to-grow-at-a-cagr-of-11-14-during-the-forecast-period-reaching-usd-61-03-bn-by-2029-", "time_published": "20230921T114119", "authors": ["Globe Newswire"], "summary": "Pune, Sept. 21, 2023 ( GLOBE NEWSWIRE ) -- A global healthcare business-consulting firm, Maximize Market Research, has published a market intelligence and competitive landscape report on the \"Biopsy Market\".", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.024217, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.029618", "ticker_sentiment_score": "0.028382", "ticker_sentiment_label": "Neutral"}, {"ticker": "GH", "relevance_score": "0.029618", "ticker_sentiment_score": "0.028382", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSMXF", "relevance_score": "0.029618", "ticker_sentiment_score": "0.028382", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOC", "relevance_score": "0.029618", "ticker_sentiment_score": "0.028382", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPGNF", "relevance_score": "0.029618", "ticker_sentiment_score": "0.028382", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXAS", "relevance_score": "0.029618", "ticker_sentiment_score": "0.028382", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.029618", "ticker_sentiment_score": "0.028382", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.029618", "ticker_sentiment_score": "0.028382", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAH", "relevance_score": "0.029618", "ticker_sentiment_score": "0.028382", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOLX", "relevance_score": "0.029618", "ticker_sentiment_score": "0.028382", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.029618", "ticker_sentiment_score": "0.028382", "ticker_sentiment_label": "Neutral"}, {"ticker": "DGX", "relevance_score": "0.029618", "ticker_sentiment_score": "0.028382", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDX", "relevance_score": "0.029618", "ticker_sentiment_score": "0.028382", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.029618", "ticker_sentiment_score": "0.028382", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.029618", "ticker_sentiment_score": "0.028382", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDSX", "relevance_score": "0.029618", "ticker_sentiment_score": "0.028382", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.029618", "ticker_sentiment_score": "0.028382", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDGXF", "relevance_score": "0.029618", "ticker_sentiment_score": "0.028382", "ticker_sentiment_label": "Neutral"}]}, {"title": "Looking At Illumina's Recent Unusual Options Activity - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/markets/options/23/09/34771604/looking-at-illuminas-recent-unusual-options-activity", "time_published": "20230920T190140", "authors": ["Benzinga Insights"], "summary": "Someone with a lot of money to spend has taken a bearish stance on Illumina ILMN. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.134181, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.779232", "ticker_sentiment_score": "0.284296", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Myriad Genetics  ( MYGN )  Secures Key Milestones in Illumina Tie-Up", "url": "https://www.zacks.com/stock/news/2152908/myriad-genetics-mygn-secures-key-milestones-in-illumina-tie-up", "time_published": "20230920T114200", "authors": ["Zacks Equity Research"], "summary": "Myriad Genetics (MYGN) achieves significant milestones in its partnership with Illumina.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/58/16163.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.947132"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.260148, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HAE", "relevance_score": "0.266828", "ticker_sentiment_score": "0.118595", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.329992", "ticker_sentiment_score": "0.217583", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MYGN", "relevance_score": "0.449219", "ticker_sentiment_score": "0.386982", "ticker_sentiment_label": "Bullish"}, {"ticker": "QTRX", "relevance_score": "0.135347", "ticker_sentiment_score": "0.071708", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cramer Is 'Astonished' That Chewy Is 'Doing This Poorly - So Many Of Us Use It' - Advance Auto Parts  ( NYSE:AAP ) , AutoZone  ( NYSE:AZO ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/23/09/34571210/cramer-is-astonished-that-chewy-is-doing-this-poorly-so-many-of-us-use-it", "time_published": "20230914T124148", "authors": ["Priya Nigam"], "summary": "On CNBC's \"Mad Money Lightning Round,\" Jim Cramer said yes to The St. Joe Company JOE. \"I've liked St. Joe forever,\" he added. When asked about Advance Auto Parts, Inc. AAP, he said, \"I like to buy best of breed, the best of breed is AutoZone, Inc. AZO.\" Cramer also said he is astonished that ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/14/jim-cramer2.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}], "overall_sentiment_score": 0.19243, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AAP", "relevance_score": "0.419153", "ticker_sentiment_score": "0.469778", "ticker_sentiment_label": "Bullish"}, {"ticker": "CHWY", "relevance_score": "0.419153", "ticker_sentiment_score": "0.285782", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CMG", "relevance_score": "0.2872", "ticker_sentiment_score": "-0.155055", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AZO", "relevance_score": "0.419153", "ticker_sentiment_score": "0.469778", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.419153", "ticker_sentiment_score": "0.342088", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DHR", "relevance_score": "0.419153", "ticker_sentiment_score": "0.342088", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Mellow yellow: BeautiTone unveils 2024 Colour of the Year, 'Illumina' - Canada NewsWire", "url": "https://www.newswire.ca/news-releases/mellow-yellow-beautitone-unveils-2024-colour-of-the-year-illumina--833957166.html", "time_published": "20230913T122600", "authors": [], "summary": "Mellow yellow: BeautiTone unveils 2024 Colour of the Year, 'Illumina' Canada ...", "banner_image": null, "source": "Canada Newswire", "category_within_source": "n/a", "source_domain": "www.newswire.ca", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.443252, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.470174", "ticker_sentiment_score": "0.594442", "ticker_sentiment_label": "Bullish"}]}, {"title": "AI Integration In Biotech & Pharma: Companies Positioned To Benefit - Recursion Pharmaceuticals  ( NASDAQ:RXRX ) ", "url": "https://www.benzinga.com/markets/penny-stocks/23/09/34451218/ai-integration-in-biotech-pharma-companies-positioned-to-benefit", "time_published": "20230911T172731", "authors": ["Steve Macalbry"], "summary": "The convergence of artificial intelligence ( AI ) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug discovery to patient care.", "banner_image": "https://cdn.benzinga.com/files/national-cancer-institute-xknubmnjbkg-unsplash_1.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.393609, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.166169", "ticker_sentiment_score": "0.189691", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.166169", "ticker_sentiment_score": "0.173764", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "How Is The Market Feeling About Illumina? - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/short-sellers/23/09/34445001/how-is-the-market-feeling-about-illumina", "time_published": "20230911T150027", "authors": ["Benzinga Insights"], "summary": "Illumina's ILMN short percent of float has fallen 3.07% since its last report. The company recently reported that it has 5.79 million shares sold short, which is 4.1% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.9 days to cover their ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.241618, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.224903", "ticker_sentiment_score": "0.085754", "ticker_sentiment_label": "Neutral"}]}, {"title": "Is the Worst Over for Illumina Stock?", "url": "https://www.fool.com/investing/2023/09/09/is-the-worst-over-for-illumina-stock/", "time_published": "20230909T121500", "authors": ["Alex Carchidi"], "summary": "There's reason to believe that the future is starting to look better.", "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.839681"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": -0.058264, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.419733", "ticker_sentiment_score": "-0.123819", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina  ( ILMN )  Down 14.2% Since Last Earnings Report: Can It Rebound?", "url": "https://www.zacks.com/stock/news/2146689/illumina-ilmn-down-142-since-last-earnings-report-can-it-rebound", "time_published": "20230908T153030", "authors": ["Zacks Equity Research"], "summary": "Illumina (ILMN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default353.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.995077"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.094415, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EXEL", "relevance_score": "0.151778", "ticker_sentiment_score": "0.04581", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.610896", "ticker_sentiment_score": "0.196274", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Top Stories Friday, Sep 8: Did Elon Musk Admit 90% Decline In Twitter's Value Since Acquisition?, Apple's Zero-Click Vulnerabilities Uncovered By Internet Watchdog Group, Gas Prices Jump As Strikes Start At Major Chevron Australia LNG Projects - Apple  ( NASDAQ:AAPL ) , Albertsons Companies  ( NYSE:ACI ) ", "url": "https://www.benzinga.com/news/23/09/34363050/did-elon-musk-admit-90-decline-in-twitters-value-since-acquisition-apples-zero-click-vulnerabilities", "time_published": "20230908T143216", "authors": ["Vandana Singh"], "summary": "Elon Musk's $44 billion acquisition of Twitter ( now X ) has been mired in controversies, but his latest admission could be a sign of just how bad it has turned out for him so far.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/08/elon_musk_should_run_from_the_twitter_deal_ljupco_smokovski_by_shutterstock_and_wikimedia_commons.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.02421, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.139064", "ticker_sentiment_score": "-0.231492", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AAPL", "relevance_score": "0.069798", "ticker_sentiment_score": "-0.008128", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVX", "relevance_score": "0.069798", "ticker_sentiment_score": "0.035368", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPOT", "relevance_score": "0.069798", "ticker_sentiment_score": "0.113506", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.069798", "ticker_sentiment_score": "0.090027", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACI", "relevance_score": "0.069798", "ticker_sentiment_score": "0.126595", "ticker_sentiment_label": "Neutral"}, {"ticker": "KR", "relevance_score": "0.207275", "ticker_sentiment_score": "0.07092", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.069798", "ticker_sentiment_score": "-0.102437", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.069798", "ticker_sentiment_score": "0.024304", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZM", "relevance_score": "0.069798", "ticker_sentiment_score": "0.024304", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOFT", "relevance_score": "0.104531", "ticker_sentiment_score": "-0.033671", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFBQF", "relevance_score": "0.069798", "ticker_sentiment_score": "0.307496", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SFTBF", "relevance_score": "0.034933", "ticker_sentiment_score": "0.298086", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LLY", "relevance_score": "0.069798", "ticker_sentiment_score": "0.19613", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Billionaire Activist Investor Carl Icahn Shows Support For Illumina's Newly Appointed CEO - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/23/09/34362243/billionaire-activist-investor-carl-icahn-shows-support-for-illuminas-newly-appointed-ceo", "time_published": "20230908T140430", "authors": ["Vandana Singh"], "summary": "Activist investor Carl Icahn has thrown his support behind Illumina Inc's ILMN new CEO, Jacob Thaysen, providing a sigh of relief for the company as it strives to recover from a contentious proxy battle with the billionaire activist investor.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/08/ilmn.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.090558, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.615462", "ticker_sentiment_score": "-0.051334", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cathie Wood's Buying These 3 Stocks Hand Over Fist", "url": "https://www.fool.com/investing/2023/09/08/cathie-woods-buying-these-3-stocks-hand-over-fist/", "time_published": "20230908T112300", "authors": ["Cory Renauer"], "summary": "A drugmaker, a gene sequencer, and a streaming business all made deep impressions on Ark Invest's stock-picking team.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F746792%2Finvestor-with-stock-chart-getty.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.980716"}, {"topic": "Earnings", "relevance_score": "0.995973"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.228712, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BEAM", "relevance_score": "0.204936", "ticker_sentiment_score": "0.264927", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AAPL", "relevance_score": "0.051774", "ticker_sentiment_score": "0.121756", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERV", "relevance_score": "0.051774", "ticker_sentiment_score": "0.113498", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPOT", "relevance_score": "0.303175", "ticker_sentiment_score": "0.195224", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PACB", "relevance_score": "0.154455", "ticker_sentiment_score": "0.082774", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.154455", "ticker_sentiment_score": "0.065401", "ticker_sentiment_label": "Neutral"}]}, {"title": "Carl Icahn says new Illumina CEO has his 'full support' months after proxy fight", "url": "https://www.cnbc.com/2023/09/07/carl-icahn-supports-new-illumina-ceo-thaysen-after-proxy-fight-.html", "time_published": "20230907T191453", "authors": ["Annika Kim Constantino"], "summary": "Activist investor Icahn's blessing is a relief for the company as it tries to rebound from a bitter proxy fight with the billionaire investor.", "banner_image": "https://image.cnbcfm.com/api/v1/image/106936357-16305276182021-09-01t195824z_1778252698_rc26hp93su6c_rtrmadp_0_illumina-results.jpeg?v=1694114093&w=1920&h=1080", "source": "CNBC", "category_within_source": "Business", "source_domain": "www.cnbc.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.053895, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.158519", "ticker_sentiment_score": "0.112845", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.310843", "ticker_sentiment_score": "-0.160412", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "$100 Invested In Illumina 20 Years Ago Would Be Worth This Much Today - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/earnings/23/09/34284302/100-invested-in-illumina-20-years-ago-would-be-worth-this-much-today", "time_published": "20230906T153050", "authors": ["Benzinga Insights"], "summary": "Illumina ILMN has outperformed the market over the past 20 years by 16.74% on an annualized basis producing an average annual return of 24.39%. Currently, Illumina has a market capitalization of $25.45 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.983605", "ticker_sentiment_score": "0.387251", "ticker_sentiment_label": "Bullish"}]}, {"title": "Illumina: Company Investigated by the Portnoy Law Firm - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/09/g34251451/illumina-company-investigated-by-the-portnoy-law-firm", "time_published": "20230905T194729", "authors": ["Globe Newswire"], "summary": "Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Sept. 05, 2023 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises Illumina, Inc. ( \"Illumina\" or \"the Company\" ) ILMN investors that the firm has initiated an investigation into possible ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.00241, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.608634", "ticker_sentiment_score": "-0.057372", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Is Illumina Stock Trading Lower Today? - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/large-cap/23/09/34242404/why-is-illumina-stock-trading-lower-today", "time_published": "20230905T163731", "authors": ["Vandana Singh"], "summary": "Illumina Inc ILMN shares are trading lower after the company appointed Jacob Thaysen as its new CEO, roughly three months after the company parted ways with Francis deSouza.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/05/ilmn.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.030988, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.211191", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.716023", "ticker_sentiment_score": "-0.310279", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Illumina names new CEO months after Icahn proxy fight over Grail deal", "url": "https://www.cnbc.com/2023/09/05/illumina-names-ceo-jacob-thaysen-after-icahn-proxy-fight-over-grail.html", "time_published": "20230905T154629", "authors": ["Annika Kim Constantino"], "summary": "The announcement comes after a proxy fight with activist investor Carl Icahn, which ended with Illumina's former CEO Francis deSouza voluntarily stepping down.", "banner_image": "https://image.cnbcfm.com/api/v1/image/106936357-16305276182021-09-01t195824z_1778252698_rc26hp93su6c_rtrmadp_0_illumina-results.jpeg?v=1693928789&w=1920&h=1080", "source": "CNBC", "category_within_source": "Business", "source_domain": "www.cnbc.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.0, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.776097", "ticker_sentiment_score": "0.228528", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "EXEL vs. ILMN: Which Stock Is the Better Value Option?", "url": "https://www.zacks.com/stock/news/2144937/exel-vs-ilmn-which-stock-is-the-better-value-option", "time_published": "20230905T154007", "authors": ["Zacks Equity Research"], "summary": "Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Exelixis ( EXEL Quick QuoteEXEL - ) or Illumina ( ILMN Quick QuoteILMN - ) . But which of these two stocks presents investors with the better value opportunity right now?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default60.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.466227, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "EXEL", "relevance_score": "0.686739", "ticker_sentiment_score": "0.580969", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.622414", "ticker_sentiment_score": "0.560052", "ticker_sentiment_label": "Bullish"}]}, {"title": "Illumina Names Jacob Thaysen as New CEO", "url": "https://www.wsj.com/business/c-suite/illumina-names-new-chief-executive-efe5ad92", "time_published": "20230905T153300", "authors": ["Chris Wack"], "summary": "Jacob Thaysen was named to the role after Francis deSouza resigned from the gene-sequencing maker in June amid a fight with regulators.", "banner_image": "https://images.wsj.net/im-846779?width=700&height=467", "source": "Wall Street Journal", "category_within_source": "Business", "source_domain": "www.wsj.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.128863, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.947069", "ticker_sentiment_score": "-0.230864", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Illumina names Agilent exec Jacob Thaysen as CEO", "url": "https://www.reuters.com/business/illumina-names-agilent-exec-jacob-thaysen-ceo-2023-09-05/", "time_published": "20230905T114533", "authors": ["Reuters"], "summary": "A sign at the front entrance to the global headquarters of Illumina is pictured in San Diego, California, U.S., November 28, 2022. REUTERS/Mike Blake/File Photo Acquire Licensing Rights", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/VVGTP5JJ75PJLPE54PQA3LLPR4.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.078331, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.355588", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.644033", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer - PR Newswire", "url": "https://www.prnewswire.com/news-releases/illuminas-board-appoints-jacob-thaysen-phd-as-its-new-chief-executive-officer-301917362.html", "time_published": "20230905T113000", "authors": [], "summary": "Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.303872, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.04872", "ticker_sentiment_score": "0.000996", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.04872", "ticker_sentiment_score": "0.106039", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.04872", "ticker_sentiment_score": "0.106039", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.375016", "ticker_sentiment_score": "0.538754", "ticker_sentiment_label": "Bullish"}]}, {"title": "Advancements in Genome Sequencing Propel Global RNA Sequencing Market Growth to 2030", "url": "https://www.prnewswire.com/news-releases/advancements-in-genome-sequencing-propel-global-rna-sequencing-market-growth-to-2030-301916843.html", "time_published": "20230904T174500", "authors": ["Research and Markets"], "summary": "DUBLIN, Sept. 4, 2023 /PRNewswire/ -- The \"RNA Sequencing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user and Region ( North America, Europe, Asia Pacific, Latin America and Middle East and Africa ) \" ...", "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.382501, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.029951", "ticker_sentiment_score": "0.125733", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.029951", "ticker_sentiment_score": "0.125733", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.05986", "ticker_sentiment_score": "0.134004", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.05986", "ticker_sentiment_score": "0.15301", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TMO", "relevance_score": "0.029951", "ticker_sentiment_score": "0.125733", "ticker_sentiment_label": "Neutral"}]}, {"title": "iSpecimen Launches New Virtual Cancer Sequencing Procurement Program - iSpecimen  ( NASDAQ:ISPC ) ", "url": "https://www.benzinga.com/pressreleases/23/08/g34111122/ispecimen-launches-new-virtual-cancer-sequencing-procurement-program", "time_published": "20230830T113000", "authors": ["Globe Newswire"], "summary": "Program to Provide Cancer Researchers with Direct Access to Highly Sought Donor Tumor Tissue Samples Virtual Inventory Comprised of Formalin-Fixed, Paraffin-Embedded ( FFPE ) Samples Screened for Mutations LEXINGTON, Mass., Aug. 30, 2023 ( GLOBE NEWSWIRE ) -- iSpecimen Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": -0.170835, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "AZTA", "relevance_score": "0.044304", "ticker_sentiment_score": "-0.10167", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.044304", "ticker_sentiment_score": "-0.10167", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPC", "relevance_score": "0.302642", "ticker_sentiment_score": "-0.185393", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Gene Fusion Testing Market's Evolution: Emerging Technologies and Clinical Impact Unveiled", "url": "https://www.prnewswire.com/news-releases/gene-fusion-testing-markets-evolution-emerging-technologies-and-clinical-impact-unveiled-301910041.html", "time_published": "20230825T214500", "authors": ["Research and Markets"], "summary": "DUBLIN, Aug. 25, 2023 /PRNewswire/ -- The \"Gene Fusion Testing Market - A Global and Regional Analysis: Focus on by Category, Technology, Indication, End User, and Region - Analysis and Forecast, 2023-2033\" report has been added to ResearchAndMarkets.com's offering.", "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.10507, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GH", "relevance_score": "0.137278", "ticker_sentiment_score": "0.04939", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.137278", "ticker_sentiment_score": "0.04939", "ticker_sentiment_label": "Neutral"}]}, {"title": "Mass Notification System Market worth $49.9 billion by 2028 - Exclusive Report by MarketsandMarkets\u2122", "url": "https://www.prnewswire.com/news-releases/mass-notification-system-market-worth-49-9-billion-by-2028---exclusive-report-by-marketsandmarkets-301909892.html", "time_published": "20230825T143000", "authors": ["MarketsandMarkets"], "summary": "CHICAGO, Aug. 25, 2023 /PRNewswire/ -- The market for mass notification systems will be characterised in the future by the integration of new technologies, personalised communication, predictive capabilities, and a strong focus on compliance, security, and safety.", "banner_image": "https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.161647"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.2378, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "JCI", "relevance_score": "0.066506", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.033282", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSI", "relevance_score": "0.066506", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMAWF", "relevance_score": "0.066506", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVBG", "relevance_score": "0.066506", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.033282", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Element Biosciences Adds Genomics Executive to Leadership Team to Accelerate Corporate Development - PR Newswire", "url": "https://www.prnewswire.com/news-releases/element-biosciences-adds-genomics-executive-to-leadership-team-to-accelerate-corporate-development-301908643.html", "time_published": "20230824T110000", "authors": [], "summary": "Element Biosciences Adds Genomics Executive to Leadership Team to Accelerate Corporate Development PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.257856, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.095899", "ticker_sentiment_score": "0.086129", "ticker_sentiment_label": "Neutral"}]}, {"title": "Synthetica Bio Strengthens Leadership Team with Industry Experts to Accelerate Strategic Growth", "url": "https://www.prnewswire.com/news-releases/synthetica-bio-strengthens-leadership-team-with-industry-experts-to-accelerate-strategic-growth-301908132.html", "time_published": "20230823T150000", "authors": ["Synthetica Bio", "Inc."], "summary": "Fast-growing generative AI company appoints accomplished executives as the biopharma industry adopts the rapidly developing technology", "banner_image": "https://mma.prnewswire.com/media/2141401/Synthetica_Bio_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.242548, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.048425", "ticker_sentiment_score": "0.050353", "ticker_sentiment_label": "Neutral"}]}, {"title": "Corporate America's Chief Critic, Carl Icahn, Gets His Comeuppance", "url": "https://www.nytimes.com/2023/08/21/business/carl-icahn-nathan-anderson-short-selling.html", "time_published": "20230821T154509", "authors": ["Maureen Farrell"], "summary": "After a short seller targeted Icahn Enterprises, the activist investor made changes. At 87, he insists he's not going anywhere and will refocus on rattling company cages.", "banner_image": "https://static01.nyt.com/images/2023/08/18/multimedia/00ICAHN-01/vbzc-articleLarge.jpg?quality=75&auto=webp&disable=upscale", "source": "New York Times", "category_within_source": "Business", "source_domain": "www.nytimes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.045538, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.042876", "ticker_sentiment_score": "0.051399", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYPL", "relevance_score": "0.021446", "ticker_sentiment_score": "0.086117", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLF", "relevance_score": "0.021446", "ticker_sentiment_score": "0.086117", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBAY", "relevance_score": "0.021446", "ticker_sentiment_score": "0.086117", "ticker_sentiment_label": "Neutral"}, {"ticker": "GM", "relevance_score": "0.021446", "ticker_sentiment_score": "0.083696", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.085629", "ticker_sentiment_score": "-0.040109", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKLA", "relevance_score": "0.021446", "ticker_sentiment_score": "0.003632", "ticker_sentiment_label": "Neutral"}, {"ticker": "IFF", "relevance_score": "0.021446", "ticker_sentiment_score": "-0.000883", "ticker_sentiment_label": "Neutral"}]}, {"title": "Wall Street Thinks Illumina Stock Will Rise 27% in 1 Year. Here's Why That Probably Won't Happen.", "url": "https://www.fool.com/investing/2023/08/21/wall-street-thinks-illumina-stock-will-rise-27-in/", "time_published": "20230821T132300", "authors": ["Alex Carchidi"], "summary": "Its core revenue won't grow, and that's not even its biggest problem at the moment.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F744485%2Fsenior-fanning-cash-retirement-social-security-getty.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.214378"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.002398, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.387875", "ticker_sentiment_score": "-0.081172", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina  ( ILMN )  Expands Presence in India With New Facility", "url": "https://www.zacks.com/stock/news/2138542/illumina-ilmn-expands-presence-in-india-with-new-facility", "time_published": "20230821T124800", "authors": ["Zacks Equity Research"], "summary": "Illumina (ILMN) boosts genomic capabilities in India with a new state-of-the-art Solutions Center.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d9/3163.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.890401"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.253893, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HAE", "relevance_score": "0.232439", "ticker_sentiment_score": "0.097355", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARRY", "relevance_score": "0.058903", "ticker_sentiment_score": "0.13", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.493965", "ticker_sentiment_score": "0.278002", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "QTRX", "relevance_score": "0.117486", "ticker_sentiment_score": "0.058188", "ticker_sentiment_label": "Neutral"}]}, {"title": "EXEL or ILMN: Which Is the Better Value Stock Right Now?", "url": "https://www.zacks.com/stock/news/2138158/exel-or-ilmn-which-is-the-better-value-stock-right-now", "time_published": "20230818T154012", "authors": ["Zacks Equity Research"], "summary": "EXEL vs. ILMN: Which Stock Is the Better Value Option?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default354.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.493064, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "EXEL", "relevance_score": "0.804025", "ticker_sentiment_score": "0.610365", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.755492", "ticker_sentiment_score": "0.599339", "ticker_sentiment_label": "Bullish"}]}, {"title": "Peering Into Illumina's Recent Short Interest - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/short-sellers/23/08/33915616/peering-into-illuminas-recent-short-interest", "time_published": "20230818T140022", "authors": ["Benzinga Insights"], "summary": "Illumina's ILMN short percent of float has fallen 16.57% since its last report. The company recently reported that it has 5.98 million shares sold short, which is 4.23% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.28 days to cover ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.241618, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.224903", "ticker_sentiment_score": "0.085754", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/earnings/23/08/33900184/heres-how-much-you-would-have-made-owning-illumina-stock-in-the-last-20-years", "time_published": "20230817T190045", "authors": ["Benzinga Insights"], "summary": "Illumina ILMN has outperformed the market over the past 20 years by 18.14% on an annualized basis producing an average annual return of 25.8%. Currently, Illumina has a market capitalization of $26.82 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.983605", "ticker_sentiment_score": "0.387251", "ticker_sentiment_label": "Bullish"}]}, {"title": "Biotech firm Illumina is enhancing its presence in the Indian market", "url": "https://www.business-standard.com/companies/news/biotech-firm-illumina-is-enhancing-its-presence-in-the-indian-market-123081700656_1.html", "time_published": "20230817T131933", "authors": ["Sohini Das"], "summary": "San Diego-based $32.7 billion biotech company Illumina is enhancing its presence in the Indian market, anticipating that the addressable market for genomic sequencing and testing will almost double from its current levels by 2027.", "banner_image": "https://bsmedia.business-standard.com/_media/bs/img/article/2017-01/19/full/1484826568-3397.jpg?im=FeatureCrop,size=(826,465)", "source": "Business Standard", "category_within_source": "GoogleRSS", "source_domain": "www.business-standard.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.174666, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.477986", "ticker_sentiment_score": "0.128438", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina expands genomics capabilities in India with opening of Solutions Center - PR Newswire", "url": "https://www.prnewswire.com/news-releases/illumina-expands-genomics-capabilities-in-india-with-opening-of-solutions-center-301903368.html", "time_published": "20230817T131500", "authors": [], "summary": "Illumina expands genomics capabilities in India with opening of Solutions Center PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.307169, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.061949", "ticker_sentiment_score": "0.106024", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.061949", "ticker_sentiment_score": "0.106024", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARRY", "relevance_score": "0.061949", "ticker_sentiment_score": "0.143059", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.607406", "ticker_sentiment_score": "0.436731", "ticker_sentiment_label": "Bullish"}]}, {"title": "Down 15% in 2023, Should You Buy the Dip With Illumina Stock?", "url": "https://www.fool.com/investing/2023/08/17/down-15-in-2023-should-you-buy-the-dip-illumina/", "time_published": "20230817T105500", "authors": ["Alex Carchidi"], "summary": "Illumina's future is looking a bit dim at the moment.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F743953%2Fa-digital-render-of-a-circuit-board-with-a-chip-in-the-center-inscribed-with-the-letters-ai.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Earnings", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.06683, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.362505", "ticker_sentiment_score": "0.063781", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Shares of SomaLogic Are Up Tuesday", "url": "https://www.fool.com/investing/2023/08/15/why-shares-of-somalogic-are-up-tuesday/", "time_published": "20230815T165238", "authors": ["Jim Halley"], "summary": "The company showed strong revenue growth in the second quarter.", "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.997902"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.197958, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.144275", "ticker_sentiment_score": "0.135297", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGC", "relevance_score": "0.636698", "ticker_sentiment_score": "0.298569", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "The Proteomics Market to grow at a CAGR of 13.05% from 2022 to 2027; Increasing advances in proteomics research ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/the-proteomics-market-to-grow-at-a-cagr-of-13-05--from-2022-to-2027-increasing-advances-in-proteomics-research-to-boost-market-growth---technavio-301898764.html", "time_published": "20230814T083000", "authors": [], "summary": "The Proteomics Market to grow at a CAGR of 13.05% from 2022 to 2027. Increasing advances in proteomics research ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.157627, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.058759", "ticker_sentiment_score": "0.053982", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.058759", "ticker_sentiment_score": "0.053982", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.058759", "ticker_sentiment_score": "0.053982", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRKR", "relevance_score": "0.058759", "ticker_sentiment_score": "0.053982", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSRLF", "relevance_score": "0.058759", "ticker_sentiment_score": "0.053982", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.058759", "ticker_sentiment_score": "0.053982", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.058759", "ticker_sentiment_score": "0.053982", "ticker_sentiment_label": "Neutral"}, {"ticker": "WAT", "relevance_score": "0.058759", "ticker_sentiment_score": "0.053982", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLK", "relevance_score": "0.058759", "ticker_sentiment_score": "0.053982", "ticker_sentiment_label": "Neutral"}]}, {"title": "Global Synthetic Biology Market to grow by USD 28,253.12 million between 2022 and 2027 | The growing application ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/global-synthetic-biology-market-to-grow-by-usd-28-253-12-million-between-2022-and-2027--the-growing-application-of-synthetic-biology-drives-the-market-301898157.html", "time_published": "20230811T230000", "authors": [], "summary": "Global Synthetic Biology Market to grow by USD 28,253.12 million between 2022 and 2027 | The growing application ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.317422, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.050572", "ticker_sentiment_score": "0.087388", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRS", "relevance_score": "0.050572", "ticker_sentiment_score": "0.087388", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXS", "relevance_score": "0.050572", "ticker_sentiment_score": "0.087388", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWST", "relevance_score": "0.050572", "ticker_sentiment_score": "0.087388", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNA", "relevance_score": "0.050572", "ticker_sentiment_score": "0.087388", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.050572", "ticker_sentiment_score": "0.087388", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNNSF", "relevance_score": "0.050572", "ticker_sentiment_score": "0.087388", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVZMY", "relevance_score": "0.050572", "ticker_sentiment_score": "0.087388", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERFSF", "relevance_score": "0.050572", "ticker_sentiment_score": "0.087388", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.050572", "ticker_sentiment_score": "0.087388", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.050572", "ticker_sentiment_score": "0.087388", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina To Webcast Upcoming Investor Conference", "url": "https://www.prnewswire.com/news-releases/illumina-to-webcast-upcoming-investor-conference-301899042.html", "time_published": "20230811T200500", "authors": ["Inc.", "Illumina"], "summary": "SAN DIEGO, Aug. 11, 2023 /PRNewswire/ -- Illumina, Inc. ( NASDAQ: ILMN ) today announced that its vice president of investor relations will be speaking at the following investor conference: \u2022 UBS MedTech, Tools and Genomics Summit 2023 on", "banner_image": "https://mma.prnewswire.com/media/1876671/Illumina_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.121058, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.721785", "ticker_sentiment_score": "0.19286", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina Inc. Inc Investors: Company Investigated by the Portnoy Law Firm - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/08/g33759688/illumina-inc-inc-investors-company-investigated-by-the-portnoy-law-firm", "time_published": "20230811T191219", "authors": ["Globe Newswire"], "summary": "Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 11, 2023 ( GLOBE NEWSWIRE ) -- The Portnoy Law Firm advises Illumina Inc. ILMN ( \"Illumina\" ) investors that the firm has initiated an investigation into whether Illumina issued false and ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.026428, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.832201", "ticker_sentiment_score": "0.06137", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Illumina  ( ILMN )  Shares Are Falling Today - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/large-cap/23/08/33753298/why-illumina-shares-are-falling-today", "time_published": "20230811T163152", "authors": ["Vandana Singh"], "summary": "Illumina Inc ILMN disclosed in an SEC filing that the Securities and Exchange Commission is the latest government agency investigating the company's $8 billion Grail acquisition.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/08/11/ilmn.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": -0.009607, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.928849", "ticker_sentiment_score": "0.109899", "ticker_sentiment_label": "Neutral"}]}, {"title": "SEC investigating Illumina over acquisition of cancer test developer Grail", "url": "https://www.cnbc.com/2023/08/11/sec-investigating-illumina-grail-acquisition.html", "time_published": "20230811T160357", "authors": ["Annika Kim Constantino"], "summary": "Illumina's acquisition of cancer test developer Grail has also faced heavy scrutiny from antitrust regulators in the U.S. and European Union.", "banner_image": "https://image.cnbcfm.com/api/v1/image/106936357-16305276182021-09-01t195824z_1778252698_rc26hp93su6c_rtrmadp_0_illumina-results.jpeg?v=1691769837&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.048629, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.848651", "ticker_sentiment_score": "0.054098", "ticker_sentiment_label": "Neutral"}]}, {"title": "Company News for Aug 11, 2023", "url": "https://www.zacks.com/stock/news/2135643/company-news-for-aug-11-2023", "time_published": "20230811T133600", "authors": ["Zacks Equity Research"], "summary": "Companies in The News Are: ...", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/38/876.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.35093, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "DDS", "relevance_score": "0.546745", "ticker_sentiment_score": "0.316808", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MFC", "relevance_score": "0.546745", "ticker_sentiment_score": "0.525939", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.546745", "ticker_sentiment_score": "0.690597", "ticker_sentiment_label": "Bullish"}, {"ticker": "G", "relevance_score": "0.546745", "ticker_sentiment_score": "0.307255", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina To Bear The Brunt Of Slowdown In Consumables Purchasing Amid Lower Demand In China: Analyst - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/08/33716616/illumina-to-bear-the-brunt-of-slowdown-in-consumables-purchasing-amid-lower-demand-", "time_published": "20230810T175535", "authors": ["Nabaparna Bhattacharya"], "summary": "Stifel analyst Daniel Arias reiterated a Buy rating on Illumina, Inc ILMN, lowering the price target to $225 from $265. ILMN recently reported better-than-expected Q2 results, where revenue of $1.18 billion was up 1% Y/Y.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/08/10/ilmn.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.87644"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.05717, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.538389", "ticker_sentiment_score": "0.24701", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina Unusual Options Activity - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/markets/options/23/08/33718149/illumina-unusual-options-activity", "time_published": "20230810T173055", "authors": ["Benzinga Insights"], "summary": "Someone with a lot of money to spend has taken a bullish stance on Illumina ILMN. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.156263, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.888579", "ticker_sentiment_score": "0.365638", "ticker_sentiment_label": "Bullish"}, {"ticker": "JPM", "relevance_score": "0.097457", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.097457", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina  ( ILMN )  Q2 Earnings Beat Estimates, Margins Contract", "url": "https://www.zacks.com/stock/news/2135276/illumina-ilmn-q2-earnings-beat-estimates-margins-contract", "time_published": "20230810T153700", "authors": ["Zacks Equity Research"], "summary": "Illumina (ILMN) shipped 109 NovaSeq X instruments in the second quarter, boosting its supply capacity to more than 390 instruments for fiscal 2023.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/3c/35363.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.650727"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.094845, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PEN", "relevance_score": "0.14131", "ticker_sentiment_score": "0.050902", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.14131", "ticker_sentiment_score": "0.02237", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.14131", "ticker_sentiment_score": "-0.006266", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.602278", "ticker_sentiment_score": "0.346094", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Alibaba, Illumina, CyberArk Software And Other Big Stocks Moving Higher On Thursday - Alarm.com Holdings  ( NASDAQ:ALRM ) , Applied Industrial  ( NYSE:AIT ) ", "url": "https://www.benzinga.com/news/23/08/33711133/alibaba-illumina-cyberark-software-and-other-big-stocks-moving-higher-on-thursday", "time_published": "20230810T143943", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded higher, with the Dow Jones gaining around 350 points on Thursday. Here are some big stocks recording gains in today's session. Capri Holdings Limited CPRI surged 56.1% to $54.03 after Tapestry announced a definitive agreement to acquire the company. Holley Inc.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/08/10/alibaba_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.999162"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.446512, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "MGNX", "relevance_score": "0.149656", "ticker_sentiment_score": "0.285522", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NN", "relevance_score": "0.149656", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "APP", "relevance_score": "0.149656", "ticker_sentiment_score": "0.42903", "ticker_sentiment_label": "Bullish"}, {"ticker": "AVAH", "relevance_score": "0.149656", "ticker_sentiment_score": "0.513103", "ticker_sentiment_label": "Bullish"}, {"ticker": "GDRX", "relevance_score": "0.149656", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAW", "relevance_score": "0.149656", "ticker_sentiment_score": "0.339397", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PGEN", "relevance_score": "0.222838", "ticker_sentiment_score": "0.193042", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "G", "relevance_score": "0.149656", "ticker_sentiment_score": "0.147925", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLIT", "relevance_score": "0.222838", "ticker_sentiment_score": "0.590763", "ticker_sentiment_label": "Bullish"}, {"ticker": "INFN", "relevance_score": "0.149656", "ticker_sentiment_score": "0.526939", "ticker_sentiment_label": "Bullish"}, {"ticker": "DDS", "relevance_score": "0.149656", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNST", "relevance_score": "0.149656", "ticker_sentiment_score": "0.339397", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AOSL", "relevance_score": "0.149656", "ticker_sentiment_score": "0.325907", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CYBR", "relevance_score": "0.222838", "ticker_sentiment_score": "0.135231", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVAX", "relevance_score": "0.149656", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLSK", "relevance_score": "0.149656", "ticker_sentiment_score": "-0.237471", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BABA", "relevance_score": "0.149656", "ticker_sentiment_score": "0.150418", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.149656", "ticker_sentiment_score": "0.439877", "ticker_sentiment_label": "Bullish"}, {"ticker": "UIHC", "relevance_score": "0.149656", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "YETI", "relevance_score": "0.149656", "ticker_sentiment_score": "0.450674", "ticker_sentiment_label": "Bullish"}, {"ticker": "TAST", "relevance_score": "0.149656", "ticker_sentiment_score": "0.339397", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SENEA", "relevance_score": "0.149656", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIT", "relevance_score": "0.149656", "ticker_sentiment_score": "0.316922", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HLLY", "relevance_score": "0.149656", "ticker_sentiment_score": "0.190438", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EVC", "relevance_score": "0.149656", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAMP", "relevance_score": "0.149656", "ticker_sentiment_score": "0.316922", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RSTGF", "relevance_score": "0.075161", "ticker_sentiment_score": "0.27182", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CPRI", "relevance_score": "0.149656", "ticker_sentiment_score": "0.086197", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks making the biggest moves premarket: Capri, Tapestry, AppLovin, Disney and more", "url": "https://www.cnbc.com/2023/08/10/stocks-making-the-biggest-moves-premarket-capri-tapestry-applovin-disney-and-more.html", "time_published": "20230810T120416", "authors": ["Sarah Min"], "summary": "These are the stocks posting the largest moves in early trading.", "banner_image": "https://image.cnbcfm.com/api/v1/image/103859546-IMG_7973r.jpg?v=1691669056&w=1920&h=1080", "source": "CNBC", "category_within_source": "Market Insider", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.130726, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BABA", "relevance_score": "0.129866", "ticker_sentiment_score": "0.109112", "ticker_sentiment_label": "Neutral"}, {"ticker": "APP", "relevance_score": "0.193723", "ticker_sentiment_score": "0.304393", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SIX", "relevance_score": "0.06515", "ticker_sentiment_score": "0.09449", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTD", "relevance_score": "0.129866", "ticker_sentiment_score": "0.120918", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.193723", "ticker_sentiment_score": "-0.132461", "ticker_sentiment_label": "Neutral"}, {"ticker": "WYNN", "relevance_score": "0.129866", "ticker_sentiment_score": "0.219115", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CPRI", "relevance_score": "0.06515", "ticker_sentiment_score": "0.018053", "ticker_sentiment_label": "Neutral"}, {"ticker": "SONO", "relevance_score": "0.193723", "ticker_sentiment_score": "-0.027329", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nasdaq, S&P 500 Futures Rally Ahead Of Inflation Data; Why This Analyst Sounds Out Caution About Stock Valuations - Alibaba Gr Holding  ( NYSE:BABA ) , Trade Desk  ( NASDAQ:TTD ) , Illumina  ( NASDAQ:ILMN ) , Krispy Kreme  ( NASDAQ:DNUT ) , Wynn Resorts  ( NASDAQ:WYNN ) , Plug Power  ( NASDAQ:PLUG ) , CarGurus  ( NASDAQ:CARG ) , Walt Disney  ( NYSE:DIS ) , Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , News  ( NASDAQ:NWSA ) , Alarm.com Holdings  ( NASDAQ:ALRM ) , CyberArk Software  ( NASDAQ:CYBR ) , Sonos  ( NASDAQ:SONO ) , US Foods Hldg  ( NYSE:USFD ) , Lordstown Motors  ( OTC:RIDEQ ) , SPDR S&P 500  ( ARCA:SPY ) ", "url": "https://www.benzinga.com/news/earnings/23/08/33701477/nasdaq-s-p-500-futures-rally-ahead-of-inflation-data-why-this-analyst-sounds-out-caution-about-stoc", "time_published": "20230810T105409", "authors": ["Shanthi Rexaline"], "summary": "Stock futures point to a higher start on Thursday as traders position themselves for the July consumer price inflation data that is due ahead of the market open. Economists and analysts are worried about the impact of recent energy price increases and rising food prices on inflation.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Nasdaq_Futures.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Economy - Monetary", "relevance_score": "0.972193"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.99393"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.098283, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BABA", "relevance_score": "0.099476", "ticker_sentiment_score": "-0.140326", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTD", "relevance_score": "0.099476", "ticker_sentiment_score": "-0.03595", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.099476", "ticker_sentiment_score": "-0.03595", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.099476", "ticker_sentiment_score": "0.190699", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NWSAL", "relevance_score": "0.049835", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNUT", "relevance_score": "0.099476", "ticker_sentiment_score": "-0.140326", "ticker_sentiment_label": "Neutral"}, {"ticker": "WYNN", "relevance_score": "0.099476", "ticker_sentiment_score": "-0.03595", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLUG", "relevance_score": "0.099476", "ticker_sentiment_score": "-0.03595", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARG", "relevance_score": "0.099476", "ticker_sentiment_score": "-0.03595", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.049835", "ticker_sentiment_score": "0.219261", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CYBR", "relevance_score": "0.099476", "ticker_sentiment_score": "-0.140326", "ticker_sentiment_label": "Neutral"}, {"ticker": "SONO", "relevance_score": "0.099476", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIDE", "relevance_score": "0.049835", "ticker_sentiment_score": "-0.131182", "ticker_sentiment_label": "Neutral"}]}, {"title": "Walt Disney and Capri Holdings shares gain, among other movers", "url": "https://www.marketwatch.com/story/walt-disney-and-capri-holdings-shares-gain-among-other-movers-a5c1c121", "time_published": "20230810T090500", "authors": ["MarketWatch"], "summary": "Plug Power stocks dives after revealing worse than expected losses.", "banner_image": "https://images.mktw.net/im-810420/social", "source": "MarketWatch", "category_within_source": "Top Stories", "source_domain": "www.marketwatch.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.650727"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.280001, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "APP", "relevance_score": "0.275867", "ticker_sentiment_score": "0.543176", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.275867", "ticker_sentiment_score": "0.186637", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.140076", "ticker_sentiment_score": "0.140463", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPR", "relevance_score": "0.275867", "ticker_sentiment_score": "0.123846", "ticker_sentiment_label": "Neutral"}, {"ticker": "KVUE", "relevance_score": "0.275867", "ticker_sentiment_score": "0.228346", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WYNN", "relevance_score": "0.275867", "ticker_sentiment_score": "0.417889", "ticker_sentiment_label": "Bullish"}, {"ticker": "CPRI", "relevance_score": "0.40348", "ticker_sentiment_score": "0.165796", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PLUG", "relevance_score": "0.275867", "ticker_sentiment_score": "-0.033883", "ticker_sentiment_label": "Neutral"}, {"ticker": "SONO", "relevance_score": "0.275867", "ticker_sentiment_score": "0.366122", "ticker_sentiment_label": "Bullish"}]}, {"title": "Disney, Alibaba And 3 Stocks To Watch Heading Into Thursday - Alibaba Gr Holding  ( NYSE:BABA ) , Walt Disney  ( NYSE:DIS ) ", "url": "https://www.benzinga.com/news/earnings/23/08/33696118/disney-alibaba-and-3-stocks-to-watch-heading-into-thursday", "time_published": "20230810T073610", "authors": ["Lisa Levin"], "summary": "With U.S. stock futures trading higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows: Wall Street expects US Foods Holding Corp. USFD to post quarterly earnings at 76 cents per share on revenue of $9.34 billion before the opening bell.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/08/10/disney_-logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}, {"topic": "Earnings", "relevance_score": "0.983783"}], "overall_sentiment_score": 0.205759, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BABA", "relevance_score": "0.511256", "ticker_sentiment_score": "0.188123", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "USFD", "relevance_score": "0.511256", "ticker_sentiment_score": "0.38582", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.511256", "ticker_sentiment_score": "0.358362", "ticker_sentiment_label": "Bullish"}, {"ticker": "NWSAL", "relevance_score": "0.182506", "ticker_sentiment_score": "0.059519", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIS", "relevance_score": "0.355588", "ticker_sentiment_score": "0.503251", "ticker_sentiment_label": "Bullish"}]}, {"title": "Illumina  ( ILMN )  Tops Q2 Earnings and Revenue Estimates", "url": "https://www.zacks.com/stock/news/2134518/illumina-ilmn-tops-q2-earnings-and-revenue-estimates", "time_published": "20230809T213017", "authors": ["Zacks Equity Research"], "summary": "Illumina (ILMN) delivered earnings and revenue surprises of 1,500% and 1.11%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default255.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999992"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.150743, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.40348", "ticker_sentiment_score": "0.143722", "ticker_sentiment_label": "Neutral"}, {"ticker": "STTK", "relevance_score": "0.208764", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks making the biggest moves after hours: Disney, Wynn Resorts, AppLovin and more", "url": "https://www.cnbc.com/2023/08/09/stocks-making-the-biggest-moves-after-hours-dis-wynn-app.html", "time_published": "20230809T210545", "authors": ["Samantha Subin"], "summary": "See which stocks are posting big moves after the bell.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107073326-1654772677535-dis.jpg?v=1691615980&w=1920&h=1080", "source": "CNBC", "category_within_source": "Market Insider", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.994953"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.184741, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "APP", "relevance_score": "0.199859", "ticker_sentiment_score": "0.263136", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WYNN", "relevance_score": "0.199859", "ticker_sentiment_score": "0.123564", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTD", "relevance_score": "0.199859", "ticker_sentiment_score": "0.24144", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.199859", "ticker_sentiment_score": "-0.036971", "ticker_sentiment_label": "Neutral"}]}, {"title": "Futures: Nasdaq, Nvidia Break Key Level; What To Do", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-nasdaq-nvidia-break-key-support-as-ai-stocks-sell-off-what-to-do/", "time_published": "20230809T205600", "authors": ["Investor's Business Daily", "ED CARSON"], "summary": "Futures: Nasdaq, Nvidia Break Key Level. What To Do Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2023/07/Stock-futuristicAIwoman-01-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Economy - Monetary", "relevance_score": "0.9545"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.99246"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.087148, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BABA", "relevance_score": "0.070036", "ticker_sentiment_score": "-0.002027", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.252749", "ticker_sentiment_score": "-0.053621", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVGO", "relevance_score": "0.139534", "ticker_sentiment_score": "-0.170154", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TTD", "relevance_score": "0.070036", "ticker_sentiment_score": "-0.321017", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ILMN", "relevance_score": "0.070036", "ticker_sentiment_score": "-0.321017", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NVO", "relevance_score": "0.093289", "ticker_sentiment_score": "-0.001061", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMCI", "relevance_score": "0.093289", "ticker_sentiment_score": "0.00652", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLB", "relevance_score": "0.046724", "ticker_sentiment_score": "-0.012967", "ticker_sentiment_label": "Neutral"}, {"ticker": "WYNN", "relevance_score": "0.070036", "ticker_sentiment_score": "-0.321017", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FLNC", "relevance_score": "0.070036", "ticker_sentiment_score": "-0.221488", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "UPST", "relevance_score": "0.116461", "ticker_sentiment_score": "-0.160476", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MRVL", "relevance_score": "0.093289", "ticker_sentiment_score": "-0.186245", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PLTR", "relevance_score": "0.116461", "ticker_sentiment_score": "-0.075294", "ticker_sentiment_label": "Neutral"}]}, {"title": "Genetics Goliath Tumbles As Earnings Outlook Falls Short", "url": "https://www.investors.com/news/technology/ilmn-stock-illumina-earnings-q2-2023/", "time_published": "20230809T202800", "authors": ["Investor's Business Daily", "ALLISON GATLIN"], "summary": "ILMN Stock Crumbles As Earnings Guidance Widely Misses Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2021/04/Stock-illumina-01-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.838487"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.977154"}], "overall_sentiment_score": 0.047898, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.891077", "ticker_sentiment_score": "0.322174", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina cuts annual profit forecast", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/illumina-cuts-annual-profit-forecast-2023-08-09/", "time_published": "20230809T202100", "authors": ["Reuters"], "summary": "The offices of gene sequencing company Illumina Inc are shown in San Diego, California January 11, 2016. REUTERS/Mike Blake/File Photo Aug 9 ( Reuters ) - Illumina Inc ( ILMN.O ) lowered annual profit forecast on Wednesday, signaling weak demand for its sequencing and diagnostic services, sending ...", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/T6BNM4HBWBPB3MOMJ7ZD3LB7BY.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.157084, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.666827", "ticker_sentiment_score": "-0.052894", "ticker_sentiment_label": "Neutral"}]}, {"title": "US Stocks Walk Inflation Tightrope As Futures Point To Cautious Recovery - DraftKings  ( NASDAQ:DKNG ) , Twilio  ( NYSE:TWLO ) , Wendy's  ( NASDAQ:WEN ) , Trade Desk  ( NASDAQ:TTD ) , Illumina  ( NASDAQ:ILMN ) , Akamai Techs  ( NASDAQ:AKAM ) , Rivian Automotive  ( NASDAQ:RIVN ) , Wynn Resorts  ( NASDAQ:WYNN ) , Plug Power  ( NASDAQ:PLUG ) , CarGurus  ( NASDAQ:CARG ) , Walt Disney  ( NYSE:DIS ) , PENN Entertainment  ( NASDAQ:PENN ) , Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , Alarm.com Holdings  ( NASDAQ:ALRM ) , Lyft  ( NASDAQ:LYFT ) , Roblox  ( NYSE:RBLX ) , Sonos  ( NASDAQ:SONO ) , Upstart Hldgs  ( NASDAQ:UPST ) , Jack In The Box  ( NASDAQ:JACK ) , SPDR S&P 500  ( ARCA:SPY ) ", "url": "https://www.benzinga.com/news/earnings/23/08/33658760/us-stocks-walk-inflation-tightrope-as-futures-point-to-cautious-recovery-why-this-analyst-downplays", "time_published": "20230809T105543", "authors": ["Shanthi Rexaline"], "summary": "Stocks could fight back after Tuesday's drubbing, although the lack of any major Main Street reading clouds the market outlook for the day. Thursday's inflation data could keep traders on tenterhooks.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Stock_market_charts_Photo_by_Gorodenkoff_on_Shutterstock_8.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Economy - Monetary", "relevance_score": "0.682689"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.999819"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.107724, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DKNG", "relevance_score": "0.09402", "ticker_sentiment_score": "-0.146466", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEN", "relevance_score": "0.09402", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTD", "relevance_score": "0.09402", "ticker_sentiment_score": "-0.07943", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.09402", "ticker_sentiment_score": "-0.07943", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKAM", "relevance_score": "0.09402", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.09402", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOX", "relevance_score": "0.047092", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WYNN", "relevance_score": "0.09402", "ticker_sentiment_score": "-0.07943", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLUG", "relevance_score": "0.09402", "ticker_sentiment_score": "-0.07943", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARG", "relevance_score": "0.09402", "ticker_sentiment_score": "-0.07943", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.047092", "ticker_sentiment_score": "0.218598", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PENN", "relevance_score": "0.186738", "ticker_sentiment_score": "-0.156944", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MCO", "relevance_score": "0.047092", "ticker_sentiment_score": "-0.15651", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RBLX", "relevance_score": "0.09402", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SONO", "relevance_score": "0.09402", "ticker_sentiment_score": "-0.07943", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPST", "relevance_score": "0.09402", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JACK", "relevance_score": "0.09402", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Invitae  ( NVTA )  Q2 2023 Earnings Call Transcript", "url": "https://www.fool.com/earnings/call-transcripts/2023/08/09/invitae-nvta-q2-2023-earnings-call-transcript/", "time_published": "20230809T060019", "authors": ["Motley Fool Transcribing"], "summary": "NVTA earnings call for the period ending June 30, 2023.", "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.977154"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.194227, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NVTA", "relevance_score": "0.018178", "ticker_sentiment_score": "0.002746", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.00606", "ticker_sentiment_score": "0.194552", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.00606", "ticker_sentiment_score": "0.059262", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.00606", "ticker_sentiment_score": "0.18438", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MS", "relevance_score": "0.00606", "ticker_sentiment_score": "0.18438", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "In-vitro Fertilization Microscopes Market Size is projected to reach USD 178.27 million by 2030, growing at a CAGR of 8.3%: Straits Research", "url": "https://www.benzinga.com/pressreleases/23/08/g33604716/in-vitro-fertilization-microscopes-market-size-is-projected-to-reach-usd-178-27-million-by-2030-gr", "time_published": "20230807T161000", "authors": ["Globe Newswire"], "summary": "New York, United States, Aug. 07, 2023 ( GLOBE NEWSWIRE ) -- In-vitro fertilisation microscopes are utilised for a variety of processes, including the examination of sperm, the preparation of oocytes for fertilisation, the actual process of in-vitro fertilisation, and an overall evaluation of ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.184469, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "OCPNF", "relevance_score": "0.031079", "ticker_sentiment_score": "0.039798", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.031079", "ticker_sentiment_score": "0.053218", "ticker_sentiment_label": "Neutral"}, {"ticker": "NINOF", "relevance_score": "0.06211", "ticker_sentiment_score": "0.030001", "ticker_sentiment_label": "Neutral"}]}, {"title": "Icahn Enterprises' bonds see buying after bond-friendly halving of distribution", "url": "https://www.marketwatch.com/story/icahn-enterprises-bonds-see-buying-after-bond-friendly-halving-of-distribution-eea313b3", "time_published": "20230804T165100", "authors": ["Ciara Linnane"], "summary": "Carl Icahn's investing arm has lost billions of dollars in market cap since a critical report by short-seller Hindenburg Research was published on May 2.", "banner_image": "https://images.mktw.net/im-830047?width=700&height=421", "source": "MarketWatch", "category_within_source": "Top Stories", "source_domain": "www.marketwatch.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.103894, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.129168", "ticker_sentiment_score": "0.045621", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.129168", "ticker_sentiment_score": "0.045621", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLF", "relevance_score": "0.129168", "ticker_sentiment_score": "0.045621", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBAY", "relevance_score": "0.129168", "ticker_sentiment_score": "0.045621", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.129168", "ticker_sentiment_score": "0.041852", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVI", "relevance_score": "0.129168", "ticker_sentiment_score": "0.045621", "ticker_sentiment_label": "Neutral"}]}, {"title": "Shares of Carl Icahn's Firm Tank After Dividend Is Cut", "url": "https://www.nytimes.com/2023/08/04/business/carl-icahn-shares-dividend.html", "time_published": "20230804T161643", "authors": ["Maureen Farrell"], "summary": "Bowing to pressure from a short seller, Mr. Icahn halved his company's quarterly dividend and said he would return to the style of investing that made him famous.", "banner_image": "https://static01.nyt.com/images/2023/08/04/multimedia/04icahn-fpgm/04icahn-fpgm-articleLarge.jpg?quality=75&auto=webp&disable=upscale", "source": "New York Times", "category_within_source": "Dealbook", "source_domain": "www.nytimes.com", "topics": [{"topic": "Earnings", "relevance_score": "0.650727"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.98396"}], "overall_sentiment_score": -0.007206, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.163909", "ticker_sentiment_score": "0.018638", "ticker_sentiment_label": "Neutral"}]}, {"title": "Icahn Enterprises' stock slides 30% after company halves quarterly distribution to $1 per unit", "url": "https://www.marketwatch.com/story/icahn-enterprises-stock-slides-28-premarket-after-company-halves-quarterly-distribution-to-1-per-unit-232e7d03", "time_published": "20230804T140600", "authors": ["Ciara Linnane"], "summary": "Icahn surprised investors on Friday by halving the quarterly distribution retail investors have come to rely on.", "banner_image": "https://images.mktw.net/im-280130/social", "source": "MarketWatch", "category_within_source": "Top Stories", "source_domain": "www.marketwatch.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.997405"}, {"topic": "Earnings", "relevance_score": "0.495866"}], "overall_sentiment_score": -0.134969, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.104683", "ticker_sentiment_score": "0.041717", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.104683", "ticker_sentiment_score": "0.041717", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLF", "relevance_score": "0.104683", "ticker_sentiment_score": "0.041717", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBAY", "relevance_score": "0.104683", "ticker_sentiment_score": "0.041717", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.104683", "ticker_sentiment_score": "0.045023", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVI", "relevance_score": "0.104683", "ticker_sentiment_score": "0.041717", "ticker_sentiment_label": "Neutral"}]}, {"title": "Carl Icahn's company stock drops 30% after IEP slashes quarterly dividend in half", "url": "https://www.cnbc.com/2023/08/04/carl-icahns-company-stock-drops-30percent-after-iep-slashes-quarterly-dividend-in-half.html", "time_published": "20230804T134739", "authors": ["Yun Li"], "summary": "Carl Icahn's conglomerate Icahn Enterprises slashed quarterly dividend in half amid notable short seller Hindenburg Research's campaign.", "banner_image": "https://image.cnbcfm.com/api/v1/image/106871436-1618996381081-gettyimages-1230188864-AFP_8XC7VQ.jpeg?v=1691021122", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.097954, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MDNDF", "relevance_score": "0.103331", "ticker_sentiment_score": "0.086615", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.103331", "ticker_sentiment_score": "0.086615", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.103331", "ticker_sentiment_score": "-0.059931", "ticker_sentiment_label": "Neutral"}]}, {"title": "CARL C. ICAHN - Icahn Enterprises  ( NASDAQ:IEP ) ", "url": "https://www.benzinga.com/pressreleases/23/08/n33572242/carl-c-icahn", "time_published": "20230804T120400", "authors": ["PRNewswire"], "summary": "SUNNY ISLES BEACH, Fla., Aug. 4, 2023 /PRNewswire/ -- As we stated in our last letter, we have reset our focus on our core activism strategy. We have long believed that activism is the best investment paradigm. We believe activism has served IEP unitholders handsomely over the years, as shown by ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.999186"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}], "overall_sentiment_score": 0.08737, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.028089", "ticker_sentiment_score": "0.188547", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CZR", "relevance_score": "0.028089", "ticker_sentiment_score": "0.188547", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HLF", "relevance_score": "0.028089", "ticker_sentiment_score": "0.188547", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EBAY", "relevance_score": "0.028089", "ticker_sentiment_score": "0.188547", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.028089", "ticker_sentiment_score": "0.174881", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CVI", "relevance_score": "0.028089", "ticker_sentiment_score": "0.188547", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Genetic Testing Market size to grow by USD 7,103.8 million from 2022 to 2027|The growing adoption of direct-to ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/genetic-testing-market-size-to-grow-by-usd-7-103-8-million-from-2022-to-2027the-growing-adoption-of-direct-to-consumer-genetic-tests-in-early-disease-diagnosis-is-a-major-trend--technavio-301891403.html", "time_published": "20230803T151000", "authors": [], "summary": "Genetic Testing Market size to grow by USD 7,103.8 million from 2022 to 2027|The growing adoption of direct-to ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.134942, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BMXMF", "relevance_score": "0.088964", "ticker_sentiment_score": "0.012455", "ticker_sentiment_label": "Neutral"}, {"ticker": "A", "relevance_score": "0.088964", "ticker_sentiment_score": "0.012455", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTG", "relevance_score": "0.088964", "ticker_sentiment_score": "0.012455", "ticker_sentiment_label": "Neutral"}, {"ticker": "COO", "relevance_score": "0.088964", "ticker_sentiment_score": "0.012455", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.088964", "ticker_sentiment_score": "0.012455", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.088964", "ticker_sentiment_score": "0.012455", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEMHF", "relevance_score": "0.088964", "ticker_sentiment_score": "0.012455", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.088964", "ticker_sentiment_score": "0.012455", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTA", "relevance_score": "0.088964", "ticker_sentiment_score": "0.012455", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.088964", "ticker_sentiment_score": "0.012455", "ticker_sentiment_label": "Neutral"}, {"ticker": "DGX", "relevance_score": "0.088964", "ticker_sentiment_score": "0.012455", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.088964", "ticker_sentiment_score": "0.012455", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.088964", "ticker_sentiment_score": "0.012455", "ticker_sentiment_label": "Neutral"}]}, {"title": " ( ILMN )  - Analyzing Illumina's Short Interest - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/short-sellers/23/08/33525597/ilmn-analyzing-illuminas-short-interest", "time_published": "20230802T160039", "authors": ["Benzinga Insights"], "summary": "Illumina's ILMN short percent of float has risen 3.47% since its last report. The company recently reported that it has 7.15 million shares sold short, which is 5.07% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.54 days to cover their ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.26961, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.224903", "ticker_sentiment_score": "0.158881", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "As Pentagon Works To Rebuild The US Industrial Base, FTC Targets America's Most Innovative Companies", "url": "https://www.forbes.com/sites/lorenthompson/2023/07/31/as-pentagon-works-to-rebuild-the-us-industrial-base-ftc-targets-americas-most-innovative-companies/", "time_published": "20230731T140637", "authors": ["Loren Thompson"], "summary": "When it comes to sustaining US technological leadership, the Pentagon and the FTC seem to be working at cross-purposes with each other.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/64c7bf1b3d3fe4b54669db63/0x0.jpg?format=jpg&width=1200", "source": "Forbes", "category_within_source": "Business", "source_domain": "www.forbes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.004887, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.080458", "ticker_sentiment_score": "0.133355", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.080458", "ticker_sentiment_score": "-0.026461", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.04028", "ticker_sentiment_score": "0.201054", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NVDA", "relevance_score": "0.04028", "ticker_sentiment_score": "-0.111825", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.04028", "ticker_sentiment_score": "-0.111825", "ticker_sentiment_label": "Neutral"}]}, {"title": "Op-ed: A.I. may take on doctors' roles sooner than later", "url": "https://www.cnbc.com/2023/07/31/op-ed-ai-may-take-on-doctors-roles-sooner-than-later.html", "time_published": "20230731T115450", "authors": ["Scott Gottlieb"], "summary": "To grasp the potential of these tools to revolutionize the practice of medicine, it pays to start with a taxonomy of the different technologies and how they're being used in medical care.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107065495-1653319714301-gettyimages-1150969092-is09by80a.jpeg?v=1690726277", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.164489, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.077343", "ticker_sentiment_score": "0.063029", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCLH", "relevance_score": "0.038717", "ticker_sentiment_score": "0.059585", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.038717", "ticker_sentiment_score": "0.059585", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.038717", "ticker_sentiment_score": "0.059585", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Inc. hosts conference call for investors", "url": "https://markets.businessinsider.com/news/stocks/illumina_conference-1029640015", "time_published": "20230729T124500", "authors": ["Markets Insider Automation"], "summary": "The company, Illumina Inc., is set to host investors and clients on a conference call on 8/9/2023 5:46:22 PM. The call comes after the company's earnings, which are set to be announced on 8/9/2023. Investors, or members of the public who wish to dial in, can join the call by visiting", "banner_image": "https://markets.businessinsider.com/Images/FacebookIcon.jpg", "source": "Business Insider", "category_within_source": "RSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.11389, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.608634", "ticker_sentiment_score": "-0.003516", "ticker_sentiment_label": "Neutral"}]}, {"title": "Proteomics market to grow by USD 21,749.32 million from 2022 to 2027 | Increasing advances in proteomics research ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/proteomics-market-to-grow-by-usd-21-749-32-million-from-2022-to-2027--increasing-advances-in-proteomics-research-boost-market-growth---technavio-301887846.html", "time_published": "20230729T043000", "authors": [], "summary": "Proteomics market to grow by USD 21,749.32 million from 2022 to 2027 | Increasing advances in proteomics research ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.283589, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.05234", "ticker_sentiment_score": "0.178869", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.05234", "ticker_sentiment_score": "0.178869", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TMO", "relevance_score": "0.05234", "ticker_sentiment_score": "0.178869", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BRKR", "relevance_score": "0.05234", "ticker_sentiment_score": "0.178869", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DSRLF", "relevance_score": "0.05234", "ticker_sentiment_score": "0.178869", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BIO", "relevance_score": "0.05234", "ticker_sentiment_score": "0.178869", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "QGEN", "relevance_score": "0.05234", "ticker_sentiment_score": "0.178869", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WAT", "relevance_score": "0.05234", "ticker_sentiment_score": "0.178869", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OLK", "relevance_score": "0.05234", "ticker_sentiment_score": "0.178869", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina and Pillar Biosciences partner to improve access to personalized cancer treatment options - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/07/n33368806/illumina-and-pillar-biosciences-partner-to-improve-access-to-personalized-cancer-treatment-options", "time_published": "20230725T131500", "authors": ["PRNewswire"], "summary": "SAN DIEGO, July 25, 2023 /PRNewswire/ -- Illumina Inc. ILMN, a global leader in DNA sequencing and array-based technologies, and Pillar Biosciences Inc., the pioneers of Decision Medicine\u2122, today announced a strategic partnership to make Pillar's suite of oncology assays commercially available ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.271168, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.052918", "ticker_sentiment_score": "0.106639", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.052918", "ticker_sentiment_score": "0.106639", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.357783", "ticker_sentiment_score": "0.386046", "ticker_sentiment_label": "Bullish"}]}, {"title": "The Next Generation Sequencing Market to grow at a CAGR of 12.45% from 2022 to 2027|Increased utilization of NGS ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/the-next-generation-sequencing-market-to-grow-at-a-cagr-of-12-45-from-2022-to-2027increased-utilization-of-ngs-methods-to-boost-market-growth---technavio-301883370.html", "time_published": "20230725T033000", "authors": [], "summary": "The Next Generation Sequencing Market to grow at a CAGR of 12.45% from 2022 to 2027|Increased utilization of NGS ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.0572, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KNCAF", "relevance_score": "0.078354", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.078354", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.078354", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.078354", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZTA", "relevance_score": "0.078354", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.078354", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONTTF", "relevance_score": "0.078354", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.078354", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPK", "relevance_score": "0.078354", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAB", "relevance_score": "0.078354", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LH", "relevance_score": "0.078354", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERFSF", "relevance_score": "0.078354", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "AI In Genomics Market is Expected to Reach $2.0 Billion | MarketsandMarkets.", "url": "https://www.benzinga.com/pressreleases/23/07/g33346227/ai-in-genomics-market-is-expected-to-reach-2-0-billion-marketsandmarkets", "time_published": "20230724T133000", "authors": ["Globe Newswire"], "summary": "Chicago, July 24, 2023 ( GLOBE NEWSWIRE ) -- In the near future, the genomics industry is set to undergo a transformative revolution driven by the rapid integration of Artificial Intelligence ( AI ) technologies.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.260955, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.048425", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.048425", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.144563", "ticker_sentiment_score": "0.050716", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTA", "relevance_score": "0.048425", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "POAI", "relevance_score": "0.048425", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPH", "relevance_score": "0.096671", "ticker_sentiment_score": "0.045159", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTHIF", "relevance_score": "0.048425", "ticker_sentiment_score": "0.148886", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.096671", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "INTC", "relevance_score": "0.048425", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina  ( ILMN )  Soars 3.4%: Is Further Upside Left in the Stock?", "url": "https://www.zacks.com/stock/news/2125954/illumina-ilmn-soars-34-is-further-upside-left-in-the-stock", "time_published": "20230724T123100", "authors": ["Zacks Equity Research"], "summary": "Illumina (ILMN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default41.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972476"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}], "overall_sentiment_score": 0.240932, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.599092", "ticker_sentiment_score": "0.357826", "ticker_sentiment_label": "Bullish"}, {"ticker": "KNSA", "relevance_score": "0.451494", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Jim Cramer Says It's Time To Buy This Financial Services Stock Down 32% YTD - Compass Pathways  ( NASDAQ:CMPS ) , ASML Holding  ( NASDAQ:ASML ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/23/07/33318106/jim-cramer-says-its-time-to-buy-this-financial-services-stock-down-32-ytd", "time_published": "20230721T140057", "authors": ["Priya Nigam"], "summary": "On CNBC's \"Mad Money Lightning Round,\" Jim Cramer said Illumina, Inc. ILMN is not even as good as Danaher Corporation DHR. \"Be careful, that's too much Illumina,\" he added. When asked about COMPASS Pathways plc CMPS, he said, \"Treatment resistant depression is incredibly difficult, no one's ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/07/21/jim_cramer_chart_shutter.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.029183, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMPS", "relevance_score": "0.275867", "ticker_sentiment_score": "-0.146477", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFA", "relevance_score": "0.362065", "ticker_sentiment_score": "-0.040067", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.362065", "ticker_sentiment_score": "-0.1688", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JNJ", "relevance_score": "0.18602", "ticker_sentiment_score": "-0.188235", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VERV", "relevance_score": "0.275867", "ticker_sentiment_score": "-0.023668", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETN", "relevance_score": "0.275867", "ticker_sentiment_score": "-0.008655", "ticker_sentiment_label": "Neutral"}, {"ticker": "KEY", "relevance_score": "0.362065", "ticker_sentiment_score": "-0.058429", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASML", "relevance_score": "0.362065", "ticker_sentiment_score": "-0.039317", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.18602", "ticker_sentiment_score": "-0.20194", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Big Business Gets Bigger", "url": "https://www.nytimes.com/2023/07/21/briefing/microsoft-activision-ftc-corporate-concentration.html", "time_published": "20230721T101228", "authors": ["German Lopez"], "summary": "When President Biden took office, he sent several signals that he was ready to take on increasing corporate concentration. Among the clearest was appointing the consumer advocate Lina Khan - a prominent critic of monopoly power - to lead the Federal Trade Commission.", "banner_image": "https://static01.nyt.com/images/2023/07/21/multimedia/21-the-morning-lede2-mkgv-promo/21-the-morning-lede2-mkgv-articleLarge.jpg?quality=75&auto=webp&disable=upscale", "source": "New York Times", "category_within_source": "GoogleRSS", "source_domain": "www.nytimes.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": -0.084795, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ATVI", "relevance_score": "0.09495", "ticker_sentiment_score": "-0.039799", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.165355", "ticker_sentiment_score": "-0.065483", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNEJF", "relevance_score": "0.047559", "ticker_sentiment_score": "0.009", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.02379", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.02379", "ticker_sentiment_score": "-0.073252", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rapid Micro Biosystems Announces Appointment of Kirk Malloy, Ph.D. as Chair of its Board of Directors - Rapid Micro Biosystems  ( NASDAQ:RPID ) ", "url": "https://www.benzinga.com/pressreleases/23/07/g33275498/rapid-micro-biosystems-announces-appointment-of-kirk-malloy-ph-d-as-chair-of-its-board-of-director", "time_published": "20230718T212056", "authors": ["Globe Newswire"], "summary": "LOWELL, Mass., July 18, 2023 ( GLOBE NEWSWIRE ) -- Rapid Micro Biosystems, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}, {"topic": "Earnings", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.269932, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "DMTK", "relevance_score": "0.033236", "ticker_sentiment_score": "0.041181", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.033236", "ticker_sentiment_score": "0.041181", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSTG", "relevance_score": "0.033236", "ticker_sentiment_score": "0.041181", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.033236", "ticker_sentiment_score": "0.041181", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPID", "relevance_score": "0.132368", "ticker_sentiment_score": "0.265665", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Rapid Micro Biosystems Announces Appointment of Kirk Malloy, Ph.D. as Chair of its Board of Directors", "url": "https://www.globenewswire.com/news-release/2023/07/18/2706903/33206/en/Rapid-Micro-Biosystems-Announces-Appointment-of-Kirk-Malloy-Ph-D-as-Chair-of-its-Board-of-Directors.html", "time_published": "20230718T212000", "authors": ["Rapid Micro Biosystems", "Inc."], "summary": "LOWELL, Mass., July 18, 2023 ( GLOBE NEWSWIRE ) -- Rapid Micro Biosystems, Inc. ( Nasdaq: RPID ) ( the \"Company\" ) , an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/12585575-0b2e-4369-bf15-500b17ccb859", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}, {"topic": "Earnings", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.276747, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "DMTK", "relevance_score": "0.033609", "ticker_sentiment_score": "0.041255", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.033609", "ticker_sentiment_score": "0.041255", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSTG", "relevance_score": "0.033609", "ticker_sentiment_score": "0.041255", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.033609", "ticker_sentiment_score": "0.041255", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPID", "relevance_score": "0.133841", "ticker_sentiment_score": "0.273325", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer, and Merck", "url": "https://www.prnewswire.com/news-releases/the-alliance-for-genomic-discovery-announces-founding-biopharma-members-abbvie-amgen-astrazeneca-bayer-and-merck-301879225.html", "time_published": "20230718T131500", "authors": ["Illumina", "Inc."], "summary": "The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1586483/4158300/Illumina_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.247888, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AZN", "relevance_score": "0.038717", "ticker_sentiment_score": "0.062494", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.337811", "ticker_sentiment_score": "0.249481", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABBV", "relevance_score": "0.038717", "ticker_sentiment_score": "0.062494", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer, and Merck - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/07/n33266647/the-alliance-for-genomic-discovery-announces-founding-biopharma-members-abbvie-amgen-astrazeneca-b", "time_published": "20230718T131500", "authors": ["PRNewswire"], "summary": "Alliance aims to accelerate therapeutic development and expand the diversity of genomic data through inclusion of more samples from currently underrepresented ancestries SAN DIEGO, July 18, 2023 /PRNewswire/ -- Illumina Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.25005, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.037681", "ticker_sentiment_score": "0.104057", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.037681", "ticker_sentiment_score": "0.104057", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.037681", "ticker_sentiment_score": "0.058386", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.075279", "ticker_sentiment_score": "0.076713", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.329307", "ticker_sentiment_score": "0.251401", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "BioVie Issues Letter to Shareholders", "url": "https://www.globenewswire.com/news-release/2023/07/18/2706267/0/en/BioVie-Issues-Letter-to-Shareholders.html", "time_published": "20230718T110000", "authors": ["BioVie", "Inc."], "summary": "CARSON CITY, Nev., July 18, 2023 ( GLOBE NEWSWIRE ) -- BioVie Inc., ( NASDAQ: BIVI ) ( \"BioVie\" or the \"Company\" ) a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative disorders, today issued the ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/f437d04b-c089-46eb-bca8-7ef64f68bc9b", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.061691, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BIVI", "relevance_score": "0.105737", "ticker_sentiment_score": "0.055053", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.060541", "ticker_sentiment_score": "0.035999", "ticker_sentiment_label": "Neutral"}]}, {"title": "Looking Into Illumina's Recent Short Interest - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/short-sellers/23/07/33254444/looking-into-illuminas-recent-short-interest", "time_published": "20230717T180029", "authors": ["Benzinga Insights"], "summary": "Illumina's ILMN short percent of float has risen 23.74% since its last report. The company recently reported that it has 6.92 million shares sold short, which is 4.9% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.3 days to cover their ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.26961, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.224903", "ticker_sentiment_score": "0.158881", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "In-vitro Diagnostics Market to grow at a CAGR of 6.89% from 2021 to 2026| Abbott Laboratories, Agilent Technologies Inc., ARKRAY Inc. and more to emerge as key players - Technavio", "url": "https://www.prnewswire.com/news-releases/in-vitro-diagnostics-market-to-grow-at-a-cagr-of-6-89--from-2021-to-2026-abbott-laboratories-agilent-technologies-inc-arkray-inc-and-more-to-emerge-as-key-players---technavio-301877804.html", "time_published": "20230717T073000", "authors": ["Technavio"], "summary": "In-vitro Diagnostics Market to grow at a CAGR of 6.89% from 2021 to 2026| Abbott Laboratories, Agilent Technologies ... PR ...", "banner_image": "https://mma.prnewswire.com/media/2154402/Technavio_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.085103, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BMXMF", "relevance_score": "0.067441", "ticker_sentiment_score": "0.065132", "ticker_sentiment_label": "Neutral"}, {"ticker": "A", "relevance_score": "0.067441", "ticker_sentiment_score": "0.065132", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMAWF", "relevance_score": "0.067441", "ticker_sentiment_score": "0.065132", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSMXF", "relevance_score": "0.067441", "ticker_sentiment_score": "0.065132", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.067441", "ticker_sentiment_score": "0.065132", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.067441", "ticker_sentiment_score": "0.065132", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.067441", "ticker_sentiment_score": "0.065132", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.067441", "ticker_sentiment_score": "0.065132", "ticker_sentiment_label": "Neutral"}, {"ticker": "DGX", "relevance_score": "0.067441", "ticker_sentiment_score": "0.065132", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDX", "relevance_score": "0.033751", "ticker_sentiment_score": "0.061231", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.067441", "ticker_sentiment_score": "0.065132", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSRLF", "relevance_score": "0.067441", "ticker_sentiment_score": "0.065132", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRFS", "relevance_score": "0.067441", "ticker_sentiment_score": "0.065132", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.067441", "ticker_sentiment_score": "0.065132", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/earnings/23/07/33236890/heres-how-much-you-would-have-made-owning-illumina-stock-in-the-last-20-years", "time_published": "20230714T213031", "authors": ["Benzinga Insights"], "summary": "Illumina ILMN has outperformed the market over the past 20 years by 18.19% on an annualized basis producing an average annual return of 26.03%. Currently, Illumina has a market capitalization of $29.59 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.983605", "ticker_sentiment_score": "0.387251", "ticker_sentiment_label": "Bullish"}]}, {"title": "American trustbusters are losing their focus", "url": "https://www.economist.com/leaders/2023/07/13/american-trustbusters-are-losing-their-focus", "time_published": "20230713T094237", "authors": [], "summary": "I trustbusters have made no secret of their distaste for big firms and big deals. Lina Khan, the head of America's Federal Trade Commission ( ) , came to office after saying that the agencies had failed for decades to do enough proper policing.", "banner_image": "https://www.economist.com/img/b/1280/720/90/media-assets/image/20230715_LDD004.jpg", "source": "The Economist", "category_within_source": "BusinessGoogleRSS", "source_domain": "www.economist.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.087478, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ATVI", "relevance_score": "0.228073", "ticker_sentiment_score": "0.005521", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.057767", "ticker_sentiment_score": "-0.02722", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.057767", "ticker_sentiment_score": "-0.097127", "ticker_sentiment_label": "Neutral"}, {"ticker": "HZNP", "relevance_score": "0.057767", "ticker_sentiment_score": "-0.097127", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.057767", "ticker_sentiment_score": "-0.097127", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina's  ( ILMN )  Latest Launch to Boost Genomics Analysis", "url": "https://www.zacks.com/stock/news/2120109/illuminas-ilmn-latest-launch-to-boost-genomics-analysis", "time_published": "20230712T161800", "authors": ["Zacks Investment Research"], "summary": "Illumina's (ILMN) DRAGEN v4.2 is expected to improve the identification of genetic disease causes, drug discovery and population genomics.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7b/850.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.219342, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HQY", "relevance_score": "0.261818", "ticker_sentiment_score": "0.047781", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOLX", "relevance_score": "0.261818", "ticker_sentiment_score": "0.158731", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BSX", "relevance_score": "0.261818", "ticker_sentiment_score": "0.047713", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.383905", "ticker_sentiment_score": "0.302431", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Top Stories Wednesday, July 12: Disney Considers Different Strategies For Star India, Broadcom Wins Conditional European Approval For VMware Deal, Google Deprioritizes Gen Z Chatbot App - Activision Blizzard  ( NASDAQ:ATVI ) , ARK Innovation ETF  ( ARCA:ARKK ) ", "url": "https://www.benzinga.com/markets/cryptocurrency/23/07/33198784/disney-considers-different-strategies-for-star-india-broadcom-wins-conditional-european-ap", "time_published": "20230712T134825", "authors": ["Vandana Singh"], "summary": "Walt Disney Co DIS is reportedly considering different strategies for its Star India business, which could include partnering with another company or even selling it, marking a shift in dynamics for a significant asset it acquired from Fox Corp.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/07/12/disneyhotstar.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.123507, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CVS", "relevance_score": "0.034039", "ticker_sentiment_score": "-0.134711", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.168963", "ticker_sentiment_score": "0.06827", "ticker_sentiment_label": "Neutral"}, {"ticker": "VMW", "relevance_score": "0.101869", "ticker_sentiment_score": "0.253662", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AVGO", "relevance_score": "0.068016", "ticker_sentiment_score": "0.237206", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.101869", "ticker_sentiment_score": "0.069503", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.068016", "ticker_sentiment_score": "-0.008054", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRK-A", "relevance_score": "0.068016", "ticker_sentiment_score": "0.172691", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "COIN", "relevance_score": "0.068016", "ticker_sentiment_score": "0.38593", "ticker_sentiment_label": "Bullish"}, {"ticker": "COTY", "relevance_score": "0.068016", "ticker_sentiment_score": "0.153567", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DPZ", "relevance_score": "0.068016", "ticker_sentiment_score": "0.222072", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MSFT", "relevance_score": "0.299072", "ticker_sentiment_score": "0.13347", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMPZF", "relevance_score": "0.034039", "ticker_sentiment_score": "0.213511", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IBM", "relevance_score": "0.135538", "ticker_sentiment_score": "0.077767", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYMLF", "relevance_score": "0.034039", "ticker_sentiment_score": "-0.057496", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATVI", "relevance_score": "0.168963", "ticker_sentiment_score": "0.151369", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FFIE", "relevance_score": "0.068016", "ticker_sentiment_score": "-0.150549", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "UBER", "relevance_score": "0.101869", "ticker_sentiment_score": "0.179029", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TAK", "relevance_score": "0.101869", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Slapped With \u20ac400M In Fines: European Commission Penalizes Company For Hasty Grail Deal - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/large-cap/23/07/33195516/illumina-slapped-with-400m-in-fines-european-commission-penalizes-company-for-hasty-grail-deal", "time_published": "20230712T122053", "authors": ["Vandana Singh"], "summary": "The European Commission has fined Illumina Inc ILMN and Grail Inc approximately \u20ac432 million and \u20ac1,000, respectively, for implementing their proposed merger before approval by the commission, in breach of EU merger control rules.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/07/12/ilmn.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.069662, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.746257", "ticker_sentiment_score": "0.058976", "ticker_sentiment_label": "Neutral"}]}, {"title": "What the Microsoft-Activision Ruling Means for the Future of Deal-Making", "url": "https://www.nytimes.com/2023/07/12/business/dealbook/microsoft-activision-ftc-khan.html", "time_published": "20230712T114430", "authors": [], "summary": "Corporate leaders are feeling emboldened by another legal defeat for the Federal Trade Commission, though the agency may still fight to block the takeover.", "banner_image": "https://static01.nyt.com/images/2023/07/12/world/12dealbook-nl/12dealbook-nl-articleLarge.jpg?quality=75&auto=webp&disable=upscale", "source": "New York Times", "category_within_source": "Dealbook", "source_domain": "www.nytimes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": -0.033934, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.142686", "ticker_sentiment_score": "0.005172", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.08183", "ticker_sentiment_score": "-0.031214", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.020491", "ticker_sentiment_score": "0.067491", "ticker_sentiment_label": "Neutral"}, {"ticker": "VMW", "relevance_score": "0.020491", "ticker_sentiment_score": "-0.011043", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.020491", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.020491", "ticker_sentiment_score": "-0.105796", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.020491", "ticker_sentiment_score": "-0.011043", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATVI", "relevance_score": "0.06142", "ticker_sentiment_score": "0.054058", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Fined $476 Million For Acquiring Cancer Test Maker Grail Without EU Approval", "url": "https://www.forbes.com/sites/siladityaray/2023/07/12/illumina-fined-476-million-by-eu-for-acquiring-cancer-test-maker-grail-without-approval/", "time_published": "20230712T110416", "authors": ["Siladitya Ray"], "summary": "The record antitrust fine from the EU comes months after the FTC ordered the company to divest its $7.1 billion acquisition of Grail.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/64ae882ec506d07c6e534a0d/0x0.jpg?format=jpg&crop=2353,1322,x0,y0,safe&width=1200", "source": "Forbes", "category_within_source": "Business", "source_domain": "www.forbes.com", "topics": [{"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.029271, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.7887", "ticker_sentiment_score": "-0.048828", "ticker_sentiment_label": "Neutral"}]}, {"title": "EU regulators fine Illumina $476 mln for closing Grail deal without green light", "url": "https://www.reuters.com/markets/deals/eu-regulators-fine-illumina-476-mln-closing-grail-deal-without-green-light-2023-07-12/", "time_published": "20230712T101100", "authors": ["Reuters"], "summary": "BRUSSELS, July 12 ( Reuters ) - EU antitrust regualators on Wednesday fined Illumina a record 432 million euros ( $476.19 million ) for closing its takeover of Grail ( GRAL.O ) before securing EU antitrust approval.", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/T6BNM4HBWBPB3MOMJ7ZD3LB7BY.jpg", "source": "Reuters", "category_within_source": "Markets", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.13791, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.733479", "ticker_sentiment_score": "-0.12475", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina hit with record fine for closing Grail deal without EU regulatory approval", "url": "https://www.cnbc.com/2023/07/12/illumina-hit-with-record-eu-fine-over-grail-deal.html", "time_published": "20230712T100444", "authors": ["Annika Kim Constantino"], "summary": "The European Commission last year blocked Illumina's $7.1 billion acquisition of Grail over concerns it would stifle innovation and consumer choice.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107217795-1680188166937-gettyimages-1245790736-RAFAPRESS_22122022-04169.jpeg?v=1689156284&w=1920&h=1080", "source": "CNBC", "category_within_source": "Business", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.029292, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.70826", "ticker_sentiment_score": "0.138359", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Fined More Than $400 Million in Europe for Closing Grail Deal Early", "url": "https://www.wsj.com/articles/illumina-fined-more-than-400-million-in-europe-for-closing-grail-deal-early-c06a10be", "time_published": "20230712T100400", "authors": ["Kim Mackrael and Peter Loftus"], "summary": "The European Union's antitrust watchdog fined the company with the maximum allowable amount for wrapping up its acquisition of the cancer-test developer while the agency was still reviewing it.", "banner_image": "https://images.wsj.net/im-774267?width=700&height=466", "source": "Wall Street Journal", "category_within_source": "Business", "source_domain": "www.wsj.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.094439, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.947069", "ticker_sentiment_score": "0.170298", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "EU fines US firm Illumina $475 million for jumping gun on buying cancer-screening company Grail", "url": "https://apnews.com/article/illumina-grail-eu-antitrust-fine-109a612a2a7e5132ac1768bfc6b595d3", "time_published": "20230712T095500", "authors": [], "summary": "BRUSSELS ( AP ) - The European Union on Wednesday slapped a $475 million fine on U.S. biotech giant Illumina for buying cancer-screening company Grail without regulators' approval, the latest setback for the deal.", "banner_image": "https://dims.apnews.com/dims4/default/603cc50/2147483647/strip/true/crop/5120x2877+0+268/resize/500x281!/quality/90/?url=https%3A%2F%2Fassets.apnews.com%2F9f%2F90%2Fbdb78ebe3c73a7458dd64e6c4d40%2Fcf07db1af009429c9c431a4e29969eb8", "source": "Associated Press", "category_within_source": "Markets", "source_domain": "apnews.com", "topics": [{"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": -0.16734, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ATVI", "relevance_score": "0.07446", "ticker_sentiment_score": "0.007253", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.649995", "ticker_sentiment_score": "-0.318027", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "ESG News Trends: Indices and Investing, the \"E\" in ESG, and More", "url": "https://www.prnewswire.com/resources/news-trends/esg-news-trends-may-june-2023", "time_published": "20230711T195127", "authors": [], "summary": "ESG News Trends: Indices and Investing, the \"E\" in ESG, and More A look at the Environmental, Social, and Governance news from PR Newswire in May and June that you might have missed. PR Newswire distributed approximately 455 Environmental, Social and Governance ( ESG ) releases in May and June ...", "banner_image": "https://www.prnewswire.com/content/dam/prnewswire/miscellaneous/PRN-News-Trends-MayJune-2023-ESG.png", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.992549"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.576289"}], "overall_sentiment_score": 0.29211, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MORN", "relevance_score": "0.134741", "ticker_sentiment_score": "0.165189", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PEP", "relevance_score": "0.054114", "ticker_sentiment_score": "0.263983", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WPRT", "relevance_score": "0.027072", "ticker_sentiment_score": "0.251636", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.027072", "ticker_sentiment_score": "0.092766", "ticker_sentiment_label": "Neutral"}, {"ticker": "INT", "relevance_score": "0.027072", "ticker_sentiment_score": "0.066398", "ticker_sentiment_label": "Neutral"}, {"ticker": "WOOF", "relevance_score": "0.027072", "ticker_sentiment_score": "0.251636", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina to face record EU antitrust fine on Wednesday for Grail deal, source says", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/illumina-face-record-eu-antitrust-fine-wednesday-grail-deal-source-says-2023-07-11/", "time_published": "20230711T185500", "authors": ["Reuters"], "summary": "BRUSSELS, July 11 ( Reuters ) - U.S. life sciences company Illumina ( ILMN.O ) will face a record EU antitrust fine on Wednesday for closing its takeover of Grail ( GRAL.O ) before it secured EU antitrust approval, a person familiar with the matter said on Tuesday.", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/DQYUBIRSSRLWXIDK6A2IF25NUE.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.332915, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.622414", "ticker_sentiment_score": "0.563602", "ticker_sentiment_label": "Bullish"}]}, {"title": "LGND or ILMN: Which Is the Better Value Stock Right Now?", "url": "https://www.zacks.com/stock/news/2119317/lgnd-or-ilmn-which-is-the-better-value-stock-right-now", "time_published": "20230711T154013", "authors": ["Zacks Investment Research"], "summary": "LGND vs. ILMN: Which Stock Is the Better Value Option?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default299.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.890401"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.473789, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.526707", "ticker_sentiment_score": "0.457978", "ticker_sentiment_label": "Bullish"}, {"ticker": "LGND", "relevance_score": "0.717937", "ticker_sentiment_score": "0.558589", "ticker_sentiment_label": "Bullish"}]}, {"title": "Carl Icahn gets breathing room from lenders following short-seller attack", "url": "https://www.foxbusiness.com/markets/carl-icahn-gets-breathing-room-lenders-following-short-seller-attack", "time_published": "20230710T162608", "authors": [], "summary": "For two months, legendary activist investor Carl Icahn has been on the defensive after a short-seller attack sent shares in his investment company down roughly 40%, raising alarms at a handful of major banks that had lent him money as the value of their collateral fell.", "banner_image": "https://cf-images.us-east-1.prod.boltdns.net/v1/static/854081161001/76140915-dd5a-4550-aff7-2f371b10ddf4/69def39f-2d7b-4dc1-a2ec-20f472f197dc/1280x720/match/image.jpg", "source": "Fox Business News", "category_within_source": "n/a", "source_domain": "www.foxbusiness.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.82617"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.038735, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BOM", "relevance_score": "0.049526", "ticker_sentiment_score": "0.012908", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.049526", "ticker_sentiment_score": "0.012908", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.098862", "ticker_sentiment_score": "-0.064974", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.049526", "ticker_sentiment_score": "0.012908", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKLA", "relevance_score": "0.049526", "ticker_sentiment_score": "0.077935", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Icahn Enterprises Stock Is Up Big Today", "url": "https://www.fool.com/investing/2023/07/10/why-icahn-enterprises-stock-is-up-big-today/", "time_published": "20230710T145536", "authors": ["Lou Whiteman"], "summary": "The famed investor is reworking loan agreements that could have put his company at risk.", "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}], "overall_sentiment_score": 0.128471, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.127456", "ticker_sentiment_score": "0.142098", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Carl Icahn Led Icahn Enterprises  ( IEP )  Stock Is Soaring Today - Icahn Enterprises  ( NASDAQ:IEP ) ", "url": "https://www.benzinga.com/news/23/07/33162885/breather-for-carl-icahn-revised-loan-agreements-and-recovery-strategy-post-short-seller-attack", "time_published": "20230710T121549", "authors": ["Vandana Singh"], "summary": "Activist investor Carl Icahn has been struggling to recover after a short-seller attack led to a 40% drop in his investment company's shares, Icahn Enterprises L.P. IEP, alarming major banks that had loaned him money as their collateral value fell.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/07/10/carl_icahn_-_photo_by_insider_monkey_via_flickr_creative_commons.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.692272"}], "overall_sentiment_score": 0.136565, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BHC", "relevance_score": "0.195025", "ticker_sentiment_score": "0.093946", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.195025", "ticker_sentiment_score": "0.093946", "ticker_sentiment_label": "Neutral"}, {"ticker": "XRX", "relevance_score": "0.195025", "ticker_sentiment_score": "0.093946", "ticker_sentiment_label": "Neutral"}]}, {"title": "MedGenome acquires Illumina's NovaSeq X Plus; launches Genome Sequencing Test | The Financial Express", "url": "https://www.financialexpress.com/healthcare/diagnostic/medgenome-acquires-illuminas-novaseq-x-plus-launches-genome-sequencing-test/3163664/", "time_published": "20230710T115100", "authors": [], "summary": "MedGenome acquires Illumina's NovaSeq X Plus. launches Genome Sequencing Test The Financial Express ...", "banner_image": "https://www.financialexpress.com/wp-content/uploads/2023/06/cats-62.jpg", "source": "The Financial Express", "category_within_source": "n/a", "source_domain": "www.financialexpress.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.345548, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.076602", "ticker_sentiment_score": "0.137739", "ticker_sentiment_label": "Neutral"}]}, {"title": "Laboratory Information Management System  ( LIMS )  Market worth $3.3 billion | MarketsandMarkets", "url": "https://www.prnewswire.com/news-releases/laboratory-information-management-system-lims-market-worth-3-3-billion--marketsandmarkets-301871794.html", "time_published": "20230707T151500", "authors": ["MarketsandMarkets"], "summary": "CHICAGO, July 7, 2023 /PRNewswire/ -- The Laboratory Information Management System ( LIMS ) industry is poised for remarkable growth in the near future as laboratories across various sectors increasingly recognize the need for efficient data management and streamlined workflows.", "banner_image": "https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "0.266143"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.351517, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.020079", "ticker_sentiment_score": "0.136736", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.020079", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DASTF", "relevance_score": "0.020079", "ticker_sentiment_score": "0.136736", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.020079", "ticker_sentiment_score": "0.136736", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.060186", "ticker_sentiment_score": "0.15109", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Will Illumina Stock Rebound After A 65% Decline In The Ongoing Inflation Shock?", "url": "https://www.forbes.com/sites/greatspeculations/2023/07/07/will-illumina-stock-rebound-after-a-65-decline-in-the-ongoing-inflation-shock/", "time_published": "20230707T130029", "authors": ["Trefis Team"], "summary": "While this may not happen anytime soon, ILMN stock looks attractive from a valuation perspective and can see higher levels.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/64a7a33d67c2f785098aa569/0x0.jpg?format=jpg&width=1200", "source": "Forbes", "category_within_source": "Markets", "source_domain": "www.forbes.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.838487"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}, {"topic": "Earnings", "relevance_score": "0.650727"}], "overall_sentiment_score": -0.048691, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.722509", "ticker_sentiment_score": "-0.011732", "ticker_sentiment_label": "Neutral"}]}, {"title": "A New Ruling Could Complicate Biden's Policy on Social Media", "url": "https://www.nytimes.com/2023/07/05/business/dealbook/biden-policy-social-media.html", "time_published": "20230705T124121", "authors": [], "summary": "A judge's decision to limit how the administration can interact with platforms could chill the White House's efforts to utilize and police big tech.", "banner_image": "https://static01.nyt.com/images/2023/07/05/multimedia/05db-newsletter-social-wmlv/05db-newsletter-social-wmlv-articleLarge.jpg?quality=75&auto=webp&disable=upscale", "source": "New York Times", "category_within_source": "Dealbook", "source_domain": "www.nytimes.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.055411, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.02018", "ticker_sentiment_score": "0.071844", "ticker_sentiment_label": "Neutral"}, {"ticker": "DWAC", "relevance_score": "0.02018", "ticker_sentiment_score": "0.051599", "ticker_sentiment_label": "Neutral"}, {"ticker": "BX", "relevance_score": "0.040348", "ticker_sentiment_score": "-0.095567", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.02018", "ticker_sentiment_score": "-0.086325", "ticker_sentiment_label": "Neutral"}]}, {"title": "A New Ruling Could Complicate Biden's Policy on Social Media", "url": "https://www.nytimes.com/2023/07/05/business/dealbook/biden-policy-social-media.html", "time_published": "20230705T124120", "authors": [], "summary": "A Conservative Judge Complicates Biden's Social Media Policy The New York Times ...", "banner_image": "https://static01.nyt.com/images/2023/07/05/multimedia/05db-newsletter-social-wmlv/05db-newsletter-social-wmlv-articleLarge.jpg?quality=75&auto=webp&disable=upscale", "source": "New York Times", "category_within_source": "GoogleRSS", "source_domain": "www.nytimes.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.053032, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.02018", "ticker_sentiment_score": "0.071844", "ticker_sentiment_label": "Neutral"}, {"ticker": "DWAC", "relevance_score": "0.02018", "ticker_sentiment_score": "0.051599", "ticker_sentiment_label": "Neutral"}, {"ticker": "BX", "relevance_score": "0.040348", "ticker_sentiment_score": "-0.095567", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.02018", "ticker_sentiment_score": "-0.086325", "ticker_sentiment_label": "Neutral"}]}, {"title": "Molecular Diagnostics Market worth $28.6 billion | MarketsandMarkets", "url": "https://www.prnewswire.com/news-releases/molecular-diagnostics-market-worth-28-6-billion--marketsandmarkets-301868746.html", "time_published": "20230703T151500", "authors": ["MarketsandMarkets"], "summary": "CHICAGO, July 3, 2023 /PRNewswire/ -- The molecular diagnostics industry is poised to undergo significant advancements in the near future, fueled by rapid technological innovation and increasing demand for personalized healthcare.", "banner_image": "https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.365926"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.266443, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BMXMF", "relevance_score": "0.02013", "ticker_sentiment_score": "-0.010248", "ticker_sentiment_label": "Neutral"}, {"ticker": "A", "relevance_score": "0.02013", "ticker_sentiment_score": "-0.010248", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.02013", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXAS", "relevance_score": "0.02013", "ticker_sentiment_score": "-0.010248", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.02013", "ticker_sentiment_score": "-0.010248", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEMHF", "relevance_score": "0.02013", "ticker_sentiment_score": "-0.010248", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOLX", "relevance_score": "0.040246", "ticker_sentiment_score": "-0.001925", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABT", "relevance_score": "0.040246", "ticker_sentiment_score": "-0.045329", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTGM", "relevance_score": "0.02013", "ticker_sentiment_score": "-0.010248", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDX", "relevance_score": "0.02013", "ticker_sentiment_score": "-0.010248", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.02013", "ticker_sentiment_score": "-0.010248", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.040246", "ticker_sentiment_score": "0.014467", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSRLF", "relevance_score": "0.02013", "ticker_sentiment_score": "-0.010248", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRFS", "relevance_score": "0.02013", "ticker_sentiment_score": "-0.010248", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.02013", "ticker_sentiment_score": "-0.010248", "ticker_sentiment_label": "Neutral"}, {"ticker": "QDEL", "relevance_score": "0.02013", "ticker_sentiment_score": "-0.010248", "ticker_sentiment_label": "Neutral"}]}, {"title": "What Does Illumina's Debt Look Like? - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/23/06/33084089/what-does-illuminas-debt-look-like", "time_published": "20230630T191656", "authors": ["Benzinga Insights"], "summary": "Shares of Illumina Inc. ILMN fell by 18.77% in the past three months. Before having a look at the importance of debt, let's look at how much debt Illumina has. Based on Illumina's financial statement as of May 5, 2023, long-term debt is at $1.49 billion and current debt is at $749.00 million, ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": -0.101986, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.411176", "ticker_sentiment_score": "0.074714", "ticker_sentiment_label": "Neutral"}]}, {"title": "Corporate agitators slow down in Q2 but ready to pounce in H2 -Barclays data", "url": "https://www.reuters.com/business/corporate-agitators-slow-down-q2-ready-pounce-h2-barclays-data-2023-06-30/", "time_published": "20230630T113200", "authors": ["Svea Herbst-Bayliss"], "summary": "NEW YORK, June 30 ( Reuters ) - Following the busiest quarter on record, activist investors slowed down in the second three months of 2023 but are expected to mount more high-profile campaigns in the second half amid pent-up demand for acquisitions and a new way of voting.", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/ZS7L3OLGXVM6FGYGY667GJ3RTM.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.576289"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.054444, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ENFN", "relevance_score": "0.06515", "ticker_sentiment_score": "0.230698", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.129866", "ticker_sentiment_score": "-0.036203", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.256314", "ticker_sentiment_score": "0.027687", "ticker_sentiment_label": "Neutral"}]}, {"title": "Synthetic Biology Market size is to grow by USD 28,253.12 million from 2022 to 2027, with 42% market growth originating from North America - Technavio", "url": "https://www.prnewswire.com/news-releases/synthetic-biology-market-size-is-to-grow-by-usd-28-253-12-million-from-2022-to-2027--with-42-market-growth-originating-from-north-america---technavio-301865648.html", "time_published": "20230629T224500", "authors": ["Technavio"], "summary": "Synthetic Biology Market size is to grow by USD 28,253.12 million from 2022 to 2027, with 42% market growth ... PR ...", "banner_image": "https://mma.prnewswire.com/media/2143016/Technavio_Logo_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.10488, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.030064", "ticker_sentiment_score": "0.081834", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXS", "relevance_score": "0.030064", "ticker_sentiment_score": "0.081834", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWST", "relevance_score": "0.030064", "ticker_sentiment_score": "0.081834", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGEN", "relevance_score": "0.030064", "ticker_sentiment_score": "0.081834", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.030064", "ticker_sentiment_score": "0.081834", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVZMY", "relevance_score": "0.030064", "ticker_sentiment_score": "0.081834", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.030064", "ticker_sentiment_score": "0.081834", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRS", "relevance_score": "0.030064", "ticker_sentiment_score": "0.081834", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNA", "relevance_score": "0.060085", "ticker_sentiment_score": "0.10001", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNNSF", "relevance_score": "0.030064", "ticker_sentiment_score": "0.081834", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.030064", "ticker_sentiment_score": "0.081834", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERFSF", "relevance_score": "0.030064", "ticker_sentiment_score": "0.081834", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.030064", "ticker_sentiment_score": "0.081834", "ticker_sentiment_label": "Neutral"}]}, {"title": "Looking Into Illumina's Recent Short Interest - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/short-sellers/23/06/33067745/looking-into-illuminas-recent-short-interest", "time_published": "20230629T203041", "authors": ["Benzinga Insights"], "summary": "Illumina's ILMN short percent of float has risen 29.84% since its last report. The company recently reported that it has 5.59 million shares sold short, which is 3.96% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.2 days to cover their ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.267375, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.224903", "ticker_sentiment_score": "0.158881", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina Unusual Options Activity For June 28 - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/markets/options/23/06/33048100/illumina-unusual-options-activity-for-june-28", "time_published": "20230628T180432", "authors": ["Benzinga Insights"], "summary": "Someone with a lot of money to spend has taken a bearish stance on Illumina ILMN. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.141547, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CCORF", "relevance_score": "0.122269", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.718485", "ticker_sentiment_score": "0.166369", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Here's Why You Should Retain Myriad Genetics  ( MYGN )  Stock Now", "url": "https://www.zacks.com/stock/news/2114180/heres-why-you-should-retain-myriad-genetics-mygn-stock-now", "time_published": "20230628T133200", "authors": ["Zacks Investment Research"], "summary": "Investors are optimistic about Myriad Genetics (MYGN) due to the performance of its oncology business and product launches.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/58/16163.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.9545"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.196403, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PEN", "relevance_score": "0.195419", "ticker_sentiment_score": "0.113874", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZBH", "relevance_score": "0.195419", "ticker_sentiment_score": "0.063419", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOLX", "relevance_score": "0.195419", "ticker_sentiment_score": "0.104743", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.049322", "ticker_sentiment_score": "-0.016", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.613499", "ticker_sentiment_score": "0.28164", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "How a big biotech's start-up gamble went wrong", "url": "https://www.ft.com/content/13073d23-ef5f-4b5d-a942-88f032f58a89", "time_published": "20230628T041808", "authors": [], "summary": "This is an audio transcript of the Behind the Money podcast episode: 'How a big biotech's start-up gamble went wrong' Good morning, everyone, and thank you for joining us on such short notice. That's Francis de Souza, the CEO of Illumina at the time, speaking on an investor relations call in ...", "banner_image": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2Fdd112b1e-a62a-4493-b01e-ce31aa8efc08.jpg?fit=scale-down&source=next&width=700", "source": "Financial Times", "category_within_source": "GoogleRSS", "source_domain": "www.ft.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.977154"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.650727"}, {"topic": "Earnings", "relevance_score": "0.161647"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.026433, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.011704", "ticker_sentiment_score": "-0.009658", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.554439", "ticker_sentiment_score": "-0.020416", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCTZF", "relevance_score": "0.011704", "ticker_sentiment_score": "0.102979", "ticker_sentiment_label": "Neutral"}]}, {"title": "How a big biotech's start-up gamble went wrong", "url": "https://www.ft.com/content/773ce8d5-0d1d-488b-80fa-27f47f61f1aa", "time_published": "20230628T040000", "authors": [], "summary": "Gene sequencer Illumina took a bet on start-up Grail during the height of the biotech boom. What happened next was not part of the plan ...", "banner_image": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fnext-video-editor-images.s3.ap-northeast-1.amazonaws.com%2Fdeb3ee69-a8f7-4b90-87a0-f074ff46a324?source=next-opengraph&fit=scale-down&width=900", "source": "Financial Times", "category_within_source": "Companies", "source_domain": "www.ft.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.214718, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.807885", "ticker_sentiment_score": "-0.24897", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Illumina Announces Job Layoffs After CEO Resignation, Icahn's Board Chess Game: What's Next? - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/general/biotech/23/06/33016165/illumina-announces-job-layoffs-after-ceo-resignation-whats-next", "time_published": "20230626T225435", "authors": ["Benzinga Staff"], "summary": "Biotechnology company Illumina, Inc. ILMN initiated layoffs within its research and development ( R&D ) team, affecting approximately 10% of that staff. These layoffs began late last Wednesday and impacted research teams at various locations, including San Diego and Foster City, California.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/06/26/shutterstock_1857404794.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.238258, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.512093", "ticker_sentiment_score": "-0.421192", "ticker_sentiment_label": "Bearish"}]}, {"title": "S&P 500: Carnival, Tesla Headline Big-Cap Losers Monday", "url": "https://www.investors.com/news/sp-500-carnival-tesla-headline-big-cap-losers-monday/", "time_published": "20230626T205400", "authors": ["Investor's Business Daily", "ED CARSON"], "summary": "Carnival ( CCL ) , Tesla ( TSLA ) , CarMax ( KMX ) , Etsy ( ETSY ) and Illumina ( ILMN ) were the five biggest S&P 500 index losers on the stock market today. The S&P 500 index fell 0.45% on Monday as Tesla stock and some other megacap stocks slumped.", "banner_image": "https://www.investors.com/wp-content/uploads/2020/08/Stock-carnivalshipdock-01-shutt.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.999956"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.043508, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "TSLA", "relevance_score": "0.769861", "ticker_sentiment_score": "0.015983", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHND", "relevance_score": "0.10607", "ticker_sentiment_score": "0.031869", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.310843", "ticker_sentiment_score": "-0.412322", "ticker_sentiment_label": "Bearish"}, {"ticker": "ILMN", "relevance_score": "0.310843", "ticker_sentiment_score": "-0.327298", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "KMX", "relevance_score": "0.406197", "ticker_sentiment_score": "-0.187719", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GS", "relevance_score": "0.10607", "ticker_sentiment_score": "0.031869", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.10607", "ticker_sentiment_score": "-0.204248", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Illumina starts job cuts, exit office space to rein in costs", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/illumina-starts-job-cuts-2023-06-26/", "time_published": "20230626T205300", "authors": ["Reuters"], "summary": "Illumina starts job cuts ...", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/7PJSFRTPEZO4VMUXEEXLAWISZU.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.115301, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.481177", "ticker_sentiment_score": "-0.178964", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture \"Insighta\" for Breakthrough Multi-Cancer Early Detection Screening", "url": "https://www.globenewswire.com/news-release/2023/06/26/2694050/0/en/Prenetics-and-Globally-Renowned-Scientist-Prof-Dennis-Lo-Establish-US-200m-Joint-Venture-Insighta-for-Breakthrough-Multi-Cancer-Early-Detection-Screening.html", "time_published": "20230626T004500", "authors": ["Prenetics Limited"], "summary": "Company will Host Conference Call to Discuss the Transaction on June 26 at 8:30 a.m. EDT Company will Host Conference Call to Discuss the Transaction on June 26 at 8:30 a.m. ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/ee226614-92ac-4907-ab0f-71fb18d8f246", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.24396, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HESG", "relevance_score": "0.037504", "ticker_sentiment_score": "0.222761", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PRE", "relevance_score": "0.074926", "ticker_sentiment_score": "0.238284", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.018757", "ticker_sentiment_score": "0.192736", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UBS", "relevance_score": "0.018757", "ticker_sentiment_score": "0.196578", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture \"Insighta\" for Breakthrough Multi-Cancer Early Detection Screening", "url": "https://www.prnewswire.com/apac/news-releases/prenetics-and-globally-renowned-scientist-prof-dennis-lo-establish-us200m-joint-venture-insighta-for-breakthrough-multi-cancer-early-detection-screening-301862595.html", "time_published": "20230626T004500", "authors": ["Prenetics"], "summary": "Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture \"Insighta\" for ... PR ...", "banner_image": "https://mma.prnewswire.com/media/2140027/Prof_Dennis_Lo_Danny_Yeung_Signing_Ceremony.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.241662, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HESG", "relevance_score": "0.037475", "ticker_sentiment_score": "0.223749", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PRE", "relevance_score": "0.074867", "ticker_sentiment_score": "0.239307", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.018743", "ticker_sentiment_score": "0.192721", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UBS", "relevance_score": "0.018743", "ticker_sentiment_score": "0.196563", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Exclusive: Hong Kong's DNA pioneers launch blood tests to find cancer", "url": "https://www.scmp.com/business/china-business/article/3225286/cuhks-dennis-lo-launches-blood-tests-prenetics-group-find-cancer-cells-liver-and-lungs-propelling", "time_published": "20230626T000011", "authors": ["Peggy Sito"], "summary": "The venture -the largest life sciences transaction in Asia this year - would also spearhead the development of a life science ecosystem in Hong Kong, and help the city's position as a biotech hub.", "banner_image": "https://img.i-scmp.com/cdn-cgi/image/fit=contain,width=425,format=auto/sites/default/files/styles/768x768/public/d8/images/canvas/2023/06/25/d51d12b2-aafa-431f-bb39-2f19370c8fb6_b0f1b5ed.jpg?itok=5uXilnZC&v=1687655892", "source": "South China Morning Post", "category_within_source": "Companies", "source_domain": "www.scmp.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.029021, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "HESG", "relevance_score": "0.04583", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NWWDF", "relevance_score": "0.04583", "ticker_sentiment_score": "0.040204", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.04583", "ticker_sentiment_score": "0.10943", "ticker_sentiment_label": "Neutral"}]}, {"title": "LGND vs. ILMN: Which Stock Is the Better Value Option?", "url": "https://www.zacks.com/stock/news/2112484/lgnd-vs-ilmn-which-stock-is-the-better-value-option", "time_published": "20230623T154011", "authors": ["Zacks Investment Research"], "summary": "Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Ligand Pharmaceuticals ( LGND Quick QuoteLGND - ) and Illumina ( ILMN Quick QuoteILMN - ) . But which of these two stocks is more attractive to value investors?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default118.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.504105, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.747404", "ticker_sentiment_score": "0.59984", "ticker_sentiment_label": "Bullish"}, {"ticker": "LGND", "relevance_score": "0.796338", "ticker_sentiment_score": "0.611216", "ticker_sentiment_label": "Bullish"}]}, {"title": "If You Invested $1000 In This Stock 20 Years Ago, You Would Have $140 Thousand Today - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/earnings/23/06/32969874/if-you-invested-1000-in-this-stock-20-years-ago-you-would-have-140-thousand-today", "time_published": "20230622T153033", "authors": ["Benzinga Insights"], "summary": "Illumina ILMN has outperformed the market over the past 20 years by 19.73% on an annualized basis producing an average annual return of 27.43%. Currently, Illumina has a market capitalization of $31.26 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_3.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.983605", "ticker_sentiment_score": "0.387251", "ticker_sentiment_label": "Bullish"}]}, {"title": "European Overreach In Tech Regulation Is Becoming A Problem For US National Security", "url": "https://www.forbes.com/sites/lorenthompson/2023/06/22/european-overreach-in-tech-regulation-is-becoming-a-problem-for-us-national-security/", "time_published": "20230622T141700", "authors": ["Loren Thompson"], "summary": "The European Union's persistent pattern of targeting US tech companies weakens the nation's security posture.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/649457523ce9519ec38daaa2/0x0.jpg?format=jpg&width=1200", "source": "Forbes", "category_within_source": "Business", "source_domain": "www.forbes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.021972, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.079788", "ticker_sentiment_score": "0.046676", "ticker_sentiment_label": "Neutral"}, {"ticker": "EADSF", "relevance_score": "0.039944", "ticker_sentiment_score": "-0.016717", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.197735", "ticker_sentiment_score": "-0.051276", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.039944", "ticker_sentiment_score": "0.07154", "ticker_sentiment_label": "Neutral"}, {"ticker": "QCOM", "relevance_score": "0.039944", "ticker_sentiment_score": "0.102773", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.039944", "ticker_sentiment_score": "-0.144689", "ticker_sentiment_label": "Neutral"}]}, {"title": "Attovia Therapeutics Launches with $60 Million Series A Financing to Unlock Potential of Novel Biparatopic Nanobody Platform", "url": "https://www.benzinga.com/pressreleases/23/06/g32919682/attovia-therapeutics-launches-with-60-million-series-a-financing-to-unlock-potential-of-novel-bipa", "time_published": "20230620T113000", "authors": ["Globe Newswire"], "summary": "Company Formed by Alamar Biosciences and Frazier Life Sciences Attobody\u2122 Platform Generates Small Format Binders for Hard-to-drug Targets", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.275656, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ZLAB", "relevance_score": "0.038717", "ticker_sentiment_score": "-0.004871", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRN", "relevance_score": "0.038717", "ticker_sentiment_score": "0.214255", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.038717", "ticker_sentiment_score": "0.027526", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSOI", "relevance_score": "0.038717", "ticker_sentiment_score": "0.186398", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BMY", "relevance_score": "0.038717", "ticker_sentiment_score": "-0.004871", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.038717", "ticker_sentiment_score": "-0.004871", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina's CEO Was Just Ousted: Should Investors Buy In Now or Steer Clear?", "url": "https://www.fool.com/investing/2023/06/20/illumina-ceo-was-just-ousted-should-investors-buy/", "time_published": "20230620T094500", "authors": ["Alex Carchidi"], "summary": "Things aren't looking up just yet.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F736576%2Fa-group-of-four-people-on-a-tandem-skydive.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.026586, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.340915", "ticker_sentiment_score": "0.091293", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nucleic Acid Isolation and Purification Market is Expected to Reach $9.2 Billion | MarketsandMarkets.", "url": "https://www.benzinga.com/pressreleases/23/06/g32912413/nucleic-acid-isolation-and-purification-market-is-expected-to-reach-9-2-billion-marketsandmarkets", "time_published": "20230619T133000", "authors": ["Globe Newswire"], "summary": "Chicago, June 19, 2023 ( GLOBE NEWSWIRE ) -- The nucleic acid isolation and purification industry is poised for remarkable growth and innovation in the near future. With the increasing demand for genomics, molecular diagnostics, and personalized medicine, the industry is set to witness ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.120729, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.027508", "ticker_sentiment_score": "-0.01803", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.027508", "ticker_sentiment_score": "-0.01803", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.054983", "ticker_sentiment_score": "0.038939", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.027508", "ticker_sentiment_score": "-0.01803", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.027508", "ticker_sentiment_score": "-0.01803", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.027508", "ticker_sentiment_score": "-0.01803", "ticker_sentiment_label": "Neutral"}]}, {"title": "Genomics Market Size to Grow by USD 18,244.34 million from 2022 to 2027, North America is estimated to contribute 37% to the global market growth - Technavio", "url": "https://www.prnewswire.com/news-releases/genomics-market-size-to-grow-by-usd-18-244-34-million-from-2022-to-2027--north-america-is-estimated-to-contribute-37-to-the-global-market-growth---technavio-301853361.html", "time_published": "20230619T071500", "authors": ["Technavio"], "summary": "Genomics Market Size to Grow by USD 18,244.34 million from 2022 to 2027, North America is estimated to contribute ... PR ...", "banner_image": "https://mma.prnewswire.com/media/2104227/Technavio_Logo_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.194272, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.078354", "ticker_sentiment_score": "0.045313", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.052283", "ticker_sentiment_score": "-0.044004", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.052283", "ticker_sentiment_score": "0.044", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.052283", "ticker_sentiment_score": "0.044", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAB", "relevance_score": "0.026155", "ticker_sentiment_score": "-0.041644", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.026155", "ticker_sentiment_score": "-0.041644", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABCM", "relevance_score": "0.052283", "ticker_sentiment_score": "-0.044004", "ticker_sentiment_label": "Neutral"}, {"ticker": "PACB", "relevance_score": "0.026155", "ticker_sentiment_score": "-0.041644", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDX", "relevance_score": "0.026155", "ticker_sentiment_score": "-0.041644", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.026155", "ticker_sentiment_score": "-0.041644", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.052283", "ticker_sentiment_score": "0.044", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONTTF", "relevance_score": "0.026155", "ticker_sentiment_score": "-0.041644", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.026155", "ticker_sentiment_score": "-0.041644", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina CEO Steps Down; Grail Soap Opera Continues", "url": "https://www.fool.com/investing/2023/06/16/illumina-ceo-steps-down-grail-soap-opera-continues/", "time_published": "20230616T195630", "authors": ["Motley Fool Staff"], "summary": "And we interview Anjay Nagpal, host of the podcast \"Brokers, Bagmen, and Moles.\" ...", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F736209%2Fa-person-looking-down-at-a-tablet-device-while-standing-in-a-data-center.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.905476"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.118548, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ATVI", "relevance_score": "0.009858", "ticker_sentiment_score": "0.013286", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.009858", "ticker_sentiment_score": "0.013286", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBD", "relevance_score": "0.009858", "ticker_sentiment_score": "0.060506", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.009858", "ticker_sentiment_score": "0.07381", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.088544", "ticker_sentiment_score": "0.036627", "ticker_sentiment_label": "Neutral"}]}, {"title": "Epigenetics Market size to grow by USD 1,148.2 million from 2022-2027 with 40% of the market growth originate from North America - Technavio", "url": "https://www.prnewswire.com/news-releases/epigenetics-market-size-to-grow-by-usd-1-148-2-million-from-2022-2027-with-40-of-the-market-growth-originate-from-north-america---technavio-301852330.html", "time_published": "20230616T141500", "authors": ["Technavio"], "summary": "Epigenetics Market size to grow by USD 1,148.2 million from 2022-2027 with 40% of the market growth originate from ... PR ...", "banner_image": "https://mma.prnewswire.com/media/2103157/Technavio_Logo_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.093069, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ENZ", "relevance_score": "0.033098", "ticker_sentiment_score": "0.02861", "ticker_sentiment_label": "Neutral"}, {"ticker": "A", "relevance_score": "0.033098", "ticker_sentiment_score": "0.02861", "ticker_sentiment_label": "Neutral"}, {"ticker": "TECH", "relevance_score": "0.033098", "ticker_sentiment_score": "0.02861", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOLX", "relevance_score": "0.033098", "ticker_sentiment_score": "0.02861", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABCM", "relevance_score": "0.033098", "ticker_sentiment_score": "0.02861", "ticker_sentiment_label": "Neutral"}, {"ticker": "PACB", "relevance_score": "0.033098", "ticker_sentiment_score": "0.02861", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.033098", "ticker_sentiment_score": "0.02861", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.033098", "ticker_sentiment_score": "0.02861", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.033098", "ticker_sentiment_score": "0.02861", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.033098", "ticker_sentiment_score": "0.02861", "ticker_sentiment_label": "Neutral"}]}, {"title": "Biochips Market size is set to grow by USD 43,273.01 million from 2022 to 2027, North America to account for 41% of the global market growth - Technavio", "url": "https://www.prnewswire.com/news-releases/biochips-market-size-is-set-to-grow-by-usd-43-273-01-million-from-2022-to-2027--north-america-to-account-for-41-of-the-global-market-growth---technavio-301851078.html", "time_published": "20230616T014500", "authors": ["Technavio"], "summary": "Biochips Market size is set to grow by USD 43,273.01 million from 2022 to 2027, North America to account for 41% of ... PR ...", "banner_image": "https://mma.prnewswire.com/media/2102011/Technavio_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.136244, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.034933", "ticker_sentiment_score": "0.052947", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.034933", "ticker_sentiment_score": "0.052947", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.034933", "ticker_sentiment_score": "0.052947", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.034933", "ticker_sentiment_score": "0.052947", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.034933", "ticker_sentiment_score": "0.052947", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCCOY", "relevance_score": "0.034933", "ticker_sentiment_score": "0.052947", "ticker_sentiment_label": "Neutral"}, {"ticker": "IEX", "relevance_score": "0.034933", "ticker_sentiment_score": "0.052947", "ticker_sentiment_label": "Neutral"}]}, {"title": "Ominous Death Cross Forms On Illumina's Chart - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/markets/23/06/32876368/ominous-death-cross-forms-on-illuminas-chart", "time_published": "20230615T145212", "authors": ["Benzinga Insights"], "summary": "If history is any guide, there may be trouble ahead for shares of Illumina ILMN. A so-called \"death cross\" has formed on its chart and, not surprisingly, this could be bearish for the stock. What To Know: Many traders use moving average crossover systems to make their decisions.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.016834, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.570165", "ticker_sentiment_score": "-0.461617", "ticker_sentiment_label": "Bearish"}]}, {"title": "Biomarkers Market to Grow Significantly by 2029- Brandessence Market Research", "url": "https://www.prnewswire.com/news-releases/biomarkers-market-to-grow-significantly-by-2029--brandessence-market-research-301851886.html", "time_published": "20230615T104000", "authors": ["Brandessence Market Research and Consulting Private Limited"], "summary": "LONDON, June 15, 2023 /PRNewswire/ -- Biomarkers are referred to as a type of measurable biological indicators or characteristics found in body tissues or fluids like blood.", "banner_image": "https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.161647"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.254892, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.023861", "ticker_sentiment_score": "-0.056634", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.023861", "ticker_sentiment_score": "0.224063", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VRTX", "relevance_score": "0.023861", "ticker_sentiment_score": "0.109009", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.023861", "ticker_sentiment_score": "0.224063", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABBV", "relevance_score": "0.023861", "ticker_sentiment_score": "0.109009", "ticker_sentiment_label": "Neutral"}, {"ticker": "GILD", "relevance_score": "0.023861", "ticker_sentiment_score": "0.109009", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.023861", "ticker_sentiment_score": "0.109009", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina's Grail Acquisition Gains Support from GOP Lawmakers and Advocacy Groups Despite FTC Resistance - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/large-cap/23/06/32858857/illuminas-grail-acquisition-gains-support-from-gop-lawmakers-and-advocacy-groups-despite-ftc-resis", "time_published": "20230614T161500", "authors": ["Vandana Singh"], "summary": "Republican lawmakers, state attorneys general, and several advocacy groups have expressed their support for Illumina Inc's ILMN acquisition of Grail Inc, even as the Federal Trade Commission ( FTC ) continues challenging the deal.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/06/14/ilmn.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.002448, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.725935", "ticker_sentiment_score": "-0.047308", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why You Should Retain Illumina  ( ILMN )  Stock for Now", "url": "https://www.zacks.com/stock/news/2108381/heres-why-you-should-retain-illumina-ilmn-stock-for-now", "time_published": "20230614T152200", "authors": ["Zacks Investment Research"], "summary": "Investors are optimistic about Illumina (ILMN) on solid long-term growth potential in the oncology space.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c0/2297.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999813"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.283695, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.045139", "ticker_sentiment_score": "0.232975", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HOLX", "relevance_score": "0.179121", "ticker_sentiment_score": "0.11826", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMSI", "relevance_score": "0.090134", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PACB", "relevance_score": "0.045139", "ticker_sentiment_score": "0.232975", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BSX", "relevance_score": "0.179121", "ticker_sentiment_score": "0.035512", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.349329", "ticker_sentiment_score": "0.448947", "ticker_sentiment_label": "Bullish"}, {"ticker": "MYGN", "relevance_score": "0.045139", "ticker_sentiment_score": "0.047419", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.045139", "ticker_sentiment_score": "0.232975", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "QGEN", "relevance_score": "0.045139", "ticker_sentiment_score": "0.232975", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina acquisition of Grail wins support from GOP lawmakers, state AGs as FTC tries to block", "url": "https://www.cnbc.com/2023/06/13/illumina-grail-deal-wins-support-from-gop-lawmakers-ags.html", "time_published": "20230613T214232", "authors": ["Annika Kim Constantino"], "summary": "The groups argued in the briefs that the FTC overstepped its authority in trying to unwind Illumina's $7.1 billion acquisition of Grail.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107217795-1680188166937-gettyimages-1245790736-RAFAPRESS_22122022-04169.jpeg?v=1686692552&w=1920&h=1080", "source": "CNBC", "category_within_source": "Business", "source_domain": "www.cnbc.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.215378, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.468029", "ticker_sentiment_score": "-0.152543", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Half-year report", "url": "https://www.globenewswire.com/news-release/2023/06/13/2686810/0/en/Half-year-report.html", "time_published": "20230613T060000", "authors": ["Hargreave Hale AIM VCT plc"], "summary": "13 June ...", "banner_image": "", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}, {"topic": "Economy - Monetary", "relevance_score": "0.999682"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Economy - Fiscal", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.650727"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.206551, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EKDHF", "relevance_score": "0.004232", "ticker_sentiment_score": "0.334156", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SHABF", "relevance_score": "0.004232", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNL", "relevance_score": "0.004232", "ticker_sentiment_score": "0.150922", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.004232", "ticker_sentiment_score": "0.02225", "ticker_sentiment_label": "Neutral"}, {"ticker": "MXCT", "relevance_score": "0.008464", "ticker_sentiment_score": "0.10247", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZDGGF", "relevance_score": "0.012696", "ticker_sentiment_score": "0.054991", "ticker_sentiment_label": "Neutral"}, {"ticker": "LDNXF", "relevance_score": "0.016927", "ticker_sentiment_score": "0.068426", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCORF", "relevance_score": "0.038074", "ticker_sentiment_score": "0.050042", "ticker_sentiment_label": "Neutral"}, {"ticker": "DROOF", "relevance_score": "0.004232", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBER", "relevance_score": "0.004232", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBHL", "relevance_score": "0.004232", "ticker_sentiment_score": "-0.013947", "ticker_sentiment_label": "Neutral"}, {"ticker": "NWG", "relevance_score": "0.004232", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "After Illumina CEO's Fall, Other Executives Are Expected to Take Hard Look at Deals", "url": "https://www.wsj.com/articles/after-illumina-ceos-fall-other-executives-are-expected-to-take-hard-look-at-deals-c95c9e8", "time_published": "20230612T191400", "authors": ["Peter Loftus"], "summary": "Francis deSouza resigned from gene-sequencing maker after regulators challenged $7.1 billion deal, triggering proxy battle with Carl Icahn.", "banner_image": "https://images.wsj.net/im-798613?width=700&height=467", "source": "Wall Street Journal", "category_within_source": "Business", "source_domain": "www.wsj.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.413174, "overall_sentiment_label": "Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.983605", "ticker_sentiment_score": "-0.664147", "ticker_sentiment_label": "Bearish"}]}, {"title": "Stocks making the biggest moves midday: Carnival, Nasdaq, Oracle, KeyCorp and more", "url": "https://www.cnbc.com/2023/06/12/stocks-making-the-biggest-moves-midday.html", "time_published": "20230612T174521", "authors": ["Michelle Fox"], "summary": "These are the stocks posting the largest moves midday.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107127606-1664563583873-gettyimages-1429099833-dsc02109_cc4d6685-dbc0-4903-aa54-1e7af15b9f4b.jpeg?v=1686591921&w=1920&h=1080", "source": "CNBC", "category_within_source": "Market Insider", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Earnings", "relevance_score": "0.77141"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.227361, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BAC", "relevance_score": "0.085022", "ticker_sentiment_score": "0.082777", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCLH", "relevance_score": "0.085022", "ticker_sentiment_score": "0.082777", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTLT", "relevance_score": "0.085022", "ticker_sentiment_score": "0.020002", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.169081", "ticker_sentiment_score": "0.001424", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.085022", "ticker_sentiment_score": "0.082777", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.085022", "ticker_sentiment_score": "0.063134", "ticker_sentiment_label": "Neutral"}, {"ticker": "KDNY", "relevance_score": "0.169081", "ticker_sentiment_score": "0.265512", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RCL", "relevance_score": "0.085022", "ticker_sentiment_score": "0.082777", "ticker_sentiment_label": "Neutral"}]}, {"title": "TriNet, Nasdaq fall; Ballard Power, Chinook Therapeutics rise, Monday, 6/12/2023", "url": "https://apnews.com/article/financial-markets-stocks-wall-street-58a2518c3cc898958159a59e72f05038", "time_published": "20230612T161913", "authors": [], "summary": "TriNet, Nasdaq fall. Ballard Power, Chinook Therapeutics rise ... The Associated Press ...", "banner_image": "https://storage.googleapis.com/afs-prod/media/afs:Medium:751921853724/700.png", "source": "Associated Press", "category_within_source": "Business", "source_domain": "apnews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.079665, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BLDP", "relevance_score": "0.443626", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FCX", "relevance_score": "0.443626", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.443626", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNET", "relevance_score": "0.443626", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.443626", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KDNY", "relevance_score": "0.443626", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Top Stories Monday, June 12: Broadcom Might Receive European Approval For $61B VMware Deal, UBS Closes Credit Suisse Takeover, Illumina CEO Steps Down Amid Activist Investor Carl Icahn's Pressure - Broadcom  ( NASDAQ:AVGO ) , BioNTech  ( NASDAQ:BNTX ) ", "url": "https://www.benzinga.com/news/23/06/32816155/broadcom-might-receive-european-approval-for-61b-vmware-deal-ubs-closes-credit-suisse-takeover-illum", "time_published": "20230612T140134", "authors": ["Vandana Singh"], "summary": "In early May, U.S. chipmaker Broadcom Inc's AVGO CEO Hock Tan proposed a pitch to EU antitrust enforcers regarding the pro-competitiveness of the proposed $61 billion bid for cloud computing firm VMware Inc VMW. Broadcom is set to gain conditional EU antitrust approval for its proposed ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/06/12/ubs_-_cs.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}], "overall_sentiment_score": 0.097787, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VMW", "relevance_score": "0.146916", "ticker_sentiment_score": "0.107795", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVGO", "relevance_score": "0.146916", "ticker_sentiment_score": "0.107795", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.146916", "ticker_sentiment_score": "0.089244", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.098255", "ticker_sentiment_score": "0.182574", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KDNY", "relevance_score": "0.098255", "ticker_sentiment_score": "0.23718", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UBS", "relevance_score": "0.242406", "ticker_sentiment_score": "0.140241", "ticker_sentiment_label": "Neutral"}, {"ticker": "IR", "relevance_score": "0.146916", "ticker_sentiment_score": "0.143017", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVS", "relevance_score": "0.098255", "ticker_sentiment_score": "0.23718", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BNTX", "relevance_score": "0.146916", "ticker_sentiment_score": "-0.300029", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CS", "relevance_score": "0.242406", "ticker_sentiment_score": "0.140241", "ticker_sentiment_label": "Neutral"}, {"ticker": "BABWF", "relevance_score": "0.049221", "ticker_sentiment_score": "0.09915", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTLS", "relevance_score": "0.098255", "ticker_sentiment_score": "0.19755", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VWAGY", "relevance_score": "0.098255", "ticker_sentiment_score": "0.132397", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.098255", "ticker_sentiment_score": "0.105783", "ticker_sentiment_label": "Neutral"}, {"ticker": "RYAOF", "relevance_score": "0.098255", "ticker_sentiment_score": "0.087612", "ticker_sentiment_label": "Neutral"}]}, {"title": "Jim Cramer's top 10 things to watch in the stock market Monday", "url": "https://www.cnbc.com/2023/06/12/jim-cramers-top-10-things-to-watch-in-the-stock-market-monday.html", "time_published": "20230612T130825", "authors": ["Jim Cramer"], "summary": "The Magnificent Seven keep rolling, the cruise lines catch price target boosts and consumers stay strong.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107190373-1675796003229-gettyimages-1463870138-029a6771_ba1de0b3-c2ff-44a3-bf63-256169e7b95c.jpeg?v=1686575305&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.961735"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.153421, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.119235", "ticker_sentiment_score": "0.103045", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.119235", "ticker_sentiment_score": "0.103045", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.119235", "ticker_sentiment_score": "0.103045", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.059785", "ticker_sentiment_score": "-0.070027", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.059785", "ticker_sentiment_score": "0.052036", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.119235", "ticker_sentiment_score": "0.031154", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.059785", "ticker_sentiment_score": "-0.027026", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.059785", "ticker_sentiment_score": "0.268147", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ORCL", "relevance_score": "0.119235", "ticker_sentiment_score": "0.103045", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.119235", "ticker_sentiment_score": "0.031154", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.119235", "ticker_sentiment_score": "0.103045", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.235823", "ticker_sentiment_score": "0.234535", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NCLH", "relevance_score": "0.119235", "ticker_sentiment_score": "-0.031135", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.178021", "ticker_sentiment_score": "-0.101176", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADBE", "relevance_score": "0.119235", "ticker_sentiment_score": "0.103045", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMD", "relevance_score": "0.119235", "ticker_sentiment_score": "0.103045", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCL", "relevance_score": "0.119235", "ticker_sentiment_score": "-0.031135", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.178021", "ticker_sentiment_score": "0.099254", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.119235", "ticker_sentiment_score": "0.102221", "ticker_sentiment_label": "Neutral"}]}, {"title": "JPMorgan Moves to Put the Epstein Case Behind It", "url": "https://www.nytimes.com/2023/06/12/business/dealbook/jpmorgan-epstein-settlement.html", "time_published": "20230612T121357", "authors": [], "summary": "JPMorgan Seeks to Settle Lawsuit by Jeffrey Epstein Victims The New York Times ...", "banner_image": "https://static01.nyt.com/images/2023/06/12/multimedia/12db-jpm-chtq/12db-jpm-chtq-articleLarge.jpg?quality=75&auto=webp&disable=upscale", "source": "New York Times", "category_within_source": "GoogleRSS", "source_domain": "www.nytimes.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": -0.014501, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "WBD", "relevance_score": "0.02018", "ticker_sentiment_score": "0.087234", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLCNF", "relevance_score": "0.02018", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.120632", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.100644", "ticker_sentiment_score": "-0.106546", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCKRF", "relevance_score": "0.02018", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Illumina  ( ILMN )  Shares Are Trading Higher Premarket Today - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/large-cap/23/06/32811818/executive-shakeup-at-illumina-ceo-francis-desouza-steps-down-amid-activist-investor-carl-icahns-pr", "time_published": "20230612T120219", "authors": ["Vandana Singh"], "summary": "Illumina Inc ( NASDAQ. ILMN ) announced that its Board of Directors accepted the resignation of Francis deSouza as Illumina's Chief Executive Officer and Director, effective June 11. Charles Dadswell, Senior Vice President and General Counsel, has been named interim CEO while the Board of ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/06/12/ilmn.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.160196, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.767202", "ticker_sentiment_score": "-0.316246", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Stocks making the biggest moves before the bell: Nasdaq, Illumina, Oracle, Carnival & more", "url": "https://www.cnbc.com/2023/06/12/stocks-making-the-biggest-moves-premarket-ndaq-ilmn-orcl-more.html", "time_published": "20230612T115604", "authors": ["Alex Harring"], "summary": "These are the stocks posting the largest moves in premarket trading.", "banner_image": "https://image.cnbcfm.com/api/v1/image/106864242-1617726580442-2020-10-09T190624Z_381267743_RC27FJ9JDL3O_RTRMADP_3_ILLUMINA-RESULTS.jpg?v=1686570964&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.131481, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVR", "relevance_score": "0.201523", "ticker_sentiment_score": "0.235348", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BCS", "relevance_score": "0.101582", "ticker_sentiment_score": "0.160929", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.201523", "ticker_sentiment_score": "-0.057637", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.201523", "ticker_sentiment_score": "0.189446", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MS", "relevance_score": "0.201523", "ticker_sentiment_score": "0.006721", "ticker_sentiment_label": "Neutral"}]}, {"title": "The daily business briefing: June 12, 2023", "url": "https://theweek.com/briefing/business-briefing/1024229/the-daily-business-briefing-june-12-2023", "time_published": "20230612T113625", "authors": ["Harold Maass"], "summary": "Investor and philanthropist George Soros is transferring control of his $25 billion empire to one of his younger sons, Alexander Soros OLIVIER HOSLET / POOL / AFP via Getty Images , The Wall Street Journal reported Sunday.", "banner_image": "https://mediacloud.theweek.com/image/upload/f_auto,t_primary-image-mobile@1/v1686569712/GettyImages-673749684.jpg", "source": "The Week News", "category_within_source": "n/a", "source_domain": "theweek.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.576289"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": -0.0454, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GETY", "relevance_score": "0.06515", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.256314", "ticker_sentiment_score": "-0.227506", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "KDNY", "relevance_score": "0.06515", "ticker_sentiment_score": "0.024108", "ticker_sentiment_label": "Neutral"}]}, {"title": "Goldman pushes back against bearish Morgan Stanley's Mike Wilson with new 4,500 S&P 500 target", "url": "https://www.marketwatch.com/story/goldman-pushes-back-against-bearish-morgan-stanleys-mike-wilson-with-new-4-500-s-p-500-target-e69059a8", "time_published": "20230612T112300", "authors": ["Barbara Kollmeyer"], "summary": "Resilient economic growth and softening inflation will keep stocks supported, says Goldman Sachs, which has a new bullish S&P 500 target.", "banner_image": "https://images.mktw.net/im-798498?width=700&height=499", "source": "MarketWatch", "category_within_source": "Top Stories", "source_domain": "www.marketwatch.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}, {"topic": "Economy - Monetary", "relevance_score": "0.890401"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.503496"}, {"topic": "Earnings", "relevance_score": "0.996675"}], "overall_sentiment_score": -0.017128, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.076847", "ticker_sentiment_score": "-0.073701", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.038468", "ticker_sentiment_score": "-0.338995", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MS", "relevance_score": "0.038468", "ticker_sentiment_score": "-0.113143", "ticker_sentiment_label": "Neutral"}, {"ticker": "KDNY", "relevance_score": "0.076847", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORCL", "relevance_score": "0.076847", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.038468", "ticker_sentiment_score": "0.111194", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESALF", "relevance_score": "0.076847", "ticker_sentiment_score": "0.275576", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BIIB", "relevance_score": "0.076847", "ticker_sentiment_score": "0.275576", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FOREX:USD", "relevance_score": "0.038468", "ticker_sentiment_score": "0.157493", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Nasdaq, S&P 500 Futures Signal Strong Start To Week - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , Illumina  ( NASDAQ:ILMN ) , Chinook Therapeutics  ( NASDAQ:KDNY ) , Oracle  ( NYSE:ORCL ) , Novartis  ( NYSE:NVS ) , SPDR S&P 500  ( ARCA:SPY ) , Biogen  ( NASDAQ:BIIB ) ", "url": "https://www.benzinga.com/markets/equities/23/06/32812362/nasdaq-s-amp-p-500-futures-signal-strong-start-to-week-on-hopes-of-fed-pause-why-this-analyst-is", "time_published": "20230612T110046", "authors": ["Shanthi Rexaline"], "summary": "U.S. stocks are set to start the week on an upbeat note, as traders begin to bake in a pause by the Federal Reserve when it meets this week. Technology stocks could large the charge but oil's slide could weigh down on the space.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Created_with_artificial_intelligence_on_MidJourney_6.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.890401"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.995973"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.057857, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.113329", "ticker_sentiment_score": "-0.117381", "ticker_sentiment_label": "Neutral"}, {"ticker": "KDNY", "relevance_score": "0.113329", "ticker_sentiment_score": "0.109584", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORCL", "relevance_score": "0.113329", "ticker_sentiment_score": "0.209008", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LPLA", "relevance_score": "0.056808", "ticker_sentiment_score": "-0.093288", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVS", "relevance_score": "0.113329", "ticker_sentiment_score": "0.109584", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.056808", "ticker_sentiment_score": "0.219998", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ESALF", "relevance_score": "0.056808", "ticker_sentiment_score": "-0.050932", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.113329", "ticker_sentiment_score": "-0.056275", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rocky history of Illumina's Grail deal", "url": "https://www.reuters.com/markets/deals/rocky-history-illuminas-grail-deal-2023-06-06/", "time_published": "20230611T174000", "authors": ["Reuters"], "summary": "June 11 ( Reuters ) - Gene-sequencing machine maker Illumina Inc ( ILMN.O ) has filed an appeal against an order from the U.S. Federal Trade Commission ( FTC ) that demands it divest cancer diagnostic test maker Grail Inc ( GRAL.O ) due to competition concerns.", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/FOXJ6PC6YZOKLH22IBF7MRNBNE.jpg", "source": "Reuters", "category_within_source": "Markets", "source_domain": "www.reuters.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.040388, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.859898", "ticker_sentiment_score": "-0.08285", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina CEO resigns amid pressure from activist investor Carl Icahn", "url": "https://apnews.com/article/illumina-ceo-resignation-shareholders-a2c8350506805926e32e82a074a3d776", "time_published": "20230611T170230", "authors": [], "summary": "NEW YORK ( AP ) - Gene sequencing test maker Illumina Inc. said Sunday that its board has accepted the resignation of its CEO and director, Francis deSouza, effective immediately.", "banner_image": "https://storage.googleapis.com/afs-prod/media/afs:Medium:751921853724/700.png", "source": "Associated Press", "category_within_source": "Business", "source_domain": "apnews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.066048, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.670742", "ticker_sentiment_score": "-0.114945", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina announces CEO transition plan as Francis deSouza resigns", "url": "https://www.cnbc.com/2023/06/11/illumina-announces-ceo-transition-plan-as-francis-desouza-resigns.html", "time_published": "20230611T140751", "authors": ["Ashley Capoot"], "summary": "Illumina announced its board of directors has accepted the resignation of CEO Francis deSouza Sunday.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107217800-1680188278361-gettyimages-1246349410-DAVOS_WEF_2023.jpeg?v=1686492471&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.206832, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.682689", "ticker_sentiment_score": "-0.413866", "ticker_sentiment_label": "Bearish"}]}, {"title": "Illumina CEO Francis deSouza Resigns", "url": "https://www.wsj.com/articles/illumina-ceo-francis-desouza-resigns-89c38eec", "time_published": "20230611T140300", "authors": ["Peter Loftus"], "summary": "Head of gene-sequencing test maker steps aside after regulators challenged deal for a cancer test-developer.", "banner_image": "https://images.wsj.net/im-798319?width=700&height=467", "source": "Wall Street Journal", "category_within_source": "Business", "source_domain": "www.wsj.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.309466, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.939207", "ticker_sentiment_score": "-0.520116", "ticker_sentiment_label": "Bearish"}]}, {"title": "Illumina CEO Francis DeSouza resigns", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/illumina-appoints-dadswell-interim-ceo-2023-06-11/", "time_published": "20230611T124805", "authors": ["Reuters"], "summary": "June 11 ( Reuters ) - The CEO of gene-sequencing machine maker Illumina ( ILMN.O ) Francis DeSouza has resigned from the group, it said on Sunday, weeks after he survived a challenge to his board seat from activist investor Carl Icahn.", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/FOXJ6PC6YZOKLH22IBF7MRNBNE.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.04602, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.377142", "ticker_sentiment_score": "0.026781", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina announces CEO transition plan", "url": "https://www.prnewswire.com/news-releases/illumina-announces-ceo-transition-plan-301847801.html", "time_published": "20230611T120000", "authors": ["Inc.", "Illumina"], "summary": "SAN DIEGO, June 11, 2023 /PRNewswire/ -- Illumina Inc. ( NASDAQ: ILMN ) , a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors has accepted the resignation of Francis deSouza as Illumina's Chief Executive Officer and as a Director, effective ...", "banner_image": "", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.17856, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.595343", "ticker_sentiment_score": "0.195872", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Global Automated Nucleic Acid Extraction Devices Market Report 2023: Growing Number of Research and Development Activities Fuels the Sector", "url": "https://www.prnewswire.com/news-releases/global-automated-nucleic-acid-extraction-devices-market-report-2023-growing-number-of-research-and-development-activities-fuels-the-sector-301847164.html", "time_published": "20230610T010000", "authors": ["Research and Markets"], "summary": "Global Automated Nucleic Acid Extraction Devices Market Report ... PR ...", "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.189726, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "DSRLF", "relevance_score": "0.033006", "ticker_sentiment_score": "0.078378", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.033006", "ticker_sentiment_score": "0.078378", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.033006", "ticker_sentiment_score": "0.078378", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDX", "relevance_score": "0.033006", "ticker_sentiment_score": "0.078378", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.033006", "ticker_sentiment_score": "0.078378", "ticker_sentiment_label": "Neutral"}]}, {"title": "DNA and Gene Chip Global Market Report 2023: Rising Demand for Early Cancer Detection is Significantly Contributing to Growth", "url": "https://www.prnewswire.com/news-releases/dna-and-gene-chip-global-market-report-2023-rising-demand-for-early-cancer-detection-is-significantly-contributing-to-growth-301847157.html", "time_published": "20230610T004500", "authors": ["Research and Markets"], "summary": "DNA and Gene Chip Global Market Report 2023: Rising Demand for ... PR ...", "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.021497, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BMXMF", "relevance_score": "0.028729", "ticker_sentiment_score": "0.105438", "ticker_sentiment_label": "Neutral"}, {"ticker": "A", "relevance_score": "0.028729", "ticker_sentiment_score": "0.105438", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIT", "relevance_score": "0.028729", "ticker_sentiment_score": "0.083718", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.086039", "ticker_sentiment_score": "0.054635", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.028729", "ticker_sentiment_score": "0.105438", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina  ( ILMN )  Sequencing Arm Grows, Margin Woes Linger", "url": "https://www.zacks.com/stock/news/2106397/illumina-ilmn-sequencing-arm-grows-margin-woes-linger", "time_published": "20230609T135000", "authors": ["Zacks Investment Research"], "summary": "Illumina's (ILMN) total sequencing activity on connected high- and mid-throughput instruments are growing strongly.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7b/850.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.993781"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.130487, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PEN", "relevance_score": "0.142847", "ticker_sentiment_score": "0.054074", "ticker_sentiment_label": "Neutral"}, {"ticker": "STIM", "relevance_score": "0.235823", "ticker_sentiment_score": "0.113698", "ticker_sentiment_label": "Neutral"}, {"ticker": "LNTH", "relevance_score": "0.18967", "ticker_sentiment_score": "0.074103", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.599092", "ticker_sentiment_score": "0.158652", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Molecular Diagnostics Market  ( Disease Area, Technology )  - Reach $36.17 Billion by 2028 at 12.1% CAGR with Oncology Segment Driving Growth During 2022-2028 | The Insight Partners", "url": "https://www.benzinga.com/pressreleases/23/06/g32755165/molecular-diagnostics-market-disease-area-technology-reach-36-17-billion-by-2028-at-12-1-cagr-with", "time_published": "20230607T114901", "authors": ["Globe Newswire"], "summary": "Pune, India, June 07, 2023 ( GLOBE NEWSWIRE ) -- The Insight Partners published latest research study on \"Molecular Diagnostics Market Size Report, Share, Revenue, Growth Strategy, Industry Trends and Forecast to 2028 - COVID-19 Impact and Global Analysis By Disease Area, Technology, Product and ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.198968, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BMXMF", "relevance_score": "0.035345", "ticker_sentiment_score": "0.061557", "ticker_sentiment_label": "Neutral"}, {"ticker": "A", "relevance_score": "0.070621", "ticker_sentiment_score": "0.005066", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.035345", "ticker_sentiment_score": "0.061557", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.105759", "ticker_sentiment_score": "0.093374", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVS", "relevance_score": "0.035345", "ticker_sentiment_score": "0.061557", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.035345", "ticker_sentiment_score": "0.061557", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEMHF", "relevance_score": "0.035345", "ticker_sentiment_score": "0.061557", "ticker_sentiment_label": "Neutral"}]}, {"title": "LGND or ILMN: Which Is the Better Value Stock Right Now?", "url": "https://www.zacks.com/stock/news/2104570/lgnd-or-ilmn-which-is-the-better-value-stock-right-now", "time_published": "20230606T154011", "authors": ["Zacks Investment Research"], "summary": "LGND vs. ILMN: Which Stock Is the Better Value Option?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default328.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.838487"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.459118, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.670742", "ticker_sentiment_score": "0.520935", "ticker_sentiment_label": "Bullish"}, {"ticker": "LGND", "relevance_score": "0.77735", "ticker_sentiment_score": "0.548432", "ticker_sentiment_label": "Bullish"}]}, {"title": "Can Apple Take the Metaverse Mainstream?", "url": "https://www.nytimes.com/2023/06/06/business/dealbook/apple-metaverse-virtual-reality.html", "time_published": "20230606T113006", "authors": [], "summary": "Apple Bets the Vision Pro Can Take the Metaverse Mainstream The New York Times ...", "banner_image": "https://static01.nyt.com/images/2023/06/06/multimedia/06db-cook-vision-tvjp/06db-cook-vision-tvjp-articleLarge.jpg?quality=75&auto=webp&disable=upscale", "source": "New York Times", "category_within_source": "GoogleRSS", "source_domain": "www.nytimes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": -0.053117, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.020491", "ticker_sentiment_score": "-0.106667", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.122477", "ticker_sentiment_score": "-0.052597", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.040969", "ticker_sentiment_score": "0.012674", "ticker_sentiment_label": "Neutral"}, {"ticker": "HST", "relevance_score": "0.020491", "ticker_sentiment_score": "-0.015286", "ticker_sentiment_label": "Neutral"}, {"ticker": "NYT", "relevance_score": "0.020491", "ticker_sentiment_score": "0.047844", "ticker_sentiment_label": "Neutral"}, {"ticker": "PK", "relevance_score": "0.020491", "ticker_sentiment_score": "0.025063", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.020491", "ticker_sentiment_score": "-0.063647", "ticker_sentiment_label": "Neutral"}]}, {"title": "Top Stories Monday, June 5: Apple's Upcoming VR Headset Marks Significant New Product Debut In Almost 10 Years, Regulators Want Tighter Capital Requirements For Large US Banks, Software Configuration Error at Grail Causes Cancer Misdiagnosis - Apple  ( NASDAQ:AAPL ) , Bed Bath & Beyond  ( OTC:BBBYQ ) ", "url": "https://www.benzinga.com/news/large-cap/23/06/32715673/apples-upcoming-vr-headset-marks-significant-new-product-debut-in-almost-10-years-regulators-want-", "time_published": "20230605T134546", "authors": ["Vandana Singh"], "summary": "U.S. regulators are reportedly gearing up to enforce stricter measures on large banks to enhance their financial stability following a series of failures among midsize banks earlier this year.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/06/05/aapl-wwdc.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Blockchain", "relevance_score": "0.451494"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.064964, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CS", "relevance_score": "0.076602", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNEJF", "relevance_score": "0.076602", "ticker_sentiment_score": "-0.217997", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EADSF", "relevance_score": "0.114682", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.076602", "ticker_sentiment_score": "-0.024875", "ticker_sentiment_label": "Neutral"}, {"ticker": "UAL", "relevance_score": "0.114682", "ticker_sentiment_score": "0.028478", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.152499", "ticker_sentiment_score": "0.014622", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.076602", "ticker_sentiment_score": "-0.101584", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBS", "relevance_score": "0.114682", "ticker_sentiment_score": "0.263919", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BBBYQ", "relevance_score": "0.114682", "ticker_sentiment_score": "0.107298", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCZ", "relevance_score": "0.038345", "ticker_sentiment_score": "0.115072", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAL", "relevance_score": "0.076602", "ticker_sentiment_score": "-0.032468", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAR", "relevance_score": "0.152499", "ticker_sentiment_score": "0.103719", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina releases 2022 Corporate Social Responsibility Report", "url": "https://www.prnewswire.com/news-releases/illumina-releases-2022-corporate-social-responsibility-report-301841937.html", "time_published": "20230605T131500", "authors": ["Inc.", "Illumina"], "summary": "SAN DIEGO, June 5, 2023 /PRNewswire/ -- Illumina Inc. ( NASDAQ: ILMN ) , a global leader in DNA sequencing and array-based technologies, today published its annual , highlighting the company's commitment to human health, and the progress made by its environmental, social, and governance ( ESG ) ...", "banner_image": "https://mma.prnewswire.com/media/2092458/Illumina_Inc_CSR_report_2022.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.303699, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.622414", "ticker_sentiment_score": "0.442911", "ticker_sentiment_label": "Bullish"}]}, {"title": "Software Configuration Error at Grail Causes Cancer Misdiagnosis Scare; Could It Impact Illumina's Acquisition Plans? - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/large-cap/23/06/32710725/software-configuration-error-at-grail-causes-cancer-misdiagnosis-scare-could-it-impact-illuminas-a", "time_published": "20230605T114720", "authors": ["Vandana Singh"], "summary": "Illumina Inc's ILMN Grail Inc acquisition is reportedly in more hot water when Grail mistakenly sent form letters to 400 patients, suggesting they may have developed cancer. Galleri, the company's primary blood test for cancer diagnosis, is designed to detect more than 50 different malignancies ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/06/05/ilmn.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.264847, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.612033", "ticker_sentiment_score": "-0.329519", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Hundreds Were Mistakenly Told They Might Have Cancer, Test Company Says", "url": "https://www.nytimes.com/2023/06/04/business/grail-blood-test-mistake-cancer.html", "time_published": "20230604T185415", "authors": [], "summary": "Grail, which makes a blood test for cancer, said a vendor's software issue caused inaccurate letters to be sent to about 400 customers last month.", "banner_image": "https://static01.nyt.com/images/2023/06/04/business/04xp-grail1/04xp-grail1-articleLarge.jpg?quality=75&auto=webp&disable=upscale", "source": "New York Times", "category_within_source": "Business", "source_domain": "www.nytimes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.097349, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.445179", "ticker_sentiment_score": "0.244731", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Around 400 patients were wrongly informed they might have cancer, biotech company says", "url": "https://www.businessinsider.com/400-patients-wrongly-informed-may-have-cancer-biotech-company-says-2023-6", "time_published": "20230603T101532", "authors": ["Isobel van Hagen"], "summary": "400 Patients Wrongly Informed They Might Have Cancer: Biotech ... - Business Insider ...", "banner_image": null, "source": "Business Insider", "category_within_source": "GoogleRSS", "source_domain": "www.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.312353, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.120431", "ticker_sentiment_score": "0.07355", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cancer test company says vendor mistakenly sent letters to 400 patients that they may have disease", "url": "https://www.foxbusiness.com/healthcare/cancer-test-company-says-telemedicine-vendor-mistakenly-sent-letters-400-patients-disease", "time_published": "20230603T011209", "authors": [], "summary": "Cancer test company Grail, Inc. said Friday its telemedicine vendor had mistakenly sent form letters to about 400 patients, telling them they may have cancer.", "banner_image": "https://cf-images.us-east-1.prod.boltdns.net/v1/static/854081161001/939443e8-90c5-4bb8-826a-332680e3356e/9936c491-d56e-4820-ba09-71b7a47d5519/1280x720/match/image.jpg", "source": "Fox Business News", "category_within_source": "n/a", "source_domain": "www.foxbusiness.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": -0.168667, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "FOX", "relevance_score": "0.31482", "ticker_sentiment_score": "-0.384739", "ticker_sentiment_label": "Bearish"}, {"ticker": "ILMN", "relevance_score": "0.31482", "ticker_sentiment_score": "0.004714", "ticker_sentiment_label": "Neutral"}]}, {"title": "Around 400 Grail Patients Mistakenly Told They Might Have Cancer-Company Blames Vendor", "url": "https://www.forbes.com/sites/antoniopequenoiv/2023/06/02/around-400-grail-patients-mistakenly-told-they-might-have-cancer-company-blames-vendor/", "time_published": "20230602T215407", "authors": ["Antonio Peque\u00f1o IV"], "summary": "The patients signed up to take Galleri, a prescription oncology detection test, and later received letters suggesting they had cancer.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/62499fdeb85d6719dc85cb1a/0x0.jpg?format=jpg&width=1200", "source": "Forbes", "category_within_source": "Business", "source_domain": "www.forbes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.352559, "overall_sentiment_label": "Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.104683", "ticker_sentiment_score": "-0.097289", "ticker_sentiment_label": "Neutral"}]}, {"title": "Global Genomics Market Analysis Report 2023: An $83.1 Billion Market by 2028 from $46.2 Billion in 2023 - Opportunities in the Use of Genomics in Specialized/Personalized Medicine", "url": "https://www.prnewswire.com/news-releases/global-genomics-market-analysis-report-2023-an-83-1-billion-market-by-2028-from-46-2-billion-in-2023---opportunities-in-the-use-of-genomics-in-specializedpersonalized-medicine-301841184.html", "time_published": "20230602T214500", "authors": ["Research and Markets"], "summary": "Global Genomics Market Analysis Report 2023: An $83.1 Billion ... PR ...", "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.161527, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.067727", "ticker_sentiment_score": "-0.04343", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.067727", "ticker_sentiment_score": "-0.04343", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.067727", "ticker_sentiment_score": "-0.04343", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.067727", "ticker_sentiment_score": "-0.04343", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.067727", "ticker_sentiment_score": "-0.04343", "ticker_sentiment_label": "Neutral"}]}, {"title": "Grail says about 400 patients incorrectly informed they may have cancer", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/grail-says-over-400-patients-incorrectly-informed-they-may-have-cancer-2023-06-02/", "time_published": "20230602T200400", "authors": ["Reuters"], "summary": "Grail says over 400 patients incorrectly informed they may have cancer ...", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/YGJBEZ5RJNKCXCTH4Q5LSTDNXI.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.379651, "overall_sentiment_label": "Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.417995", "ticker_sentiment_score": "-0.400421", "ticker_sentiment_label": "Bearish"}]}, {"title": "Why The Biotech Buying Bonanza Will Likely Continue", "url": "https://www.investors.com/news/technology/biotech-stocks-are-in-blistering-ma-climate-ftc-could-change-that/", "time_published": "20230602T171700", "authors": ["ALLISON GATLIN", "Investor's Business Daily"], "summary": "Biotech Stocks Are In A 'Blistering' M&A Climate. The FTC Could ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2023/06/wJumpB060523.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.94762"}, {"topic": "Earnings", "relevance_score": "0.962106"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.993781"}], "overall_sentiment_score": 0.055036, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NVO", "relevance_score": "0.031529", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RETA", "relevance_score": "0.031529", "ticker_sentiment_score": "0.163574", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BLU", "relevance_score": "0.031529", "ticker_sentiment_score": "-0.045458", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROIV", "relevance_score": "0.031529", "ticker_sentiment_score": "0.161618", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMGN", "relevance_score": "0.110028", "ticker_sentiment_score": "-0.017979", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.172097", "ticker_sentiment_score": "0.001427", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARWR", "relevance_score": "0.031529", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRWD", "relevance_score": "0.031529", "ticker_sentiment_score": "0.117903", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTC", "relevance_score": "0.015767", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTRS", "relevance_score": "0.031529", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLY", "relevance_score": "0.031529", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGEN", "relevance_score": "0.063008", "ticker_sentiment_score": "0.016034", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCCC", "relevance_score": "0.031529", "ticker_sentiment_score": "-0.058796", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.047278", "ticker_sentiment_score": "0.036401", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPRX", "relevance_score": "0.031529", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.047278", "ticker_sentiment_score": "-0.146624", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALNY", "relevance_score": "0.031529", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "APLS", "relevance_score": "0.031529", "ticker_sentiment_score": "0.066264", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISEE", "relevance_score": "0.031529", "ticker_sentiment_score": "-0.045458", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALPMF", "relevance_score": "0.015767", "ticker_sentiment_score": "0.089075", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.078714", "ticker_sentiment_score": "-0.025629", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.031529", "ticker_sentiment_score": "0.012717", "ticker_sentiment_label": "Neutral"}, {"ticker": "HZNP", "relevance_score": "0.031529", "ticker_sentiment_score": "-0.047297", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVN", "relevance_score": "0.031529", "ticker_sentiment_score": "-0.058796", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCO", "relevance_score": "0.031529", "ticker_sentiment_score": "0.032413", "ticker_sentiment_label": "Neutral"}, {"ticker": "GILD", "relevance_score": "0.031529", "ticker_sentiment_score": "0.089095", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARGX", "relevance_score": "0.015767", "ticker_sentiment_score": "0.110607", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.031529", "ticker_sentiment_score": "0.012628", "ticker_sentiment_label": "Neutral"}, {"ticker": "RXDX", "relevance_score": "0.031529", "ticker_sentiment_score": "0.022789", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.031529", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina's  ( ILMN )  New AI Tool to Predict Genomics Disease", "url": "https://www.zacks.com/stock/news/2103423/illuminas-ilmn-new-ai-tool-to-predict-genomics-disease", "time_published": "20230602T164400", "authors": ["Zacks Investment Research"], "summary": "Illumina's (ILMN) PrimateAI-3D will be made broadly available to the genomics community integrated across Illumina Connected Software.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7b/850.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.216071, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HOLX", "relevance_score": "0.200688", "ticker_sentiment_score": "0.042808", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMSI", "relevance_score": "0.101154", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.388879", "ticker_sentiment_score": "0.242012", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ADUS", "relevance_score": "0.151222", "ticker_sentiment_score": "0.123685", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Is Horizon Therapeutics  ( HZNP )  Down 9% Since Last Earnings Report?", "url": "https://www.zacks.com/stock/news/2103324/why-is-horizon-therapeutics-hznp-down-9-since-last-earnings-report", "time_published": "20230602T153132", "authors": ["Zacks Investment Research"], "summary": "Horizon Therapeutics (HZNP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default177.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99237"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}], "overall_sentiment_score": -0.014226, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "HZNP", "relevance_score": "0.395012", "ticker_sentiment_score": "0.087044", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.269776", "ticker_sentiment_score": "0.068662", "ticker_sentiment_label": "Neutral"}]}, {"title": "Global Functional Genomics Market to Reach $46.24 Billion by 2033 - Exclusive DeepTech M-A-P\u2122 Analysis by BIS Research", "url": "https://www.prnewswire.com/news-releases/global-functional-genomics-market-to-reach-46-24-billion-by-2033---exclusive-deeptech-m-a-p-analysis-by-bis-research-301841288.html", "time_published": "20230602T151500", "authors": ["BIS Research"], "summary": "Global Functional Genomics Market to Reach $46.24 Billion by 2033 ... PR ...", "banner_image": "https://mma.prnewswire.com/media/495163/BIS_Research_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.229651, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.06179", "ticker_sentiment_score": "0.062004", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONTTF", "relevance_score": "0.06179", "ticker_sentiment_score": "0.062004", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.06179", "ticker_sentiment_score": "0.062004", "ticker_sentiment_label": "Neutral"}]}, {"title": "Top Stories Friday, June 2: Elon Musk Praises Quality of Made in China Teslas, Exxon Eyes Double Output With New Fracking Tech, Netflix Shareholders Vote Against Fat Exec. Pay - Apple  ( NASDAQ:AAPL ) , Amazon.com  ( NASDAQ:AMZN ) ", "url": "https://www.benzinga.com/news/23/06/32689492/elon-musk-praises-china-made-teslas-exxon-eyes-double-output-with-new-fracking-tech-ne", "time_published": "20230602T133157", "authors": ["Akanksha Bakshi"], "summary": "Tesla Inc TSLA CEO Elon Musk is back in America after a two-day trip to China, his first since the onset of the COVID-19 pandemic. The billionaire entrepreneur made a pitstop at Giga Shanghai as part of his tour and delivered a late-night speech praising his Chinese staff.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/06/02/tesla_model_3_front-wikimedia.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.938793"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": 0.186311, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NFLX", "relevance_score": "0.074926", "ticker_sentiment_score": "-0.043238", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.074926", "ticker_sentiment_score": "0.050706", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.074926", "ticker_sentiment_score": "0.077691", "ticker_sentiment_label": "Neutral"}, {"ticker": "VMW", "relevance_score": "0.049991", "ticker_sentiment_score": "0.004", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.149192", "ticker_sentiment_score": "0.111894", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVGO", "relevance_score": "0.099787", "ticker_sentiment_score": "0.116565", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.049991", "ticker_sentiment_score": "0.2223", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JPM", "relevance_score": "0.049991", "ticker_sentiment_score": "-0.121222", "ticker_sentiment_label": "Neutral"}, {"ticker": "NYT", "relevance_score": "0.025008", "ticker_sentiment_score": "0.002776", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.074926", "ticker_sentiment_score": "0.169908", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RKLB", "relevance_score": "0.049991", "ticker_sentiment_score": "-0.113236", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.049991", "ticker_sentiment_score": "-0.006995", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.074926", "ticker_sentiment_score": "0.153491", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VWAGY", "relevance_score": "0.049991", "ticker_sentiment_score": "0.112238", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPHAY", "relevance_score": "0.049991", "ticker_sentiment_score": "0.129212", "ticker_sentiment_label": "Neutral"}, {"ticker": "XOM", "relevance_score": "0.074926", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.049991", "ticker_sentiment_score": "0.070008", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLTR", "relevance_score": "0.049991", "ticker_sentiment_score": "0.012001", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMT", "relevance_score": "0.074926", "ticker_sentiment_score": "0.024437", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Takes AI to Genomics: Launch of PrimateAI-3D for Accurate Disease Prediction - Edwards Lifesciences  ( NYSE:EW ) , Hologic  ( NASDAQ:HOLX ) , Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/general/biotech/23/06/32689141/illumina-takes-ai-to-genomics-launch-of-primateai-3d-for-accurate-disease-prediction", "time_published": "20230602T125421", "authors": ["Nabaparna Bhattacharya"], "summary": "Illumina, Inc. ILMN launched PrimateAI-3D, an artificial intelligence ( AI ) algorithm that predicts disease-causing genetic mutations in patients. PrimateAI-3D utilizes deep neural network architectures similar to ChatGPT and AlphaFold, but is trained on genome sequences rather than human ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/06/02/ilmn.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.13617, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.308891", "ticker_sentiment_score": "-0.361869", "ticker_sentiment_label": "Bearish"}, {"ticker": "HOLX", "relevance_score": "0.308891", "ticker_sentiment_score": "0.238703", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.679474", "ticker_sentiment_score": "0.495912", "ticker_sentiment_label": "Bullish"}]}, {"title": "Global primate genome study reveals their evolution of human health", "url": "https://www.business-standard.com/india-news/global-primate-genome-study-reveals-their-evolution-of-human-health-123060200706_1.html", "time_published": "20230602T121303", "authors": ["Business Standard"], "summary": "A series of global studies of genomes of primates have revealed key features of their evolution, human disease, and biodiversity conservation.", "banner_image": "https://bsmedia.business-standard.com/_media/bs/img/article/2023-04/16/full/1681662285-2772.jpg?im=FeatureCrop,width=826,height=465", "source": "Business Standard", "category_within_source": "GoogleRSS", "source_domain": "www.business-standard.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.082216, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.143415", "ticker_sentiment_score": "0.136656", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina board appoints Hologic CEO as non-exec chairman", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/illumina-board-appoints-hologic-ceo-non-exec-chairman-2023-06-02/", "time_published": "20230602T114500", "authors": ["Reuters"], "summary": "June 2 ( Reuters ) - Illumina Inc ( ILMN.O ) said on Friday it had elected two new independent board members, including Hologic Inc ( HOLX.O ) CEO Stephen MacMillan as the non-executive chairperson, with immediate effect.", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/PRTNSJIJEJOAZJ4P4MJ4L3ZK4Y.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.135332, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.266828", "ticker_sentiment_score": "-0.21484", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HOLX", "relevance_score": "0.266828", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.504646", "ticker_sentiment_score": "0.313233", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina's Board of Directors elects two experienced Independent Directors to Board", "url": "https://www.prnewswire.com/news-releases/illuminas-board-of-directors-elects-two-experienced-independent-directors-to-board-301841153.html", "time_published": "20230602T113000", "authors": ["Inc.", "Illumina"], "summary": "Illumina's Board of Directors elects two experienced Independent ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1876671/Illumina_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.190422, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EW", "relevance_score": "0.138464", "ticker_sentiment_score": "0.068784", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOLX", "relevance_score": "0.092569", "ticker_sentiment_score": "0.061015", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.046363", "ticker_sentiment_score": "0.031755", "ticker_sentiment_label": "Neutral"}, {"ticker": "BERY", "relevance_score": "0.046363", "ticker_sentiment_score": "0.031755", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSX", "relevance_score": "0.046363", "ticker_sentiment_score": "0.034351", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.228717", "ticker_sentiment_score": "0.155616", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.046363", "ticker_sentiment_score": "0.034351", "ticker_sentiment_label": "Neutral"}, {"ticker": "PG", "relevance_score": "0.046363", "ticker_sentiment_score": "0.034351", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXN", "relevance_score": "0.046363", "ticker_sentiment_score": "0.034351", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.046363", "ticker_sentiment_score": "0.031755", "ticker_sentiment_label": "Neutral"}]}, {"title": "Carl Icahn Buys Activist Target Illumina, Adds To Southwest Gas Stake", "url": "https://www.forbes.com/sites/gurufocus/2023/06/01/carl-icahn-buys-activist-target-illumina-adds-to-southwest-gas-stake/", "time_published": "20230601T215856", "authors": ["GuruFocus"], "summary": "Guru releases 1st-quarter portfolio ...", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/5e6b995baa5428000759c17d/0x0.jpg?format=jpg&crop=3000,1686,x0,y35,safe&width=1200", "source": "Forbes", "category_within_source": "Money", "source_domain": "www.forbes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.933642"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.159321, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "OXY", "relevance_score": "0.037155", "ticker_sentiment_score": "0.057301", "ticker_sentiment_label": "Neutral"}, {"ticker": "NWL", "relevance_score": "0.220141", "ticker_sentiment_score": "0.057128", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWX", "relevance_score": "0.220141", "ticker_sentiment_score": "0.128198", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGG", "relevance_score": "0.037155", "ticker_sentiment_score": "0.041915", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.220141", "ticker_sentiment_score": "0.118207", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVI", "relevance_score": "0.07423", "ticker_sentiment_score": "0.060465", "ticker_sentiment_label": "Neutral"}, {"ticker": "NGS", "relevance_score": "0.037155", "ticker_sentiment_score": "0.043834", "ticker_sentiment_label": "Neutral"}, {"ticker": "VALU", "relevance_score": "0.147818", "ticker_sentiment_score": "-0.013288", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRI", "relevance_score": "0.220141", "ticker_sentiment_score": "0.005072", "ticker_sentiment_label": "Neutral"}, {"ticker": "FE", "relevance_score": "0.07423", "ticker_sentiment_score": "0.060465", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Is Repligen  ( RGEN )  Up 2.7% Since Last Earnings Report?", "url": "https://www.zacks.com/stock/news/2102649/why-is-repligen-rgen-up-27-since-last-earnings-report", "time_published": "20230601T153124", "authors": ["Zacks Investment Research"], "summary": "Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default99.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.998645"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}], "overall_sentiment_score": 0.071463, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RGEN", "relevance_score": "0.497391", "ticker_sentiment_score": "0.201027", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.176825", "ticker_sentiment_score": "0.050679", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina  ( ILMN )  to Present Real-World CGP Data at ASCO Meet '23", "url": "https://www.zacks.com/stock/news/2101877/illumina-ilmn-to-present-real-world-cgp-data-at-asco-meet-23", "time_published": "20230531T131600", "authors": ["Zacks Investment Research"], "summary": "At the ASCO meeting, Illumina (ILMN) is set to showcase data that highlights better outcomes for cancer patients who receive comprehensive genomic testing.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e7/2307.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.980509"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.186256, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PEN", "relevance_score": "0.176717", "ticker_sentiment_score": "0.060541", "ticker_sentiment_label": "Neutral"}, {"ticker": "STIM", "relevance_score": "0.290262", "ticker_sentiment_score": "0.178278", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LNTH", "relevance_score": "0.234119", "ticker_sentiment_score": "0.119347", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.497126", "ticker_sentiment_score": "0.161168", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina CEO survived Icahn's challenge by more than 2-to-1 margin", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/illumina-ceo-survived-icahns-challenge-by-more-than-2-to-1-margin-2023-05-30/", "time_published": "20230530T224053", "authors": ["Svea Herbst-Bayliss"], "summary": "[1/2] The offices of gene sequencing company Illumina Inc are shown in San Diego, California January 11, 2016. REUTERS/Mike Blake", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/FO6BIP6VHFIZFNTW5DY555BPRQ.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}], "overall_sentiment_score": 0.019086, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMG", "relevance_score": "0.082111", "ticker_sentiment_score": "-0.014349", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.52949", "ticker_sentiment_score": "-0.026664", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSHZF", "relevance_score": "0.082111", "ticker_sentiment_score": "-0.014349", "ticker_sentiment_label": "Neutral"}, {"ticker": "UL", "relevance_score": "0.082111", "ticker_sentiment_score": "-0.014349", "ticker_sentiment_label": "Neutral"}]}, {"title": "Genetic Testing Services Market Anticipated to Hit US$ 31.5 Billion by 2031, expanding at a CAGR of 8.4%: TMR Report", "url": "https://www.benzinga.com/pressreleases/23/05/g32605190/genetic-testing-services-market-anticipated-to-hit-us-31-5-billion-by-2031-expanding-at-a-cagr-of-", "time_published": "20230526T213000", "authors": ["Globe Newswire"], "summary": "Wilmington, Delaware, United States, May 26, 2023 ( GLOBE NEWSWIRE ) -- The global genetic testing services market is projected to flourish at a CAGR of 8.4% from 2023 to 2031. As per the report published by TMR, the global genetic testing services market is expected to exceed a value of US$ 31.5 ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.28012, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NEO", "relevance_score": "0.043499", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DGX", "relevance_score": "0.043499", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LH", "relevance_score": "0.043499", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.043499", "ticker_sentiment_score": "-0.005961", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.043499", "ticker_sentiment_score": "-0.005961", "ticker_sentiment_label": "Neutral"}]}, {"title": "Global Next-Generation Breast Cancer Diagnostic and Screening Market Report 2023: Sector is Expected to Reach $9.8 Billion by 2032 at a CAGR of 12.57%", "url": "https://www.prnewswire.com/news-releases/global-next-generation-breast-cancer-diagnostic-and-screening-market-report-2023-sector-is-expected-to-reach-9-8-billion-by-2032-at-a-cagr-of-12-57-301835577.html", "time_published": "20230526T151500", "authors": ["Research and Markets"], "summary": "Global Next-Generation Breast Cancer Diagnostic and Screening ... PR ...", "banner_image": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.243259, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.038407", "ticker_sentiment_score": "-0.075346", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEO", "relevance_score": "0.038407", "ticker_sentiment_score": "-0.075346", "ticker_sentiment_label": "Neutral"}, {"ticker": "LH", "relevance_score": "0.038407", "ticker_sentiment_score": "-0.075346", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.038407", "ticker_sentiment_score": "-0.075346", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.038407", "ticker_sentiment_score": "-0.075346", "ticker_sentiment_label": "Neutral"}]}, {"title": "Is a Debt Deal Nigh? The Market Sees Signs of Optimism.", "url": "https://www.nytimes.com/2023/05/26/business/debt-ceiling-deal-markets.html", "time_published": "20230526T112435", "authors": [], "summary": "Stock and bond trading suggest that investors see an imminent deal to raise the debt limit and prevent the federal government from defaulting.", "banner_image": "https://static01.nyt.com/images/2023/05/26/multimedia/26db-mccarthy-qzfm/26db-mccarthy-qzfm-articleLarge.jpg?quality=75&auto=webp&disable=upscale", "source": "New York Times", "category_within_source": "Dealbook", "source_domain": "www.nytimes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.996023"}, {"topic": "Manufacturing", "relevance_score": "0.2"}], "overall_sentiment_score": 0.117375, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.021718", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.021718", "ticker_sentiment_score": "0.017643", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.043421", "ticker_sentiment_score": "0.147519", "ticker_sentiment_label": "Neutral"}, {"ticker": "PARA", "relevance_score": "0.021718", "ticker_sentiment_score": "0.066236", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.043421", "ticker_sentiment_score": "-0.136547", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.043421", "ticker_sentiment_score": "-0.000997", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.021718", "ticker_sentiment_score": "0.027119", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.021718", "ticker_sentiment_score": "0.027119", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.043421", "ticker_sentiment_score": "0.095854", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGPGF", "relevance_score": "0.021718", "ticker_sentiment_score": "0.308125", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TSLA", "relevance_score": "0.021718", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSSMY", "relevance_score": "0.065091", "ticker_sentiment_score": "0.071487", "ticker_sentiment_label": "Neutral"}, {"ticker": "XOM", "relevance_score": "0.021718", "ticker_sentiment_score": "0.020244", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina announces preliminary results of annual meeting", "url": "https://www.prnewswire.com/news-releases/illumina-announces-preliminary-results-of-annual-meeting-301835034.html", "time_published": "20230525T181700", "authors": ["Inc.", "Illumina"], "summary": "Illumina shareholders re-elect eight of nine Illumina directors", "banner_image": "https://mma.prnewswire.com/media/1876671/Illumina_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.259176, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.070725", "ticker_sentiment_score": "0.098492", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.62523", "ticker_sentiment_score": "0.352192", "ticker_sentiment_label": "Bullish"}]}, {"title": "Icahn wins one board seat at Illumina", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/icahn-wins-one-board-seat-illumina-2023-05-25/", "time_published": "20230525T175900", "authors": ["Reuters"], "summary": "Icahn wins one board seat at ...", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/2NJNCPNURVNEJDGYDRK7KT5M4M.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.026044, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.699089", "ticker_sentiment_score": "0.053278", "ticker_sentiment_label": "Neutral"}]}, {"title": "Icahn Nominee Elected to Illumina's Board", "url": "https://www.wsj.com/articles/icahn-nominee-elected-to-illuminas-board-6bcee863", "time_published": "20230525T174500", "authors": ["Peter Loftus"], "summary": "Shareholders selected one of the activist investor's picks, who will replace on the board a director who had served as Illumina's chairman.", "banner_image": "https://images.wsj.net/im-788928?width=700&height=468", "source": "Wall Street Journal", "category_within_source": "Business", "source_domain": "www.wsj.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.02498, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.716023", "ticker_sentiment_score": "-0.039747", "ticker_sentiment_label": "Neutral"}]}, {"title": "Check Out What Whales Are Doing With ILMN - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/markets/options/23/05/32581126/check-out-what-whales-are-doing-with-ilmn", "time_published": "20230525T173316", "authors": ["Benzinga Insights"], "summary": "Someone with a lot of money to spend has taken a bullish stance on Illumina ILMN. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.186738, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.813694", "ticker_sentiment_score": "0.316097", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina shareholders vote to install Carl Icahn board nominee, oust chair", "url": "https://www.cnbc.com/2023/05/25/illumina-installs-carl-icahn-board-nominee-ousts-chair-.html", "time_published": "20230525T172144", "authors": ["Annika Kim Constantino"], "summary": "Carl Icahn has accused Illumina's management and board of poor oversight, particularly with regard to the company's acquisition of cancer test maker Grail.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107164604-1670850801645-gettyimages-1240065665-RIVIAN_AUTOMOTIVE.jpeg?v=1684944598", "source": "CNBC", "category_within_source": "Business", "source_domain": "www.cnbc.com", "topics": [{"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.091192, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.630923", "ticker_sentiment_score": "0.210501", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina shareholders vote chairman out", "url": "https://www.axios.com/2023/05/25/illumina-shareholders-vote-chairman-thompson-out", "time_published": "20230525T163311", "authors": ["https://www.axios.com/authors/mflaherty", "Michael Flaherty"], "summary": "Illumina investors voted chairman John Thompson off the board of directors on Thursday as Carl Icahn's months-long battle against the $32 billion gene-sequencing equipment maker crossed the finish line at the company's annual meeting.", "banner_image": "https://images.axios.com/bsIzFRtIkL2VnoXwVVsgu3j6BKE=/0x0:1920x1080/1920x1080/2023/05/24/1684966022567.jpg?w=1920", "source": "Axios", "category_within_source": "Markets", "source_domain": "www.axios.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.111969, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.091509", "ticker_sentiment_score": "0.034522", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.509589", "ticker_sentiment_score": "0.162863", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Top Stories Thursday, May 25: Bill Ackman Thinks Rival Icahn's Firm Still Overvalued, Nvidia Nears $1 Trillion Market Cap, Freshpet's Largest Shareholder Pushes For Board Overhaul - NVIDIA  ( NASDAQ:NVDA ) ", "url": "https://www.benzinga.com/news/earnings/23/05/32573579/bill-ackman-thinks-rival-icahns-firm-still-overvalued-nvidia-nears-1-trillion-market-cap-freshpets-", "time_published": "20230525T132650", "authors": ["Vandana Singh"], "summary": "Pershing Square Capital Management founder and CEO Bill Ackman weighed in on billionaire Carl Icahn and his company following the release of a short report by Hindenburg Research. Ackman commented that there were some interesting takeaways from the unfolding situation.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/05/25/carl_icahn_-_photo_by_insider_monkey_via_flickr_creative_commons_0.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.94762"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.161315, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.114318", "ticker_sentiment_score": "0.124476", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.114318", "ticker_sentiment_score": "0.160313", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AAPL", "relevance_score": "0.114318", "ticker_sentiment_score": "0.013997", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVX", "relevance_score": "0.076358", "ticker_sentiment_score": "0.237547", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DLTR", "relevance_score": "0.114318", "ticker_sentiment_score": "-0.012573", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.076358", "ticker_sentiment_score": "0.325541", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GRAB", "relevance_score": "0.076358", "ticker_sentiment_score": "0.100305", "ticker_sentiment_label": "Neutral"}, {"ticker": "EADSF", "relevance_score": "0.114318", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRPT", "relevance_score": "0.076358", "ticker_sentiment_score": "-0.159047", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SFTBF", "relevance_score": "0.076358", "ticker_sentiment_score": "0.1052", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVL", "relevance_score": "0.114318", "ticker_sentiment_score": "0.064835", "ticker_sentiment_label": "Neutral"}, {"ticker": "KCGI", "relevance_score": "0.076358", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.114318", "ticker_sentiment_score": "-0.020289", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.076358", "ticker_sentiment_score": "0.060618", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLTR", "relevance_score": "0.076358", "ticker_sentiment_score": "0.114333", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSHZF", "relevance_score": "0.038223", "ticker_sentiment_score": "0.063348", "ticker_sentiment_label": "Neutral"}]}, {"title": "Is Illumina Stock A Better Pick Over TMO?", "url": "https://www.forbes.com/sites/greatspeculations/2023/05/25/is-illumina-stock-a-better-pick-over-tmo/", "time_published": "20230525T130035", "authors": ["Trefis Team"], "summary": "ILMN trades at a higher valuation of 7.3x trailing revenues, compared to 4.6x for TMO, partly due to its financial position.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/646ef2f45456a7bf7e03a6f8/0x0.jpg?format=jpg&width=1200", "source": "Forbes", "category_within_source": "Markets", "source_domain": "www.forbes.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}], "overall_sentiment_score": 0.234903, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.754242", "ticker_sentiment_score": "0.375687", "ticker_sentiment_label": "Bullish"}, {"ticker": "TMO", "relevance_score": "0.673971", "ticker_sentiment_score": "0.368379", "ticker_sentiment_label": "Bullish"}]}, {"title": "Why activist investors are going to have a busy year", "url": "https://www.economist.com/business/2023/05/25/why-activist-investors-are-going-to-have-a-busy-year", "time_published": "20230525T125902", "authors": [], "summary": "If you think they have gone soft, think again ...", "banner_image": "https://www.economist.com/img/b/1424/1873/90/media-assets/image/20230527_DE_US.jpg", "source": "The Economist", "category_within_source": "Business", "source_domain": "www.economist.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}], "overall_sentiment_score": 0.040955, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SHAK", "relevance_score": "0.036255", "ticker_sentiment_score": "0.068938", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.072435", "ticker_sentiment_score": "0.056485", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOTMF", "relevance_score": "0.036255", "ticker_sentiment_score": "0.044102", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSHZF", "relevance_score": "0.036255", "ticker_sentiment_score": "0.05203", "ticker_sentiment_label": "Neutral"}]}, {"title": "Carl Icahn's Power Play at Illumina: Potential Board Changes and Management Overhaul - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/large-cap/23/05/32570426/carl-icahns-power-play-at-illumina-potential-board-changes-and-management-overhaul", "time_published": "20230525T121913", "authors": ["Vandana Singh"], "summary": "According to undisclosed sources, activist investor Carl Icahn is poised to secure enough shareholder support to place Andrew Teno, an Icahn nominee, to join the board of Illumina Inc ILMN.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/05/25/carl_icahn_-_photo_by_insider_monkey_via_flickr_creative_commons.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.139123, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.699089", "ticker_sentiment_score": "0.171962", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Carl Icahn's Battle with Illumina Comes to a Head", "url": "https://www.nytimes.com/2023/05/25/business/icahn-illumina-shareholder-vote.html", "time_published": "20230525T114515", "authors": [], "summary": "Carl Icahn's Proxy Fight With Illumina Comes to a Vote The New York Times ...", "banner_image": "https://static01.nyt.com/images/2023/05/25/multimedia/25db-icahn-bfqc/25db-icahn-bfqc-articleLarge.jpg?quality=75&auto=webp&disable=upscale", "source": "New York Times", "category_within_source": "GoogleRSS", "source_domain": "www.nytimes.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": -0.031652, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.020456", "ticker_sentiment_score": "-0.202817", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GOOG", "relevance_score": "0.020456", "ticker_sentiment_score": "0.245102", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NVDA", "relevance_score": "0.020456", "ticker_sentiment_score": "0.099528", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.020456", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.020456", "ticker_sentiment_score": "0.102178", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.081691", "ticker_sentiment_score": "-0.015585", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.102013", "ticker_sentiment_score": "-0.153065", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GS", "relevance_score": "0.020456", "ticker_sentiment_score": "0.102178", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSM", "relevance_score": "0.020456", "ticker_sentiment_score": "0.109413", "ticker_sentiment_label": "Neutral"}]}, {"title": "Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF  ( RYH ) ?", "url": "https://www.zacks.com/stock/news/2099430/should-you-invest-in-the-invesco-sp-500-equal-weight-health-care-etf-ryh", "time_published": "20230525T102006", "authors": ["Zacks Investment Research"], "summary": "Sector ETF report for ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default84.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}], "overall_sentiment_score": 0.246345, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PODD", "relevance_score": "0.130217", "ticker_sentiment_score": "0.070327", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.256989", "ticker_sentiment_score": "0.173379", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MRNA", "relevance_score": "0.130217", "ticker_sentiment_score": "0.070327", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.130217", "ticker_sentiment_score": "0.070327", "ticker_sentiment_label": "Neutral"}]}, {"title": "Exclusive: Icahn poised to win at least one seat on Illumina's board -sources", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/icahn-poised-win-least-one-seat-illuminas-board-sources-2023-05-25/", "time_published": "20230525T005800", "authors": ["Svea Herbst-Bayliss", "Greg Roumeliotis"], "summary": "Exclusive: Icahn poised to win at least one seat on Illumina's board ... ...", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/PRTNSJIJEJOAZJ4P4MJ4L3ZK4Y.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.305168, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.672055", "ticker_sentiment_score": "0.378102", "ticker_sentiment_label": "Bullish"}]}, {"title": "Is Invesco S&P 500 Equal Weight Health Care ETF  ( RYH )  a Strong ETF Right Now?", "url": "https://www.zacks.com/stock/news/2098841/is-invesco-sp-500-equal-weight-health-care-etf-ryh-a-strong-etf-right-now", "time_published": "20230524T102006", "authors": ["Zacks Investment Research"], "summary": "Smart Beta ETF report for ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default26.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999953"}], "overall_sentiment_score": 0.330425, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PODD", "relevance_score": "0.118064", "ticker_sentiment_score": "0.067312", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.233556", "ticker_sentiment_score": "0.275816", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MRNA", "relevance_score": "0.118064", "ticker_sentiment_score": "0.067312", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.118064", "ticker_sentiment_score": "0.067312", "ticker_sentiment_label": "Neutral"}]}, {"title": "Carl Icahn's wealth has plunged by $15 billion since a short-seller targeted him - but the activist investor says he's ready to fight back", "url": "https://markets.businessinsider.com/news/stocks/carl-icahn-wealth-net-worth-billionaire-investor-short-seller-hindenburg-2023-5", "time_published": "20230523T102300", "authors": ["George Glover"], "summary": "Carl Icahn Fights Back After Hindenburg Report Cuts Wealth by $15 ... - Markets Insider ...", "banner_image": "https://i.insider.com/646c8a22fee1b300197a5aea?width=1200&format=jpeg", "source": "Business Insider", "category_within_source": "GoogleRSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.01684, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.102449", "ticker_sentiment_score": "-0.107024", "ticker_sentiment_label": "Neutral"}]}, {"title": "$100 Invested In This Stock 15 Years Ago Would Be Worth $500 Today - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/earnings/23/05/32511375/100-invested-in-this-stock-15-years-ago-would-be-worth-500-today", "time_published": "20230522T153026", "authors": ["Benzinga Insights"], "summary": "Illumina ILMN has outperformed the market over the past 15 years by 4.29% on an annualized basis producing an average annual return of 11.95%. Currently, Illumina has a market capitalization of $32.86 billion.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.983605", "ticker_sentiment_score": "0.387251", "ticker_sentiment_label": "Bullish"}]}, {"title": "Icahn's fight with Illumina heads to high-stakes vote", "url": "https://www.axios.com/2023/05/22/illumina-icahn-ote", "time_published": "20230522T095930", "authors": ["Michael Flaherty", "https://www.axios.com/authors/mflaherty"], "summary": "Icahn's Illumina fight heads to high-stakes vote ...", "banner_image": "https://images.axios.com/3fFE4OvPl2YETkTUxYmeltffZvA=/0x0:4000x2250/1920x1080/2023/05/21/1684672378269.jpg?w=1920", "source": "Axios", "category_within_source": "Markets", "source_domain": "www.axios.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.028564, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.101797", "ticker_sentiment_score": "0.075027", "ticker_sentiment_label": "Neutral"}, {"ticker": "GETY", "relevance_score": "0.051003", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.250902", "ticker_sentiment_score": "-0.075348", "ticker_sentiment_label": "Neutral"}]}, {"title": "Icahn Is No Saint, but Illumina Can Still Use a Flawed Savior", "url": "https://www.wsj.com/articles/icahn-is-no-saint-but-illumina-can-still-use-a-flawed-savior-2cf81bac", "time_published": "20230520T140000", "authors": ["David Wainer"], "summary": "Despite a short seller's accusations that his company has inflated its asset prices, Carl Icahn's effort to shake up Illumina's board is still very much in the interest of shareholders.", "banner_image": "https://images.wsj.net/im-784530?width=700&height=466", "source": "Wall Street Journal", "category_within_source": "Markets", "source_domain": "www.wsj.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.431768, "overall_sentiment_label": "Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.535653", "ticker_sentiment_score": "-0.589431", "ticker_sentiment_label": "Bearish"}]}, {"title": "A Wounded Carl Icahn Makes His Play at a Struggling Illumina", "url": "https://www.barrons.com/articles/a-wounded-carl-icahn-makes-his-play-at-a-struggling-illumina-fab6a51f", "time_published": "20230519T231700", "authors": ["Josh Nathan-Kazis"], "summary": "A Wounded Carl Icahn Makes His Play at a Struggling ...", "banner_image": "https://images.barrons.com/im-784835?width=620&height=413", "source": "Barrons", "category_within_source": "n/a", "source_domain": "www.barrons.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.222742, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.817578", "ticker_sentiment_score": "-0.366932", "ticker_sentiment_label": "Bearish"}]}, {"title": "Illumina Unusual Options Activity - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/markets/options/23/05/32474450/illumina-unusual-options-activity", "time_published": "20230518T191709", "authors": ["Benzinga Insights"], "summary": "A whale with a lot of money to spend has taken a noticeably bearish stance on Illumina. Looking at options history for Illumina ILMN we detected 15 strange trades. If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.143804, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.838176", "ticker_sentiment_score": "0.109356", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Board Chair issues letter to shareholders and urges shareholders to vote the WHITE proxy card FOR all nine of Illumina's nominees", "url": "https://www.prnewswire.com/news-releases/illumina-board-chair-issues-letter-to-shareholders-and-urges-shareholders-to-vote-the-white-proxy-card-for-all-nine-of-illuminas-nominees-301828702.html", "time_published": "20230518T145100", "authors": ["Inc.", "Illumina"], "summary": "Illumina Board Chair issues letter to shareholders and urges ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1876671/Illumina_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.980922"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.905476"}], "overall_sentiment_score": 0.171274, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.417086", "ticker_sentiment_score": "0.178195", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina Board Chair issues letter to shareholders and urges shareholders to vote the WHITE proxy card FOR all nine of Illumina's nominees - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/05/n32468373/illumina-board-chair-issues-letter-to-shareholders-and-urges-shareholders-to-vote-the-white-proxy-", "time_published": "20230518T145100", "authors": ["PRNewswire"], "summary": "Board Chair John Thompson issues letter to Illumina shareholders ahead of the company's Annual Meeting on May 25, 2023, at 10:00 am Pacific Time ( 1:00 pm Eastern Time ) Illumina requests shareholders to vote the WHITE proxy card today FOR all nine of Illumina's director nominees", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.980922"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.94762"}], "overall_sentiment_score": 0.168942, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.4142", "ticker_sentiment_score": "0.177355", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Here's Why You Should Retain Myriad Genetics  ( MYGN )  Stock Now", "url": "https://www.zacks.com/stock/news/2096913/heres-why-you-should-retain-myriad-genetics-mygn-stock-now", "time_published": "20230518T142100", "authors": ["Zacks Investment Research"], "summary": "Myriad Genetics (MYGN) is likely to benefit from testing volumes across product segments and the latest partnerships, reflecting a positive share price movement.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default20.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.9545"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.230784, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PEN", "relevance_score": "0.187827", "ticker_sentiment_score": "0.066198", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZBH", "relevance_score": "0.187827", "ticker_sentiment_score": "0.091677", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOLX", "relevance_score": "0.187827", "ticker_sentiment_score": "0.101692", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.047371", "ticker_sentiment_score": "0.069", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.56005", "ticker_sentiment_score": "0.457252", "ticker_sentiment_label": "Bullish"}]}, {"title": "Illumina  ( ILMN )  Progresses in Pathogen Genomic Technologies", "url": "https://www.zacks.com/stock/news/2096905/illumina-ilmn-progresses-in-pathogen-genomic-technologies", "time_published": "20230518T141600", "authors": ["Zacks Investment Research"], "summary": "Illumina's (ILMN) genomic surveillance solutions enable better pathogen preparedness and response.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default37.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.980509"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.194029, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PEN", "relevance_score": "0.187221", "ticker_sentiment_score": "0.063126", "ticker_sentiment_label": "Neutral"}, {"ticker": "STIM", "relevance_score": "0.306963", "ticker_sentiment_score": "0.186258", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LNTH", "relevance_score": "0.247838", "ticker_sentiment_score": "0.124917", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.472338", "ticker_sentiment_score": "0.331031", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Is The FBI Sourcing Enzymes From Patagonia For Drug Detection?", "url": "https://www.forbes.com/sites/johncumbers/2023/05/17/why-is-the-fbi-sourcing-enzymes-from-patagonia-for-drug-detection/", "time_published": "20230517T154021", "authors": ["John Cumbers"], "summary": "Why is the FBI sourcing enzymes for drug detection from Patagonia? The answer lies in an unconventional start-up that's blazing a new trail for biotech.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/6464f37e0ac50f72aa7a7422/0x0.jpg?format=jpg&width=1200", "source": "Forbes", "category_within_source": "Business", "source_domain": "www.forbes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.194313, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.0312", "ticker_sentiment_score": "0.206608", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Carl Icahn Buys The Dip Amidst Hindenburg's Short Report - Icahn Enterprises  ( NASDAQ:IEP ) , Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/23/05/32430799/carl-icahn-buys-the-dip-amidst-hindenburgs-short-report", "time_published": "20230516T183229", "authors": ["AJ Fabino"], "summary": "Billionaire activist investor Carl Icahn faced a steep challenge recently as his conglomerate, Icahn Enterprises L.P. IEP, was the subject of a short report issued by well-known short seller Hindenburg Research.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/CarlIcahn.InsiderMonkey.Flickr.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.060082, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.325208", "ticker_sentiment_score": "0.399605", "ticker_sentiment_label": "Bullish"}]}, {"title": "Illumina's Debt Overview - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/23/05/32429814/illuminas-debt-overview", "time_published": "20230516T180144", "authors": ["Benzinga Insights"], "summary": "Over the past three months, shares of Illumina Inc. ILMN fell by 5.05%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": -0.108799, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.28442", "ticker_sentiment_score": "-0.112064", "ticker_sentiment_label": "Neutral"}]}, {"title": "China International Medical Equipment Fair 2023 Held in Shanghai in May, Showcasing Cutting-Edge Healthcare Technologies", "url": "https://markets.businessinsider.com/news/stocks/china-international-medical-equipment-fair-2023-held-in-shanghai-in-may-showcasing-cutting-edge-healthcare-technologies-1032327834", "time_published": "20230515T142700", "authors": [], "summary": "SHANGHAI, May 15, 2023 /PRNewswire/ -- The 87th edition of the China International Medical Equipment Fair ( CMEF ) has opened its door to the world in Shanghai.", "banner_image": "https://mma.prnewswire.com/media/2076887/image_1.jpg", "source": "Business Insider", "category_within_source": "RSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Earnings", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.293315, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.07423", "ticker_sentiment_score": "0.066876", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHTDF", "relevance_score": "0.07423", "ticker_sentiment_score": "0.133259", "ticker_sentiment_label": "Neutral"}, {"ticker": "SZIHF", "relevance_score": "0.07423", "ticker_sentiment_score": "0.176859", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina sends letter to shareholders detailing why Illumina's nominees far outmatch Icahn's slate in skills and experience", "url": "https://www.prnewswire.com/news-releases/illumina-sends-letter-to-shareholders-detailing-why-illuminas-nominees-far-outmatch-icahns-slate-in-skills-and-experience-301824235.html", "time_published": "20230515T113000", "authors": ["Inc.", "Illumina"], "summary": "Illumina sends letter to shareholders detailing why Illumina's ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1876671/Illumina_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.99793"}, {"topic": "Earnings", "relevance_score": "0.955357"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.148707, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.053599", "ticker_sentiment_score": "0.090716", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCYT", "relevance_score": "0.013409", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FATE", "relevance_score": "0.013409", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.409295", "ticker_sentiment_score": "0.219232", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina sends letter to shareholders detailing why Illumina's nominees far outmatch Icahn's slate in skills and experience - Icahn Enterprises  ( NASDAQ:IEP ) , Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/05/n32389245/illumina-sends-letter-to-shareholders-detailing-why-illuminas-nominees-far-outmatch-icahns-slate-i", "time_published": "20230515T113000", "authors": ["PRNewswire"], "summary": "Illumina's director nominees bring deep commercial, scientific and business experience from leading organizations including Microsoft, Symantec, and Medco-UBC Leading proxy advisory firm ISS has recommended Illumina shareholders vote FOR Illumina CEO Francis deSouza and Board member Robert Epstein", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999186"}, {"topic": "Earnings", "relevance_score": "0.955357"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.148702, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.05339", "ticker_sentiment_score": "0.090697", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCYT", "relevance_score": "0.013357", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FATE", "relevance_score": "0.013357", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.407844", "ticker_sentiment_score": "0.218711", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "'Biotech is the ultimate impact investment' - family offices can't get enough of it", "url": "https://www.ft.com/content/20d69b46-11fd-4904-8d6c-86927a3f4cd5", "time_published": "20230515T040003", "authors": [], "summary": "Strong personal interest in healthcare among reasons for increase in flow of family office money into venture capital ...", "banner_image": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F2330800a-6e2e-4aca-bded-34721fc15526.jpg?dpr=1&fit=scale-down&quality=highest&source=next&width=700", "source": "Financial Times", "category_within_source": "Companies", "source_domain": "www.ft.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.132625, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.017269", "ticker_sentiment_score": "-0.053337", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYPL", "relevance_score": "0.017269", "ticker_sentiment_score": "-0.053337", "ticker_sentiment_label": "Neutral"}, {"ticker": "IOVA", "relevance_score": "0.017269", "ticker_sentiment_score": "-0.022054", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.017269", "ticker_sentiment_score": "0.004301", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.017269", "ticker_sentiment_score": "0.067736", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTX", "relevance_score": "0.051774", "ticker_sentiment_score": "0.114497", "ticker_sentiment_label": "Neutral"}]}, {"title": "Leading Proxy Advisory Firm ISS Recommends Illumina Shareholders Vote \"FOR\" Eight of Illumina's Highly Qualified Director Nominees", "url": "https://www.prnewswire.com/news-releases/leading-proxy-advisory-firm-iss-recommends-illumina-shareholders-vote-for-eight-of-illuminas-highly-qualified-director-nominees-301823819.html", "time_published": "20230512T231200", "authors": ["Inc.", "Illumina"], "summary": "Leading Proxy Advisory Firm ISS Recommends Illumina ... PR ...", "banner_image": "", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.224658, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.040484", "ticker_sentiment_score": "0.167298", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.611832", "ticker_sentiment_score": "0.405554", "ticker_sentiment_label": "Bullish"}]}, {"title": "Leading Proxy Advisory Firm ISS Recommends Illumina Shareholders Vote \"FOR\" Eight of Illumina's Highly Qualified Director Nominees - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/05/n32376410/leading-proxy-advisory-firm-iss-recommends-illumina-shareholders-vote-for-eight-of-illuminas-highl", "time_published": "20230512T231200", "authors": ["PRNewswire"], "summary": "SAN DIEGO, May 12, 2023 /PRNewswire/ -- Illumina ILMN, a global leader in DNA sequencing and array-based technologies, today announced that Institutional Shareholder Services ( \"ISS\" ) , a leading independent proxy voting and corporate governance advisory firm, recommends Illumina shareholders ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.222376, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.039944", "ticker_sentiment_score": "0.167067", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.605463", "ticker_sentiment_score": "0.403584", "ticker_sentiment_label": "Bullish"}]}, {"title": "Peering Into Illumina's Recent Short Interest - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/short-sellers/23/05/32370473/peering-into-illuminas-recent-short-interest", "time_published": "20230512T181529", "authors": ["Benzinga Insights"], "summary": "Illumina's ILMN short percent of float has risen 3.16% since its last report. The company recently reported that it has 4.60 million shares sold short, which is 3.26% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.8 days to cover their ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.267375, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.224903", "ticker_sentiment_score": "0.158881", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Jim Cramer's top 10 things to watch in the stock market Friday", "url": "https://www.cnbc.com/2023/05/12/jim-cramers-top-10-things-to-watch-in-the-stock-market-friday.html", "time_published": "20230512T131510", "authors": ["Jim Cramer"], "summary": "Wolfe downgrades Club name Disney (DIS) to peer perform from outperform (hold from buy) without a price target.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107162851-1670440405736-gettyimages-1163406336-AFP_1JQ17S.jpeg?v=1683897310&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.972756"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}], "overall_sentiment_score": -0.050845, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "TGT", "relevance_score": "0.182047", "ticker_sentiment_score": "-0.111567", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.061159", "ticker_sentiment_score": "-0.06588", "ticker_sentiment_label": "Neutral"}, {"ticker": "COST", "relevance_score": "0.182047", "ticker_sentiment_score": "0.120042", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.121959", "ticker_sentiment_score": "-0.04193", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.121959", "ticker_sentiment_score": "0.034857", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTD", "relevance_score": "0.182047", "ticker_sentiment_score": "-0.102536", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.121959", "ticker_sentiment_score": "-0.067094", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.182047", "ticker_sentiment_score": "-0.021066", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.061159", "ticker_sentiment_score": "-0.043044", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.182047", "ticker_sentiment_score": "-0.010596", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMT", "relevance_score": "0.298749", "ticker_sentiment_score": "-0.093719", "ticker_sentiment_label": "Neutral"}]}, {"title": "How FTX Missed a Potentially Lucrative Opportunity", "url": "https://www.nytimes.com/2023/05/11/business/dealbook/ftx-sam-bankman-fried.html", "time_published": "20230511T121312", "authors": [], "summary": "Working through the bankruptcy of FTX, Sam Bankman-Fried's collapsed crypto exchange, is proving more complicated all the time. The latest evidence: a potentially lucrative missed opportunity that's come to light after FTX offloaded warrants to buy an obscure crypto token.", "banner_image": "https://static01.nyt.com/images/2023/05/11/multimedia/11db-sbf-kjwc/11db-sbf-kjwc-articleLarge.jpg?quality=75&auto=webp&disable=upscale", "source": "New York Times", "category_within_source": "GoogleRSS", "source_domain": "www.nytimes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}, {"topic": "Blockchain", "relevance_score": "0.451494"}], "overall_sentiment_score": -0.048647, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.023696", "ticker_sentiment_score": "-0.184918", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MSFT", "relevance_score": "0.023696", "ticker_sentiment_score": "0.051442", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.071005", "ticker_sentiment_score": "0.12125", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.023696", "ticker_sentiment_score": "0.094739", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.023696", "ticker_sentiment_score": "-0.001899", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFTBF", "relevance_score": "0.023696", "ticker_sentiment_score": "-0.115003", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.023696", "ticker_sentiment_score": "-0.002723", "ticker_sentiment_label": "Neutral"}]}, {"title": "Vertical Mergers Are in the Crosshairs after Microsoft's Activision Acquisition Was Blocked", "url": "https://www.barrons.com/articles/vertical-mergers-microsoft-activision-acquisition-blocked-regulation-26c83fe", "time_published": "20230511T080000", "authors": ["Sandeep Vaheesan"], "summary": "After Microsoft-Activision, Vertical Mergers Are in the Crosshairs ...", "banner_image": "https://images.barrons.com/im-779483?width=639&height=426", "source": "Barrons", "category_within_source": "n/a", "source_domain": "www.barrons.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.08396, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ATVI", "relevance_score": "0.291038", "ticker_sentiment_score": "0.070344", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.486365", "ticker_sentiment_score": "0.135375", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.037213", "ticker_sentiment_score": "-0.089552", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.037213", "ticker_sentiment_score": "-0.089552", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.037213", "ticker_sentiment_score": "-0.089552", "ticker_sentiment_label": "Neutral"}]}, {"title": "Glass Lewis backs Icahn's nominees for Illumina", "url": "https://www.reuters.com/business/glass-lewis-backs-icahns-nominees-illumina-2023-05-10/", "time_published": "20230510T153245", "authors": ["Reuters"], "summary": "Glass Lewis backs Icahn's nominees for ...", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/WZ5NP67GVBJXFJ4WZXXR7OPFHU.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.087775, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.850784", "ticker_sentiment_score": "0.123321", "ticker_sentiment_label": "Neutral"}]}, {"title": "Carl Icahn's company stock falls as much as 20% after prosecutors seek financial information", "url": "https://www.cnbc.com/2023/05/10/carl-icahns-company-stock-tumbles-after-prosecutors-seek-financial-information.html", "time_published": "20230510T144417", "authors": ["Yun Li"], "summary": "Regulators contacted Icahn Enterprises last Wednesday seeking information about corporate governance and other materials.", "banner_image": "https://image.cnbcfm.com/api/v1/image/103937625-20160913-9052-2268rr.jpg?v=1683729857&w=1920&h=1080", "source": "CNBC", "category_within_source": "Finance", "source_domain": "www.cnbc.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": 0.182947, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MDNDF", "relevance_score": "0.097457", "ticker_sentiment_score": "0.085029", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.097457", "ticker_sentiment_score": "0.085029", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Unusual Options Activity - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/markets/options/23/05/32317773/illumina-unusual-options-activity", "time_published": "20230510T141616", "authors": ["Benzinga Insights"], "summary": "Someone with a lot of money to spend has taken a bullish stance on Illumina ILMN. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.147287, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.873432", "ticker_sentiment_score": "0.388477", "ticker_sentiment_label": "Bullish"}]}, {"title": "16 top healthcare bankers and dealmakers reveal their predictions for the future of digital health", "url": "https://www.businessinsider.com/the-top-healthcare-bankers-and-dealmakers-future-of-digital-health-2023-5", "time_published": "20230510T100000", "authors": ["Blake Dodge", "Shelby Livingston", "Rebecca Torrence", "Yeji Jesse Lee"], "summary": "List: Top Healthcare Bankers, Dealmakers on Future of Digital Health - Business Insider ...", "banner_image": null, "source": "Business Insider", "category_within_source": "GoogleRSS", "source_domain": "www.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "IPO", "relevance_score": "0.769861"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.999976"}, {"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.996675"}], "overall_sentiment_score": 0.160265, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.013732", "ticker_sentiment_score": "0.102415", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVS", "relevance_score": "0.02746", "ticker_sentiment_score": "0.098793", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.02746", "ticker_sentiment_score": "0.045785", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.013732", "ticker_sentiment_score": "0.120845", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.013732", "ticker_sentiment_score": "0.007029", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.041181", "ticker_sentiment_score": "0.055288", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSCR", "relevance_score": "0.041181", "ticker_sentiment_score": "0.074944", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOCS", "relevance_score": "0.041181", "ticker_sentiment_score": "0.074944", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCORF", "relevance_score": "0.013732", "ticker_sentiment_score": "-0.006013", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEARQ", "relevance_score": "0.013732", "ticker_sentiment_score": "-0.00619", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCM", "relevance_score": "0.013732", "ticker_sentiment_score": "0.041644", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Unusual Options Activity - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/markets/options/23/05/32270643/illumina-unusual-options-activity", "time_published": "20230508T180059", "authors": ["Benzinga Insights"], "summary": "A whale with a lot of money to spend has taken a noticeably bullish stance on Illumina. Looking at options history for Illumina ILMN we detected 14 strange trades. If we consider the specifics of each trade, it is accurate to state that 64% of the investors opened trades with bullish ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.196359, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.836003", "ticker_sentiment_score": "0.279601", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina Sends Letter to Shareholders Highlighting Board Strength, Weakness of Icahn's \"Plan\"", "url": "https://www.prnewswire.com/news-releases/illumina-sends-letter-to-shareholders-highlighting-board-strength-weakness-of-icahns-plan-301817959.html", "time_published": "20230508T113000", "authors": ["Inc.", "Illumina"], "summary": "Illumina Sends Letter to Shareholders Highlighting Board Strength ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1876671/Illumina_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.918141"}, {"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.123982, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.016564", "ticker_sentiment_score": "0.049357", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.452877", "ticker_sentiment_score": "0.169536", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Better Gene Sequencing Stock: Illumina vs. Bionano Genomics", "url": "https://www.fool.com/investing/2023/05/06/better-gene-sequencing-stock-illumina-vs-bionano/", "time_published": "20230506T120000", "authors": ["Alex Carchidi"], "summary": "This is a classic matchup of a grizzled top dog against a scrappy competitor.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F729509%2Ftwo-scientists-work-at-lab-bench-with-scope.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.316726"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}], "overall_sentiment_score": 0.117926, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.580852", "ticker_sentiment_score": "0.144669", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNGO", "relevance_score": "0.085782", "ticker_sentiment_score": "0.02488", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Illumina Fell 11.6% in April", "url": "https://www.fool.com/investing/2023/05/06/why-illumina-fell-116-in-april/", "time_published": "20230506T112456", "authors": ["Royston Yang"], "summary": "The gene-sequencing company reported weaker results while the Federal Trade Commission has ordered it to divest its Grail acquisition.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F731339%2Fgenetic-sequencing.jpg&op=resize&w=700", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.05662, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SPGI", "relevance_score": "0.09439", "ticker_sentiment_score": "0.114283", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.714116", "ticker_sentiment_score": "0.07446", "ticker_sentiment_label": "Neutral"}]}, {"title": "BHP Group  ( NYSE:BHP )  Upgraded by StockNews.com to Strong-Buy", "url": "https://www.defenseworld.net/2023/05/04/bhp-group-nysebhp-upgraded-by-stocknews-com-to-strong-buy.html", "time_published": "20230504T102242", "authors": ["Defense World Staff"], "summary": "StockNews.com upgraded shares of BHP Group ( NYSE:BHP - Get Rating ) from a buy rating to a strong-buy rating in a research note released on Wednesday morning. BHP has been the topic of several other reports.", "banner_image": "https://www.marketbeat.com/logos/bhp-billiton-logo.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.503496"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.238947, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BCS", "relevance_score": "0.068896", "ticker_sentiment_score": "0.073351", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHP", "relevance_score": "0.91621", "ticker_sentiment_score": "0.40828", "ticker_sentiment_label": "Bullish"}, {"ticker": "C", "relevance_score": "0.068896", "ticker_sentiment_score": "0.073351", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.068896", "ticker_sentiment_score": "0.09673", "ticker_sentiment_label": "Neutral"}]}, {"title": "Black Stone Minerals  ( NYSE:BSM )  Downgraded by StockNews.com to Hold", "url": "https://www.defenseworld.net/2023/05/04/black-stone-minerals-nysebsm-downgraded-by-stocknews-com-to-hold.html", "time_published": "20230504T095243", "authors": ["Defense World Staff"], "summary": "Black Stone Minerals ( NYSE:BSM ) Downgraded by StockNews.com ... Defense World ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/black-stone-minerals-lp-logo.png?v=20221117145151&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999999"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Energy & Transportation", "relevance_score": "0.5"}], "overall_sentiment_score": 0.330262, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BSM", "relevance_score": "0.687757", "ticker_sentiment_score": "0.439449", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.050359", "ticker_sentiment_score": "0.134056", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.050359", "ticker_sentiment_score": "0.000994", "ticker_sentiment_label": "Neutral"}]}, {"title": "AGCO  ( NYSE:AGCO )  Downgraded to Buy at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/agco-nyseagco-downgraded-to-buy-at-stocknews-com.html", "time_published": "20230504T095242", "authors": ["Defense World Staff"], "summary": "StockNews.com lowered shares of AGCO ( NYSE:AGCO - Get Rating ) from a strong-buy rating to a buy rating in a research note issued to investors on Wednesday.", "banner_image": "https://www.marketbeat.com/logos/agco-co-logo.jpg?v=20221109143952", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.220782, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AGCO", "relevance_score": "0.864831", "ticker_sentiment_score": "0.384055", "ticker_sentiment_label": "Bullish"}, {"ticker": "GS", "relevance_score": "0.047654", "ticker_sentiment_score": "0.044552", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.047654", "ticker_sentiment_score": "0.068", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.047654", "ticker_sentiment_score": "0.044552", "ticker_sentiment_label": "Neutral"}]}, {"title": "City Office REIT  ( NYSE:CIO )  Upgraded by StockNews.com to Hold", "url": "https://www.defenseworld.net/2023/05/04/city-office-reit-nysecio-upgraded-by-stocknews-com-to-hold.html", "time_published": "20230504T095241", "authors": ["Defense World Staff"], "summary": "StockNews.com upgraded shares of City Office REIT ( NYSE:CIO - Get Rating ) from a sell rating to a hold rating in a research report report published on Wednesday morning. Separately, B.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/city-office-reit-inc-logo.jpg&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}], "overall_sentiment_score": 0.219597, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CIO", "relevance_score": "0.882924", "ticker_sentiment_score": "0.372961", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.089129", "ticker_sentiment_score": "0.113697", "ticker_sentiment_label": "Neutral"}]}, {"title": "Avista  ( NYSE:AVA )  Downgraded by StockNews.com to \"Sell\"", "url": "https://www.defenseworld.net/2023/05/04/avista-nyseava-downgraded-by-stocknews-com-to-sell.html", "time_published": "20230504T095241", "authors": ["Defense World Staff"], "summary": "StockNews.com lowered shares of Avista ( NYSE:AVA - Get Rating ) from a hold rating to a sell rating in a report issued on Wednesday. Several other equities research analysts have also recently weighed in on the stock.", "banner_image": "https://www.marketbeat.com/logos/avista-co-logo.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.623304"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.283501, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AVA", "relevance_score": "0.837665", "ticker_sentiment_score": "0.467342", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.065506", "ticker_sentiment_score": "0.101225", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRU", "relevance_score": "0.130571", "ticker_sentiment_score": "0.246951", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "The Cigna Group  ( NYSE:CI )  Downgraded by StockNews.com to \"Buy\"", "url": "https://www.defenseworld.net/2023/05/04/the-cigna-group-nyseci-downgraded-by-stocknews-com-to-buy.html", "time_published": "20230504T095241", "authors": ["Defense World Staff"], "summary": "StockNews.com lowered shares of The Cigna Group ( NYSE:CI - Get Rating ) from a strong-buy rating to a buy rating in a research report sent to investors on Wednesday morning.", "banner_image": "https://www.marketbeat.com/logos/cigna-co-logo.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.304102, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LNC", "relevance_score": "0.085324", "ticker_sentiment_score": "0.234095", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CI", "relevance_score": "0.801457", "ticker_sentiment_score": "0.487951", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.042723", "ticker_sentiment_score": "0.196785", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Ambev  ( NYSE:ABEV )  Upgraded to Strong-Buy by StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/ambev-nyseabev-upgraded-to-strong-buy-by-stocknews-com.html", "time_published": "20230504T094642", "authors": ["Defense World Staff"], "summary": "StockNews.com upgraded shares of Ambev ( NYSE:ABEV - Get Rating ) from a buy rating to a strong-buy rating in a research report report published on Wednesday morning. Separately, UBS Group upgraded shares of Ambev from a sell rating to a buy rating in a report on Thursday, January 12th.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/ambev-sa-(adr)-logo.png&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.286554, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABEV", "relevance_score": "0.887012", "ticker_sentiment_score": "0.476112", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.090134", "ticker_sentiment_score": "0.083466", "ticker_sentiment_label": "Neutral"}]}, {"title": "Franklin Street Properties  ( NYSEAMERICAN:FSP )  Downgraded to Sell at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/franklin-street-properties-nyseamericanfsp-downgraded-to-sell-at-stocknews-com.html", "time_published": "20230504T094441", "authors": ["Defense World Staff"], "summary": "Franklin Street Properties ( NYSEAMERICAN:FSP ) Downgraded to ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/franklin-street-properties-corp-logo.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.266143"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.302224, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BAC", "relevance_score": "0.101154", "ticker_sentiment_score": "0.204143", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.050679", "ticker_sentiment_score": "0.094014", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.101154", "ticker_sentiment_score": "0.204143", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Viavi Solutions  ( NASDAQ:VIAV )  Downgraded by StockNews.com to \"Hold\"", "url": "https://www.defenseworld.net/2023/05/04/viavi-solutions-nasdaqviav-downgraded-by-stocknews-com-to-hold.html", "time_published": "20230504T093246", "authors": ["Defense World Staff"], "summary": "Viavi Solutions ( NASDAQ:VIAV ) Downgraded by StockNews.com to ... Defense World ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/viavi-solutions-inc-logo.jpg&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999998"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.235269, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "VIAV", "relevance_score": "0.768826", "ticker_sentiment_score": "0.3799", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.053035", "ticker_sentiment_score": "0.111226", "ticker_sentiment_label": "Neutral"}]}, {"title": "NVR  ( NYSE:NVR )  Downgraded to \"Hold\" at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/nvr-nysenvr-downgraded-to-hold-at-stocknews-com.html", "time_published": "20230504T092249", "authors": ["Defense World Staff"], "summary": "StockNews.com lowered shares of NVR ( NYSE:NVR - Get Rating ) from a buy rating to a hold rating in a research report report published on Wednesday. Separately, KeyCorp upped their price target on shares of NVR from $5,120.00 to $6,000.00 and gave the stock an overweight rating in a research ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/nvr-inc-logo.png&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.999999"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.313532, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.056943", "ticker_sentiment_score": "0.055292", "ticker_sentiment_label": "Neutral"}, {"ticker": "KEY", "relevance_score": "0.056943", "ticker_sentiment_score": "-0.004", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVR", "relevance_score": "0.775361", "ticker_sentiment_score": "0.495517", "ticker_sentiment_label": "Bullish"}]}, {"title": "Olin  ( NYSE:OLN )  Downgraded to \"Hold\" at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/olin-nyseoln-downgraded-to-hold-at-stocknews-com.html", "time_published": "20230504T092249", "authors": ["Defense World Staff"], "summary": "StockNews.com cut shares of Olin ( NYSE:OLN - Get Rating ) from a buy rating to a hold rating in a research report released on Wednesday morning. Several other equities research analysts have also issued reports on the stock.", "banner_image": "https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&Symbol=OLN", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999999"}, {"topic": "Earnings", "relevance_score": "0.576289"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.242976, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "OLN", "relevance_score": "0.747616", "ticker_sentiment_score": "0.398336", "ticker_sentiment_label": "Bullish"}, {"ticker": "GS", "relevance_score": "0.048036", "ticker_sentiment_score": "0.059394", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.048036", "ticker_sentiment_score": "0.059394", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.048036", "ticker_sentiment_score": "0.034001", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.048036", "ticker_sentiment_score": "0.059394", "ticker_sentiment_label": "Neutral"}]}, {"title": "Kroger  ( NYSE:KR )  Downgraded to Buy at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/kroger-nysekr-downgraded-to-buy-at-stocknews-com.html", "time_published": "20230504T092249", "authors": ["Defense World Staff"], "summary": "StockNews.com cut shares of Kroger ( NYSE:KR - Get Rating ) from a strong-buy rating to a buy rating in a research report sent to investors on Wednesday. KR has been the subject of a number of other research reports.", "banner_image": "https://www.marketbeat.com/logos/the-kroger-co-logo.png?v=20221101143339", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.999999"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.290066, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "WFC", "relevance_score": "0.046907", "ticker_sentiment_score": "0.080101", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.046907", "ticker_sentiment_score": "0.112", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.046907", "ticker_sentiment_score": "0.080101", "ticker_sentiment_label": "Neutral"}, {"ticker": "KR", "relevance_score": "0.783279", "ticker_sentiment_score": "0.479619", "ticker_sentiment_label": "Bullish"}]}, {"title": "Varex Imaging  ( NASDAQ:VREX )  Upgraded by StockNews.com to \"Buy\"", "url": "https://www.defenseworld.net/2023/05/04/varex-imaging-nasdaqvrex-upgraded-by-stocknews-com-to-buy.html", "time_published": "20230504T090041", "authors": ["Defense World Staff"], "summary": "Varex Imaging ( NASDAQ:VREX ) Upgraded by StockNews.com to ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/varex-imaging-logo.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.994953"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.263402, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "C", "relevance_score": "0.148273", "ticker_sentiment_score": "0.261416", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ENV", "relevance_score": "0.148273", "ticker_sentiment_score": "0.261416", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.07446", "ticker_sentiment_score": "0.070094", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.148273", "ticker_sentiment_score": "0.261416", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VREX", "relevance_score": "0.839046", "ticker_sentiment_score": "0.434774", "ticker_sentiment_label": "Bullish"}]}, {"title": "Global Water Resources  ( NASDAQ:GWRS )  Upgraded to \"Buy\" at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/global-water-resources-nasdaqgwrs-upgraded-to-buy-at-stocknews-com.html", "time_published": "20230504T090041", "authors": ["Defense World Staff"], "summary": "Global Water Resources ( NASDAQ:GWRS ) Upgraded to \"Buy\" at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/global-water-resources-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}, {"topic": "Earnings", "relevance_score": "0.576289"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.243683, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GWRS", "relevance_score": "0.79006", "ticker_sentiment_score": "0.396658", "ticker_sentiment_label": "Bullish"}, {"ticker": "AWON", "relevance_score": "0.071357", "ticker_sentiment_score": "0.001007", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.142144", "ticker_sentiment_score": "0.174491", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MET", "relevance_score": "0.071357", "ticker_sentiment_score": "0.141284", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.071357", "ticker_sentiment_score": "0.067501", "ticker_sentiment_label": "Neutral"}]}, {"title": "Westamerica Bancorporation  ( NASDAQ:WABC )  Downgraded by StockNews.com to Sell", "url": "https://www.defenseworld.net/2023/05/04/westamerica-bancorporation-nasdaqwabc-downgraded-by-stocknews-com-to-sell.html", "time_published": "20230504T084854", "authors": ["Defense World Staff"], "summary": "Westamerica Bancorporation ( NASDAQ:WABC ) Downgraded by ... Defense World ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/westamerica-bancorporation-logo.png?v=20221129103848&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.158365, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.080458", "ticker_sentiment_score": "0.123396", "ticker_sentiment_label": "Neutral"}, {"ticker": "WABC", "relevance_score": "0.914052", "ticker_sentiment_score": "0.275838", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Southern Missouri Bancorp  ( NASDAQ:SMBC )  Downgraded to \"Sell\" at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/southern-missouri-bancorp-nasdaqsmbc-downgraded-to-sell-at-stocknews-com.html", "time_published": "20230504T084853", "authors": ["Defense World Staff"], "summary": "Southern Missouri Bancorp ( NASDAQ:SMBC ) Downgraded to \"Sell ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/southern-missouri-bancorp-inc-logo.png?v=20221212215608", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.32417, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LGGNF", "relevance_score": "0.092748", "ticker_sentiment_score": "0.270476", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SMBC", "relevance_score": "0.705612", "ticker_sentiment_score": "0.511351", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.046452", "ticker_sentiment_score": "0.094897", "ticker_sentiment_label": "Neutral"}]}, {"title": "Texas Roadhouse  ( NASDAQ:TXRH )  Downgraded to Hold at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/texas-roadhouse-nasdaqtxrh-downgraded-to-hold-at-stocknews-com.html", "time_published": "20230504T084853", "authors": ["Defense World Staff"], "summary": "Texas Roadhouse ( NASDAQ:TXRH ) Downgraded to Hold at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/texas-roadhouse-logo.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.82617"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.261978, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BCS", "relevance_score": "0.042122", "ticker_sentiment_score": "0.060279", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.042122", "ticker_sentiment_score": "0.060279", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBCPF", "relevance_score": "0.042122", "ticker_sentiment_score": "0.060279", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCTR", "relevance_score": "0.084127", "ticker_sentiment_score": "0.207538", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TXRH", "relevance_score": "0.830322", "ticker_sentiment_score": "0.43221", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.042122", "ticker_sentiment_score": "0.070651", "ticker_sentiment_label": "Neutral"}]}, {"title": "Resources Connection  ( NASDAQ:RGP )  Upgraded to Strong-Buy by StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/resources-connection-nasdaqrgp-upgraded-to-strong-buy-by-stocknews-com.html", "time_published": "20230504T084852", "authors": ["Defense World Staff"], "summary": "Resources Connection ( NASDAQ:RGP ) Upgraded to Strong-Buy by ... Defense World ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/resources-connection-inc-logo.png&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.288592, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "RGP", "relevance_score": "0.811513", "ticker_sentiment_score": "0.492354", "ticker_sentiment_label": "Bullish"}, {"ticker": "ALIZF", "relevance_score": "0.130571", "ticker_sentiment_score": "0.237713", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.065506", "ticker_sentiment_score": "0.110802", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.065506", "ticker_sentiment_score": "0.063066", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBS", "relevance_score": "0.130571", "ticker_sentiment_score": "0.237713", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Ross Stores  ( NASDAQ:ROST )  Upgraded by StockNews.com to Buy", "url": "https://www.defenseworld.net/2023/05/04/ross-stores-nasdaqrost-upgraded-by-stocknews-com-to-buy.html", "time_published": "20230504T084852", "authors": ["Defense World Staff"], "summary": "StockNews.com upgraded shares of Ross Stores ( NASDAQ:ROST - Get Rating ) from a hold rating to a buy rating in a report published on Wednesday morning. Other research analysts have also recently issued reports about the company. Robert W.", "banner_image": "https://www.marketbeat.com/logos/ross-stores-inc-logo.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.237909, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ROST", "relevance_score": "0.719858", "ticker_sentiment_score": "0.339776", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.047844", "ticker_sentiment_score": "0.00099", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.047844", "ticker_sentiment_score": "0.04154", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.047844", "ticker_sentiment_score": "0.04154", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.047844", "ticker_sentiment_score": "0.065998", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.047844", "ticker_sentiment_score": "0.04154", "ticker_sentiment_label": "Neutral"}]}, {"title": "P.A.M. Transportation Services  ( NASDAQ:PTSI )  Lowered to Hold at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/p-a-m-transportation-services-nasdaqptsi-lowered-to-hold-at-stocknews-com.html", "time_published": "20230504T084851", "authors": ["Defense World Staff"], "summary": "P.A.M. Transportation Services ( NASDAQ:PTSI ) Lowered to Hold at ... Defense World ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/pam-transportation-services-inc-logo.png?v=20221208152519&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}, {"topic": "Earnings", "relevance_score": "0.875462"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.256868, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.147818", "ticker_sentiment_score": "0.254613", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.07423", "ticker_sentiment_score": "0.067886", "ticker_sentiment_label": "Neutral"}]}, {"title": "Marriott International  ( NASDAQ:MAR )  Downgraded by StockNews.com to \"Hold\"", "url": "https://www.defenseworld.net/2023/05/04/marriott-international-nasdaqmar-downgraded-by-stocknews-com-to-hold.html", "time_published": "20230504T084851", "authors": ["Defense World Staff"], "summary": "Marriott International ( NASDAQ:MAR ) Downgraded by StockNews ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/marriott-international-inc-logo.png?v=20200227112206", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.803643"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.197612, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TFC", "relevance_score": "0.046907", "ticker_sentiment_score": "0.037507", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.046907", "ticker_sentiment_score": "0.000988", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.046907", "ticker_sentiment_score": "0.063983", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.046907", "ticker_sentiment_score": "0.037507", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAR", "relevance_score": "0.900454", "ticker_sentiment_score": "0.340747", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "The9  ( NASDAQ:NCTY )  Upgraded to Sell by StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/the9-nasdaqncty-upgraded-to-sell-by-stocknews-com.html", "time_published": "20230504T084851", "authors": ["Defense World Staff"], "summary": "StockNews.com upgraded shares of The9 ( NASDAQ:NCTY - Get Rating ) to a sell rating in a report published on Wednesday. Shares of NCTY stock opened at $0.80 on Wednesday. The stock's 50 day simple moving average is $0.90 and its 200 day simple moving average is $0.90.", "banner_image": "https://www.marketbeat.com/logos/the9-limited-logo.jpg?v=20230112154725", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Blockchain", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.36991, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "STT", "relevance_score": "0.204072", "ticker_sentiment_score": "0.342779", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ENV", "relevance_score": "0.204072", "ticker_sentiment_score": "0.342779", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.102888", "ticker_sentiment_score": "0.108752", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCTY", "relevance_score": "0.907244", "ticker_sentiment_score": "0.595695", "ticker_sentiment_label": "Bullish"}, {"ticker": "UBS", "relevance_score": "0.204072", "ticker_sentiment_score": "0.342779", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Gladstone Capital  ( NASDAQ:GLAD )  Downgraded by StockNews.com to Sell", "url": "https://www.defenseworld.net/2023/05/04/gladstone-capital-nasdaqglad-downgraded-by-stocknews-com-to-sell.html", "time_published": "20230504T084850", "authors": ["Defense World Staff"], "summary": "Gladstone Capital ( NASDAQ:GLAD ) Downgraded by StockNews ... Defense World ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/gladstone-capital-corp-logo.jpg&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.99793"}, {"topic": "Earnings", "relevance_score": "0.938238"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.263981, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GLAD", "relevance_score": "0.900063", "ticker_sentiment_score": "0.444493", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.077094", "ticker_sentiment_score": "0.141272", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.077094", "ticker_sentiment_score": "0.186098", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JPM", "relevance_score": "0.077094", "ticker_sentiment_score": "0.141272", "ticker_sentiment_label": "Neutral"}]}, {"title": "Commercial Vehicle Group  ( NASDAQ:CVGI )  Upgraded to Strong-Buy by StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/commercial-vehicle-group-nasdaqcvgi-upgraded-to-strong-buy-by-stocknews-com.html", "time_published": "20230504T084850", "authors": ["Defense World Staff"], "summary": "Commercial Vehicle Group ( NASDAQ:CVGI ) Upgraded to Strong ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/commercial-vehicle-group-inc-logo.png?v=20221216145034", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.980922"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.294842, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CVGI", "relevance_score": "0.810649", "ticker_sentiment_score": "0.467044", "ticker_sentiment_label": "Bullish"}, {"ticker": "AWON", "relevance_score": "0.074692", "ticker_sentiment_score": "0.001011", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNGPF", "relevance_score": "0.074692", "ticker_sentiment_score": "0.222687", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.074692", "ticker_sentiment_score": "0.069038", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.148731", "ticker_sentiment_score": "0.280801", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Incyte  ( NASDAQ:INCY )  Lowered to \"Buy\" at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/incyte-nasdaqincy-lowered-to-buy-at-stocknews-com.html", "time_published": "20230504T084850", "authors": ["Defense World Staff"], "summary": "StockNews.com lowered shares of Incyte ( NASDAQ:INCY - Get Rating ) from a strong-buy rating to a buy rating in a report published on Wednesday. INCY has been the subject of several other research reports. Mizuho lowered their target price on shares of Incyte from $95.00 to $82.00 in a research ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/incyte-co-logo.png?v=20221104071538&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}, {"topic": "Earnings", "relevance_score": "0.576289"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.239568, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "INCY", "relevance_score": "0.939207", "ticker_sentiment_score": "0.411673", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.071145", "ticker_sentiment_score": "0.059971", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.071145", "ticker_sentiment_score": "0.058422", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.071145", "ticker_sentiment_score": "0.058422", "ticker_sentiment_label": "Neutral"}]}, {"title": "Creative Media & Community Trust Co.  ( NASDAQ:CMCT )  Downgraded by StockNews.com to \"Sell\"", "url": "https://www.defenseworld.net/2023/05/04/creative-media-community-trust-co-nasdaqcmct-downgraded-by-stocknews-com-to-sell.html", "time_published": "20230504T084849", "authors": ["Defense World Staff"], "summary": "Creative Media & Community Trust Co. ( NASDAQ:CMCT ... Defense World ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/cim-commercial-trust-corp-logo.png&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.327756, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BK", "relevance_score": "0.142989", "ticker_sentiment_score": "0.244082", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "STT", "relevance_score": "0.142989", "ticker_sentiment_score": "0.244082", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CMCT", "relevance_score": "0.823417", "ticker_sentiment_score": "0.52423", "ticker_sentiment_label": "Bullish"}, {"ticker": "BX", "relevance_score": "0.071784", "ticker_sentiment_score": "0.197176", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.071784", "ticker_sentiment_score": "0.167776", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "BlackRock Capital Investment  ( NASDAQ:BKCC )  Upgraded by StockNews.com to Hold", "url": "https://www.defenseworld.net/2023/05/04/blackrock-capital-investment-nasdaqbkcc-upgraded-by-stocknews-com-to-hold.html", "time_published": "20230504T084846", "authors": ["Defense World Staff"], "summary": "BlackRock Capital Investment ( NASDAQ:BKCC ) Upgraded by ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/blackrock-capital-investment-co-logo.png?v=20221215085328", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.803643"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.214378"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.199356, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.824317", "ticker_sentiment_score": "0.332923", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WFC", "relevance_score": "0.082963", "ticker_sentiment_score": "-0.118615", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKCC", "relevance_score": "0.855251", "ticker_sentiment_score": "0.345063", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.082963", "ticker_sentiment_score": "0.088125", "ticker_sentiment_label": "Neutral"}, {"ticker": "RJF", "relevance_score": "0.082963", "ticker_sentiment_score": "0.146879", "ticker_sentiment_label": "Neutral"}]}, {"title": "Alliance Resource Partners  ( NASDAQ:ARLP )  Downgraded to \"Buy\" at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/alliance-resource-partners-nasdaqarlp-downgraded-to-buy-at-stocknews-com.html", "time_published": "20230504T084846", "authors": ["Defense World Staff"], "summary": "Alliance Resource Partners ( NASDAQ:ARLP ) Downgraded to \"Buy ... Defense World ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/alliance-resource-partners-lp-logo.png?v=20221122161039&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.999365"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.253632, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NRHI", "relevance_score": "0.053271", "ticker_sentiment_score": "-0.011032", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARLP", "relevance_score": "0.714949", "ticker_sentiment_score": "0.390873", "ticker_sentiment_label": "Bullish"}, {"ticker": "PNC", "relevance_score": "0.106305", "ticker_sentiment_score": "0.252423", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.053271", "ticker_sentiment_score": "-0.011032", "ticker_sentiment_label": "Neutral"}]}, {"title": "Zimmer Biomet  ( NYSE:ZBH )  Upgraded to Strong-Buy at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/zimmer-biomet-nysezbh-upgraded-to-strong-buy-at-stocknews-com.html", "time_published": "20230504T084846", "authors": ["Defense World Staff"], "summary": "Zimmer Biomet ( NYSE:ZBH ) Upgraded to Strong-Buy at StockNews ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/zimmer-biomet-holdings-inc-logo.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.803643"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.222652, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TFC", "relevance_score": "0.052801", "ticker_sentiment_score": "0.05073", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZBH", "relevance_score": "0.791709", "ticker_sentiment_score": "0.372543", "ticker_sentiment_label": "Bullish"}, {"ticker": "JEF", "relevance_score": "0.052801", "ticker_sentiment_score": "0.05073", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCTR", "relevance_score": "0.105372", "ticker_sentiment_score": "0.193598", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BAC", "relevance_score": "0.052801", "ticker_sentiment_score": "0.05073", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.052801", "ticker_sentiment_score": "0.045165", "ticker_sentiment_label": "Neutral"}]}, {"title": "Whitestone REIT  ( NYSE:WSR )  Downgraded to \"Hold\" at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/whitestone-reit-nysewsr-downgraded-to-hold-at-stocknews-com.html", "time_published": "20230504T084846", "authors": ["Defense World Staff"], "summary": "Whitestone REIT ( NYSE:WSR ) Downgraded to \"Hold\" at StockNews ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/whitestone-reit-logo.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}], "overall_sentiment_score": 0.191523, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.104228", "ticker_sentiment_score": "0.089704", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.104228", "ticker_sentiment_score": "0.00108", "ticker_sentiment_label": "Neutral"}, {"ticker": "WSR", "relevance_score": "0.850429", "ticker_sentiment_score": "0.280256", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Suburban Propane Partners  ( NYSE:SPH )  Downgraded to \"Hold\" at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/suburban-propane-partners-nysesph-downgraded-to-hold-at-stocknews-com.html", "time_published": "20230504T084845", "authors": ["Defense World Staff"], "summary": "Suburban Propane Partners ( NYSE:SPH ) Downgraded to \"Hold\" at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/suburban-propane-partners-lp-logo.jpg?v=20221205140612", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.296119, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SPH", "relevance_score": "0.771193", "ticker_sentiment_score": "0.504058", "ticker_sentiment_label": "Bullish"}, {"ticker": "PNC", "relevance_score": "0.136499", "ticker_sentiment_score": "0.247529", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FNLC", "relevance_score": "0.136499", "ticker_sentiment_score": "0.247529", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.068502", "ticker_sentiment_score": "0.117065", "ticker_sentiment_label": "Neutral"}]}, {"title": "Tenaris  ( NYSE:TS )  Upgraded to \"Strong-Buy\" at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/tenaris-nysets-upgraded-to-strong-buy-at-stocknews-com.html", "time_published": "20230504T084845", "authors": ["Defense World Staff"], "summary": "StockNews.com upgraded shares of Tenaris ( NYSE:TS - Get Rating ) from a buy rating to a strong-buy rating in a report released on Wednesday morning. Other equities research analysts have also recently issued research reports about the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/tenaris-logo.jpg&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.503496"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.294336, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BCS", "relevance_score": "0.127795", "ticker_sentiment_score": "0.269102", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.064104", "ticker_sentiment_score": "0.056459", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.064104", "ticker_sentiment_score": "0.059079", "ticker_sentiment_label": "Neutral"}, {"ticker": "TS", "relevance_score": "0.828466", "ticker_sentiment_score": "0.4788", "ticker_sentiment_label": "Bullish"}]}, {"title": "Eastman Chemical  ( NYSE:EMN )  Upgraded by StockNews.com to Buy", "url": "https://www.defenseworld.net/2023/05/04/eastman-chemical-nyseemn-upgraded-by-stocknews-com-to-buy.html", "time_published": "20230504T084845", "authors": ["Defense World Staff"], "summary": "StockNews.com upgraded shares of Eastman Chemical ( NYSE:EMN - Get Rating ) from a hold rating to a buy rating in a research note released on Wednesday morning. EMN has been the subject of several other reports.", "banner_image": "https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&Symbol=EMN", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.225079, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BCS", "relevance_score": "0.059488", "ticker_sentiment_score": "0.060011", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNS", "relevance_score": "0.059488", "ticker_sentiment_score": "0.060011", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.059488", "ticker_sentiment_score": "0.113588", "ticker_sentiment_label": "Neutral"}, {"ticker": "AROW", "relevance_score": "0.118647", "ticker_sentiment_score": "0.173827", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EMN", "relevance_score": "0.843783", "ticker_sentiment_score": "0.384373", "ticker_sentiment_label": "Bullish"}, {"ticker": "LCNB", "relevance_score": "0.118647", "ticker_sentiment_score": "0.173827", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KEY", "relevance_score": "0.059488", "ticker_sentiment_score": "0.060011", "ticker_sentiment_label": "Neutral"}]}, {"title": "Kite Realty Group Trust  ( NYSE:KRG )  Downgraded by StockNews.com to \"Sell\"", "url": "https://www.defenseworld.net/2023/05/04/kite-realty-group-trust-nysekrg-downgraded-by-stocknews-com-to-sell.html", "time_published": "20230504T084845", "authors": ["Defense World Staff"], "summary": "Kite Realty Group Trust ( NYSE:KRG ) Downgraded by StockNews ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/kite-realty-group-trust-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.265938, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "KRG", "relevance_score": "0.775361", "ticker_sentiment_score": "0.427092", "ticker_sentiment_label": "Bullish"}, {"ticker": "DSECF", "relevance_score": "0.113597", "ticker_sentiment_score": "0.224229", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MITSF", "relevance_score": "0.113597", "ticker_sentiment_score": "0.224229", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.056943", "ticker_sentiment_score": "0.121516", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.056943", "ticker_sentiment_score": "0.014996", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSUMF", "relevance_score": "0.113597", "ticker_sentiment_score": "0.224229", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Molson Coors Beverage  ( NYSE:TAP )  Upgraded by StockNews.com to \"Buy\"", "url": "https://www.defenseworld.net/2023/05/04/molson-coors-beverage-nysetap-upgraded-by-stocknews-com-to-buy.html", "time_published": "20230504T084845", "authors": ["Defense World Staff"], "summary": "Molson Coors Beverage ( NYSE:TAP ) Upgraded by StockNews.com ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/molson-coors-beverage-logo.png?v=20221108170750", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.658903"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.270613, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "STT", "relevance_score": "0.104455", "ticker_sentiment_score": "0.264307", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TAP", "relevance_score": "0.7877", "ticker_sentiment_score": "0.456766", "ticker_sentiment_label": "Bullish"}, {"ticker": "BCS", "relevance_score": "0.05234", "ticker_sentiment_score": "0.062656", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.05234", "ticker_sentiment_score": "0.062656", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.05234", "ticker_sentiment_score": "0.066006", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.05234", "ticker_sentiment_score": "0.062656", "ticker_sentiment_label": "Neutral"}]}, {"title": "Timken  ( NYSE:TKR )  Downgraded by StockNews.com to \"Buy\"", "url": "https://www.defenseworld.net/2023/05/04/timken-nysetkr-downgraded-by-stocknews-com-to-buy.html", "time_published": "20230504T084845", "authors": ["Defense World Staff"], "summary": "StockNews.com downgraded shares of Timken ( NYSE:TKR - Get Rating ) from a strong-buy rating to a buy rating in a report released on Wednesday morning.", "banner_image": "https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&Symbol=TKR", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.846708"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.248638, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "C", "relevance_score": "0.051221", "ticker_sentiment_score": "0.083644", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.051221", "ticker_sentiment_score": "0.083644", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.051221", "ticker_sentiment_score": "0.071054", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.051221", "ticker_sentiment_score": "0.083644", "ticker_sentiment_label": "Neutral"}, {"ticker": "JEF", "relevance_score": "0.051221", "ticker_sentiment_score": "0.083644", "ticker_sentiment_label": "Neutral"}, {"ticker": "TKR", "relevance_score": "0.777746", "ticker_sentiment_score": "0.403342", "ticker_sentiment_label": "Bullish"}, {"ticker": "MET", "relevance_score": "0.102231", "ticker_sentiment_score": "0.187866", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KEY", "relevance_score": "0.051221", "ticker_sentiment_score": "0.083644", "ticker_sentiment_label": "Neutral"}, {"ticker": "RJF", "relevance_score": "0.102231", "ticker_sentiment_score": "0.187866", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Piedmont Office Realty Trust  ( NYSE:PDM )  Downgraded by StockNews.com to Sell", "url": "https://www.defenseworld.net/2023/05/04/piedmont-office-realty-trust-nysepdm-downgraded-by-stocknews-com-to-sell.html", "time_published": "20230504T084844", "authors": ["Defense World Staff"], "summary": "Piedmont Office Realty Trust ( NYSE:PDM ) Downgraded by ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/piedmont-office-realty-trust-logo.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.999701"}, {"topic": "Earnings", "relevance_score": "0.891286"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.248524, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PDM", "relevance_score": "0.861522", "ticker_sentiment_score": "0.415302", "ticker_sentiment_label": "Bullish"}, {"ticker": "DSECF", "relevance_score": "0.146916", "ticker_sentiment_score": "0.282576", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VIRT", "relevance_score": "0.073773", "ticker_sentiment_score": "0.227536", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.073773", "ticker_sentiment_score": "0.069973", "ticker_sentiment_label": "Neutral"}]}, {"title": "Granite Construction  ( NYSE:GVA )  Lowered to \"Hold\" at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/granite-construction-nysegva-lowered-to-hold-at-stocknews-com.html", "time_published": "20230504T084844", "authors": ["Defense World Staff"], "summary": "Granite Construction ( NYSE:GVA ) Lowered to \"Hold\" at StockNews ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/granite-construction-incorporated-logo.png?v=20221129142856", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.503496"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.270086, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AWON", "relevance_score": "0.064449", "ticker_sentiment_score": "0.002003", "ticker_sentiment_label": "Neutral"}, {"ticker": "GVA", "relevance_score": "0.774846", "ticker_sentiment_score": "0.452841", "ticker_sentiment_label": "Bullish"}, {"ticker": "GS", "relevance_score": "0.064449", "ticker_sentiment_score": "0.088074", "ticker_sentiment_label": "Neutral"}, {"ticker": "MET", "relevance_score": "0.128478", "ticker_sentiment_score": "0.236594", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.064449", "ticker_sentiment_score": "0.049589", "ticker_sentiment_label": "Neutral"}]}, {"title": "USA Compression Partners  ( NYSE:USAC )  Upgraded to Buy by StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/usa-compression-partners-nyseusac-upgraded-to-buy-by-stocknews-com.html", "time_published": "20230504T084844", "authors": ["Defense World Staff"], "summary": "USA Compression Partners ( NYSE:USAC ) Upgraded to Buy by ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/usa-compression-partners-lp-logo.JPG", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.252703, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LPLA", "relevance_score": "0.124164", "ticker_sentiment_score": "0.224753", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.062271", "ticker_sentiment_score": "0.001001", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBCPF", "relevance_score": "0.062271", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.062271", "ticker_sentiment_score": "0.090459", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.062271", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "USAC", "relevance_score": "0.84035", "ticker_sentiment_score": "0.439334", "ticker_sentiment_label": "Bullish"}]}, {"title": "Sysco  ( NYSE:SYY )  Upgraded by StockNews.com to \"Strong-Buy\"", "url": "https://www.defenseworld.net/2023/05/04/sysco-nysesyy-upgraded-by-stocknews-com-to-strong-buy.html", "time_published": "20230504T084844", "authors": ["Defense World Staff"], "summary": "StockNews.com upgraded shares of Sysco ( NYSE:SYY - Get Rating ) from a buy rating to a strong-buy rating in a report issued on Wednesday morning. Other equities analysts have also recently issued research reports about the company. TheStreet upgraded Sysco from a c+ rating to a b rating in a ...", "banner_image": "https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&Symbol=SYY", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.658903"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.214558, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TFC", "relevance_score": "0.05749", "ticker_sentiment_score": "-0.006", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYY", "relevance_score": "0.805739", "ticker_sentiment_score": "0.369013", "ticker_sentiment_label": "Bullish"}, {"ticker": "BAC", "relevance_score": "0.05749", "ticker_sentiment_score": "-0.006", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSSMY", "relevance_score": "0.114682", "ticker_sentiment_score": "0.230814", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WFC", "relevance_score": "0.05749", "ticker_sentiment_score": "-0.006", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.05749", "ticker_sentiment_score": "0.052363", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.05749", "ticker_sentiment_score": "-0.006", "ticker_sentiment_label": "Neutral"}]}, {"title": "Curtiss-Wright  ( NYSE:CW )  Upgraded to Strong-Buy by StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/curtiss-wright-nysecw-upgraded-to-strong-buy-by-stocknews-com.html", "time_published": "20230504T084844", "authors": ["Defense World Staff"], "summary": "Curtiss-Wright ( NYSE:CW ) Upgraded to Strong-Buy by StockNews ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/curtiss-wright-co-logo.jpg?v=20221110160156", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.82617"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.234752, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TFC", "relevance_score": "0.053271", "ticker_sentiment_score": "0.0787", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.053271", "ticker_sentiment_score": "0.000998", "ticker_sentiment_label": "Neutral"}, {"ticker": "CW", "relevance_score": "0.795733", "ticker_sentiment_score": "0.391211", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.053271", "ticker_sentiment_score": "0.086349", "ticker_sentiment_label": "Neutral"}]}, {"title": "Transocean  ( NYSE:RIG )  Upgraded to Sell by StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/transocean-nyserig-upgraded-to-sell-by-stocknews-com.html", "time_published": "20230504T084844", "authors": ["Defense World Staff"], "summary": "StockNews.com upgraded shares of Transocean ( NYSE:RIG - Get Rating ) to a sell rating in a research report released on Wednesday morning. Several other research analysts also recently weighed in on the stock.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/transocean-logo.png&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.779048"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.301802, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.099476", "ticker_sentiment_score": "0.261417", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BK", "relevance_score": "0.099476", "ticker_sentiment_score": "0.261417", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RIG", "relevance_score": "0.76497", "ticker_sentiment_score": "0.477318", "ticker_sentiment_label": "Bullish"}, {"ticker": "AWON", "relevance_score": "0.049835", "ticker_sentiment_score": "0.000993", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.148731", "ticker_sentiment_score": "0.133889", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.049835", "ticker_sentiment_score": "0.058066", "ticker_sentiment_label": "Neutral"}]}, {"title": "Sonoco Products  ( NYSE:SON )  Upgraded to \"Buy\" by StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/sonoco-products-nyseson-upgraded-to-buy-by-stocknews-com.html", "time_published": "20230504T084844", "authors": ["Defense World Staff"], "summary": "StockNews.com upgraded shares of Sonoco Products ( NYSE:SON - Get Rating ) from a hold rating to a buy rating in a research note published on Wednesday morning. Several other equities research analysts also recently weighed in on the company.", "banner_image": "https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&Symbol=SON", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.803643"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.18597, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "C", "relevance_score": "0.046724", "ticker_sentiment_score": "-0.017657", "ticker_sentiment_label": "Neutral"}, {"ticker": "SON", "relevance_score": "0.758753", "ticker_sentiment_score": "0.300037", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BAC", "relevance_score": "0.046724", "ticker_sentiment_score": "-0.017657", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.046724", "ticker_sentiment_score": "0.074989", "ticker_sentiment_label": "Neutral"}]}, {"title": "Laboratory Co. of America  ( NYSE:LH )  Upgraded by StockNews.com to Buy", "url": "https://www.defenseworld.net/2023/05/04/laboratory-co-of-america-nyselh-upgraded-by-stocknews-com-to-buy.html", "time_published": "20230504T084844", "authors": ["Defense World Staff"], "summary": "Laboratory Co. of America ( NYSE:LH ) Upgraded by StockNews.com ... Defense World ...", "banner_image": "https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&Symbol=LH", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.263302, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TFC", "relevance_score": "0.040899", "ticker_sentiment_score": "0.021488", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHB", "relevance_score": "0.040899", "ticker_sentiment_score": "0.186812", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "C", "relevance_score": "0.040899", "ticker_sentiment_score": "0.021488", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.040899", "ticker_sentiment_score": "0.021488", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.040899", "ticker_sentiment_score": "0.185351", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MS", "relevance_score": "0.040899", "ticker_sentiment_score": "0.021488", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSECF", "relevance_score": "0.081691", "ticker_sentiment_score": "0.194742", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LH", "relevance_score": "0.162528", "ticker_sentiment_score": "0.09759", "ticker_sentiment_label": "Neutral"}]}, {"title": "McEwen Mining  ( NYSE:MUX )  Upgraded to \"Sell\" at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/mcewen-mining-nysemux-upgraded-to-sell-at-stocknews-com.html", "time_published": "20230504T084843", "authors": ["Defense World Staff"], "summary": "StockNews.com upgraded shares of McEwen Mining ( NYSE:MUX - Get Rating ) ( TSE:MUX ) to a sell rating in a report released on Wednesday. Separately, HC Wainwright boosted their target price on McEwen Mining from $10.25 to $10.75 and gave the stock a buy rating in a research report on ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/mcewen-mining-inc-logo.jpg&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.29247, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TD", "relevance_score": "0.197413", "ticker_sentiment_score": "0.293645", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MUX", "relevance_score": "0.919882", "ticker_sentiment_score": "0.489975", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.099476", "ticker_sentiment_score": "0.13715", "ticker_sentiment_label": "Neutral"}]}, {"title": "Franklin Street Properties  ( NYSE:FSP )  Rating Lowered to Sell at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/franklin-street-properties-nysefsp-rating-lowered-to-sell-at-stocknews-com.html", "time_published": "20230504T082841", "authors": ["Defense World Staff"], "summary": "Franklin Street Properties ( NYSE:FSP ) Rating Lowered to Sell at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/generic-stocks6.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.163857, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.186738", "ticker_sentiment_score": "0.058217", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Initiates Coverage on Value Line  ( NASDAQ:VALU ) ", "url": "https://www.defenseworld.net/2023/05/04/stocknews-com-initiates-coverage-on-value-line-nasdaqvalu-2.html", "time_published": "20230504T052043", "authors": ["Defense World Staff"], "summary": "Analysts at StockNews.com began coverage on shares of Value Line ( NASDAQ:VALU - Get Rating ) in a research report issued on Thursday. The brokerage set a \"hold\" rating on the financial services provider's stock. Shares of NASDAQ VALU opened at $45.55 on Thursday.", "banner_image": "https://www.marketbeat.com/logos/value-line-inc-logo.png?v=20221209132904", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}, {"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.329988, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BK", "relevance_score": "0.155954", "ticker_sentiment_score": "0.302705", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VALU", "relevance_score": "0.884459", "ticker_sentiment_score": "0.537956", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.078354", "ticker_sentiment_score": "0.108194", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBS", "relevance_score": "0.155954", "ticker_sentiment_score": "0.302705", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Medpace  ( NASDAQ:MEDP )  Stock Rating Lowered by StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/medpace-nasdaqmedp-stock-rating-lowered-by-stocknews-com.html", "time_published": "20230504T052043", "authors": ["Defense World Staff"], "summary": "Medpace ( NASDAQ:MEDP - Get Rating ) was downgraded by StockNews.com from a \"buy\" rating to a \"hold\" rating in a note issued to investors on Thursday. Separately, Robert W. Baird lifted their price objective on shares of Medpace from $226.00 to $233.00 and gave the stock a \"neutral\" rating in a ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/medpace-holdings-inc-logo.jpg&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}], "overall_sentiment_score": 0.270391, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MEDP", "relevance_score": "0.859898", "ticker_sentiment_score": "0.448367", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.078354", "ticker_sentiment_score": "0.092416", "ticker_sentiment_label": "Neutral"}]}, {"title": "Ceragon Networks  ( NASDAQ:CRNT )  Raised to \"Buy\" at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/ceragon-networks-nasdaqcrnt-raised-to-buy-at-stocknews-com.html", "time_published": "20230504T052042", "authors": ["Defense World Staff"], "summary": "Ceragon Networks ( NASDAQ:CRNT ) Raised to \"Buy\" at StockNews ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/ceragon-networks-ltd-logo.jpg?v=20221220145743", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.24489, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRNT", "relevance_score": "0.892945", "ticker_sentiment_score": "0.41363", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.098659", "ticker_sentiment_score": "0.126152", "ticker_sentiment_label": "Neutral"}]}, {"title": "United-Guardian  ( NASDAQ:UG )  Earns Buy Rating from Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/united-guardian-nasdaqug-earns-buy-rating-from-analysts-at-stocknews-com.html", "time_published": "20230504T052042", "authors": ["Defense World Staff"], "summary": "United-Guardian ( NASDAQ:UG ) Earns Buy Rating from Analysts at ... Defense World ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/united-guardian-inc-logo.png?v=20211203103746&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.331364, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.09402", "ticker_sentiment_score": "0.131555", "ticker_sentiment_label": "Neutral"}, {"ticker": "UG", "relevance_score": "0.90178", "ticker_sentiment_score": "0.543017", "ticker_sentiment_label": "Bullish"}, {"ticker": "UBS", "relevance_score": "0.186738", "ticker_sentiment_score": "0.303872", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Inogen  ( NASDAQ:INGN )  Rating Increased to Hold at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/inogen-nasdaqingn-rating-increased-to-hold-at-stocknews-com.html", "time_published": "20230504T052042", "authors": ["Defense World Staff"], "summary": "Inogen ( NASDAQ:INGN - Get Rating ) was upgraded by equities researchers at StockNews.com from a \"sell\" rating to a \"hold\" rating in a note issued to investors on Thursday. INGN has been the topic of a number of other reports.", "banner_image": "https://www.marketbeat.com/logos/inogen-inc-logo.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}], "overall_sentiment_score": 0.240111, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.074926", "ticker_sentiment_score": "0.036417", "ticker_sentiment_label": "Neutral"}, {"ticker": "INGN", "relevance_score": "0.961451", "ticker_sentiment_score": "0.414746", "ticker_sentiment_label": "Bullish"}]}, {"title": "ObsEva  ( NASDAQ:OBSV )  Receives New Coverage from Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/obseva-nasdaqobsv-receives-new-coverage-from-analysts-at-stocknews-com.html", "time_published": "20230504T052042", "authors": ["Defense World Staff"], "summary": "ObsEva ( NASDAQ:OBSV ) Receives New Coverage from Analysts at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/obseva-sa-logo.png?v=20230117114420", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.264931, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CS", "relevance_score": "0.199859", "ticker_sentiment_score": "0.289573", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OBSVF", "relevance_score": "0.8362", "ticker_sentiment_score": "0.435741", "ticker_sentiment_label": "Bullish"}, {"ticker": "BAC", "relevance_score": "0.199859", "ticker_sentiment_score": "0.289573", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.100729", "ticker_sentiment_score": "0.069719", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Upgrades Remark  ( NASDAQ:MARK )  to Sell", "url": "https://www.defenseworld.net/2023/05/04/stocknews-com-upgrades-remark-nasdaqmark-to-sell.html", "time_published": "20230504T052041", "authors": ["Defense World Staff"], "summary": "Remark ( NASDAQ:MARK - Get Rating ) was upgraded by equities researchers at StockNews.com to a \"sell\" rating in a note issued to investors on Thursday. NASDAQ MARK opened at $1.04 on Thursday. The company has a fifty day moving average of $1.19 and a two-hundred day moving average of $0.96.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/remark-holdings-inc-logo.jpg?v=20221222093948&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.317741, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "III", "relevance_score": "0.279015", "ticker_sentiment_score": "0.341765", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "STT", "relevance_score": "0.188193", "ticker_sentiment_score": "0.255447", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BAC", "relevance_score": "0.094762", "ticker_sentiment_score": "0.181205", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VIRT", "relevance_score": "0.094762", "ticker_sentiment_score": "0.181205", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.094762", "ticker_sentiment_score": "0.181958", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MARK", "relevance_score": "0.878286", "ticker_sentiment_score": "0.519424", "ticker_sentiment_label": "Bullish"}]}, {"title": "StockNews.com Upgrades Travelzoo  ( NASDAQ:TZOO )  to \"Strong-Buy\"", "url": "https://www.defenseworld.net/2023/05/04/stocknews-com-upgrades-travelzoo-nasdaqtzoo-to-strong-buy.html", "time_published": "20230504T052041", "authors": ["Defense World Staff"], "summary": "Travelzoo ( NASDAQ:TZOO - Get Rating ) was upgraded by investment analysts at StockNews.com from a \"buy\" rating to a \"strong-buy\" rating in a research note issued to investors on Thursday.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/Travelzoo_logo.png&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.272212, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "III", "relevance_score": "0.272029", "ticker_sentiment_score": "0.261678", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BK", "relevance_score": "0.138066", "ticker_sentiment_score": "0.162114", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TZOO", "relevance_score": "0.932163", "ticker_sentiment_score": "0.461676", "ticker_sentiment_label": "Bullish"}, {"ticker": "STT", "relevance_score": "0.138066", "ticker_sentiment_score": "0.162114", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.069294", "ticker_sentiment_score": "0.131446", "ticker_sentiment_label": "Neutral"}]}, {"title": "Minerva Neurosciences  ( NASDAQ:NERV )  Earns Sell Rating from Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/minerva-neurosciences-nasdaqnerv-earns-sell-rating-from-analysts-at-stocknews-com.html", "time_published": "20230504T052041", "authors": ["Defense World Staff"], "summary": "Minerva Neurosciences ( NASDAQ:NERV ) Earns Sell Rating from ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/minerva-neurosciences-inc-logo.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999976"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.30201, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.124809", "ticker_sentiment_score": "0.238687", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TFC", "relevance_score": "0.062597", "ticker_sentiment_score": "0.204509", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.062597", "ticker_sentiment_score": "0.020419", "ticker_sentiment_label": "Neutral"}, {"ticker": "NERV", "relevance_score": "0.72844", "ticker_sentiment_score": "0.397798", "ticker_sentiment_label": "Bullish"}, {"ticker": "UBS", "relevance_score": "0.124809", "ticker_sentiment_score": "0.238687", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "StockNews.com Lowers Cadence Design Systems  ( NASDAQ:CDNS )  to Hold", "url": "https://www.defenseworld.net/2023/05/04/stocknews-com-lowers-cadence-design-systems-nasdaqcdns-to-hold.html", "time_published": "20230504T052041", "authors": ["Defense World Staff"], "summary": "StockNews.com Lowers Cadence Design Systems ( NASDAQ:CDNS ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/cadence-design-syste-logo.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.315451, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AB", "relevance_score": "0.09495", "ticker_sentiment_score": "0.222837", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CDNS", "relevance_score": "0.74287", "ticker_sentiment_score": "0.448951", "ticker_sentiment_label": "Bullish"}, {"ticker": "BAC", "relevance_score": "0.047559", "ticker_sentiment_score": "0.089111", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.047559", "ticker_sentiment_score": "0.125997", "ticker_sentiment_label": "Neutral"}]}, {"title": "American Shared Hospital Services  ( NYSE:AMS )  Earns Hold Rating from Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/american-shared-hospital-services-nyseams-earns-hold-rating-from-analysts-at-stocknews-com.html", "time_published": "20230504T051444", "authors": ["Defense World Staff"], "summary": "American Shared Hospital Services ( NYSE:AMS ) Earns Hold Rating ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/generic-stocks14.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.196474, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.169676", "ticker_sentiment_score": "0.089301", "ticker_sentiment_label": "Neutral"}]}, {"title": "Avalon  ( NYSE:AWX )  Coverage Initiated at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/avalon-nyseawx-coverage-initiated-at-stocknews-com.html", "time_published": "20230504T051442", "authors": ["Defense World Staff"], "summary": "Investment analysts at StockNews.com began coverage on shares of Avalon ( NYSE:AWX - Get Rating ) in a report released on Thursday. The firm set a \"hold\" rating on the stock. Avalon stock opened at $2.66 on Thursday. Avalon has a twelve month low of $2.52 and a twelve month high of $4.40.", "banner_image": "https://www.marketbeat.com/logos/generic-stocks10.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Energy & Transportation", "relevance_score": "0.5"}], "overall_sentiment_score": 0.121736, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.178459", "ticker_sentiment_score": "0.039545", "ticker_sentiment_label": "Neutral"}, {"ticker": "WM", "relevance_score": "0.501398", "ticker_sentiment_score": "0.076423", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Begins Coverage on Almaden Minerals  ( NYSE:AAU ) ", "url": "https://www.defenseworld.net/2023/05/04/stocknews-com-begins-coverage-on-almaden-minerals-nyseaau.html", "time_published": "20230504T051441", "authors": ["Defense World Staff"], "summary": "Analysts at StockNews.com assumed coverage on shares of Almaden Minerals ( NYSE:AAU - Get Rating ) in a report issued on Thursday. The firm set a \"sell\" rating on the stock. Almaden Minerals stock opened at $0.12 on Thursday. The stock has a market cap of $16.81 million, a PE ratio of -1.75 and ...", "banner_image": "https://www.marketbeat.com/logos/generic-stocks8.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.151704, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.197413", "ticker_sentiment_score": "0.04257", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.197413", "ticker_sentiment_score": "0.04257", "ticker_sentiment_label": "Neutral"}]}, {"title": "Ashford  ( NYSE:AINC )  Coverage Initiated by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/ashford-nyseainc-coverage-initiated-by-analysts-at-stocknews-com.html", "time_published": "20230504T051441", "authors": ["Defense World Staff"], "summary": "Ashford ( NYSE:AINC ) Coverage Initiated by Analysts at StockNews ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/generic-stocks.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.217079, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.195814", "ticker_sentiment_score": "0.084158", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Begins Coverage on Ampio Pharmaceuticals  ( NYSE:AMPE ) ", "url": "https://www.defenseworld.net/2023/05/04/stocknews-com-begins-coverage-on-ampio-pharmaceuticals-nyseampe.html", "time_published": "20230504T051441", "authors": ["Defense World Staff"], "summary": "StockNews.com Begins Coverage on Ampio Pharmaceuticals ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/generic-stocks4.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.137886, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.181137", "ticker_sentiment_score": "0.076151", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.181137", "ticker_sentiment_score": "0.076151", "ticker_sentiment_label": "Neutral"}]}, {"title": "Golden Minerals  ( NYSE:AUMN )  Coverage Initiated by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/golden-minerals-nyseaumn-coverage-initiated-by-analysts-at-stocknews-com.html", "time_published": "20230504T051441", "authors": ["Defense World Staff"], "summary": "Golden Minerals ( NYSE:AUMN ) Coverage Initiated by Analysts at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/generic-stocks10.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.311109, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.173333", "ticker_sentiment_score": "0.101148", "ticker_sentiment_label": "Neutral"}]}, {"title": "Air Industries Group  ( NYSE:AIRI )  Now Covered by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/air-industries-group-nyseairi-now-covered-by-analysts-at-stocknews-com-2.html", "time_published": "20230504T051441", "authors": ["Defense World Staff"], "summary": "Air Industries Group ( NYSE:AIRI ) Now Covered by Analysts at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/generic-stocks7.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.181453, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.163909", "ticker_sentiment_score": "0.035692", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Begins Coverage on Barnwell Industries  ( NYSE:BRN ) ", "url": "https://www.defenseworld.net/2023/05/04/stocknews-com-begins-coverage-on-barnwell-industries-nysebrn.html", "time_published": "20230504T051246", "authors": ["Defense World Staff"], "summary": "Investment analysts at StockNews.com began coverage on shares of Barnwell Industries ( NYSE:BRN - Get Rating ) in a report issued on Thursday. The brokerage set a \"hold\" rating on the stock. BRN stock opened at $2.66 on Thursday.", "banner_image": "https://www.marketbeat.com/logos/generic-stocks13.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.280597, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.18967", "ticker_sentiment_score": "0.048288", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Begins Coverage on AMCON Distributing  ( NYSE:DIT ) ", "url": "https://www.defenseworld.net/2023/05/04/stocknews-com-begins-coverage-on-amcon-distributing-nysedit.html", "time_published": "20230504T051246", "authors": ["Defense World Staff"], "summary": "StockNews.com assumed coverage on shares of AMCON Distributing ( NYSE:DIT - Get Rating ) in a note issued to investors on Thursday. The brokerage set a \"hold\" rating on the stock. DIT stock opened at $176.50 on Thursday. The stock has a market cap of $107.84 million, a price-to-earnings ratio ...", "banner_image": "https://www.marketbeat.com/logos/generic-stocks6.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.209656, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.185306", "ticker_sentiment_score": "0.040648", "ticker_sentiment_label": "Neutral"}]}, {"title": "Spark Networks  ( NYSE:LOV )  Earns Hold Rating from Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/spark-networks-nyselov-earns-hold-rating-from-analysts-at-stocknews-com-2.html", "time_published": "20230504T051246", "authors": ["Defense World Staff"], "summary": "Spark Networks ( NYSE:LOV ) Earns Hold Rating from Analysts at ... Defense World ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/spark-networks-se-logo.png?v=20220314104405&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.135115, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.146025", "ticker_sentiment_score": "0.110078", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOV", "relevance_score": "0.902368", "ticker_sentiment_score": "0.2355", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "StockNews.com Initiates Coverage on Atento  ( NYSE:ATTO ) ", "url": "https://www.defenseworld.net/2023/05/04/stocknews-com-initiates-coverage-on-atento-nyseatto.html", "time_published": "20230504T051246", "authors": ["Defense World Staff"], "summary": "Equities research analysts at StockNews.com started coverage on shares of Atento ( NYSE:ATTO - Get Rating ) in a research report issued on Thursday. The brokerage set a \"hold\" rating on the business services provider's stock. Shares of NYSE ATTO opened at $1.24 on Thursday.", "banner_image": "https://www.marketbeat.com/logos/atento-sa-logo.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.955357"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.233858, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ATTO", "relevance_score": "0.912705", "ticker_sentiment_score": "0.398821", "ticker_sentiment_label": "Bullish"}, {"ticker": "GS", "relevance_score": "0.244109", "ticker_sentiment_score": "0.212024", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.123526", "ticker_sentiment_score": "0.15719", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Brooklyn ImmunoTherapeutics  ( NYSE:BTX )  Coverage Initiated by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/brooklyn-immunotherapeutics-nysebtx-coverage-initiated-by-analysts-at-stocknews-com.html", "time_published": "20230504T051246", "authors": ["Defense World Staff"], "summary": "Brooklyn ImmunoTherapeutics ( NYSE:BTX ) Coverage Initiated by ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/brooklyn-immunotherapeutics-inc-logo.png?v=20221104084421", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}], "overall_sentiment_score": 0.161717, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ERNA", "relevance_score": "0.122269", "ticker_sentiment_score": "0.036218", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.122269", "ticker_sentiment_score": "0.036218", "ticker_sentiment_label": "Neutral"}]}, {"title": "Global Cord Blood  ( NYSE:CO )  Now Covered by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/global-cord-blood-nyseco-now-covered-by-analysts-at-stocknews-com-2.html", "time_published": "20230504T051245", "authors": ["Defense World Staff"], "summary": "Global Cord Blood ( NYSE:CO ) Now Covered by Analysts at ... Defense World ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/global-cord-blood-co-logo.jpg?v=20221214071832&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.255567, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CO", "relevance_score": "0.876805", "ticker_sentiment_score": "0.428099", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.09439", "ticker_sentiment_score": "0.060371", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTRS", "relevance_score": "0.09439", "ticker_sentiment_score": "0.211399", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "StockNews.com Upgrades CEMEX  ( NYSE:CX )  to Strong-Buy", "url": "https://www.defenseworld.net/2023/05/04/stocknews-com-upgrades-cemex-nysecx-to-strong-buy.html", "time_published": "20230504T051245", "authors": ["Defense World Staff"], "summary": "CEMEX ( NYSE:CX - Get Rating ) was upgraded by equities researchers at StockNews.com from a \"buy\" rating to a \"strong-buy\" rating in a research note issued on Thursday. Separately, The Goldman Sachs Group upgraded shares of CEMEX from a \"neutral\" rating to a \"buy\" rating in a research report on ...", "banner_image": "https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&Symbol=CX", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.350272, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "GS", "relevance_score": "0.07887", "ticker_sentiment_score": "0.113728", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCQEF", "relevance_score": "0.15697", "ticker_sentiment_score": "0.34404", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.07887", "ticker_sentiment_score": "0.092672", "ticker_sentiment_label": "Neutral"}]}, {"title": "Culp  ( NYSE:CULP )  Now Covered by StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/culp-nyseculp-now-covered-by-stocknews-com.html", "time_published": "20230504T051245", "authors": ["Defense World Staff"], "summary": "Research analysts at StockNews.com assumed coverage on shares of Culp ( NYSE:CULP - Get Rating ) in a report released on Thursday. The firm set a \"sell\" rating on the textile maker's stock. NYSE:CULP opened at $5.40 on Thursday. The firm has a market cap of $66.47 million, a P/E ratio of -2.01 ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/culp-inc-logo.jpg?v=20230104132031&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.891286"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.172268, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.153961", "ticker_sentiment_score": "0.198426", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CULP", "relevance_score": "0.153961", "ticker_sentiment_score": "0.086172", "ticker_sentiment_label": "Neutral"}, {"ticker": "TETAB", "relevance_score": "0.153961", "ticker_sentiment_score": "0.198426", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.077343", "ticker_sentiment_score": "0.065186", "ticker_sentiment_label": "Neutral"}]}, {"title": "Easterly Government Properties  ( NYSE:DEA )  Upgraded to Hold at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/easterly-government-properties-nysedea-upgraded-to-hold-at-stocknews-com.html", "time_published": "20230504T051245", "authors": ["Defense World Staff"], "summary": "Easterly Government Properties ( NYSE:DEA ) Upgraded to Hold at ... Defense World ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/easterly-government-properties-inc-logo.jpg&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.882182"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.249872, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TFC", "relevance_score": "0.065685", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DEA", "relevance_score": "0.812724", "ticker_sentiment_score": "0.410167", "ticker_sentiment_label": "Bullish"}, {"ticker": "VCTR", "relevance_score": "0.130926", "ticker_sentiment_score": "0.219378", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.065685", "ticker_sentiment_score": "0.073107", "ticker_sentiment_label": "Neutral"}]}, {"title": "Zovio  ( NYSE:ZVO )  Research Coverage Started at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/zovio-nysezvo-research-coverage-started-at-stocknews-com.html", "time_published": "20230504T051245", "authors": ["Defense World Staff"], "summary": "Equities research analysts at StockNews.com assumed coverage on shares of Zovio ( NYSE:ZVO - Get Rating ) in a research report issued to clients and investors on Thursday. The firm set a \"hold\" rating on the stock. Shares of ZVO opened at $0.00 on Thursday.", "banner_image": "https://www.marketbeat.com/logos/zovio-inc-logo.jpg?v=20221212132559", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.149315, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ZVOI", "relevance_score": "0.83383", "ticker_sentiment_score": "0.252766", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.182506", "ticker_sentiment_score": "0.069786", "ticker_sentiment_label": "Neutral"}]}, {"title": "Aspira Women's Health  ( NYSE:AWH )  Coverage Initiated by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/aspira-womens-health-nyseawh-coverage-initiated-by-analysts-at-stocknews-com.html", "time_published": "20230504T051245", "authors": ["Defense World Staff"], "summary": "Aspira Women's Health ( NYSE:AWH ) Coverage Initiated by Analysts ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/generic-stocks9.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.215471, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AWH", "relevance_score": "0.885652", "ticker_sentiment_score": "0.363672", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.178459", "ticker_sentiment_score": "0.080332", "ticker_sentiment_label": "Neutral"}]}, {"title": "M/I Homes  ( NYSE:MHO )  Rating Lowered to Buy at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/m-i-homes-nysemho-rating-lowered-to-buy-at-stocknews-com.html", "time_published": "20230504T051244", "authors": ["Defense World Staff"], "summary": "M/I Homes ( NYSE:MHO - Get Rating ) was downgraded by research analysts at StockNews.com from a \"strong-buy\" rating to a \"buy\" rating in a research note issued to investors on Thursday.", "banner_image": "https://www.marketbeat.com/logos/m-i-homes-inc-logo.jpg?v=20221130172227", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}], "overall_sentiment_score": 0.275596, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.061473", "ticker_sentiment_score": "0.090712", "ticker_sentiment_label": "Neutral"}]}, {"title": "Endeavor Group  ( NYSE:EDR )  Rating Increased to Buy at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/endeavor-group-nyseedr-rating-increased-to-buy-at-stocknews-com.html", "time_published": "20230504T051244", "authors": ["Defense World Staff"], "summary": "Endeavor Group ( NYSE:EDR ) Rating Increased to Buy at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/endeavor-group-holdings-inc-logo.jpg?v=20210517151101", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.30224, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.102668", "ticker_sentiment_score": "0.193853", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EDR", "relevance_score": "0.698049", "ticker_sentiment_score": "0.42965", "ticker_sentiment_label": "Bullish"}, {"ticker": "AWON", "relevance_score": "0.051441", "ticker_sentiment_score": "0.000995", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.051441", "ticker_sentiment_score": "0.148124", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.102668", "ticker_sentiment_score": "0.193853", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Extra Space Storage  ( NYSE:EXR )  Rating Increased to Hold at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/extra-space-storage-nyseexr-rating-increased-to-hold-at-stocknews-com.html", "time_published": "20230504T051244", "authors": ["Defense World Staff"], "summary": "Extra Space Storage ( NYSE:EXR ) Rating Increased to Hold at ... Defense World ...", "banner_image": "https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&Symbol=EXR", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.922939"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.298626, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TFC", "relevance_score": "0.045743", "ticker_sentiment_score": "0.085045", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXR", "relevance_score": "0.670511", "ticker_sentiment_score": "0.426692", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.045743", "ticker_sentiment_score": "0.037004", "ticker_sentiment_label": "Neutral"}, {"ticker": "KEY", "relevance_score": "0.045743", "ticker_sentiment_score": "0.085045", "ticker_sentiment_label": "Neutral"}]}, {"title": "Phoenix New Media  ( NYSE:FENG )  Research Coverage Started at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/phoenix-new-media-nysefeng-research-coverage-started-at-stocknews-com-2.html", "time_published": "20230504T051244", "authors": ["Defense World Staff"], "summary": "Phoenix New Media ( NYSE:FENG ) Research Coverage Started at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/phoenix-new-media-logo.JPG", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.086146, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "FENG", "relevance_score": "0.902573", "ticker_sentiment_score": "0.150976", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "III", "relevance_score": "0.259727", "ticker_sentiment_score": "-0.06277", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.131643", "ticker_sentiment_score": "0.088657", "ticker_sentiment_label": "Neutral"}]}, {"title": "Atlanticus  ( NASDAQ:ATLC )  Downgraded to Hold at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/atlanticus-nasdaqatlc-downgraded-to-hold-at-stocknews-com.html", "time_published": "20230504T051243", "authors": ["Defense World Staff"], "summary": "Atlanticus ( NASDAQ:ATLC - Get Rating ) was downgraded by equities research analysts at StockNews.com from a \"buy\" rating to a \"hold\" rating in a report released on Thursday.", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/atlanticus-holdings-co-logo.png?v=20221213150238&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.30908, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ATLC", "relevance_score": "0.934855", "ticker_sentiment_score": "0.515485", "ticker_sentiment_label": "Bullish"}, {"ticker": "IVZ", "relevance_score": "0.194242", "ticker_sentiment_score": "0.358594", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.097854", "ticker_sentiment_score": "0.128122", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Initiates Coverage on Aptose Biosciences  ( NASDAQ:APTO ) ", "url": "https://www.defenseworld.net/2023/05/04/stocknews-com-initiates-coverage-on-aptose-biosciences-nasdaqapto.html", "time_published": "20230504T051243", "authors": ["Defense World Staff"], "summary": "StockNews.com Initiates Coverage on Aptose Biosciences ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/aptose-biosciences-inc-logo.jpg?v=20230104143303", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.22354, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TD", "relevance_score": "0.17715", "ticker_sentiment_score": "0.21679", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RBCPF", "relevance_score": "0.089129", "ticker_sentiment_score": "0.070249", "ticker_sentiment_label": "Neutral"}, {"ticker": "APTO", "relevance_score": "0.926714", "ticker_sentiment_score": "0.384953", "ticker_sentiment_label": "Bullish"}, {"ticker": "CCORF", "relevance_score": "0.089129", "ticker_sentiment_score": "0.070249", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.089129", "ticker_sentiment_score": "0.094374", "ticker_sentiment_label": "Neutral"}]}, {"title": "Essential Utilities  ( NYSE:WTRG )  Downgraded to Sell at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/essential-utilities-nysewtrg-downgraded-to-sell-at-stocknews-com.html", "time_published": "20230504T051243", "authors": ["Defense World Staff"], "summary": "Essential Utilities ( NYSE:WTRG ) Downgraded to Sell at StockNews ... Defense World ...", "banner_image": "https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&Symbol=WTRG", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.999976"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.266143"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.211586, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "WTRG", "relevance_score": "0.830764", "ticker_sentiment_score": "0.321929", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NGS", "relevance_score": "0.064449", "ticker_sentiment_score": "0.097357", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBCPF", "relevance_score": "0.064449", "ticker_sentiment_score": "0.040042", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.064449", "ticker_sentiment_score": "0.040042", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.064449", "ticker_sentiment_score": "0.097357", "ticker_sentiment_label": "Neutral"}]}, {"title": "Molina Healthcare  ( NYSE:MOH )  Lifted to \"Strong-Buy\" at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/molina-healthcare-nysemoh-lifted-to-strong-buy-at-stocknews-com.html", "time_published": "20230504T051243", "authors": ["Defense World Staff"], "summary": "Molina Healthcare ( NYSE:MOH ) Lifted to \"Strong-Buy\" at StockNews ... Defense World ...", "banner_image": "https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&Symbol=MOH", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.623304"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.247377, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TFC", "relevance_score": "0.059935", "ticker_sentiment_score": "0.068008", "ticker_sentiment_label": "Neutral"}, {"ticker": "STT", "relevance_score": "0.119532", "ticker_sentiment_score": "0.213511", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BCS", "relevance_score": "0.059935", "ticker_sentiment_score": "0.068008", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.119532", "ticker_sentiment_score": "0.213511", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.059935", "ticker_sentiment_score": "0.104852", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOH", "relevance_score": "0.867357", "ticker_sentiment_score": "0.415071", "ticker_sentiment_label": "Bullish"}]}, {"title": "StockNews.com Upgrades Merck & Co., Inc.  ( NYSE:MRK )  to Strong-Buy", "url": "https://www.defenseworld.net/2023/05/04/stocknews-com-upgrades-merck-co-inc-nysemrk-to-strong-buy.html", "time_published": "20230504T051243", "authors": ["Defense World Staff"], "summary": "StockNews.com Upgrades Merck & Co., Inc. ( NYSE:MRK ) to Strong ... Defense World ...", "banner_image": "https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&Symbol=MRK", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.293327, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AWON", "relevance_score": "0.043898", "ticker_sentiment_score": "0.00098", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.043898", "ticker_sentiment_score": "0.05601", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.043898", "ticker_sentiment_score": "0.125825", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.043898", "ticker_sentiment_score": "0.05601", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.043898", "ticker_sentiment_score": "0.05601", "ticker_sentiment_label": "Neutral"}]}, {"title": "ARCA biopharma  ( NASDAQ:ABIO )  Coverage Initiated by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/arca-biopharma-nasdaqabio-coverage-initiated-by-analysts-at-stocknews-com.html", "time_published": "20230504T051243", "authors": ["Defense World Staff"], "summary": "ARCA biopharma ( NASDAQ:ABIO ) Coverage Initiated by Analysts at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/arca-biopharma-inc-logo.png?v=20211013111358", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.150617, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABIO", "relevance_score": "0.928139", "ticker_sentiment_score": "0.26294", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.158519", "ticker_sentiment_score": "0.071433", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.158519", "ticker_sentiment_score": "0.004037", "ticker_sentiment_label": "Neutral"}]}, {"title": "Ames National  ( NASDAQ:ATLO )  Downgraded to \"Sell\" at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/ames-national-nasdaqatlo-downgraded-to-sell-at-stocknews-com-2.html", "time_published": "20230504T051242", "authors": ["Defense World Staff"], "summary": "Ames National ( NASDAQ:ATLO ) Downgraded to \"Sell\" at ... Defense World ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/ames-national-co-logo.jpg?v=20211104144652&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.217302, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ATLO", "relevance_score": "0.878286", "ticker_sentiment_score": "0.368744", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.094762", "ticker_sentiment_score": "0.133457", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPLA", "relevance_score": "0.188193", "ticker_sentiment_score": "0.176707", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Aethlon Medical  ( NASDAQ:AEMD )  Coverage Initiated by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/aethlon-medical-nasdaqaemd-coverage-initiated-by-analysts-at-stocknews-com-2.html", "time_published": "20230504T051242", "authors": ["Defense World Staff"], "summary": "Aethlon Medical ( NASDAQ:AEMD ) Coverage Initiated by Analysts at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/aethlon-medical-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}, {"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.174527, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AEMD", "relevance_score": "0.883106", "ticker_sentiment_score": "0.298213", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.083251", "ticker_sentiment_score": "-0.08065", "ticker_sentiment_label": "Neutral"}]}, {"title": "Colony Bankcorp  ( NASDAQ:CBAN )  Rating Increased to Hold at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/colony-bankcorp-nasdaqcban-rating-increased-to-hold-at-stocknews-com.html", "time_published": "20230504T051242", "authors": ["Defense World Staff"], "summary": "Colony Bankcorp ( NASDAQ:CBAN ) Rating Increased to Hold at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/colony-bankcorp-inc-logo.png?v=20221216144900", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.23284, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.07887", "ticker_sentiment_score": "0.065416", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBAN", "relevance_score": "0.886842", "ticker_sentiment_score": "0.394532", "ticker_sentiment_label": "Bullish"}]}, {"title": "NexPoint Residential Trust  ( NYSE:NXRT )  Rating Increased to Hold at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/nexpoint-residential-trust-nysenxrt-rating-increased-to-hold-at-stocknews-com.html", "time_published": "20230504T051242", "authors": ["Defense World Staff"], "summary": "NexPoint Residential Trust ( NYSE:NXRT ) Rating Increased to Hold ... Defense World ...", "banner_image": "https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&Symbol=NXRT", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.503496"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.230363, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NXRT", "relevance_score": "0.841981", "ticker_sentiment_score": "0.384535", "ticker_sentiment_label": "Bullish"}, {"ticker": "TFC", "relevance_score": "0.07031", "ticker_sentiment_score": "0.061243", "ticker_sentiment_label": "Neutral"}, {"ticker": "FITB", "relevance_score": "0.140076", "ticker_sentiment_score": "0.1722", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.07031", "ticker_sentiment_score": "0.001006", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.07031", "ticker_sentiment_score": "0.128326", "ticker_sentiment_label": "Neutral"}]}, {"title": "Ternium  ( NYSE:TX )  Cut to \"Buy\" at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/ternium-nysetx-cut-to-buy-at-stocknews-com.html", "time_published": "20230504T051242", "authors": ["Defense World Staff"], "summary": "Ternium ( NYSE:TX - Get Rating ) was downgraded by StockNews.com from a \"strong-buy\" rating to a \"buy\" rating in a research report issued on Thursday. Several other equities research analysts also recently commented on the stock.", "banner_image": "https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&Symbol=TX", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.999993"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.207006, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "C", "relevance_score": "0.134214", "ticker_sentiment_score": "0.138452", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.067347", "ticker_sentiment_score": "0.072197", "ticker_sentiment_label": "Neutral"}, {"ticker": "TX", "relevance_score": "0.871772", "ticker_sentiment_score": "0.352259", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.067347", "ticker_sentiment_score": "0.063949", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.067347", "ticker_sentiment_score": "0.072197", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEIC", "relevance_score": "0.134214", "ticker_sentiment_score": "0.196143", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.067347", "ticker_sentiment_score": "-0.029045", "ticker_sentiment_label": "Neutral"}]}, {"title": "Vale  ( NYSE:VALE )  Coverage Initiated at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/vale-nysevale-coverage-initiated-at-stocknews-com.html", "time_published": "20230504T051242", "authors": ["Defense World Staff"], "summary": "Equities research analysts at StockNews.com assumed coverage on shares of Vale ( NYSE:VALE - Get Rating ) in a research report issued on Thursday. The firm set a \"buy\" rating on the basic materials company's stock.", "banner_image": "https://www.marketbeat.com/logos/vale-sa-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.752319"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.191755, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "C", "relevance_score": "0.066414", "ticker_sentiment_score": "0.022106", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBCPF", "relevance_score": "0.066414", "ticker_sentiment_score": "0.022106", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.066414", "ticker_sentiment_score": "0.064896", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.066414", "ticker_sentiment_score": "0.022106", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.066414", "ticker_sentiment_score": "0.022106", "ticker_sentiment_label": "Neutral"}]}, {"title": "Rollins  ( NYSE:ROL )  Stock Rating Upgraded by StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/rollins-nyserol-stock-rating-upgraded-by-stocknews-com-2.html", "time_published": "20230504T051242", "authors": ["Defense World Staff"], "summary": "Rollins ( NYSE:ROL - Get Rating ) was upgraded by research analysts at StockNews.com from a \"hold\" rating to a \"buy\" rating in a note issued to investors on Thursday. ROL has been the topic of several other research reports.", "banner_image": "https://www.marketbeat.com/logos/rollins-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999993"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.263832, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BK", "relevance_score": "0.128822", "ticker_sentiment_score": "0.272515", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.064623", "ticker_sentiment_score": "0.002003", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.064623", "ticker_sentiment_score": "0.066159", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROL", "relevance_score": "0.831914", "ticker_sentiment_score": "0.434007", "ticker_sentiment_label": "Bullish"}]}, {"title": "StockNews.com Lowers Thermo Fisher Scientific  ( NYSE:TMO )  to Hold", "url": "https://www.defenseworld.net/2023/05/04/stocknews-com-lowers-thermo-fisher-scientific-nysetmo-to-hold.html", "time_published": "20230504T051242", "authors": ["Defense World Staff"], "summary": "Thermo Fisher Scientific ( NYSE:TMO - Get Rating ) was downgraded by equities research analysts at StockNews.com from a \"buy\" rating to a \"hold\" rating in a research note issued on Thursday. TMO has been the subject of several other research reports.", "banner_image": "https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&Symbol=TMO", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.346164, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.043658", "ticker_sentiment_score": "0.08793", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.043658", "ticker_sentiment_score": "0.09603", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.771557", "ticker_sentiment_score": "0.539983", "ticker_sentiment_label": "Bullish"}]}, {"title": "Ayala Pharmaceuticals  ( NASDAQ:ADXS )  Coverage Initiated at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/ayala-pharmaceuticals-nasdaqadxs-coverage-initiated-at-stocknews-com.html", "time_published": "20230504T051242", "authors": ["Defense World Staff"], "summary": "Ayala Pharmaceuticals ( NASDAQ:ADXS ) Coverage Initiated at ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/generic-stocks6.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.046056, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.181137", "ticker_sentiment_score": "0.048354", "ticker_sentiment_label": "Neutral"}]}, {"title": "Argo Group International  ( NASDAQ:ARGO )  Coverage Initiated at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/argo-group-international-nasdaqargo-coverage-initiated-at-stocknews-com-2.html", "time_published": "20230504T051242", "authors": ["Defense World Staff"], "summary": "Argo Group International ( NASDAQ:ARGO ) Coverage Initiated at ... Defense World ...", "banner_image": "https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/argo-group-international-holdings-ltd-logo.png?v=20230427064410&w=240&h=240&zc=2", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.095574, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.16849", "ticker_sentiment_score": "0.03642", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARGO", "relevance_score": "0.47672", "ticker_sentiment_score": "0.03146", "ticker_sentiment_label": "Neutral"}]}, {"title": "Allied Healthcare Products  ( NASDAQ:AHPI )  Coverage Initiated by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2023/05/04/allied-healthcare-products-nasdaqahpi-coverage-initiated-by-analysts-at-stocknews-com.html", "time_published": "20230504T051242", "authors": ["Defense World Staff"], "summary": "Allied Healthcare Products ( NASDAQ:AHPI ) Coverage Initiated by ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/allied-healthcare-products-inc-logo.jpg?v=20211103153637", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}], "overall_sentiment_score": 0.205949, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.113597", "ticker_sentiment_score": "0.171178", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Icahn Enterprises Fires Back At Hindenburg's Ponzi-Like Scheme Allegations: 'Intended Solely To Generate Profits' - Icahn Enterprises  ( NASDAQ:IEP ) ", "url": "https://www.benzinga.com/news/mid-cap/23/05/32194998/icahn-enterprises-fires-back-at-hindenburgs-ponzi-like-scheme-allegations-intended-solely-to-generat", "time_published": "20230503T195255", "authors": ["AJ Fabino"], "summary": "Icahn Enterprises LP IEP responded strongly to a short-seller report by Hindenburg Research that accused the investment firm's founder, Carl Icahn, of mismanagement.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/05/03/icahn_shutter.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}], "overall_sentiment_score": 0.0, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MDNDF", "relevance_score": "0.13459", "ticker_sentiment_score": "0.081082", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.13459", "ticker_sentiment_score": "0.081082", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSHZF", "relevance_score": "0.13459", "ticker_sentiment_score": "0.081082", "ticker_sentiment_label": "Neutral"}]}, {"title": "Hindenburg's next shot: Short seller erases fifth of Icahn empire's value | The Financial Express", "url": "https://www.financialexpress.com/market/hindenburgs-next-shot-short-seller-erases-fifth-of-icahn-empires-value/3072448/", "time_published": "20230503T060819", "authors": [], "summary": "Hindenburg's next shot: Short seller erases fifth of Icahn empire's value The Financial Express ...", "banner_image": "https://www.financialexpress.com/wp-content/uploads/2023/05/KPKNQRZHC5OLRPQ6NE23TMAMFM.jpg", "source": "The Financial Express", "category_within_source": "n/a", "source_domain": "www.financialexpress.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.078173, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "TPNTF", "relevance_score": "0.054983", "ticker_sentiment_score": "0.208923", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MDNDF", "relevance_score": "0.054983", "ticker_sentiment_score": "-0.021974", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWX", "relevance_score": "0.054983", "ticker_sentiment_score": "-0.021974", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.054983", "ticker_sentiment_score": "-0.021974", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKLA", "relevance_score": "0.054983", "ticker_sentiment_score": "0.082828", "ticker_sentiment_label": "Neutral"}, {"ticker": "SQ", "relevance_score": "0.054983", "ticker_sentiment_score": "0.082828", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCD", "relevance_score": "0.054983", "ticker_sentiment_score": "-0.021974", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSHZF", "relevance_score": "0.054983", "ticker_sentiment_score": "0.208923", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "XRX", "relevance_score": "0.054983", "ticker_sentiment_score": "-0.021974", "ticker_sentiment_label": "Neutral"}]}, {"title": "US short-seller says iconic investor Icahn has 'ponzi-like' biz", "url": "https://www.aljazeera.com/economy/2023/5/2/us-short-seller-says-iconic-investor-icahn-has-ponzi-like-biz", "time_published": "20230502T195525", "authors": [], "summary": "Hindenburg Research said Carl Icahn takes money from new investors 'to pay out dividends to old investors'. Iconic activist investor Carl Icahn was on Tuesday hit with a challenge of his own from a prominent short-seller, who alleged the billionaire's conglomerate is substantially overvalued, ...", "banner_image": "https://www.aljazeera.com/wp-content/uploads/2023/05/2014-02-11T000000Z_419152994_GM1EA2C0K1101_RTRMADP_3_APPLE-ICAHN-1683054674.jpg?resize=770%2C513&quality=80", "source": "Al Jareeza", "category_within_source": "n/a", "source_domain": "www.aljazeera.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.119885, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "HLF", "relevance_score": "0.071357", "ticker_sentiment_score": "0.042189", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDNDF", "relevance_score": "0.071357", "ticker_sentiment_score": "0.042189", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.071357", "ticker_sentiment_score": "-0.094519", "ticker_sentiment_label": "Neutral"}, {"ticker": "SQ", "relevance_score": "0.071357", "ticker_sentiment_score": "0.141917", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCD", "relevance_score": "0.071357", "ticker_sentiment_score": "0.042189", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSHZF", "relevance_score": "0.071357", "ticker_sentiment_score": "0.172221", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Hindenburg Research goes after Carl Icahn in latest campaign for market-moving short seller", "url": "https://www.cnbc.com/2023/05/02/hindenburg-research-takes-on-carl-icahn-in-latest-campaign-for-market-moving-short-seller.html", "time_published": "20230502T123831", "authors": ["Yun Li"], "summary": "The Nathan Anderson-led firm took a short position against Icahn Enterprises, alleging \"inflated\" asset valuations, among other reasons.", "banner_image": "https://image.cnbcfm.com/api/v1/image/103937645-20160913-9095-2269.jpg?v=1683031111&w=1920&h=1080", "source": "CNBC", "category_within_source": "Finance", "source_domain": "www.cnbc.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.197387, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MDNDF", "relevance_score": "0.183895", "ticker_sentiment_score": "0.118821", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.183895", "ticker_sentiment_score": "0.118821", "ticker_sentiment_label": "Neutral"}]}, {"title": "Economic reality and antitrust theory paralyse M&A", "url": "https://www.moneycontrol.com/news/opinion/economic-reality-and-antitrust-theory-paralyse-ma-10514501.html", "time_published": "20230502T115950", "authors": [], "summary": "Dealmakers need to have a handle on today and optimism about tomorrow. Right now they have neither ...", "banner_image": "https://images.moneycontrol.com/static-mcnews/2023/02/Nirmala-Sitharaman.png?impolicy=website&width=168&height=118", "source": "Money Control", "category_within_source": "Economy", "source_domain": "www.moneycontrol.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.838487"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.144147, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.047465", "ticker_sentiment_score": "-0.100072", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.094762", "ticker_sentiment_score": "-0.09185", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.094762", "ticker_sentiment_score": "-0.09185", "ticker_sentiment_label": "Neutral"}, {"ticker": "VMW", "relevance_score": "0.047465", "ticker_sentiment_score": "-0.100072", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVGO", "relevance_score": "0.047465", "ticker_sentiment_score": "-0.100072", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.094762", "ticker_sentiment_score": "-0.08612", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATVI", "relevance_score": "0.047465", "ticker_sentiment_score": "-0.100072", "ticker_sentiment_label": "Neutral"}]}, {"title": "Biden will end Covid vaccine mandates for federal workers and international travelers on May 11", "url": "https://www.cnbc.com/2023/05/01/covid-biden-will-end-vaccine-mandates-for-federal-workers-travelers.html", "time_published": "20230502T003901", "authors": ["Spencer Kimball"], "summary": "The Biden administration will end Covid vaccine mandates for federal employees, contractors and air travelers on May 11.", "banner_image": "https://image.cnbcfm.com/api/v1/image/106800835-1606137435956-laxx.jpg?v=1682983112&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.168398, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.082677", "ticker_sentiment_score": "-0.265959", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BIIB", "relevance_score": "0.082677", "ticker_sentiment_score": "0.285622", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.082677", "ticker_sentiment_score": "0.148346", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Issues Shareholder Letter and Requests Shareholders Vote for the Illumina Director Nominees on the WHITE Proxy Card", "url": "https://www.prnewswire.com/news-releases/illumina-issues-shareholder-letter-and-requests-shareholders-vote-for-the-illumina-director-nominees-on-the-white-proxy-card-301812221.html", "time_published": "20230501T185900", "authors": ["Inc.", "Illumina"], "summary": "Illumina Issues Shareholder Letter and Requests Shareholders Vote ... PR ...", "banner_image": "", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.99999"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.263428, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.494288", "ticker_sentiment_score": "0.368124", "ticker_sentiment_label": "Bullish"}]}, {"title": "Illumina Issues Shareholder Letter and Requests Shareholders Vote for the Illumina Director Nominees on the WHITE Proxy Card - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/05/n32131025/illumina-issues-shareholder-letter-and-requests-shareholders-vote-for-the-illumina-director-nomine", "time_published": "20230501T185900", "authors": ["PRNewswire"], "summary": "Strong NovaSeqTM X shipments drove solid Illumina first quarter results; company commits to grow Core Illumina non-GAAP operating margins to 27%[1] in 2025 Announces more than $100 million in annualized cost savings Carl Icahn's campaign is spreading false information", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.999997"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.261166, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.492839", "ticker_sentiment_score": "0.36752", "ticker_sentiment_label": "Bullish"}]}, {"title": "Illumina Unusual Options Activity - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/markets/options/23/05/32128595/illumina-unusual-options-activity", "time_published": "20230501T173110", "authors": ["Benzinga Insights"], "summary": "Someone with a lot of money to spend has taken a bearish stance on Illumina ILMN. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.119845, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.868151", "ticker_sentiment_score": "0.268223", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Genomic Urine Test Detects Bladder Cancer from DNA Up to 12 Years Before Clinical Signs and Symptoms Appear", "url": "https://markets.businessinsider.com/news/stocks/genomic-urine-test-detects-bladder-cancer-from-dna-up-to-12-years-before-clinical-signs-and-symptoms-appear-1032278531", "time_published": "20230501T143000", "authors": [], "summary": "Advances in Next-Generation DNA Sequencing and Machine Learning Enable Rapid Analysis of Genetic Mutations to Determine Cancer Risk", "banner_image": "https://mma.prnewswire.com/media/2066186/Convergent_Genomics_Genomic_urine_test_UroAmp.jpg", "source": "Business Insider", "category_within_source": "RSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.162819, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.038717", "ticker_sentiment_score": "-0.019717", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments", "url": "https://www.cnbc.com/2023/05/01/states-medicare-alzheimers-treatments.html", "time_published": "20230501T130001", "authors": ["Spencer Kimball"], "summary": "Attorneys general from 23 states, Washington D.C., and two U.S. territories called on Medicare to cover Alzheimer's treatments without restrictions.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107090864-1658245265138-NUP_198367_01033_copy.jpg?v=1682945506", "source": "CNBC", "category_within_source": "Business", "source_domain": "www.cnbc.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.048171, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.041181", "ticker_sentiment_score": "-0.255497", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BIIB", "relevance_score": "0.041181", "ticker_sentiment_score": "0.274564", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.041181", "ticker_sentiment_score": "0.141776", "ticker_sentiment_label": "Neutral"}]}, {"title": "Carl Icahn calls Illumina Q1 results 'very disappointing,' slams cost-cutting plan", "url": "https://www.cnbc.com/2023/04/28/carl-icahn-slams-illumina-q1-results-and-cost-cutting-plan.html", "time_published": "20230428T183516", "authors": ["Annika Kim Constantino"], "summary": "Activist investor Carl Icahn accused Illumina CEO Francis deSouza of trying to downplay the company's \"decidedly mediocre\" Q1 2023 results this week.", "banner_image": "https://image.cnbcfm.com/api/v1/image/105086085-GettyImages-94611745.jpg?v=1682642917", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.988787"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.119409, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.732373", "ticker_sentiment_score": "-0.300199", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Market Rally Volatile And Tight Amid Big Earnings Moves", "url": "https://www.investors.com/news/market-rally-wobbles-amid-big-earnings-moves-from-microsoft-meta-crocs-cloudflare/", "time_published": "20230428T163600", "authors": ["Investor's Business Daily", "IBD STAFF"], "summary": "Market Rally Wobbles Amid Big Earnings Moves From Microsoft ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2016/04/SSA-040816-shutterstock.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Economy - Monetary", "relevance_score": "0.838487"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.999999"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "1.0"}], "overall_sentiment_score": -0.102594, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MEDP", "relevance_score": "0.054773", "ticker_sentiment_score": "-0.11609", "ticker_sentiment_label": "Neutral"}, {"ticker": "MXL", "relevance_score": "0.036532", "ticker_sentiment_score": "-0.090238", "ticker_sentiment_label": "Neutral"}, {"ticker": "TER", "relevance_score": "0.036532", "ticker_sentiment_score": "-0.090238", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROKU", "relevance_score": "0.036532", "ticker_sentiment_score": "0.069232", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVX", "relevance_score": "0.054773", "ticker_sentiment_score": "-0.079945", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDNDF", "relevance_score": "0.036532", "ticker_sentiment_score": "-0.005866", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.036532", "ticker_sentiment_score": "-0.136848", "ticker_sentiment_label": "Neutral"}, {"ticker": "CROX", "relevance_score": "0.072987", "ticker_sentiment_score": "-0.030714", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXN", "relevance_score": "0.036532", "ticker_sentiment_score": "-0.090238", "ticker_sentiment_label": "Neutral"}, {"ticker": "STM", "relevance_score": "0.054773", "ticker_sentiment_score": "-0.092033", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.091162", "ticker_sentiment_score": "-0.00108", "ticker_sentiment_label": "Neutral"}, {"ticker": "MA", "relevance_score": "0.036532", "ticker_sentiment_score": "0.141804", "ticker_sentiment_label": "Neutral"}, {"ticker": "V", "relevance_score": "0.072987", "ticker_sentiment_score": "0.148237", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLY", "relevance_score": "0.054773", "ticker_sentiment_score": "-0.068368", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMG", "relevance_score": "0.072987", "ticker_sentiment_score": "-0.006113", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.054773", "ticker_sentiment_score": "-0.11609", "ticker_sentiment_label": "Neutral"}, {"ticker": "GE", "relevance_score": "0.072987", "ticker_sentiment_score": "0.029672", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYX", "relevance_score": "0.036532", "ticker_sentiment_score": "-0.1106", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLAC", "relevance_score": "0.036532", "ticker_sentiment_score": "-0.090238", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.036532", "ticker_sentiment_score": "-0.041307", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.145364", "ticker_sentiment_score": "-0.098456", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPOT", "relevance_score": "0.036532", "ticker_sentiment_score": "-0.066788", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSX", "relevance_score": "0.054773", "ticker_sentiment_score": "-0.11609", "ticker_sentiment_label": "Neutral"}, {"ticker": "GM", "relevance_score": "0.072987", "ticker_sentiment_score": "-0.017451", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.054773", "ticker_sentiment_score": "-0.11609", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMCI", "relevance_score": "0.036532", "ticker_sentiment_score": "-0.108377", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.072987", "ticker_sentiment_score": "-0.111796", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.036532", "ticker_sentiment_score": "-0.067681", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHDN", "relevance_score": "0.036532", "ticker_sentiment_score": "0.169405", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EW", "relevance_score": "0.054773", "ticker_sentiment_score": "-0.11609", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRC", "relevance_score": "0.091162", "ticker_sentiment_score": "-0.109548", "ticker_sentiment_label": "Neutral"}, {"ticker": "INTC", "relevance_score": "0.072987", "ticker_sentiment_score": "-0.093739", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOW", "relevance_score": "0.036532", "ticker_sentiment_score": "-0.1106", "ticker_sentiment_label": "Neutral"}, {"ticker": "XOM", "relevance_score": "0.036532", "ticker_sentiment_score": "-0.077119", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDNS", "relevance_score": "0.036532", "ticker_sentiment_score": "-0.042982", "ticker_sentiment_label": "Neutral"}, {"ticker": "PI", "relevance_score": "0.036532", "ticker_sentiment_score": "-0.090238", "ticker_sentiment_label": "Neutral"}, {"ticker": "WOLF", "relevance_score": "0.036532", "ticker_sentiment_score": "-0.090238", "ticker_sentiment_label": "Neutral"}, {"ticker": "NET", "relevance_score": "0.091162", "ticker_sentiment_score": "-0.095446", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.091162", "ticker_sentiment_score": "-0.037536", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.036532", "ticker_sentiment_score": "-0.06261", "ticker_sentiment_label": "Neutral"}]}, {"title": "A Look Into Illumina's Debt - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/23/04/32088120/a-look-into-illuminas-debt", "time_published": "20230428T161635", "authors": ["Benzinga Insights"], "summary": "Shares of Illumina Inc. ILMN fell by 2.89% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": -0.12072, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.276909", "ticker_sentiment_score": "-0.109759", "ticker_sentiment_label": "Neutral"}]}, {"title": "Global Multicancer Screening Market to Reach $7.78 Billion by 2032 - Exclusive DeepTech M-A-P\u2122 Analysis by BIS Research", "url": "https://www.prnewswire.com/news-releases/global-multicancer-screening-market-to-reach-7-78-billion-by-2032---exclusive-deeptech-m-a-p-analysis-by-bis-research-301810667.html", "time_published": "20230428T151500", "authors": ["BIS Research"], "summary": "Global Multicancer Screening Market to Reach $7.78 Billion by 2032 ... PR ...", "banner_image": "https://mma.prnewswire.com/media/495163/BIS_Research_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.167762, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "KNCAF", "relevance_score": "0.055621", "ticker_sentiment_score": "-0.021001", "ticker_sentiment_label": "Neutral"}, {"ticker": "A", "relevance_score": "0.055621", "ticker_sentiment_score": "-0.021001", "ticker_sentiment_label": "Neutral"}, {"ticker": "GH", "relevance_score": "0.055621", "ticker_sentiment_score": "-0.021001", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTA", "relevance_score": "0.055621", "ticker_sentiment_score": "-0.021001", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLGT", "relevance_score": "0.055621", "ticker_sentiment_score": "-0.021001", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXAS", "relevance_score": "0.055621", "ticker_sentiment_score": "-0.021001", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.055621", "ticker_sentiment_score": "-0.021001", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.055621", "ticker_sentiment_score": "-0.021001", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.055621", "ticker_sentiment_score": "-0.021001", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRA", "relevance_score": "0.055621", "ticker_sentiment_score": "-0.021001", "ticker_sentiment_label": "Neutral"}, {"ticker": "LH", "relevance_score": "0.165788", "ticker_sentiment_score": "-0.029253", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.055621", "ticker_sentiment_score": "-0.021001", "ticker_sentiment_label": "Neutral"}]}, {"title": "Top Stories Friday, Apr. 28: Microsoft Strikes Nware Deal to Woo European Officials Over Activision Acquisition, Lyft Lay-offs Over 1K Employees, Big Oil Earnings - Alibaba Group Holding  ( NYSE:BABA ) , Activision Blizzard  ( NASDAQ:ATVI ) ", "url": "https://www.benzinga.com/news/earnings/23/04/32084110/microsoft-strikes-nware-deal-to-woo-european-officials-over-activision-acquisition-lyft-lay-offs-ov", "time_published": "20230428T140625", "authors": ["Vandana Singh"], "summary": "Microsoft Corp MSFT President Brad Smith tweeted that European cloud gaming platform Nware inked a 10-year agreement to stream PC games built by Xbox on Nware's platform. After the acquisition closes, the deal also includes rights to stream Activision Blizzard, Inc's ATVI titles on Nware's ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/04/28/msft-atvi_0.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.928769"}], "overall_sentiment_score": 0.055216, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BABA", "relevance_score": "0.089797", "ticker_sentiment_score": "0.009817", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.089797", "ticker_sentiment_score": "-0.182935", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CVX", "relevance_score": "0.089797", "ticker_sentiment_score": "-0.260532", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ILMN", "relevance_score": "0.178459", "ticker_sentiment_score": "-0.231197", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NTDOF", "relevance_score": "0.089797", "ticker_sentiment_score": "-0.182935", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LDNXF", "relevance_score": "0.04497", "ticker_sentiment_score": "0.076555", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.089797", "ticker_sentiment_score": "0.260326", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MSFT", "relevance_score": "0.134339", "ticker_sentiment_score": "-0.034278", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNEJF", "relevance_score": "0.178459", "ticker_sentiment_score": "-0.007205", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSSMY", "relevance_score": "0.04497", "ticker_sentiment_score": "0.02573", "ticker_sentiment_label": "Neutral"}, {"ticker": "XOM", "relevance_score": "0.089797", "ticker_sentiment_score": "-0.182935", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ATVI", "relevance_score": "0.089797", "ticker_sentiment_score": "0.027218", "ticker_sentiment_label": "Neutral"}, {"ticker": "DB", "relevance_score": "0.134339", "ticker_sentiment_score": "0.180692", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "First Republic's Troubles Reignite Fears of a Banking Crisis", "url": "https://www.nytimes.com/2023/04/28/business/dealbook/first-republic-deal.html", "time_published": "20230428T121543", "authors": [], "summary": "First Republic Struggles to Find a Deal as Biden Officials Weigh a ... The New York Times ...", "banner_image": "https://static01.nyt.com/images/2023/04/28/multimedia/28db-firstrepublic-cqlm/28db-firstrepublic-cqlm-articleLarge.jpg?quality=75&auto=webp&disable=upscale", "source": "New York Times", "category_within_source": "GoogleRSS", "source_domain": "www.nytimes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Economy - Monetary", "relevance_score": "0.451494"}, {"topic": "Financial Markets", "relevance_score": "0.999186"}, {"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.024211, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.022018", "ticker_sentiment_score": "0.122587", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.022018", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.022018", "ticker_sentiment_score": "-0.015824", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOX", "relevance_score": "0.022018", "ticker_sentiment_score": "-0.145192", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCKRF", "relevance_score": "0.022018", "ticker_sentiment_score": "-0.030641", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.044019", "ticker_sentiment_score": "0.158199", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SSNLF", "relevance_score": "0.022018", "ticker_sentiment_score": "-0.203725", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "OXY", "relevance_score": "0.022018", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MHVYF", "relevance_score": "0.022018", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "XOM", "relevance_score": "0.044019", "ticker_sentiment_score": "-0.018996", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATVI", "relevance_score": "0.022018", "ticker_sentiment_score": "0.00927", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBD", "relevance_score": "0.022018", "ticker_sentiment_score": "0.052836", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSBHF", "relevance_score": "0.022018", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLCNF", "relevance_score": "0.022018", "ticker_sentiment_score": "-0.030641", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBX", "relevance_score": "0.022018", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:EUR", "relevance_score": "0.022018", "ticker_sentiment_score": "-0.231056", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "FDA Warns Cybersecurity Vulnerability For Illumina Sequencers - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/large-cap/23/04/32077477/fda-warns-cybersecurity-vulnerability-for-illumina-sequencers", "time_published": "20230428T115200", "authors": ["Vandana Singh"], "summary": "The FDA issued a letter noting that nearly the entire Illumina Inc's ILMN sequencer lineup carries a cybersecurity vulnerability that could impact genomic data results or even result in a data breach.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/04/28/ilmn.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.233359, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.920196", "ticker_sentiment_score": "-0.374879", "ticker_sentiment_label": "Bearish"}]}, {"title": "Adagene Announces Updates to its Board of Directors - Adagene  ( NASDAQ:ADAG ) ", "url": "https://www.benzinga.com/pressreleases/23/04/g32079215/adagene-announces-updates-to-its-board-of-directors", "time_published": "20230428T110011", "authors": ["Globe Newswire"], "summary": "SAN DIEGO and SUZHOU, China, April 28, 2023 ( GLOBE NEWSWIRE ) -- Adagene Inc. ( \"Adagene\" ) ADAG, a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies today announced updates to its board of directors ( the \"Board\" ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}], "overall_sentiment_score": 0.171178, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GLP", "relevance_score": "0.036812", "ticker_sentiment_score": "0.122811", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.036812", "ticker_sentiment_score": "-0.010569", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADAG", "relevance_score": "0.420316", "ticker_sentiment_score": "0.271898", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Adagene Announces Updates to its Board of Directors", "url": "https://www.globenewswire.com/news-release/2023/04/28/2657314/0/en/Adagene-Announces-Updates-to-its-Board-of-Directors.html", "time_published": "20230428T110000", "authors": ["Adagene Inc."], "summary": "SAN DIEGO and SUZHOU, China, April 28, 2023 ( GLOBE NEWSWIRE ) -- Adagene Inc. ( \"Adagene\" ) ( Nasdaq: ADAG ) , a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies today announced updates to its board of directors ( ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c377318b-edf7-42c0-8e7c-63a02bbe47b0", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.173555, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GLP", "relevance_score": "0.037155", "ticker_sentiment_score": "0.125913", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.037155", "ticker_sentiment_score": "0.006742", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADAG", "relevance_score": "0.423843", "ticker_sentiment_score": "0.196986", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Eli Lilly's Obesity Treatment Hopeful Just Crushed Sales Estimates", "url": "https://www.investors.com/news/technology/eli-lilly-stock-eli-lilly-earnings-q1-2023/", "time_published": "20230427T125700", "authors": ["ALLISON GATLIN", "Investor's Business Daily"], "summary": "Eli Lilly Stock Jumps As Diabetes Newcomer Crushes Sales ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2018/12/stock-Eli-Lilly-02-Shutter.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.744043"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}], "overall_sentiment_score": 0.296207, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LLY", "relevance_score": "0.937588", "ticker_sentiment_score": "0.553125", "ticker_sentiment_label": "Bullish"}, {"ticker": "VKTX", "relevance_score": "0.290607", "ticker_sentiment_score": "0.104201", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMGN", "relevance_score": "0.290607", "ticker_sentiment_score": "0.104201", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.147818", "ticker_sentiment_score": "-0.008306", "ticker_sentiment_label": "Neutral"}]}, {"title": "AbbVie Plunges As Humira Biosimilars Take A 25% Cut", "url": "https://www.investors.com/news/technology/abbvie-stock-abbvie-earnings-q1-2023/", "time_published": "20230427T124600", "authors": ["Investor's Business Daily", "ALLISON GATLIN"], "summary": "AbbVie Stock Crumbles As Humira Biosimilars Take A 25% Cut ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2018/06/stock-AbbVie-04-company.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}], "overall_sentiment_score": 0.212311, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BSX", "relevance_score": "0.159569", "ticker_sentiment_score": "-0.485408", "ticker_sentiment_label": "Bearish"}, {"ticker": "ILMN", "relevance_score": "0.159569", "ticker_sentiment_score": "-0.008732", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.892763", "ticker_sentiment_score": "0.420863", "ticker_sentiment_label": "Bullish"}]}, {"title": "Will Merck's Earnings Beat Give It A Sorely Needed Boost?", "url": "https://www.investors.com/news/technology/merck-stock-merck-earnings-q1-2023/", "time_published": "20230427T103000", "authors": ["Investor's Business Daily", "ALLISON GATLIN"], "summary": "Merck ( MRK ) topped Wall Street's first-quarter forecasts Thursday thanks to blockbusters Keytruda and Gardasil. The results could give Merck stock a much-needed boost. During the March quarter, cancer treatment Keytruda generated nearly $5.8 billion in sales, notching 20% year-over-year ...", "banner_image": "https://www.investors.com/wp-content/uploads/2018/04/stock-Merck-03-shutter.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.744043"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": -0.063437, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.096283", "ticker_sentiment_score": "-0.006719", "ticker_sentiment_label": "Neutral"}]}, {"title": "As Regulators Block Tech Deals, They Increasingly Look to the Future", "url": "https://www.nytimes.com/2023/04/27/technology/regulation-tech-microsoft-activision.html", "time_published": "20230427T090033", "authors": [], "summary": "British regulators cited the newness of the cloud gaming field to block Microsoft's $69 billion acquisition of Activision, a shift in antitrust strategy.", "banner_image": "https://static01.nyt.com/images/2023/04/27/business/27future-antitrust/27future-antitrust-articleLarge.jpg?quality=75&auto=webp&disable=upscale", "source": "New York Times", "category_within_source": "Business", "source_domain": "www.nytimes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": -0.151303, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ATVI", "relevance_score": "0.105759", "ticker_sentiment_score": "-0.138625", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.175348", "ticker_sentiment_score": "0.005948", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.175348", "ticker_sentiment_score": "0.073671", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.105759", "ticker_sentiment_score": "-0.167062", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ILMN", "relevance_score": "0.209668", "ticker_sentiment_score": "-0.180177", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Opinion | The Dark Lesson of the Microsoft-Activision Mess", "url": "https://www.nytimes.com/2023/04/27/opinion/microsoft-activision-ftc-antitrust-grail-eu.html", "time_published": "20230427T090024", "authors": [], "summary": "Congress has given federal regulators broad authority over key areas of our society, and the actions of those regulators often have profound effects on our lives and on our future. We applaud the swift and decisive actions by financial regulators to prevent the run on Silicon Valley Bank from ...", "banner_image": "https://static01.nyt.com/images/2023/04/27/opinion/00Clayton/00Clayton-articleLarge.jpg?quality=75&auto=webp&disable=upscale", "source": "New York Times", "category_within_source": "GoogleRSS", "source_domain": "www.nytimes.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.161481, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ATVI", "relevance_score": "0.081276", "ticker_sentiment_score": "0.022746", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.081276", "ticker_sentiment_score": "0.080168", "ticker_sentiment_label": "Neutral"}, {"ticker": "NYT", "relevance_score": "0.027134", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.027134", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.054236", "ticker_sentiment_score": "0.061988", "ticker_sentiment_label": "Neutral"}]}, {"title": "When Megamergers Fall Apart", "url": "https://www.nytimes.com/2023/04/26/business/dealbook/when-megamergers-fall-apart.html", "time_published": "20230426T233914", "authors": [], "summary": "British officials blocked Microsoft's $69 billion acquisition of Activision, raising the question how often deals fall apart?", "banner_image": "https://static01.nyt.com/images/2023/04/26/business/ma-promo/ma-promo-facebookJumbo.png", "source": "New York Times", "category_within_source": "Dealbook", "source_domain": "www.nytimes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}], "overall_sentiment_score": -0.121806, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AON", "relevance_score": "0.068698", "ticker_sentiment_score": "0.101881", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.136888", "ticker_sentiment_score": "-0.1327", "ticker_sentiment_label": "Neutral"}, {"ticker": "QCOM", "relevance_score": "0.068698", "ticker_sentiment_score": "-0.27273", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ILMN", "relevance_score": "0.068698", "ticker_sentiment_score": "-0.070389", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATVI", "relevance_score": "0.333557", "ticker_sentiment_score": "-0.260213", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SAVE", "relevance_score": "0.068698", "ticker_sentiment_score": "0.054754", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNH", "relevance_score": "0.068698", "ticker_sentiment_score": "0.054754", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's How Much You Would Have Made Owning Illumina Stock In The Last 10 Years - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/earnings/23/04/32019080/heres-how-much-you-would-have-made-owning-illumina-stock-in-the-last-10-years", "time_published": "20230426T190031", "authors": ["Benzinga Insights"], "summary": "Illumina ILMN has outperformed the market over the past 10 years by 2.88% on an annualized basis producing an average annual return of 12.62%. Currently, Illumina has a market capitalization of $33.57 billion.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1092.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.983605", "ticker_sentiment_score": "0.387251", "ticker_sentiment_label": "Bullish"}]}, {"title": "Illumina CEO touts Grail's 100% revenue growth amid proxy fight with Icahn", "url": "https://www.cnbc.com/2023/04/26/illumina-ceo-touts-grail-revenue-amid-proxy-fight-with-icahn-.html", "time_published": "20230426T182652", "authors": ["Annika Kim Constantino"], "summary": "CEO Francis deSouza said San Diego-based Illumina can significantly expand the market for Grail's early cancer screening test.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107231287-16825121301682512126-29187084968-1080pnbcnews.jpg?v=1682513318&w=750&h=422&vtcrop=y", "source": "CNBC", "category_within_source": "Business", "source_domain": "www.cnbc.com", "topics": [{"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.064288, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.745397", "ticker_sentiment_score": "-0.105427", "ticker_sentiment_label": "Neutral"}]}, {"title": "Tech Stocks Lead As Microsoft Surges On Earnings", "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-rise-as-microsoft-surges-on-earnings-tesla-stock-downgrade-facebook-earnings-next/", "time_published": "20230426T141100", "authors": ["Investor's Business Daily", "SCOTT LEHTONEN"], "summary": "Dow Jones Falls On Boeing, Microsoft Earnings. Tesla Stock Slides ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2017/02/stock-wallStreet-1-shutter.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.995921"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.129243, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DKNG", "relevance_score": "0.213048", "ticker_sentiment_score": "0.148012", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.02695", "ticker_sentiment_score": "-0.050812", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.080728", "ticker_sentiment_score": "-0.042439", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.13414", "ticker_sentiment_score": "-0.079897", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.02695", "ticker_sentiment_score": "0.110235", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.107495", "ticker_sentiment_score": "0.056942", "ticker_sentiment_label": "Neutral"}, {"ticker": "CROX", "relevance_score": "0.213048", "ticker_sentiment_score": "0.152436", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LVS", "relevance_score": "0.13414", "ticker_sentiment_score": "0.05901", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKE", "relevance_score": "0.13414", "ticker_sentiment_score": "0.091714", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXN", "relevance_score": "0.02695", "ticker_sentiment_score": "0.110235", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.02695", "ticker_sentiment_score": "0.104022", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.213048", "ticker_sentiment_score": "0.056373", "ticker_sentiment_label": "Neutral"}, {"ticker": "LULU", "relevance_score": "0.05387", "ticker_sentiment_score": "0.108735", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.160633", "ticker_sentiment_score": "-0.154295", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "V", "relevance_score": "0.13414", "ticker_sentiment_score": "0.11003", "ticker_sentiment_label": "Neutral"}, {"ticker": "BA", "relevance_score": "0.02695", "ticker_sentiment_score": "0.110235", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina  ( ILMN )  Q1 Earnings Beat Estimates, Margins Contract", "url": "https://www.zacks.com/stock/news/2084868/illumina-ilmn-q1-earnings-beat-estimates-margins-contract", "time_published": "20230426T132600", "authors": ["Zacks Investment Research"], "summary": "Illumina's (ILMN) Q1 revenues decline year over year, reflecting the impact of Covid-19 monitoring headwinds and the transition of its high-throughput customers to NovaSeq X.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/45/26891.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.918141"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.054438, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PODD", "relevance_score": "0.123844", "ticker_sentiment_score": "0.003498", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSIC", "relevance_score": "0.123844", "ticker_sentiment_score": "0.046875", "ticker_sentiment_label": "Neutral"}, {"ticker": "LNTH", "relevance_score": "0.123844", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.608634", "ticker_sentiment_score": "0.21909", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MYGN", "relevance_score": "0.031079", "ticker_sentiment_score": "-0.006796", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina's Q1 Revenue Drop, Dwindling Margins: Outlines Cost Cutting Plans With $100M Savings - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/earnings/23/04/32005451/illuminas-q1-revenue-drop-dwindling-margins-outlines-cost-cutting-plans-with-100m-savings", "time_published": "20230426T112013", "authors": ["Vandana Singh"], "summary": "In its Q1 earnings release, Illumina Inc ILMN unveiled plans to accelerate margin improvement and create flexibility for further investment in high-growth areas. The company aims to reduce its annualized run rate expenses by more than $100 million starting later this year.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/04/26/ilmn.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.77141"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.014461, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.835692", "ticker_sentiment_score": "0.551506", "ticker_sentiment_label": "Bullish"}]}, {"title": "Illumina  ( ILMN )  Beats Q1 Earnings and Revenue Estimates", "url": "https://www.zacks.com/stock/news/2084569/illumina-ilmn-beats-q1-earnings-and-revenue-estimates", "time_published": "20230425T214512", "authors": ["Zacks Investment Research"], "summary": "Illumina (ILMN) delivered earnings and revenue surprises of 300% and 2.42%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default55.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999992"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.157728, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SABS", "relevance_score": "0.208166", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.402403", "ticker_sentiment_score": "0.173131", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina unveils plans to cut costs as it faces shrinking margins", "url": "https://www.cnbc.com/2023/04/25/illumina-plans-cost-cuts-as-it-faces-shrinking-margins.html", "time_published": "20230425T211324", "authors": ["Annika Kim Constantino"], "summary": "The plans aim to reduce Illumina's annualized run rate expenses by more than $100 million starting later this year.", "banner_image": "https://image.cnbcfm.com/api/v1/image/105747304-1550582214345gettyimages-503696288.jpeg?v=1682332326", "source": "CNBC", "category_within_source": "Earnings", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.067346, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.761617", "ticker_sentiment_score": "0.259504", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina Beats Quarterly Views As Grail Battle Continues", "url": "https://www.investors.com/news/technology/ilmn-stock-illumina-earnings-q1-2023/", "time_published": "20230425T205500", "authors": ["Investor's Business Daily", "ALLISON GATLIN"], "summary": "ILMN Stock: Illumina Narrowly Squeaks Out Quarterly Beat As Grail ... Investor's Business Daily ...", "banner_image": "https://www.investors.com/wp-content/uploads/2021/04/Stock-illumina-01-adobe.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.980922"}], "overall_sentiment_score": 0.211144, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.983211", "ticker_sentiment_score": "0.24996", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "This Is What Whales Are Betting On Illumina - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/markets/options/23/04/31997104/this-is-what-whales-are-betting-on-illumina", "time_published": "20230425T190056", "authors": ["Benzinga Insights"], "summary": "Someone with a lot of money to spend has taken a bearish stance on Illumina ILMN. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.15791, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.720958", "ticker_sentiment_score": "0.166609", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "EXEL or ILMN: Which Is the Better Value Stock Right Now?", "url": "https://www.zacks.com/stock/news/2084353/exel-or-ilmn-which-is-the-better-value-stock-right-now", "time_published": "20230425T154014", "authors": ["Zacks Investment Research"], "summary": "EXEL vs. ILMN: Which Stock Is the Better Value Option?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default300.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.474443, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "EXEL", "relevance_score": "0.76367", "ticker_sentiment_score": "0.548181", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.70749", "ticker_sentiment_score": "0.534154", "ticker_sentiment_label": "Bullish"}]}, {"title": "New Studies on Convergent Genomics' Urine Test for Bladder Cancer to be Presented at 2023 American Urological Association  ( AUA )  Annual Meeting", "url": "https://markets.businessinsider.com/news/stocks/new-studies-on-convergent-genomics-urine-test-for-bladder-cancer-to-be-presented-at-2023-american-urological-association-aua-annual-meeting-1032258990", "time_published": "20230425T143000", "authors": [], "summary": "New Studies on Convergent Genomics' Urine Test for Bladder Cancer to be Presented at 2023 American Urological Association (AUA) Annual Meeting ...", "banner_image": "https://c212.net/c/img/favicon.png?sn=AQ80075&sd=2023-04-25", "source": "Business Insider", "category_within_source": "RSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.041104, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.086245", "ticker_sentiment_score": "-0.018877", "ticker_sentiment_label": "Neutral"}]}, {"title": "GRI Bio  ( NASDAQ: GRI )  Announces Board of Director Appointments Adding Leadership and Expertise Spanning a Combined 75 Years in Both Public and Private Sectors in the Life Sciences Industry", "url": "https://www.globenewswire.com/news-release/2023/04/24/2652685/0/en/GRI-Bio-NASDAQ-GRI-Announces-Board-of-Director-Appointments-Adding-Leadership-and-Expertise-Spanning-a-Combined-75-Years-in-Both-Public-and-Private-Sectors-in-the-Life-Sciences-Ind.html", "time_published": "20230424T120500", "authors": ["GRI Bio", "Inc."], "summary": "LA JOLLA, CA, April 24, 2023 ( GLOBE NEWSWIRE ) -- GRI Bio, Inc. ( NASDAQ: GRI ) ( \"GRI Bio\" or the \"Company\" ) , a biotechnology company advancing an innovative pipeline of Natural Killer T ( \"NKT\" ) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/afba4c8f-7869-4dd7-9134-6b92f69e2de8", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.684621"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.95493"}], "overall_sentiment_score": 0.08804, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.025433", "ticker_sentiment_score": "0.032179", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.025433", "ticker_sentiment_score": "0.032179", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGLS", "relevance_score": "0.025433", "ticker_sentiment_score": "0.032179", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.025433", "ticker_sentiment_score": "0.047183", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRB", "relevance_score": "0.025433", "ticker_sentiment_score": "-0.011965", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROIV", "relevance_score": "0.025433", "ticker_sentiment_score": "0.032179", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLON", "relevance_score": "0.025433", "ticker_sentiment_score": "0.00928", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRTX", "relevance_score": "0.025433", "ticker_sentiment_score": "0.032179", "ticker_sentiment_label": "Neutral"}]}, {"title": "Looking At Illumina's Recent Unusual Options Activity - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/markets/options/23/04/31943954/looking-at-illuminas-recent-unusual-options-activity", "time_published": "20230421T204616", "authors": ["Benzinga Insights"], "summary": "A whale with a lot of money to spend has taken a noticeably bearish stance on Illumina. Looking at options history for Illumina ILMN we detected 21 strange trades. If we consider the specifics of each trade, it is accurate to state that 23% of the investors opened trades with bullish ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.149164, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.733479", "ticker_sentiment_score": "0.05813", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Global Genetic Analysis Market size is expected to reach $22.31 billion by 2028 | Brandessence Market Research", "url": "https://www.prnewswire.com/news-releases/the-global-genetic-analysis-market-size-is-expected-to-reach-22-31-billion-by-2028--brandessence-market-research-301803924.html", "time_published": "20230421T091700", "authors": ["Brandessence Market Research And Consulting Private Limited"], "summary": "The Global Genetic Analysis Market size is expected to reach ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.161647"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.170779, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NTRA", "relevance_score": "0.03319", "ticker_sentiment_score": "0.064881", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTA", "relevance_score": "0.03319", "ticker_sentiment_score": "0.064881", "ticker_sentiment_label": "Neutral"}, {"ticker": "DGX", "relevance_score": "0.03319", "ticker_sentiment_score": "0.064881", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.03319", "ticker_sentiment_score": "0.064881", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.03319", "ticker_sentiment_score": "0.064881", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.03319", "ticker_sentiment_score": "0.064881", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROSGQ", "relevance_score": "0.03319", "ticker_sentiment_score": "0.064881", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPK", "relevance_score": "0.03319", "ticker_sentiment_score": "0.064881", "ticker_sentiment_label": "Neutral"}, {"ticker": "LH", "relevance_score": "0.03319", "ticker_sentiment_score": "0.064881", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERFSF", "relevance_score": "0.03319", "ticker_sentiment_score": "0.064881", "ticker_sentiment_label": "Neutral"}, {"ticker": "PKI", "relevance_score": "0.03319", "ticker_sentiment_score": "0.064881", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:UZS", "relevance_score": "0.03319", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Urges Shareholders to Vote the WHITE Proxy Card FOR all Nine of Illumina's Nominees", "url": "https://www.prnewswire.com/news-releases/illumina-urges-shareholders-to-vote-the-white-proxy-card-for-all-nine-of-illuminas-nominees-301802727.html", "time_published": "20230420T123000", "authors": ["Inc.", "Illumina"], "summary": "Illumina Urges Shareholders to Vote the WHITE Proxy Card FOR all ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1876671/Illumina_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.839681"}, {"topic": "Earnings", "relevance_score": "0.905476"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.227315, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.018397", "ticker_sentiment_score": "0.115324", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCYT", "relevance_score": "0.018397", "ticker_sentiment_score": "0.077042", "ticker_sentiment_label": "Neutral"}, {"ticker": "FATE", "relevance_score": "0.018397", "ticker_sentiment_score": "0.077042", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCSG", "relevance_score": "0.018397", "ticker_sentiment_score": "0.077042", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.371786", "ticker_sentiment_score": "0.241435", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Myriad Genetics  ( MYGN )  Gets Permit to Expand Tumor Testing", "url": "https://www.zacks.com/stock/news/2080924/myriad-genetics-mygn-gets-permit-to-expand-tumor-testing", "time_published": "20230419T125300", "authors": ["Zacks Investment Research"], "summary": "Myriad Genetics (MYGN) and Intermountain Precision Genomics receive the New York State Clinical Laboratory Permit to offer solid tumor testing to patients in all 50 U.S. states.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/37/2337.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.157427, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PODD", "relevance_score": "0.217346", "ticker_sentiment_score": "0.080229", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVNS", "relevance_score": "0.217346", "ticker_sentiment_score": "0.121966", "ticker_sentiment_label": "Neutral"}, {"ticker": "LNTH", "relevance_score": "0.269776", "ticker_sentiment_score": "0.096141", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.054983", "ticker_sentiment_score": "-0.004", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.465196", "ticker_sentiment_score": "0.262038", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Tarsus Pharmaceuticals, Inc.  ( TARS )  Soars 8.6%: Is Further Upside Left in the Stock?", "url": "https://www.zacks.com/stock/news/2080055/tarsus-pharmaceuticals-inc-tars-soars-86-is-further-upside-left-in-the-stock", "time_published": "20230418T100400", "authors": ["Zacks Investment Research"], "summary": "Tarsus Pharmaceuticals, Inc. (TARS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default280.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.253483, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TARS", "relevance_score": "0.524949", "ticker_sentiment_score": "0.365535", "ticker_sentiment_label": "Bullish"}, {"ticker": "ILMN", "relevance_score": "0.524949", "ticker_sentiment_score": "-0.108566", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why You Shouldn't Buy the Dip With Illumina Stock", "url": "https://www.fool.com/investing/2023/04/14/heres-why-you-shouldnt-buy-the-dip-with-illumina-s/", "time_published": "20230414T121000", "authors": ["Alex Carchidi"], "summary": "There aren't many factors driving its growth at the moment.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F727606%2Fwarren-buffett-brka-brkb-berkshire-hathaway-motley-fool2.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.214378"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.158781, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.425746", "ticker_sentiment_score": "0.201749", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Genomics Market to be Worth $72.62 Billion by 2030 - Exclusive Report by Meticulous Research\u00ae", "url": "https://www.benzinga.com/pressreleases/23/04/g31790465/genomics-market-to-be-worth-72-62-billion-by-2030-exclusive-report-by-meticulous-research", "time_published": "20230413T150000", "authors": ["Globe Newswire"], "summary": "Redding, California, April 13, 2023 ( GLOBE NEWSWIRE ) -- According to a new market research report titled, 'Genomics Market by Offering ( Systems, Consumables, Software, Services ) , Technology ( Sequencing, Microarray, PCR ) , Application ( Diagnostics, Life Science Research ) , End User ( ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160332, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.022686", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PACB", "relevance_score": "0.022686", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.045353", "ticker_sentiment_score": "0.090479", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.022686", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.022686", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.022686", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONTTF", "relevance_score": "0.022686", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.022686", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.022686", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "What Does Illumina's Debt Look Like? - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/23/04/31772253/what-does-illuminas-debt-look-like", "time_published": "20230412T154630", "authors": ["Benzinga Insights"], "summary": "Over the past three months, shares of Illumina Inc. ILMN moved higher by 10.93%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": -0.0822, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.358152", "ticker_sentiment_score": "0.018222", "ticker_sentiment_label": "Neutral"}]}, {"title": "Next-Generation Sequencing Data Analysis Market to Reach USD 5.4 Bn by 2032 | Transparency Market Research", "url": "https://www.benzinga.com/pressreleases/23/04/g31770310/next-generation-sequencing-data-analysis-market-to-reach-usd-5-4-bn-by-2032-transparency-market-re", "time_published": "20230412T143000", "authors": ["Globe Newswire"], "summary": "Wilmington, Delaware, United States, April 12, 2023 ( GLOBE NEWSWIRE ) -- The global next-generation sequencing data analysis market was valued at USD 610.6 Mn in 2021 and is projected to reach USD 5.4 Bn by 2032 growing at a CAGR of 16.6%.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.08163, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.03878", "ticker_sentiment_score": "0.066392", "ticker_sentiment_label": "Neutral"}, {"ticker": "PACB", "relevance_score": "0.03878", "ticker_sentiment_score": "0.066392", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.03878", "ticker_sentiment_score": "0.066392", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.03878", "ticker_sentiment_score": "0.066392", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.03878", "ticker_sentiment_score": "0.066392", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.03878", "ticker_sentiment_score": "0.066392", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERFSF", "relevance_score": "0.03878", "ticker_sentiment_score": "0.066392", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina  ( ILMN )  Partners With Henry Ford Health for NGS Test", "url": "https://www.zacks.com/stock/news/2077349/illumina-ilmn-partners-with-henry-ford-health-for-ngs-test", "time_published": "20230412T120100", "authors": ["Zacks Investment Research"], "summary": "Illumina (ILMN) collaborates with Henry Ford Health to conduct a series of studies that is likely to focus on the genetic drivers of cardiovascular disease.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/8e/391.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.207296, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PODD", "relevance_score": "0.222327", "ticker_sentiment_score": "0.081685", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVNS", "relevance_score": "0.275867", "ticker_sentiment_score": "0.09818", "ticker_sentiment_label": "Neutral"}, {"ticker": "LNTH", "relevance_score": "0.275867", "ticker_sentiment_score": "0.103893", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.328091", "ticker_sentiment_score": "0.218957", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Research Antibodies and Reagents Market to Grow at a CAGR of 6.6% | TMR Study", "url": "https://www.benzinga.com/pressreleases/23/04/g31763964/research-antibodies-and-reagents-market-to-grow-at-a-cagr-of-6-6-tmr-study", "time_published": "20230412T103000", "authors": ["Globe Newswire"], "summary": "Wilmington, Delaware, United States, April 12, 2023 ( GLOBE NEWSWIRE ) -- Significance of research antibodies and reagents for a wide range of applications in scientific research is driving the market.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.064978, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.036869", "ticker_sentiment_score": "0.063982", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABCM", "relevance_score": "0.036869", "ticker_sentiment_score": "0.063982", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.036869", "ticker_sentiment_score": "0.063982", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDX", "relevance_score": "0.036869", "ticker_sentiment_score": "0.063982", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.036869", "ticker_sentiment_score": "0.063982", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.036869", "ticker_sentiment_score": "0.063982", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHR", "relevance_score": "0.036869", "ticker_sentiment_score": "0.063982", "ticker_sentiment_label": "Neutral"}, {"ticker": "PKI", "relevance_score": "0.036869", "ticker_sentiment_score": "0.063982", "ticker_sentiment_label": "Neutral"}]}, {"title": "Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow - BeiGene  ( NASDAQ:BGNE ) , Bristol-Myers Squibb  ( NYSE:BMY ) ", "url": "https://www.benzinga.com/general/biotech/23/04/31741766/hillstream-biopharmas-drug-candidate-hsb-1216-could-be-one-to-watch-as-global-oncology-market-con", "time_published": "20230411T122809", "authors": ["Ernest Dela Aglanu"], "summary": "A surge in oncology drug development, coupled with increased patient access and early diagnosis, has resulted in a massive increase in global spending on cancer treatments. Due to this, the global oncology market has been growing at an unprecedented pace over the past few years.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/04/11/shutterstock_1526469227.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.06929, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DD", "relevance_score": "0.156461", "ticker_sentiment_score": "0.071429", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSTK", "relevance_score": "0.052455", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGNE", "relevance_score": "0.104683", "ticker_sentiment_score": "-0.151137", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ILMN", "relevance_score": "0.104683", "ticker_sentiment_score": "-0.151137", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JNJ", "relevance_score": "0.104683", "ticker_sentiment_score": "-0.151137", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CRMD", "relevance_score": "0.104683", "ticker_sentiment_score": "0.05909", "ticker_sentiment_label": "Neutral"}, {"ticker": "HILS", "relevance_score": "0.207571", "ticker_sentiment_score": "0.084366", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.104683", "ticker_sentiment_score": "0.05909", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.104683", "ticker_sentiment_score": "0.05909", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.104683", "ticker_sentiment_score": "-0.151137", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow - BeiGene  ( NASDAQ:BGNE ) , Bristol-Myers Squibb  ( NYSE:BMY ) ", "url": "https://www.benzinga.com/general/biotech/23/04/31741764/hillstream-biopharmas-drug-candidate-hsb-1216-could-be-one-to-watch-as-global-oncology-market-con", "time_published": "20230411T122808", "authors": ["Ernest Dela Aglanu"], "summary": "A surge in oncology drug development, coupled with increased patient access and early diagnosis, has resulted in a massive increase in global spending on cancer treatments. Due to this, the global oncology market has been growing at an unprecedented pace over the past few years.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/04/11/shutterstock_1526469227.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.06929, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "DD", "relevance_score": "0.156461", "ticker_sentiment_score": "0.071429", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSTK", "relevance_score": "0.052455", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGNE", "relevance_score": "0.104683", "ticker_sentiment_score": "-0.151137", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ILMN", "relevance_score": "0.104683", "ticker_sentiment_score": "-0.151137", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JNJ", "relevance_score": "0.104683", "ticker_sentiment_score": "-0.151137", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CRMD", "relevance_score": "0.104683", "ticker_sentiment_score": "0.05909", "ticker_sentiment_label": "Neutral"}, {"ticker": "HILS", "relevance_score": "0.207571", "ticker_sentiment_score": "0.084366", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.104683", "ticker_sentiment_score": "0.05909", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.104683", "ticker_sentiment_score": "0.05909", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.104683", "ticker_sentiment_score": "-0.151137", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Activist investors just had their busiest quarter ever as they looked to capitalize on weak share prices globally", "url": "https://markets.businessinsider.com/news/stocks/stocks-activist-investors-proxy-fights-busiest-quarter-disney-icahn-salesforce-2023-4", "time_published": "20230410T173033", "authors": ["Carla Moz\u00e9e"], "summary": "Activist Investors Mark Busiest Quarter Ever As Share Prices Slump - Markets Insider ...", "banner_image": "https://i.insider.com/5c706bdd2628983a3654dbdb?width=1200&format=jpeg", "source": "Business Insider", "category_within_source": "GoogleRSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": -0.019383, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.166743", "ticker_sentiment_score": "-0.194196", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BCS", "relevance_score": "0.083833", "ticker_sentiment_score": "0.043917", "ticker_sentiment_label": "Neutral"}]}, {"title": "Is There Any Hope for Illumina Stock?", "url": "https://www.fool.com/investing/2023/04/08/is-there-any-hope-for-illumina-stock/", "time_published": "20230408T133700", "authors": ["Alex Carchidi"], "summary": "Being in trouble with regulators in two major markets sure won't help anything.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F727101%2Fbuffett17-tmf.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "0.214378"}], "overall_sentiment_score": -0.060021, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.436009", "ticker_sentiment_score": "0.020556", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina  ( ILMN )  to Expand Genomics Capacity With New Pact", "url": "https://www.zacks.com/stock/news/2075478/illumina-ilmn-to-expand-genomics-capacity-with-new-pact", "time_published": "20230406T133800", "authors": ["Zacks Investment Research"], "summary": "Illumina's (ILMN) recent collaboration is built on the shared goal of the organizations to expand sequencing capabilities and capacity for all people in Africa.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/bc/379.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}], "overall_sentiment_score": 0.214183, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HOLX", "relevance_score": "0.240489", "ticker_sentiment_score": "0.153591", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AVNS", "relevance_score": "0.181591", "ticker_sentiment_score": "0.048776", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSIC", "relevance_score": "0.240489", "ticker_sentiment_score": "-0.047229", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.509035", "ticker_sentiment_score": "0.380517", "ticker_sentiment_label": "Bullish"}]}, {"title": "Carl Icahn says Illumina's appeal of FTC order to divest Grail is 'an almost impossible battle'", "url": "https://www.cnbc.com/2023/04/05/carl-icahn-illumina-appeal-of-ftc-grail-order-is-an-almost-impossible-battle.html", "time_published": "20230405T203358", "authors": ["Annika Kim Constantino"], "summary": "Carl Icahn shares common ground with the FTC, which argued that Illumina's acquisition of cancer test developer Grail would stifle competition and innovation.", "banner_image": "https://image.cnbcfm.com/api/v1/image/101140453-1680725617243-GettyImages-141972353rr.jpg?v=1680726838&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.002433, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PACB", "relevance_score": "0.076602", "ticker_sentiment_score": "-0.126559", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.709804", "ticker_sentiment_score": "0.007767", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina's  ( ILMN )  NovaSeq X Exceeds 200 Order Milestone", "url": "https://www.zacks.com/stock/news/2075013/illuminas-ilmn-novaseq-x-exceeds-200-order-milestone", "time_published": "20230405T155500", "authors": ["Zacks Investment Research"], "summary": "Illumina's (ILMN) NovaSeq X records the strongest pre-launch demand ever witnessed for any instrument.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e6/2371.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}], "overall_sentiment_score": 0.249053, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HOLX", "relevance_score": "0.216376", "ticker_sentiment_score": "0.01165", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVNS", "relevance_score": "0.16317", "ticker_sentiment_score": "0.055985", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSIC", "relevance_score": "0.216376", "ticker_sentiment_score": "-0.051904", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.54984", "ticker_sentiment_score": "0.454593", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bioinformatics Market Revenue to Cross USD 44.9 Bn by 2028 with CAGR of 5.9% | TMR Study", "url": "https://www.benzinga.com/pressreleases/23/04/g31677115/bioinformatics-market-revenue-to-cross-usd-44-9-bn-by-2028-with-cagr-of-5-9-tmr-study", "time_published": "20230405T123000", "authors": ["Globe Newswire"], "summary": "Wilmington, Delaware, United States, April 05, 2023 ( GLOBE NEWSWIRE ) -- According to the exclusive research by Transparency Market Research, the global bioinformatics market was valued USD 24.7 Bn in 2020 and is projected to reach USD 44.9 Bn by 2028 with CAGR of 5.9%.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.227947, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.036983", "ticker_sentiment_score": "0.120418", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.036983", "ticker_sentiment_score": "0.120418", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Unusual Options Activity - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/markets/options/23/04/31667395/illumina-unusual-options-activity", "time_published": "20230404T203104", "authors": ["Benzinga Insights"], "summary": "Someone with a lot of money to spend has taken a bearish stance on Illumina ILMN. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.164693, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.758293", "ticker_sentiment_score": "0.21891", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Signature Bank Insiders Sold More Than $100 Million In Shares", "url": "https://www.benzinga.com/news/23/04/31655780/signature-bank-insiders-sold-more-than-100-million-in-shares", "time_published": "20230404T130348", "authors": ["GRIT Capital"], "summary": "Jamie Dimon is probably hoping a few more banks have trouble so he can scoop up their assets for cheap. Today may be a good day to mute \"Trump\" on your Twitter feeds.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/04/04/tech-daily-ztymiqecyh4-unsplash_2.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.995077"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.051008, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.042122", "ticker_sentiment_score": "0.056732", "ticker_sentiment_label": "Neutral"}, {"ticker": "BX", "relevance_score": "0.042122", "ticker_sentiment_score": "0.328284", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.042122", "ticker_sentiment_score": "-0.092712", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.042122", "ticker_sentiment_score": "-0.265957", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ATVI", "relevance_score": "0.042122", "ticker_sentiment_score": "0.056877", "ticker_sentiment_label": "Neutral"}, {"ticker": "LRLCF", "relevance_score": "0.042122", "ticker_sentiment_score": "0.201859", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SBNY", "relevance_score": "0.042122", "ticker_sentiment_score": "0.143105", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAM", "relevance_score": "0.042122", "ticker_sentiment_score": "-0.097606", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMT", "relevance_score": "0.042122", "ticker_sentiment_score": "-0.036434", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:SHIB", "relevance_score": "0.042122", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:DOGE", "relevance_score": "0.084127", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "FTC shows health care muscle in blocking Illumina-Grail deal", "url": "https://www.axios.com/2023/04/04/ftc-muscle-blocking-illumina-grail", "time_published": "20230404T100000", "authors": ["Tina Reed", "https://www.axios.com/authors/treed"], "summary": "The decision by the Federal Trade Commission to block DNA sequencing giant Illumina's $7.1 billion purchase of Grail puts the focus on how much power one company should wield in the burgeoning cancer detection market.", "banner_image": "https://images.axios.com/XRmzEU3kbooO8Pf8jxcMrL0HTt4=/0x0:1920x1080/1920x1080/2023/04/03/1680554915038.jpg?w=1920", "source": "Axios", "category_within_source": "Markets", "source_domain": "www.axios.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.00483, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GH", "relevance_score": "0.063258", "ticker_sentiment_score": "-0.014093", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.572601", "ticker_sentiment_score": "0.048298", "ticker_sentiment_label": "Neutral"}]}, {"title": "Healthcare Payer Services Market Forecast 2022-2029: Demand, Business Growth, Opportunity, Application, Cost, Sales, Service, End-Use, Size, Top Manufacturers Analysis - Cognizant, EXL, HGS Ltd., Accenture | Brandessence Market Research", "url": "https://www.prnewswire.com/news-releases/healthcare-payer-services-market-forecast-2022-2029-demand-business-growth-opportunity-application-cost-sales-service-end-use-size-top-manufacturers-analysis--cognizant-exl-hgs-ltd-accenture--brandessence-market-re-301789347.html", "time_published": "20230404T084300", "authors": ["Brandessence Market Research And Consulting Private Limited"], "summary": "Healthcare Payer Services Market Forecast 2022-2029: Demand ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}, {"topic": "Earnings", "relevance_score": "0.108179"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.377795, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "NVTA", "relevance_score": "0.035086", "ticker_sentiment_score": "0.143066", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIT", "relevance_score": "0.035086", "ticker_sentiment_score": "0.123504", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.035086", "ticker_sentiment_score": "0.143066", "ticker_sentiment_label": "Neutral"}, {"ticker": "G", "relevance_score": "0.035086", "ticker_sentiment_score": "0.123504", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMO", "relevance_score": "0.035086", "ticker_sentiment_score": "0.143066", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNC", "relevance_score": "0.035086", "ticker_sentiment_score": "0.143066", "ticker_sentiment_label": "Neutral"}, {"ticker": "QGEN", "relevance_score": "0.035086", "ticker_sentiment_score": "0.143066", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACN", "relevance_score": "0.035086", "ticker_sentiment_score": "0.123504", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCSG", "relevance_score": "0.139669", "ticker_sentiment_score": "0.253969", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FOREX:UZS", "relevance_score": "0.035086", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "FTC Overturns Approval of $7 Billion Illumina-Grail Deal", "url": "https://www.fool.com/investing/2023/04/03/ftc-overturns-approval-of-7-billion-illumina-grail/", "time_published": "20230404T000028", "authors": ["The Daily Upside"], "summary": "It's probably too late to put the champagne back in the bottle. Some six months after biotech giant Illumina gained regulatory approval for its...", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F725895%2Fvirtual-reality-goggles-dollar-signs.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.100388, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.09402", "ticker_sentiment_score": "-0.054762", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.712214", "ticker_sentiment_score": "0.057911", "ticker_sentiment_label": "Neutral"}]}, {"title": "FTC orders Illumina to unwind $7B deal for cancer test developer Grail", "url": "https://www.foxbusiness.com/markets/ftc-orders-illumina-unwind-7b-deal-cancer-test-developer-grail", "time_published": "20230403T185038", "authors": [], "summary": "The Federal Trade Commission ( FTC ) on Monday ordered life sciences company Illumina to unwind its $7.1 billion acquisition of cancer detection test developer Grail Inc., citing antitrust concerns.", "banner_image": "https://cf-images.us-east-1.prod.boltdns.net/v1/static/854081161001/a820bb74-640d-46d1-b4f7-2ee0f1eaf32d/97ae7947-a575-4229-a8aa-60815cb36a3c/1280x720/match/image.jpg", "source": "Fox Business News", "category_within_source": "n/a", "source_domain": "www.foxbusiness.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.007389, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.580434", "ticker_sentiment_score": "0.37524", "ticker_sentiment_label": "Bullish"}]}, {"title": "Why Illumina  ( ILMN )  Shares Are Falling Today - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/government/23/04/31638853/ftc-orders-illumina-to-divest-grail-mounts-pressure-on-company-amid-proxy-fight-with-icahn", "time_published": "20230403T174930", "authors": ["Vandana Singh"], "summary": "The Fed\u00ader\u00adal Trade Com\u00admis\u00adsion has or\u00addered Il\u00adlu\u00admi\u00adna Inc ILMN to di\u00advest Grail Inc, saying that the deal would stifle competition and innovation in the U.S. market for cancer tests.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/04/03/ilmn.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.026016, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.598621", "ticker_sentiment_score": "-0.148132", "ticker_sentiment_label": "Neutral"}]}, {"title": "FTC orders Illumina to divest cancer test maker Grail on competition grounds", "url": "https://www.marketwatch.com/story/ftc-orders-illumina-to-divest-grail-illumina-plans-to-appeal-71f76ba3", "time_published": "20230403T173900", "authors": ["Emily Bary", "Ciara Linnane"], "summary": "Illumina acquired Grail in 2021 despite concerns from regulators in the U.S. and Europe. The company will appeal the FTC decision.", "banner_image": "https://images.mktw.net/im-756589/social", "source": "MarketWatch", "category_within_source": "Top Stories", "source_domain": "www.marketwatch.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}], "overall_sentiment_score": 0.031641, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.779861", "ticker_sentiment_score": "0.144628", "ticker_sentiment_label": "Neutral"}]}, {"title": "FTC Orders Biotech Illumina To Unwind Grail Deal Amid Icahn Battle", "url": "https://www.investors.com/news/technology/ilmn-stock-ftc-orders-biotech-illumina-to-unwind-grail-deal-amid-icahn-battle/", "time_published": "20230403T172500", "authors": ["REINHARDT KRAUSE", "Investor's Business Daily"], "summary": "The Federal Trade Commission ordered Monday that biotech firm Illumina ( ILMN ) must unwind its $8 billion purchase of the cancer-testing startup Grail. ILMN stock fell on the news. The FTC order arrives amid activist investor Carl Icahn's battle with the biotech's management.", "banner_image": "https://www.investors.com/wp-content/uploads/2018/10/Stock-Illumina-04-company.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}], "overall_sentiment_score": -0.139263, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EXAS", "relevance_score": "0.227007", "ticker_sentiment_score": "-0.382341", "ticker_sentiment_label": "Bearish"}, {"ticker": "GH", "relevance_score": "0.227007", "ticker_sentiment_score": "-0.382341", "ticker_sentiment_label": "Bearish"}, {"ticker": "ILMN", "relevance_score": "0.939207", "ticker_sentiment_score": "-0.336272", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "U.S. Orders Illumina to Divest Cancer Tester Grail", "url": "https://www.barrons.com/articles/illumina-stock-divest-cancer-tester-grail-ftc-cee3c313", "time_published": "20230403T161500", "authors": ["Bill Alpert"], "summary": "The Federal Trade Commission ordered Monday that the gene-sequencing leader Illumina must unwind its $8 billion purchase of the cancer-testing start-up Grail. The FTC order wasn't much of a surprise. Illumina stock ( ticker: ILMN ) dropped 1.5% to $229, while the Nasdaq Composite was down 1%.", "banner_image": "https://images.barrons.com/im-756452/social", "source": "Barrons", "category_within_source": "n/a", "source_domain": "www.barrons.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.105931, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.998692", "ticker_sentiment_score": "0.193564", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "US FTC orders Illumina to divest cancer detection test maker Grail", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/us-ftc-orders-illumina-divest-cancer-detection-test-maker-grail-2023-04-03/", "time_published": "20230403T152100", "authors": ["Diane Bartz"], "summary": "WASHINGTON, April 3 ( Reuters ) - The U.S. Federal Trade Commission ( FTC ) on Monday ordered Illumina ( ILMN.O ) to divest cancer diagnostic test maker Grail, finding that its ownership would stifle competition in the U.S. market for cancer tests.", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/XI42YQ7T3ZMMLDQUDSYKAH7SFQ.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.07036, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.669956", "ticker_sentiment_score": "-0.143221", "ticker_sentiment_label": "Neutral"}]}, {"title": "FTC orders Illumina to divest $7.1 billion acquisition of cancer test developer Grail", "url": "https://www.cnbc.com/2023/04/03/ftc-orders-illumina-to-divest-grail-acquisition.html", "time_published": "20230403T151123", "authors": ["Annika Kim Constantino"], "summary": "The decision reverses an administrative judge's ruling that dismissed the FTC's initial challenge of Illumina's $7.1 billion Grail deal.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107217800-1680188278361-gettyimages-1246349410-DAVOS_WEF_2023.jpeg?v=1680534683&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.029404, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.542261", "ticker_sentiment_score": "-0.071707", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Will Appeal FTC Decision in Federal Court, Will Seek US Resolution by Late 2023 or Early 2024", "url": "https://www.prnewswire.com/news-releases/illumina-will-appeal-ftc-decision-in-federal-court-will-seek-us-resolution-by-late-2023-or-early-2024-301788509.html", "time_published": "20230403T150800", "authors": ["Illumina", "Inc."], "summary": "Illumina Will Appeal FTC Decision in Federal Court, Will Seek US ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1876671/Illumina_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.295056, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.081001", "ticker_sentiment_score": "0.07224", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.081001", "ticker_sentiment_score": "0.07224", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.639942", "ticker_sentiment_score": "0.635089", "ticker_sentiment_label": "Bullish"}]}, {"title": "FTC Rejects Illumina's $7 Billion Deal for Cancer-Test Developer Grail", "url": "https://www.wsj.com/articles/ftc-rejects-illuminas-7-billion-deal-for-cancer-test-developer-grail-50d2c05c", "time_published": "20230403T144400", "authors": ["Jonathan D. Rockoff and Peter Loftus"], "summary": "The agency said the combination would hurt competition for cancer-detection tests while raising prices.", "banner_image": "https://images.wsj.net/im-756383?width=860&height=574", "source": "Wall Street Journal", "category_within_source": "Business", "source_domain": "www.wsj.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.142948, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.939207", "ticker_sentiment_score": "-0.252824", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Millions will start losing Medicaid coverage as Covid safety net is dismantled", "url": "https://www.cnbc.com/2023/03/31/medicaid-millions-to-lose-coverage-as-covid-safety-net-dismantled.html", "time_published": "20230331T201003", "authors": ["Spencer Kimball"], "summary": "As many as 15 million people stand to lose Medicaid coverage as safety net expansions implemented during the Covid pandemic are dismantled.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107218594-1680277069745-gettyimages-1249984450-LRadin_033023.jpeg?v=1680293403&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.028814, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.087185", "ticker_sentiment_score": "-0.022964", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.043658", "ticker_sentiment_score": "-0.09603", "ticker_sentiment_label": "Neutral"}]}, {"title": "Biden administration appeals Texas court decision striking down free Obamacare coverage of preventive care", "url": "https://www.cnbc.com/2023/03/31/obamacare-biden-appeals-ruling-striking-down-free-preventive-care.html", "time_published": "20230331T180113", "authors": ["Spencer Kimball"], "summary": "The types of preventive services covered under Obamacare can range from screenings for certain types of cancers to HIV prevention drugs.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107218440-16802670962023-03-31t121812z_1595111548_rc2050an5ziz_rtrmadp_0_usa-biden.jpeg?v=1680285673&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.26174, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.163909", "ticker_sentiment_score": "-0.031475", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.082393", "ticker_sentiment_score": "-0.100042", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTX", "relevance_score": "0.082393", "ticker_sentiment_score": "0.05994", "ticker_sentiment_label": "Neutral"}]}, {"title": "Carl Icahn blasts Illumina for nearly doubling CEO's pay despite steep drop in market value", "url": "https://www.cnbc.com/2023/03/31/carl-icahn-blasts-illumina-ceo-pay-raise.html", "time_published": "20230331T161759", "authors": ["Annika Kim Constantino"], "summary": "Activist investor Carl Icahn ramped up his proxy fight against Illumina with a blistering statement.", "banner_image": "https://image.cnbcfm.com/api/v1/image/103940630-20160913-9076-2269.jpg?v=1680279479&w=1920&h=1080", "source": "CNBC", "category_within_source": "Business", "source_domain": "www.cnbc.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.009754, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.771104", "ticker_sentiment_score": "0.012072", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina nearly settled with Icahn", "url": "https://www.axios.com/2023/03/30/illumina-icahn-proxy-fight-jesus-christ", "time_published": "20230330T203748", "authors": ["Michael Flaherty", "https://www.axios.com/authors/mflaherty"], "summary": "Illumina nearly avoided its fight with Carl Icahn via an agreement that would have put one nominee of the veteran activist on the company's board, according to its preliminary proxy filing on Thursday. Driving the news: Talks broke down due to Icahn wanting two seats, as well as additional demands.", "banner_image": "https://images.axios.com/V_gbAdXKHS6lEom5bxGC3ZCkplk=/0x0:6240x3510/1920x1080/2023/03/30/1680206963095.jpg?w=1920", "source": "Axios", "category_within_source": "Markets", "source_domain": "www.axios.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.15254, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.666827", "ticker_sentiment_score": "-0.291985", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Judge strikes down Obamacare coverage of preventive care for cancers, diabetes, HIV and other conditions", "url": "https://www.cnbc.com/2023/03/30/obamacare-judge-overturns-coverage-of-some-preventive-care.html", "time_published": "20230330T165240", "authors": ["Spencer Kimball"], "summary": "Christian businesses sued the government arguing the Obamacare mandate violates their religious freedom because it covers of drugs that prevent HIV infection.", "banner_image": "https://image.cnbcfm.com/api/v1/image/106480933-1586376506660ap_19284211636852.jpg?v=1680196024&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.170893, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.132004", "ticker_sentiment_score": "-0.309976", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PFE", "relevance_score": "0.06623", "ticker_sentiment_score": "-0.098172", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTX", "relevance_score": "0.06623", "ticker_sentiment_score": "0.057499", "ticker_sentiment_label": "Neutral"}]}, {"title": "Icahn, Illumina discussed settlement before proxy fight - filing", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/icahn-illumina-discussed-settlement-before-proxy-fight-filing-2023-03-30/", "time_published": "20230330T165200", "authors": ["Reuters"], "summary": "[1/2] A sign at the front entrance to the global headquarters of Illumina is pictured in San Diego, California, U.S., November 28, 2022. REUTERS/Mike Blake", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/BFX5SBI6BRI3BARC56GHCYUNI4.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}], "overall_sentiment_score": -0.077611, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BBWI", "relevance_score": "0.12546", "ticker_sentiment_score": "0.041423", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.793468", "ticker_sentiment_score": "-0.19253", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "5 Artificial Intelligence ETFs For Investors To Ride The AI Wave - Plus One Bonus Alternative", "url": "https://www.forbes.com/sites/qai/2023/03/30/5-artificial-intelligence-etfs-for-investors-to-ride-the-ai-waveplus-one-bonus-alternative/", "time_published": "20230330T161422", "authors": ["Q.ai - Powering a Personal Wealth Movement"], "summary": "For investors looking to invest in AI, we're going to cover a number of the most popular artificial intelligence ETFs out there.", "banner_image": "https://imageio.forbes.com/specials-images/imageserve/6425b51751f40621dc8ad237/0x0.jpg?format=jpg&width=1200", "source": "Forbes", "category_within_source": "Money", "source_domain": "www.forbes.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Blockchain", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.248516, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PATH", "relevance_score": "0.032513", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TER", "relevance_score": "0.032513", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DE", "relevance_score": "0.032513", "ticker_sentiment_score": "0.06848", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.032513", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "YASKF", "relevance_score": "0.032513", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.032513", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPGP", "relevance_score": "0.032513", "ticker_sentiment_score": "0.159285", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KYCCF", "relevance_score": "0.032513", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.032513", "ticker_sentiment_score": "0.06848", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESLT", "relevance_score": "0.032513", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KDP", "relevance_score": "0.032513", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDNS", "relevance_score": "0.032513", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCZ", "relevance_score": "0.032513", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FANUF", "relevance_score": "0.064973", "ticker_sentiment_score": "0.088092", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.064973", "ticker_sentiment_score": "0.088092", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina urges shareholders to reject Carl Icahn's board nominees as proxy fight heats up", "url": "https://www.cnbc.com/2023/03/30/illumina-urges-shareholders-to-reject-carl-icahns-board-nominees.html", "time_published": "20230330T151439", "authors": ["Annika Kim Constantino"], "summary": "Illumina told shareholders that Carl Icahn's board nominees would \"threaten the progress\" of the biotech company's core business.", "banner_image": "https://image.cnbcfm.com/api/v1/image/103937623-20160913-9058-2268.jpg?v=1680189279&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.031117, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.760593", "ticker_sentiment_score": "-0.095335", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Files Preliminary Proxy, Urging Shareholders to Vote for Its Director Nominees and Withhold for Each Icahn Group Nominee", "url": "https://www.prnewswire.com/news-releases/illumina-files-preliminary-proxy-urging-shareholders-to-vote-for-its-director-nominees-and-withhold-for-each-icahn-group-nominee-301785915.html", "time_published": "20230330T131500", "authors": ["Inc.", "Illumina"], "summary": "Illumina Files Preliminary Proxy, Urging Shareholders to Vote for Its ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1876671/Illumina_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.108864, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.452337", "ticker_sentiment_score": "0.144941", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Files Preliminary Proxy, Urging Shareholders to Vote for Its Director Nominees and Withhold for Each Icahn Group Nominee - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/pressreleases/23/03/n31582866/illumina-files-preliminary-proxy-urging-shareholders-to-vote-for-its-director-nominees-and-withhol", "time_published": "20230330T131500", "authors": ["PRNewswire"], "summary": "SAN DIEGO, March 30, 2023 /PRNewswire/ -- Illumina ILMN, a global leader in DNA sequencing and array-based technologies, today filed its preliminary proxy statement with the Securities and Exchange Commission, which contains important information for shareholders.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.744043"}], "overall_sentiment_score": 0.108842, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.448981", "ticker_sentiment_score": "0.14424", "ticker_sentiment_label": "Neutral"}]}, {"title": "Dueling court cases in Washington state and Texas could determine legality of abortion pill", "url": "https://www.cnbc.com/2023/03/29/abortion-pill-dueling-court-cases-could-determine-legality-of-mifepristone.html", "time_published": "20230329T184235", "authors": ["Spencer Kimball"], "summary": "A hearing in Spokane place took place Tuesday as a judge in Texas is expected to rule in another case that threatens to pull the abortion pill from the market.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107192675-16760408802023-01-12t064527z_1294207122_rc2hoy9d7bbg_rtrmadp_0_usa-abortion-pill-legal.jpeg?v=1680115355&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.007259, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.030524", "ticker_sentiment_score": "-0.208088", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PFE", "relevance_score": "0.030524", "ticker_sentiment_score": "-0.091531", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTX", "relevance_score": "0.030524", "ticker_sentiment_score": "0.05537", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.030524", "ticker_sentiment_score": "0.235817", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Illumina  ( ILMN )  to Enable Tertiary Analysis With New Launch", "url": "https://www.zacks.com/stock/news/2072012/illumina-ilmn-to-enable-tertiary-analysis-with-new-launch", "time_published": "20230329T160800", "authors": ["Zacks Investment Research"], "summary": "Illumina's (ILMN) Connected Software is an end-to-end software system that standardizes analysis tools and connects data across the genomics workflow.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/41/899.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.891286"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}], "overall_sentiment_score": 0.10886, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "HOLX", "relevance_score": "0.191549", "ticker_sentiment_score": "0.139162", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVNS", "relevance_score": "0.144275", "ticker_sentiment_score": "0.051898", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSIC", "relevance_score": "0.191549", "ticker_sentiment_score": "-0.047234", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.328611", "ticker_sentiment_score": "0.162963", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Illumina  ( ILMN )  Shares Are Soaring Today - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/23/03/31548961/whats-the-similiarity-between-disney-and-illumina-billionaire-activist-investor-wanted-retired-ceo-t", "time_published": "20230329T144906", "authors": ["Vandana Singh"], "summary": "After launching a proxy battle against Illumina Inc ILMN, activist investor Carl Icahn has clarified that he wants management change with former CEO Jay Flatley to come back and Grail divested.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/03/29/ilmn.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.035506, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.696319", "ticker_sentiment_score": "-0.132075", "ticker_sentiment_label": "Neutral"}]}, {"title": "Carl Icahn wants to bring back Illumina's ex-CEO 'immediately' as proxy fight intensifies", "url": "https://www.cnbc.com/2023/03/29/carl-icahn-wants-to-bring-back-illuminas-ex-ceo-immediately.html", "time_published": "20230329T142410", "authors": ["Annika Kim Constantino"], "summary": "Icahn said Illumina should bring back former CEO Jay Flatley, saying current management is making the mistake of holding onto the $7.1 billion Grail deal.", "banner_image": "https://image.cnbcfm.com/api/v1/image/103937645-20160913-9095-2269.jpg?v=1680099850&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.021693, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.744851", "ticker_sentiment_score": "0.082944", "ticker_sentiment_label": "Neutral"}]}, {"title": "FDA approves over-the-counter sales of lifesaving opioid overdose treatment Narcan nasal spray", "url": "https://www.cnbc.com/2023/03/29/opioids-fda-approves-over-the-counter-sales-of-narcan-.html", "time_published": "20230329T125400", "authors": ["Spencer Kimball"], "summary": "The FDA's decision means people will be able to buy the 4mg nasal spray without a prescription in supermarkets, convenience stores and vending machines.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107216311-1680014523042-gettyimages-1248283971-YouthOverdoses.jpeg?v=1680094440&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.004876, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.113866", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.113866", "ticker_sentiment_score": "-0.20938", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BNTX", "relevance_score": "0.057079", "ticker_sentiment_score": "0.056603", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.057079", "ticker_sentiment_score": "0.094943", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.057079", "ticker_sentiment_score": "0.246002", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Carl Icahn wants to bring back Illumina's ex-CEO -WSJ", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/carl-icahn-wants-bring-back-illuminas-ex-ceo-wsj-2023-03-29/", "time_published": "20230329T121900", "authors": ["Reuters"], "summary": "Carl Icahn wants to bring back ...", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/BFX5SBI6BRI3BARC56GHCYUNI4.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}], "overall_sentiment_score": -0.049261, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BBWI", "relevance_score": "0.183895", "ticker_sentiment_score": "0.193174", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ILMN", "relevance_score": "0.896455", "ticker_sentiment_score": "-0.091386", "ticker_sentiment_label": "Neutral"}]}, {"title": "News Exclusive | Carl Icahn Wants to Bring Illumina's Old CEO Back, Disney-Style", "url": "https://www.wsj.com/articles/carl-icahn-wants-to-bring-illuminas-old-ceo-back-disney-style-3a6a6279", "time_published": "20230329T113200", "authors": ["David Wainer"], "summary": "The billionaire activist, who has launched a proxy battle at Illumina, wants change at the management level too, and he has a candidate in mind for the top spot: former CEO Jay Flatley.", "banner_image": "https://images.wsj.net/im-753165/social", "source": "Wall Street Journal", "category_within_source": "Markets", "source_domain": "www.wsj.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.057605, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.629492", "ticker_sentiment_score": "0.087346", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks With Rising Relative Strength: Illumina", "url": "https://www.investors.com/ibd-data-stories/stocks-with-rising-relative-strength-illumina-2/", "time_published": "20230327T070000", "authors": ["INVESTOR'S BUSINESS DAILY", "Investor's Business Daily"], "summary": "On Monday, Illumina ( ILMN ) received an upgrade to its Relative Strength ( RS ) Rating, from 69 to 79. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength. IBD's unique rating measures market leadership with a 1 ( worst ) to 99 ( best ...", "banner_image": "https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg", "source": "Investors Business Daily", "category_within_source": "n/a", "source_domain": "www.investors.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.260709, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NTRA", "relevance_score": "0.33628", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.722944", "ticker_sentiment_score": "0.265291", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TMO", "relevance_score": "0.33628", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Illumina Issues Statement in Response to Carl Icahn's Letter", "url": "https://www.prnewswire.com/news-releases/illumina-issues-statement-in-response-to-carl-icahns-letter-301781202.html", "time_published": "20230324T195900", "authors": ["Illumina", "Inc."], "summary": "SAN DIEGO, March 24, 2023 /PRNewswire/ -- Illumina, Inc. ( NASDAQ: ILMN ) , a global leader in DNA sequencing and array-based technologies, issued the following statement in response to a letter from Carl Icahn dated March 24, 2023:", "banner_image": "", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.134617, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.457859", "ticker_sentiment_score": "0.181415", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Carl Icahn claims Illumina directors got extra insurance to close 'disastrous' $7.1 billion Grail deal", "url": "https://www.cnbc.com/2023/03/24/carl-icahn-illumina-directors-got-extra-insurance-to-close-grail-deal.html", "time_published": "20230324T161915", "authors": ["Annika Kim Constantino"], "summary": "Carl Icahn claims Illumina directors demanded extra personal liability insurance before the biotech company signed off on a $7.1 billion acquisition of Grail ...", "banner_image": "https://image.cnbcfm.com/api/v1/image/106868162-1618431044008-coinbasefix.png?v=1679668796", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}, {"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}], "overall_sentiment_score": -0.041278, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.693907", "ticker_sentiment_score": "-0.03835", "ticker_sentiment_label": "Neutral"}]}, {"title": "Individual Stock Picks As The Fed Tightens Financial Conditions Further Despite Banking Stress - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/23/03/31493689/individual-stock-picks-as-the-fed-tightens-financial-conditions-further-despite-banking-stress", "time_published": "20230324T153223", "authors": ["Bill Baruch"], "summary": "We provide free access to the episode's chart pack, including all of the data discussed. Illumina's ILMN stock has been cut in half since making a double top in 2021. At a 155 NTM P/E, the stock is not cheap after making a loss over the trailing twelve-month period ( resulting in a -7.7 TTM P/E ) ...", "banner_image": "https://cdn.benzinga.com/files/triple_play_4.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.138113, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "INTU", "relevance_score": "0.226301", "ticker_sentiment_score": "0.094555", "ticker_sentiment_label": "Neutral"}, {"ticker": "PXD", "relevance_score": "0.152018", "ticker_sentiment_score": "0.106601", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.226301", "ticker_sentiment_score": "0.021488", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOW", "relevance_score": "0.076358", "ticker_sentiment_score": "0.081882", "ticker_sentiment_label": "Neutral"}]}, {"title": "World TB Day 2023: Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa", "url": "https://www.prnewswire.com/apac/news-releases/world-tb-day-2023-illumina-and-genoscreen-launch-next-generation-sequencing-innovation-to-eliminate-tuberculosis-in-africa-301780665.html", "time_published": "20230324T152453", "authors": ["Illumina"], "summary": "World TB Day 2023: Illumina and GenoScreen Launch Next ... PR ...", "banner_image": "https://mma.prnewswire.com/media/2038930/3952437/illumina_logo_pumpkin.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.064927, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.046273", "ticker_sentiment_score": "0.070854", "ticker_sentiment_label": "Neutral"}, {"ticker": "META", "relevance_score": "0.046273", "ticker_sentiment_score": "0.070854", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.398499", "ticker_sentiment_score": "0.107371", "ticker_sentiment_label": "Neutral"}]}, {"title": "Top Stories Friday, Mar. 24: Binance Suspends Trading, Twitter To Remove Legacy Verified Checkmarks", "url": "https://www.benzinga.com/general/biotech/23/03/31491362/binance-suspends-trading-european-bank-trouble-twitter-to-remove-legacy-verified-checkmarks-today", "time_published": "20230324T134448", "authors": ["Vandana Singh"], "summary": "Deutsche Bank AG DB shares came under pressure following a spike in credit default swaps amid persistent concerns regarding the stability of European banks.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/03/24/binance-photo_by_primakov_on_shutterstock.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.977154"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.041141, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MSFT", "relevance_score": "0.152741", "ticker_sentiment_score": "0.115613", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAPL", "relevance_score": "0.076724", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "OUST", "relevance_score": "0.152741", "ticker_sentiment_score": "-0.148686", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.076724", "ticker_sentiment_score": "0.008265", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFG", "relevance_score": "0.076724", "ticker_sentiment_score": "-0.092062", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.152741", "ticker_sentiment_score": "-0.224198", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ATVI", "relevance_score": "0.114865", "ticker_sentiment_score": "0.052198", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.076724", "ticker_sentiment_score": "0.058622", "ticker_sentiment_label": "Neutral"}, {"ticker": "DB", "relevance_score": "0.076724", "ticker_sentiment_score": "0.004337", "ticker_sentiment_label": "Neutral"}, {"ticker": "SQ", "relevance_score": "0.114865", "ticker_sentiment_score": "0.046858", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMT", "relevance_score": "0.076724", "ticker_sentiment_score": "0.144882", "ticker_sentiment_label": "Neutral"}]}, {"title": "Carl Icahn Steps Up Battle With Illumina, Says Directors Asked Additional Insurance For Grail Deal - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/large-cap/23/03/31490112/carl-icahn-steps-up-battle-with-illumina-says-directors-asked-additional-insurance-for-grail-deal", "time_published": "20230324T131825", "authors": ["Vandana Singh"], "summary": "Activist Carl Icahn reportedly accused Illumina Inc ILMN directors of demanding extra personal liability insurance before agreeing to close the $8 billion purchase of cancer screening company Grail Inc as regulators were against the deal.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/03/24/ilmn_logo_light__2e301674e19c42aeac379ecbe6cd5f8c.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.063796, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.859085", "ticker_sentiment_score": "-0.138642", "ticker_sentiment_label": "Neutral"}]}, {"title": "Icahn claims Illumina directors got insurance to close Grail deal -FT", "url": "https://www.reuters.com/markets/deals/icahn-claims-illumina-directors-got-insurance-close-grail-deal-ft-2023-03-24/", "time_published": "20230324T072000", "authors": ["Reuters"], "summary": "Icahn claims Illumina directors got insurance to close Grail deal ...", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/FKA4GFPZHNOYVOYCH6VMMN4AXE.jpg", "source": "Reuters", "category_within_source": "Markets", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.041181, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.682689", "ticker_sentiment_score": "-0.144925", "ticker_sentiment_label": "Neutral"}]}, {"title": "A Look Into Illumina's Debt - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/news/23/03/31463712/a-look-into-illuminas-debt", "time_published": "20230322T194622", "authors": ["Benzinga Insights"], "summary": "Shares of Illumina Inc. ILMN rose by 16.97% in the past three months. Before having a look at the importance of debt, let's look at how much debt Illumina has. Based on Illumina's balance sheet as of February 17, 2023, long-term debt is at $1.49 billion and current debt is at $1.25 billion, ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": -0.125176, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.398148", "ticker_sentiment_score": "0.030854", "ticker_sentiment_label": "Neutral"}]}, {"title": "Moderna CEO Stephane Bancel defends fivefold price hike of Covid vaccine during Senate grilling", "url": "https://www.cnbc.com/2023/03/22/moderna-ceo-stephane-bancel-defends-fivefold-price-hike-of-covid-vaccine-during-senate-grilling.html", "time_published": "20230322T180914", "authors": ["Spencer Kimball"], "summary": "Bernie Sanders pressed Stephane Bancel during the Senate hearing to make a commitment that Moderna will not increase the vaccine's list price to $130.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107213219-16794981331679498131-28690746219-1080pnbcnews.jpg?v=1679498378&w=750&h=422&vtcrop=y", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}], "overall_sentiment_score": 0.107514, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.325515", "ticker_sentiment_score": "-0.125351", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.047844", "ticker_sentiment_score": "-0.155748", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NVO", "relevance_score": "0.047844", "ticker_sentiment_score": "-0.233839", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PFE", "relevance_score": "0.095517", "ticker_sentiment_score": "0.052039", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.047844", "ticker_sentiment_score": "-0.233839", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": " ( ILMN )  - Analyzing Illumina's Short Interest - Illumina  ( NASDAQ:ILMN ) ", "url": "https://www.benzinga.com/short-sellers/23/03/31461604/ilmn-analyzing-illuminas-short-interest", "time_published": "20230322T173055", "authors": ["Benzinga Insights"], "summary": "Illumina's ILMN short percent of float has risen 6.04% since its last report. The company recently reported that it has 4.34 million shares sold short, which is 3.16% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.4 days to cover their ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5520.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.267375, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ILMN", "relevance_score": "0.224903", "ticker_sentiment_score": "0.158881", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Watch live: Moderna CEO Stephane Bancel testifies before Senate on Covid vaccine price hike", "url": "https://www.cnbc.com/2023/03/22/watch-live-moderna-ceo-stephane-bancel-testifies-before-senate-on-covid-vaccine-price-hike.html", "time_published": "20230322T141830", "authors": ["Spencer Kimball"], "summary": "The Boston biotech company plans to charge $130 per dose once the vaccination program moves to the private market as early as this fall.", "banner_image": "https://image.cnbcfm.com/api/v1/image/106528250-1588939822963gettyimages-1192157964.jpeg?v=1679494710&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.146462, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.273807", "ticker_sentiment_score": "0.026601", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.092927", "ticker_sentiment_score": "-0.16427", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NVO", "relevance_score": "0.092927", "ticker_sentiment_score": "-0.246616", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PFE", "relevance_score": "0.184598", "ticker_sentiment_score": "0.074065", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.092927", "ticker_sentiment_score": "-0.246616", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Potentially deadly fungus Candida auris is spreading at an 'alarming rate,' CDC says", "url": "https://www.cnbc.com/2023/03/21/candida-auris-fungus-resistant-to-drugs-spreading-rapidly-cdc-says.html", "time_published": "20230321T185755", "authors": ["Spencer Kimball"], "summary": "Candida auris was limited to New York City and Chicago, but has since been detected in more than half of U.S. states and has become endemic in some areas.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107212450-1679413772206-gettyimages-1219040692-941_04_bsip_015899_022.jpeg?v=1679425075&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}], "overall_sentiment_score": -0.053392, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "COST", "relevance_score": "0.046999", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.046999", "ticker_sentiment_score": "-0.15554", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NVO", "relevance_score": "0.046999", "ticker_sentiment_score": "-0.233609", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PFE", "relevance_score": "0.093836", "ticker_sentiment_score": "0.051766", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.046999", "ticker_sentiment_score": "-0.233609", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "WMT", "relevance_score": "0.046999", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Texas judge could invoke 1873 Comstock Act to roll back mail delivery of abortion pill mifepristone", "url": "https://www.cnbc.com/2023/03/21/abortion-pill-texas-judge-could-invoke-comstock-act-to-roll-back-mail-delivery.html", "time_published": "20230321T144317", "authors": ["Spencer Kimball"], "summary": "U.S. Judge Matthew Kacsmaryk raised the Comstock Act repeatedly in last week's hearing for the case challenging FDA approval of mifepristone.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107174439-1672928072887-gettyimages-1241524355-AFP_32D82WV.jpeg?v=1679409797&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}], "overall_sentiment_score": 0.065108, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CVS", "relevance_score": "0.02849", "ticker_sentiment_score": "-0.181032", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "COST", "relevance_score": "0.02849", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.02849", "ticker_sentiment_score": "-0.147026", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.056943", "ticker_sentiment_score": "-0.185989", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PFE", "relevance_score": "0.056943", "ticker_sentiment_score": "0.048108", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.02849", "ticker_sentiment_score": "-0.223281", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "WMT", "relevance_score": "0.02849", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Biden signs legislation to declassify certain intelligence on Covid pandemic origins", "url": "https://www.cnbc.com/2023/03/20/covid-origins-biden-signs-bill-to-declassify-intelligence-on-wuhan-lab.html", "time_published": "20230320T214806", "authors": ["Spencer Kimball"], "summary": "Biden signed legislation requiring the declassification of information on any possible links between a lab in China and the origins of the Covid-19 pandemic.", "banner_image": "https://image.cnbcfm.com/api/v1/image/107211804-16793383412023-03-20t173604z_745872913_rc2sxz9uxhrd_rtrmadp_0_usa-biden.jpeg?v=1679348886&w=1920&h=1080", "source": "CNBC", "category_within_source": "Top News", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.055498, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "COST", "relevance_score": "0.080728", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.080728", "ticker_sentiment_score": "-0.160136", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NVO", "relevance_score": "0.160633", "ticker_sentiment_score": "-0.246474", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MRNA", "relevance_score": "0.080728", "ticker_sentiment_score": "0.123269", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.238913", "ticker_sentiment_score": "-0.065765", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.080728", "ticker_sentiment_score": "-0.24028", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "WMT", "relevance_score": "0.080728", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}]}